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DUODENUM-PRESERVING
PANCREATIC HEAD RESECTION AND
RESECTION OF THE HEAD OF THE
PANCREAS COMBINED WITH
SEGMENTAL DUODENECTOMY
I. Kozlov, A. Smirnov and A. Chzao
A Vishnevsky Institute of Surgery, Russia
Introduction: To estimate possibility of performance of
the organ-preserving pancreatic resections as alterna-
tives to pancreaticoduodenectomy.
Method: Thirty-one patients underwent duodenum-pre-
serving pancreatic head resection (DPPHR) and pan-
creatic head resection combined with segmental
duodenectomy (PHRSD). DPPHR was performed in
16 patients with a preoperative diagnosis of serous
(n = 6) and mucinous (n = 5) cystadenomas, branch-
duct intraductal papillary mucinous tumors (n = 4),
neuroendocrine adenoma (n = 1). Alimentary tract
reconstruction after DPPHR was performed by pancre-
atojejunostomy (Roux-en-Y) (n = 14) and pancreatoga-
strostomy (1). Double pancreatojejunostomy (n = 1)
was performed after laparoscopic proximal pancreatec-
tomy combined with medial pancreatectomy in multifo-
cal IPMN-BD. Laparoscopic approach was chosen in 3
cases from all DPPHR.
PHRSD was performed in 15 patients with chronic pan-
creatitis complicated by duodenal dystrophy. Alimentary
tract reconstruction was performed in all patients by
duodenoduodenostomy combined with pancreaticojejun-
ostomy and choledochojejunostomy (n = 6)–first option,
pancreatogastrostomy and choledochoduodenostomy
(n = 8)–second option, pancreaticooduodenostomy
duct-to-mucosa and choledochoduodenostomy (n = 1)–
third option. Choledochoduodenostomy was carried out
below the duodenoduodenostomy level always.
Results: No differences were noted in the mean opera-
tion time and estimated blood loss between the 2 proce-
dures. Ischemia of duodenum didn’t note in 1 case of
DPPHR. Careful attention paid to superior posterior
pancreatico-duodenal artery preservation when per-
forming DPPHR. Major postoperative complication
constituted the following: bile duct stricture (n = 2) in
DPPHR delayed gastric emptying (n = 2) and postop-
erative bleeding (n = 1) in PHRSD. Newly developed
diabetes mellitus occurred in 1 patient. Exocrine pan-
creatic insufficiency was observed in 2 patients after
PHRSD. There was no hospital or long-term mortality.
Conclusions: DPPHR is recommended first for a benign
or low-grade pancreatic head lesion. PHRSD is a safe
and reasonable technique appropriate for selected
patients with chronic pancreatitis complicated by duode-
nal dystrophy. We found benign periampullary lesions
could be conservatively treated with DPPHR and
PHRSD, which could substitute for classic pancreatico-
duodenectomy.
PPP24-002
THE NEW SCORING SYSTEM
EVALUATION FOR RISK ASSESSMENT
OF MALIGNANCY IN BRANCH DUCT
INTARDUCTAL PAPILLARY
MUCINOUS NEOPLASMS
I. Yoshioka, K. Shibuya, K. Matsui, S. Sawada,
I. Hashimoto, S. Hojo, T. Okumura, T. Yoshida,
T. Nagata and K. Tsukada
University of Toyama, Japan
Introduction: Considering high incidences of malignant/
invasive lesion in main duct intraductal papillary
mucinous neoplasms, surgical resection is strongly rec-
ommended. On the other hand, indication of resection
is still controversial in branch duct intraductal papillary
mucinous neoplasm (BD-IPMN), because of the diffi-
culty of evaluation of malignancy. The purpose of this
study is to examine the characteristics of resected BD-
IPMN in our institution and the selection for surgical
resection.
Method: Nineteen patients having a surgical pathology
specimen showing BD-IPMN were retrospectively
reviewed between 1998 and 2012. Patient- and disease-
specific information including demographics, presenta-
tion, diagnostic workup, operative procedures and
pathology were abstracted from the patient’s medical
record in a retrospective fashion.
Results: The groups were divided based on their
pathology into benign in 47% (9/19), high-grade dys-
plasia (HGD) (including carcinoma in situ) in 21% (4/
19), and invasive cancer in 32% (6/19).To evaluate
malignant potential, we were scored cystic lesion size,
mural nodule size and diameter of main pancreatic duct
of the BD-IPMN cases as follows: cystic lesion size is
<29 mm in 0 point, 30–49 mm in 1 point and >50 mm
in 2 point. Mural nodule size is <2 mm in 0 point, 3–
5 mm in 1 point and 6 mm in 2 point. Diameter of
main pancreatic duct is <4 mm in 0 point, 5–8 mm in 1
point and >9 mm in 2 point. By summing the each
point, 0–2 points is grade A, 3–4 points is grade B and
5–6 points is grade C. Eight cases of benign were
included in grade A, one case of benign, 4 cases of
HGD and 1 case of invasive cancer were included in
grade B and 1 case of HGD and 3 cases of invasive
cancer were included in grade C (the v2 test,
p = 0.007).
Conclusions: Our scoring system using three indepen-
dent factors may be helpful for predicting of BD-
IPMN.
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CONSERVATIVE TREATMENT AND
PERCUTANEOUS CATHETER
DRAINAGE IMPROVE OUTCOME OF
NECROTIZING PANCREATITIS
S. Junjun, L. Weifeng, Q. Shifang and Y. Yanhui
He First Affiliated Hospital of Henan University of
Science and Technology, China
Introduction: Surgical intervention in necrotizing pan-
creatitis (NP) is associated with high mortality. Guide-
lines recommend fine needle aspiration (FNA) in
patients with NP and signs of sepsis. Because infection
of necrosis is considered an indication for surgery,
operations are often performed early. We changed
treatment toward a conservative approach with percu-
taneous catheter drainage (PCD) in NP, thereby reduc-
ing the rate of open surgery and mortality.
Method: Retrospectively analyzed patients who were
operated on for FNA-proven infection of NP (n = 22,
group 1) were compared to patients subjected to con-
servative treatment along with PCD in NP (n = 30,
group 2) who were followed prospectively.
Results: On admission, between these 2 groups, most
baseline data did not show any statistical difference,
including age, gender, etiology, body mass index
(BMI), C-reactive protein (CRP) level, Acute Physiol-
ogy and Chronic Health Evaluation II score (APACHE
II), Balthazar computed tomography [CT] score. In
group 2, all 30 patients were implemented maximum
conservative treatment, 25 of 30 patients were cured by
PCD (83.3%), open necrosectomy were needed for 3
patients (10.0%) and 2 dead during hospitalization
(6.7%).Whereas, in group 1, surgical operation rate
was 45.6% and hospital mortality 31.8%, both of the
ratios were differed significantly compared with group
2, 45.6% vs 10%, p = 0.008, 31.8% vs 6.7%; p = 0.027
respectively. Furthemore, Hospital stay were signifi-
cantly higher in group 1 compared with the group 2
(39  13.4 vs 90  18.5; p = 0.033).
Conclusions: A conservative approach with PCD as the
first choice to treatment NP might decrease the rate of
surgical operation and mortality compared with previ-
ous serial FNA and consecutive indication for surgery
in case of proven infection. In addition, Employing
PCD to treatment NP is effective and secure.
PPP24-004
PANCOMINE: A MULTI-OMICS
DATABASE FOR PANCREATIC CANCER
S.Y. Lee1, M.-S. Kwon1, S.H. Kim2, J.S. Park3,
J.Y. Park3, Y.H. Choi3, J.-Y. Jang2 and T.S. Park1
1Seoul National University, Korea; 2Seoul National
University Hospital, Korea; 3SK Telecom, Korea
Introduction: Pancreatic cancer is a malignant neo-
plasm that originated from the cells in pancreatic tis-
sues. Due to its high mortality and late diagnosis,
broad biological aspects about the pancreatic cancer
have been investigated. Despite the numerous recent
investigations of pancreatic cancer, there is no database
available for PDAC which provides a comprehensive
view of biological aspects. The comprehensive investi-
gation for previously studied candidates is hard to
achieve without careful data mining by hand.
Method: In order to overcome those limitations, we
present Pancomine in this paper, a multi-omics data-
base for pancreatic cancer, which is a fully user-con-
trollable and visualized database for the integrated
information mining about pancreatic cancer. Basically,
Pancomine is a database of previously published data-
sets produced by microarray or NGS technology. In
addition, Pancomine provides a comprehensive compar-
ison across the studies, a genetic candidates the previ-
ously published multi-omics data that produced by
microarray and NGS technology, and also is able to
visualize those results by using many informative plots;
such as, heatmap, pairwise scatter plot and parallel
coordinate plot.
Results: As a result, we constructed Pancomine by
gathering several public omics experiment results from
pancreatic cancer and developing visualization methods
to show the results more intuitively.
Conclusions: We expect Pancomine to be great database
for a preliminary investigation of pancreatic cancer.
PPP24-005
ASSOCIATION OF INTEGRIN BETA4
(ITGB4) GENE POLYMORPHISM WITH
PANCREATIC ADENOCARCINOMA
S.R. Mohebbi, P. Azimzadeh, S. Romani,
S. Kazemian, N. Ebrahimi, H.A. Aghdaei,
A.H.M. Alizadeh and M.R. Zali
Gastroenterology and Liver Diseases Research Center,
Shahid Beheshti University of Medical Sciences, Iran
Introduction: Pancreas cancer (PC) is a multifactorial
disease. Genetic background and variations occurred in
specific genes’ sequence could affect the susceptibility of
individuals to PC development. The aim of our study
was to determine the role of single nucleotide polymor-
phisms of three cancer related genes including CDKN2A,
ITGB4 and IL-16 in risk of PC development.
Method: A total of 243 individuals including 104
known pancreatic ductal adenocarcinoma patients and
139 healthy controls were subjected for the study. Four
selected single nucleotide polymorphisms (SNP) were
genotyped using polymerase chain reaction (PCR)-
restriction fragment length polymorphism (RFLP)
method.
Results: The case and control groups were consisted of
104 Iranian patients (61 male and 43 female, mean
age = 62.4  13.4) and 139 healthy controls (75 male
and 64 female, mean age = 48.4  16.6) respectively.
Our results showed a significant difference between
genotype distribution of ITGB4 gene polymorphism
(rs743554) among PC patients and healthy control sub-
jects.
Conclusions: Integrin beta-4 also identified as CD104
(Cluster of Differentiation 104) and mediates cell-
matrix and cell-cell adhesion in all cell types especially
in cancerous cells. Our results suggest that ITGB4 gene
rs743554 polymorphism is significantly associated with
increasing risk of pancreas cancer among our popula-
tion.
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PPP24-006
INVASION OF THE SPLENIC ARTERY
IS A PROGNOSTIC FACTOR AFTER
DISTAL PANCREATECTOMY FOR
PANCREATIC CANCER OF THE BODY
AND TAIL
Keinosuke Ishido1, Yoshikazu Toyoki1, Daisuke
Kudo1, Norihisa Kimura1, Taiichi Wakiya1, Daichi
Ichinohe1 and Kenichi Hakamada1
1Hirosaki University Graduate School of Medicine,
Japan
Introduction: Survival after curative resection for pan-
creatic ductal adenocarcinoma (PDA) of the body and
tail remains poor. In PDA of the head, infiltration to
the superior mesenteric artery or vein is reported to be
associated with poor prognosis, even if curative resec-
tion is performed. However, in PDA of the body and
tail, the correlation between prognosis and infiltration
to the splenic artery and vein has been poorly investi-
gated. Therefore, we evaluated prognostic factors in
PDA of the body and tail after curative resection.
Method: Between 1992 and 2012 in our institution, 66
patients who underwent distal pancreatectomy (DP) for
PDA of the body and tail were analyzed. Clinicopatho-
logical prognostic factors for survival were evaluated.
Univariate and multivariable analyses were performed.
Results: The 1-, 3-, and 5-year survival rate were
60.9%, 31.7%, and 20.1%, respectively. Invasion of the
splenic artery (SA) was observed in 24 patients
(36.4%). Patients with SA invasion had a significantly
poor prognosis compared with those without SA inva-
sion (median survival: 10.9 vs. 38.7 months, p = 0.001).
On the other hand, splenic vein (SV) invasion did not
affect prognosis. On multivariable analysis, lymph node
metastases and SA invasion were independent predic-
tors of survival.
Conclusions: SA invasion and lymph node metastasis
were crucial prognostic factors in PDA of the body
and tail, whereas SV invasion was not associated with
poor prognosis.
PPP24-007
COULD PYLORUS RESECTION
PANCREATICODUODENECTOMY AND
BRAUN RECONSTRUCTION REDUCE
DELAYED GASTRIC EMPTYING?
O.A. Guevara1, I.D. Martin2 and R. Oliveros3
1Instituto Nacional de Cancerologia, Universidad
Nacional de Colombia, Colombia; 2Universidad Nacional
de Colombia, Colombia; 3Instituto Nacional de
Cancerologia, Colombia
Introduction: Some studies suggest than Pylorus Resec-
tion Pancreaticoduodenectomy (PRPD) may reduce
Delayed Gastric Emptying (DGE). Braun enteroenter-
ostomy has been suggested to decrease DGE as well.
We compare subsequently 3 resection/reconstruction
techniques regarding its impact on DGE, and an analy-
sis restricted by pancreatic fistula Grade B/C as a con-
founder factor.
Method: A before/after study was conducted in an on-
cologic reference institution in Colombia (South Amer-
ica), including consecutive Pancreaticoduodenectomies
(PD), excluding antrectomy procedures. In sequential
groups patients undergone to a Pylorus preserving PD
(PPPD), a PRPD, and a PRPD with Braun entero-
enterostomy (PRPD-B) in 14, 14, and 15 patients
respectively. Perioperative management was uniform
during the study. Pancreatic fistula and DGE was
defined and graded according to International Study
Group of Pancreatic Surgery. Outcomes were incidence
of DGE and postoperative day tolerating diet. A sub-
group analysis was performed excluding 5 patients with
Pancreatic fistula Grade B/C.
Results: No statistical differences between groups in age,
sex, ASA classification, surgical time, operative bleeding,
and diabetes were found. Median age was 60 years (IQR
49–65), operating time 420 minutes (IQR 365-505), in-
traoperative bleeding 600 mL (450–900), postoperative
hospital stay 12 days (IQR 10–20) and postoperative tol-
erating diet was 8th day (IQR 6–18). Five patients devel-
oped Grade B/C pancreatic fistula and 48% DGE (25%
Grade B/C). After exclusion of patient with pancreatic
fistula Grade B/C, analysis shown DGE in 64%, 64%
and 30% (p = 0.15) and a median of oral intake at 8th,
9th and 6th postoperative day (p = 0.08) in PPPD,
PRPD and PRPD-B respectively.
Conclusions: A trend to earlier oral feeding and
decreased incidence of DGE were found in PRPD-B,
compared with PPPD and PRPD, when patients with
pancreatic fistula Grade B/C were excluded. This prob-
lem deserves larger and randomized trials and exploring
the role of bile reflux in DGE.
PPP24-008
INDICATIONS OF THE LIMITED
OPERATION FOR INTRADUCTAL
PAPILLARY MUCINOUS NEOPLASM
OF THE PANCREAS
M. Shinzeki, I. Matsumoto, T. Goto, A. Takebe,
S. Asari, T. Okazaki, M. Kido, T. Ajiki, T. Fukumoto
and Y. Ku
Kobe University Graduate School of Medicine, Japan
Introduction: Intraductal papillary mucinous neoplasm
of the pancreas (IPMN) shows various pathological
features from low grade dysplasia to invasive carci-
noma. An accurate diagnosis and adequate surgery is
mandatory for complete cure.
Limited operations without systemic lymph node dis-
sections (Partial pancreatectomy, Middle pancreatec-
tomy, duodenum preserving pancreas head resection,
laparoscopic pancreatic resection and so on) were
reported but little is known about prediction for inva-
sive IPMN and frequency of lymph node metastasis
(LNM). The purpose of this study is to investigate the
predictive factors for invasive IPMN to clarify the indi-
cation for the limited operation without systemic lymph
node dissection.
Method: We investigated 96 patients who underwent
pancreatic resection for IPMNs. Resected specimens
were evaluated histopathologically with regard to the
presence of mural nodules, malignant component,
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lymph node involvement. The lesions were classified
into non-invasive and invasive groups. Preoperative
imaging findings and pathological results were com-
pared between the 2 groups.
Results: Of the 97 patients, 50 had benign lesions, and
46 had malignant lesions including carcinoma in situ
(n = 20), invasive carcinoma (n = 26). LNM were pre-
sented in 2 cases of invasive IPMNs. Univariate and
Multivariate analysis confirmed that positive imaging
findings for invasive lesion and the size of mural nodule
≥10 mm were significant predictive factors for invasive
IPMN.
Conclusions: Limited operation could be considered for
the cases without the positive imaging findings for inva-
sive lesion and mural nodules ≥10 mm. Conversely,
standard pancreatic resection with systemic lymph node
dissection would be recommended in patients with IP-
MNs with aforementioned factors.
PPP24-009
LAPAROSCOPIC PANCREAS-SPARING
SUBTOTAL DUODENECTOMY IN
GASTROINTESTINAL STROMAL
TUMOR OF THE DUODENUM:
COMPARISON WITH OPEN SURGERY
S.H. Choi, C.M. Kang, S.H. Lee, J.H. Lee,
H.K. Hwang and W.J. Lee
Yonsei University College of Medicine, Korea
Introduction: Although organ-preserving operation for
benign and borderline duodenal tumors has been
regarded as reasonable strategy, laparoscopic pancreas-
sparing subtotal duodenectomy (LapPSSD) was rarely
reported. The aim of this study was to compare the
perioperative surgical outcomes laparoscopic approach
with open surgery.
Method: Between March 2010 and June 2013, 7 con-
secutive LapPSSD for duodenal gastrointestinal stro-
mal tumor (GIST) were performed. The demographics
and surgical outcomes of LapPSSD were compared
with the data-base of 7 patients who underwent open
PSSD during same period. Subtotal duodenectomy was
defined as distal duodenal resection of ampulla of Vater
to first portion of jejunum. All patients underwent side-
to-side duodenojejunostomy after subtotal duodenecto-
my, and jejunal limb was placed to retrocolic pattern.
Results: One of patients underwent LapPSSD con-
verted to laparotomy because of mesocolonic involve-
ment by the tumor. The mean operative time was
significantly longer (281.4 vs 210.0 minutes), but lesser
estimated blood loss (88.6 vs 364.3 mL) and shorter
length of postoperative hospital stay (7.4 vs 22.6 days)
were observed in LapPSSD group compared with
OpenPSSD group. The tumor size was similar (3.6 vs
4.8 cm) and tumor-free surgical resection margins were
achieved in all study patients. The most frequent post-
operative complication was delayed gastric emptying in
both groups (3 vs 5 patients). Three patients of Lapa-
PSSD readmitted after early discharge, and 2 of them
underwent re-operation for obstruction of jejunal limb.
There was one recurrence in OpenPSSD group among
all patients at a mean follow-up of 11.9 months.
Conclusions: Laparoscopic pancreas-preserving subtotal
duodenectomy is technically feasible and attractive
strategy in well-selected benign or borderline duodenal
tumors. However, delayed gastric emptying is a major
concern of postoperative complication, and it is needed
to be study further for its cause and solution.
PPP24-010
WHIPPLE PROCEDURE FOR
PERIAMPULLARY ADENOCARCINOMA
IN A LOW VOLUME DISTRICT
HOSPITAL
I. Triantafyllidis and C. Demertzidis
General Surgeon, Greece
Introduction: The only curative option for patients with
pancreatic cancer is surgical resection. The potential for
significant morbidity and mortality following these pro-
cedures along with short-term survival benefit has
called into question the role of surgery in this disease.
The purpose of this report is to review the current stan-
dards of the Whipple pancreaticoduodenectomy and
show that excellent results are achievable in a low-vol-
ume, community hospital.
Method: The study was designed as a retrospective
review of medical records of all patients who under-
went pancreatoduodenal resection for periampullary
carcinoma between August 2008 and August 2013.
Results: There were 13 pyloric-sparing pancreaticoduo-
denectomies (PSPD) and 31 standard Whipple opera-
tions. Mean age for patients was 60 years. There were 10
female and 21 male patients. For the pancreatic anasto-
moses, 3 were pancreaticogastrostomies and 41 were
pancreaticojejunostomies. Mortality was 9.1% and
major complications occurred in 8 patients which
included pancreatic fistula, bile leak, intra-abdominal
abscesses, intra-abdominal bleeding, upper gastrointesti-
nal bleeding, and delayed gastric emptying. Reoperation
was required in only three patients. Average hospital stay
was 12 days. Long-term complications were peptic ulcer
disease, liver abscess and pancreatic insufficiency. Long-
term survival was achieved in periampullary malignan-
cies including pancreatic with excellent functional status.
Conclusions: Major pancreatic surgery can be per-
formed safely at community hospitals with careful
selection of patients. The most important prerequisite is
that the surgeon be adequately trained in the proce-
dure. It is imperative that each hospital is responsible
for providing morbidity and mortality figures related to
pancreatic procedures performed at their institution.
PPP24-011
ENUCLEATION OF PANCREATIC
NEOPLASMS
K.B. Song, S.C. Kim, Y.-J. Lee, K.-M. Park, J.H. Lee,
J.S. Nam, J.H. Yoon, D.J. Lee and J.W. Lee
Asan Medical Cente,Ulsan University, Korea
Introduction: Standard resections for benign and bor-
derline neoplasms of the pancreas are associated with a
significant risk of postoperative morbidity and long-
term functional impairment, whereas enucleation has
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less morbidities and preserves healthy parenchyma and
pancreatic function.
Method: From March 2005 to July 2013, 57 cases of
enucleation for benign tumors in the pancreas were
identified through retrospective review of medical
records.
Results: Mean age was 51.7 years. Median tumor size
was 2.5 cm (range: 0.5–8 cm). The most common
indication for enucleation was pancreatic neuroendo-
crine tumor (18, 31.6%). A clinically significant pan-
creatic fistula (grade B, C) was reported in 8 patients
(14%). The patients with the tumor of pancreatic
head and neck had more pancreatic fistula after enu-
cleation (6/21, 28.6%). Thirty two patients were
addressed with open and twenty five with laparo-
scopic procedure. There were no differences of clinical
outcomes between 2 groups (Age, Sex, BMI, ASA,
postoperative hospital stay, new onset DM, postoper-
ative complication). At a median follow-up of 45
months there were no new onset diabetes, recurrence
and mortality.
Conclusions: Enucleation is a safe and effective proce-
dure for the treatment of benign and borderline pancre-
atic neoplasms. It preserves pancreatic function and is
not associated with recurrence. Even though the inci-
dence of postoperative complications including pancre-
atic fistula, is acceptable, The enucleation for
pancreatic head and neck tumors should be evaluated
carefully to prevent postoperative complications.
PPP24-012
LAPAROSCOPIC CORPOROCAUDAL
PANCREATECTOMY. SINGLE CENTER
EXPERIENCE
C. Derosas, A. Cambara, J. Ormazabal, A. Rojas,
M. Ferrario and E. Buckel
Clinica Las Condes, Chile
Introduction: Laparoscopic surgery has become the
procedure of choice in selected pancreatic pathologies.
The reported national experience with this technique is
limited. The purpose of the present report is to show
our results in laparoscopic corporocaudal pancreatec-
tomy (LCCP).
Method: We performed a retrospective database review
of patients who underwent LCCP from 2003 to date.
Patient’s characteristics, indications and operative out-
comes of pure LCCP are presented.
Results: Between the mentioned dates we intent 20
LCCP (Mean age 52.7; 70% female). 95% (19 cases)
were pure laparoscopic procedures, 1 case was con-
verted to open surgery (splenic vein lesion). Splenic
preservation was possible in 35% (7/19) of cases. The
median time of hospitalization was 8.8  4.9 days.
Total morbidity was 26%; a 15.8% (3/19) presented
pancreatic leak, none required re-exploration. One in-
trabdominal collection (percutaneously treated) and 2
(10.5%) medical complications (1 pneumonia, 1 Central
venous catheter related sepsis), only one patient
required blood transfusion. Pathological specimens
showed 6 neuroendocrine tumor, 3 Mucinous Cystic
Neoplasms, 3 Adenocarcinomas, 4 Solid Pseudopapil-
lary Neoplasms, 1 Intraductal Papillary Mucinous
Neoplasms, 1 Serous Microcystic Tumor, 1 Renal Cell
Metastasis. All neoplasms had negative margins. There
was no mortality.
Conclusions: Due to these results, LCCP is in our expe-
rience the approach of choice in selected pancreatic
tumors. Low morbidity and no mortality make it a
very safe technique, leading to prompt postoperative
recovery, faster laboral reinsertion and optimal aes-
thetic results.
PPP24-013
MIR-221/222 PROMOTE PANCREATIC
CANCER PROGRESSION THROUGH
TIMP-2 DEPENDENT MANNER
Z. Wang, P. Li, Z. Wu and Q. Ma
Department hepatobiliaryi Surgery, China
Introduction: Pancreatic ductal adenocarcinoma
(PDAC) is a lethal disease in nearly all patients, due to
its strong aggressive ability. MicroRNAs have been
investigated in the regulation of cell cycle progression,
apoptosis and invasion of pancreatic cancer cells. MiR-
221 and miR-222 (miR-221/222), upregulated in many
other cancers, can regulate several cellular signaling
pathways. However, the association of miR-221/222
with pancreatic cancer progression was not completely
elucidated.
Method: The expression method of miR-221/222
between pancreatic cancer tissues compared with their
nontumor counterparts was evaluated by qRT-PCR.
Viability, cell cycle, apoptosis and invasion capability
of pancreatic cancer cells transfected with miR-221/222
was detected by MTT assay, flow cytometer and tran-
swell assay, respectively.To investigate the miR-221/222
target genes and their conserved sites, the TargetScan
Release 5.2 was used for target prediction. Further, the
target of miR-221/222 was determined by luciferase
reporter and western blot assay.
Results: MiR-221/222 is upregulated in PDAC tissue
and cell lines and Its change after transfection Over-
expression of miR-221/222 significantly promoted pan-
creatic cancer cell proliferation, inhibited apoptosis and
increase cell invasion. Bioinformatic analysis combining
with validation experiments identified TIMP-2 is a
direct target of miR-221/222.
Conclusions: These data indicate that overexpressed
miR-221/222 may play an oncogenic role in pancreatic
cancer progression by inhibiting TIMP-2 directly which
leading to increased cell invasion.
PPP24-014
LAPAROSCOPIC ENUCLEATION FOR
PANCREATIC CYSTIC NEOPLASM
M.J. Kim1, D.W. Choi2, S.H. Choi2 and J.S. Heo2
1Jeju National University Hospital, Korea; 2Samsung
Medical Center,Sungkyunkwan University, Korea
Introduction: Pancreatic cystic neoplasm (PCN) is rela-
tively rare with low malignant potential. Enucleation
could be an alternative procedure for managing benign
neoplasm of pancreas with preserving pancreatic func-
tion. The purpose of the current study was to identify
practical availability of laparoscopic enucleation for
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PCN by analysis of the surgical outcomes at a single
institution.
Method: Archived records of 60 patients with PCN
who underwent enucleation between 1994 and 2010
were retrospectively reviewed.
Results: Laparoscopic enucleation was achieved suc-
cessfully for 10 patients (90.9%). The median tumor
size of the laparoscopic enucleated group was 1.2 (0.9–
5) cm. Laparoscopic enucleation was performed for
endocrine neoplasm in 7 patients, mucinous cystic neo-
plasm in 2 patients, and solid pseudopapillary neo-
plasm in 2 cases. All the patients had benign tumors at
the final pathological report. During the median fol-
low-up period of 31.5 months, there was no postopera-
tive complication or perioperative mortality was
observed. One case with 5 cm sized head tumor devel-
oped the liver metastasis 6 month after the primary
operation.
Conclusions: Laparoscopic enucleation is a safe and
feasible procedure that could become the treatment of
choice for patients with small sized benign PCN. Pre-
operative pancreatic duct stenting by endoscopic ultra-
sonography could help to decrease the postoperative
pancreatic fistula occurrence.
PPP24-015
TUBE GASTROSTOMY COULD NOT
PREVENT DGE AFTTER
PANCREATICODUODENECTOMY
J.K. Kim, D.S. Yoon and J.S. Park
Gangnam Severance Hospital, Yonsei University, Korea
Introduction: Delayed gastric emptying (DGE) is one
of troublesome complications after pancreaticoduoden-
ectomy. Tube gastrostomy introduced for the manage-
ment of DGE. But there has been a little report about
gastric decompression procedure can prevent DGE.
This study aimed to present postoperative DGE rates
between routine gastrostomy group and non- decom-
pression group.
Method: From January 2007 to March 2013, 266
patients with pancreas resection were included in this
study. Tube gastrostomy introduced in 167 patients but
99 patients were included in non- decompression group.
Results: DGE after pancreaticoduodenectomy was
developed 44 patients (16.5%), employing the Interna-
tional Study Group of Pancreatic Surgery (ISGPS) con-
sensus definition. Thirty six patients (21.6%) developed
DGE in Tube gastrostomy group but 8 in non- decom-
pression group.
Conclusions: This study showed that routine gastrosto-
my could not prevent DGE. Further investigations are
needed to judge the routine gastrostomy decompres-
sion.
PPP24-016
PALLIATIVE PANCREATIC RESECTION
FOR PANCREATIC DUCTAL
ADENOCARCINOMA WITH DISTANT
METASTASIS
K.B. Song1, S.C. Kim1, Y.H. Kim2, Y.-J. Lee1,
K.-M. Park1, J.H. Lee1, J.S. Nam1, J.H. Yoon1,
D.J. Lee1 and J.W. Lee1
1Asan Medical Center,Ulsan University, Korea; 2Ajou
University Hospital, Korea
Introduction: Pancreas ductal adenocarcinoma (PDAC)
with distant metastasis has very poor prognosis. It has
been considered contraindication to operation. There-
fore, there’s no reports about prognosis of palliative
resection for stage IV PDAC. The aim of this report
was to investigate the prognosis of palliative pancreatic
resection and the factors related to survival for stage
IV PDAC.
Method: Between 2000 and 2009, 863 patients under-
went operation for PDAC in our hospital. Of them, 36
patients underwent palliative pancreatic resection. They
were classified into two groups according to survival of
12 months: long (group L, n = 13) and short (group S,
n = 23).
Results: The median age was 60.5 years (range, 44–78)
and 24 patients (66.7%) were male. The pattern of
metastasis were multiple liver (n = 13), peritoneal or
omental seeding (n = 10), single liver (n = 7), multiple
liver and lung (n = 2), lymph node (LN) 16 (n = 2),
brain (n = 1), ovary (n = 1). Additional partial hepatec-
tomy or radiofrequency ablation (RFA) for liver metas-
tasis was performed in 7 single liver metastasis and 8 of
13 multiple liver metastasis. Ovary and LN 16 metasta-
sis were also surgically removed. The median survival
was 8.8 months (range 2.2–68.0). 1 and 2 year survival
rate was 36.1% and 13.9%, respectively. Univariate
analysis showed that group S had a tendency high CA
19-9 level and regional LN metastasis. Single liver
metastasis had 11.1 months survival compared to 8.5
of other metastasis. Compared to S, more in L group
had postoperative adjuvant therapy (92.3% vs 72.7%).
Conclusions: Our study showed relative long survival
of median 8.5 months in palliative resection of stage IV
PDAC. Especially, patients who underwent surgical
resection or RFA for single liver metastasis showed
11.1 months median survival. If more cases can be
accumulated, surgical criteria and strategy for long-
term survival may be suggested in patients with stage
IV PDAC.
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PPP24-017
PERCUTANEOUS TRANSHEPATIC
PORTAL VENOUS ANGIOPLASTY AND
STENTING FOR BLEEDING JEJUNAL
VARICES CAUSED BY PORTAL VEIN
HYPERTENSION AFTER
PANCREATICODUODENECTOMY
M. Ikeda1, H. Toyoda1, K. Imano1, K. Paku1,
Y. Sakamoto2, T. Hashimoto3, T. Kuroda1 and
H. Koyama1
1Senpo Tokyo Takanawa Hospital, Japan; 2University of
Tokyo, Japan; 3University of Showa, Fujigaoka
Hosiptal, Japan
Introduction: Some papers reported the successful treat-
ment with portal veint stent for melena after pancreati-
coduodenectomy, caused by benign stenosis of main
flow of portal vein and developed varices near hepati-
cojejunostomy. Inspection of double baloon endoscopy
after treatment has not been reported yet.
Method: Our case was 65-years-old male, pancreatico-
duodenectomy was underwent for repeated pancreatitis
due to IPMN of pancreas head. Minor leakage of pan-
creas juice was detected and portal vein was com-
pressed by fluid collection and it was not detected by
CT scan. Pathology showed benign IPMN. Three
month later he came to our hospital for anemia and
melena, varies around hepaticojejunostomy were
detected. Stenosis was caused by inflammation and
absorption of liquid, so we should try to do angio-
plasty and stent placement. Two metalic stent were
placed after angioplasty by percutaneous transhepatic
portal venous approach.
Results: Flow of portal vein was recovered then melena
was stopped from that day. one week later, CT showed
less varices around hepaticojejunostomy and also dou-
ble baloon endscopy showed that there was no bleeding.
Anticoagulant therapy has been continued until now.
Conclusions: We report less invasive treatment for por-
tal veins stenosis after pancreaticoduodenectomy.
PPP24-018
SOLID PSEUDOPAPILLARY
NEOPLASM OF THE PANCREAS, A
RARE TUMOR
I.Y. Park1, H.J. Choi1, D.D. You3, K.Y. Paik5,
T.H. Hong2 and K.H. Kim4
1Bucheon St. Mary’s Hospital, Catholic University of
Korea, Korea; 2Seoul St. Mary’s Hospital,Catholic
University of Korea, Korea; 3St. Vincent’s Hospital,
Catholic University of Korea, Korea; 4Uijeongbu St.
Mary’s Hospital, Catholic University of Korea, Korea;
5Yoeuido St. Mary’s Hospital, Catholic University of
Korea, Korea
Introduction: The solid pseudopapillary neoplasm
(SPN) of the pancreas is a rare neoplasm. This neo-
plasm is more common in young women between the
third and fourth decade of life. It may produce nonspe-
cific symptoms. Many cases are asymptomatic and
diagnosed incidentally.
Method: A retrospective review of ten cases of SPN
who were treated at our department between July 2006
and August 2013 was performed. The clinicopathologic
characteristics and surgical treatment are described in
detail.
Results: Data of 10 patients who underwent pancrea-
tectomy for SPN of the pancreas was evaluated. Mean
age was 33.9 years and composition of gender was 9
female and 1 male. Abdominal pain was present in 4,
occasional vomiting in 1, epigastric discomfort in 1,
palpable mass in 1 and no specific symptom in 3
patients. One patient had liver metastasis. The location
of tumor was pancreas head in 4, pancreas tail in 5 and
pancreas body in 1 patient. Pylorus preserving pancre-
atoduodenectomy was performed in 4, distal pancrea-
tectomy in 5, and median pancreatectomy in 1 patient.
One patient of distal pancreatectomy developed grade
A pancreatic juice leakage. There was no postoperative
mortality in our series.
Conclusions: Radical surgery is the treatment of choice
for the SPN of the pancreas, given the facts that no
other treatment have proven being effective. Only sur-
gical treatment is curative because SPEN is low grade
malignant tumor.
PPP24-019
LYMPH NODE METASTASIS AS A
PROGNOSTIC FACTOR IN PRIMARY
DUODENAL CANCER TREATED BY
PANCREATICODUODENECTOMY
J.H. Lee and W.J. Lee
Yonsei University College of Medicine, Korea
Introduction: Primary duodenal cancer (PDC) is rare
malignancy but most frequently involved segment of
small bowel adenocarcinoma. And the prognostic fac-
tor affecting survival with PDC patients remain contro-
versial. This study analyzed the twelve-year experience
at single institution with PDC to define factors that
have an impact on patient survival.
Method: We reviewed the medical records of 209
patients diagnosed with duodenal cancer from January
1995 to November 2012 retrospectively. Among them,
25 patients were found to have PDC and underwent
PPPD. Clinical and pathologic data were evaluated
using uni- and multivariate analyses.
Results: Nineteen patients were male and 6 were female,
with a mean age of 61.5  11.7 years. The median dis-
ease free survival (DFS) was 47.7 months (95% CI,
18.2–77.1) and the median overall survival (OS) was
50.1 months (95% CI, 33.6–66.5 months). And the 1-, 3-
, 5 year survival rate were 90.2%, 61.2%, 22.9% respec-
tively. The tumor location (p = 0.642), tumor size
(p = 0.549), tumor grade (p = 0.769), T-stage
(p = 0.828) and TNM stage (p = 0.082) were not statisti-
cally significant factor in survival. Lymph node (LN)
metastasis was identified as statistically significant prog-
nostic factor (p = 0.044). Ten patients (40%) were pN0,
8 patients (32%) were N1 and 7 patients (28%) were N2.
There was no survival difference between N1 and N2
(p = 0.336). However, there was statistical significantly
DFS (7.8 months, 2.8–12.7 months vs 25.3 months,
21.1–29.4 months, p = 0.019) and OS (35.6 months, 0.0–
74.5 months vs 54.9 months, 12.1–97.6 months, p =
0.016) difference between LN metastasis positive
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(pN1, 2) and LN metastasis negative (pN0) groups. In
comparative analysis, survival of primary duodenal
cancer is superior to that of resected pancreatic ductal
adenocarcinoma (50.1 months, 33.65–66.55 months vs
25.8 months, 21.6–30.0 months, p = 0.043).
Conclusions: Lymph node metastasis is an important
prognostic factor in PDC. Active lymphadenectomy
should be considered when PPPD is planned for PDC.
PPP24-020
PANCREATIC PSEUDOPAPILLARY
TUMOUR: A RARE MISDIAGNOSED
ENTITY
A.C. Ariffin1, Z. Zuhdi2, A. Azman2, H. Othman2 and
R. Jarmin2
1Universiti Sains Islam Malaysia, Malaysia; 2Universiti
Kebangsaan Malaysia, Malaysia
Introduction: Solid pseudopapillary pancreatic tumour
is a rare entity. The atypical presentation causes a
delayed or misdiagnosis of these pathology. It most
commonly affects the female population in the 2nd and
3rd decade of life. The presentation varies from non-
specific abdominal pain to incidental findings in asymp-
tomatic patients. It is a low-grade malignancy that is
curable by excision of the tumour. We report a case of
a rare pseudopapillary pancreatic tumour diagnosed
post operatively.
Method: This is a 17-years-old Malay girl with no rele-
vant medical or surgical illness presented with right hypo-
chondrium pain for 3 years duration. Physical
examination revealed a right hypochondrium mass.
Blood investigations were normal. Subsequent computed
tomography revealed a cystic lesion at the right side of the
duodenum or arising from the lower head of pancreas.
A diagnostic hypothesis of a pancreatic cystic neoplasm
was high on our list. A decision for surgical resection
was made and intra operatively revealed a large cystic
mass 7 cm 9 9 cm appears to be originating from the
head of pancreas with multiple lymph nodes enlarge-
ment. No metastatic lesion seen.
The ensuing histopathology result revealed the diagno-
sis of solid pseudopapillary neoplasm of the pancreas.
Results: –
Conclusions: Solid pseudopapillary tumour of pancreas
is a rare entity usually misdiagnosed. It affects mostly
female in their 20’s and 30’s. It is a low-grade malig-
nancy that fair very well due to the potential curable
by resection.
PPP24-021
IS PANCREATIC FISTULA ASSOCIATED
WITH WORSE OVERALL SURVIVAL IN
PATIENTS WITH PANCREATIC
CARCINOMA?
Y. Murakami, K. Uemura, T. Sudo, Y. Hashimoto,
N. Kondo, N. Nakagawa, H. Sasaki and T. Sueda
Institute of Biochemical and Health Sciences, Hiroshima
University, Japan
Introduction: Pancreatic fistula (PF) is one of the lead-
ing complications after pancreatic resection pancreatic
carcinoma. However, there have been few reports con-
cerning the effect of PF on long-term outcomes. The
aim of this study was to determine whether PF was
associated with deterioration of long-term outcomes in
patients with pancreatic carcinoma after surgical resec-
tion.
Method: Medical records of 210 patients with pancre-
atic carcinoma who underwent tumor resection were
reviewed retrospectively. PF was defined as grade B or
C PF according to the criteria of the International Sur-
gical Group of Pancreatic Fistula. Clinicopathological
factors were compared between patients with and with-
out PF. Univariate and multivariate survival analyses
were used to determine the effect of PF on long-term
survival.
Results: Thirty-one patients (15%) developed postoper-
ative PF, and 179 (85%) did not. The 31 cases of PF
consisted of 27 grade B PF and 4 grade C PF. There
were no differences in the use of adjuvant chemother-
apy, tumor differentiation, lymph node status, surgical
margin status, or UICC stage between groups. Overall
5 year survival rates for patients with and without PF
were 25% and 27%, respectively. There was no signifi-
cant difference in overall survival between the 2 groups
(p = 0.743). Multivariate analysis demonstrated that
the use of postoperative adjuvant chemotherapy
(p < 0.001), tumor differentiation (p = 0.005), and
lymph node metastasis (p < 0.001) were factors inde-
pendently associated with overall survival.
Conclusions: These results suggested that PF was not
associated with deterioration of long-term outcomes in
patients with pancreatic carcinoma.
PPP24-022
THE POSTOPERATIVE PANCREATIC
FISTULA AFTER DISTAL
PANCREATECTOMY WITH STAPLER
CLOSURE–RELATIONSHIP BETWEEN
CARTRIDGE AND THICKNESS OF THE
PANCREAS–
N. Ooshima, T. Hatori, S. Suzuki, R. Suzuki,
A. Kimijima, W. Izuno and M. Yamamoto
Tokyo Womens Medical University, Japan
Introduction: The stapler closure is useful for distal
pancreatectomy (DP) from the point of view of the
simplicity of the procedure because of no difference of
the rate of postoperative pancreatic fistula (POPF)
between stapler closure and hand-sewn closure in sev-
eral trials. The aim of this study was to evaluate the
POPF after DP with stapler closure from the point of
view of the relationship between cartridge and thickness
of the pancreas.
Method: A total of 107 patients who underwent DP
with stapler closure (ECHELON FLEXTM 60 ENDO-
PATH or ECHELON 60 ENDOPATH) between
April 2007 and August 2013 were examined retrospec-
tively. They included 39 PDACs, 18 IPMNs, 13 MCNs,
15 pNETs, 8 SPNs, 5 SCNs and 9 others. The pancreas
at the transection site was normal soft in all patients.
Results: (1) The thickness of the pancreas at the tran-
section site was more than 20 mm in 4 patients, 16-
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20 mm in 27 patients, 11–15 mm in 58 patients and less
than 10 mm in 18 patients. The rates of POPF were
50%, 7%, 7% and 11%, respectively. (2) The green
cartridge (closed staple height is 2.0 mm) was used in
the 51 patients with an average of the 15 mm (10–27)
thickness of the pancreas, the gold (1.8 mm) was in the
24 patients with 16 mm (11–20), the blue (1.5 mm) was
in the 20 patients with 12 mm (8–16) and the white
(1.0 mm) was in the 12 patients with 9 mm (7–15). The
rate of POPF was 14% of the patients with green car-
tridge, 0% with blue, 10% with gold and 8% with
white.
Conclusions: The stapler cartridge should be used
according to the thickness of the transection site of the
pancreas to minimize the POPF after DP.
PPP24-023
CLINICAL EFFICACY OF
NEOADJUVANT CHEMORADIATION
THERAPY FOR UNRESECTABLE
LOCALLY ADVANCED PANCREATIC
CANCER
K. Takano, M. Okiiara, T. Sano, N. Chiba,
S. Kawachi and M. Shimazu
Tokyo Medical University Hachioji Medical Center,
Japangoshima University, Japan
Introduction: Complete macroscopic resection in com-
bination with chemoradiation therapy is the only
potential treatment for pancreatic cancer. However, the
clinical efficacy of neoadjuvant therapy in terms of sur-
gical and oncological outcomes continues to be contro-
versial. We sought to assess the results of resection
after neoadjuvant chemoradiation therapy for unresec-
table pancreatic cancer.
Method: Consecutive patients undergoing neoadjuvant
chemoradiation therapy from June 2010 to June 2013
were identified from a prospectively collected database.
Unresectability was defined as infiltration of the celiac
axis or superior mesenteric artery (>180°) in accordance
with the National Comprehensive Cancer Network
guidelines. All patients received a median dose of 50.4
Gy plus gemcitabine (400 mg/m2) / TS1 (40 mg/m2),
and restaging was performed 4–6 weeks after comple-
tion of chemoradiation therapy. Resection rates, peri-
operative results, and overall survival were analyzed.
Results: Of 46 patients, 13 (28.3%) had received neo-
adjuvant chemoradiation therapy (11, pancreatic head
cancer and 2, pancreatic body and tail cancer). Of these
13 patients, 6 (46.2%) underwent successful resection,
whereas 7 underwent exploration only or no surgical
treatment. Of the 6 patients who underwent successful
resection, R0 resection was achieved in 5 (38.5%) and
R1 resection was achieved in 1 (7.7%). Patients who
underwent resection after chemoradiation therapy
tended to have a better overall survival rate than those
who did not undergo resection (1-year survival rate,
75.0% vs 42.9%, p = 0.300).
Conclusions: For locally advanced, unresectable pancre-
atic cancer, R0 or R1 resection can be achieved in almost
50% of patients who undergo surgery after neoadjuvant
chemoradiation therapy. Survival rates in these patients
tend to be higher than those in patients who are unable
to undergo resection and similar to those in patients with
initially resectable pancreatic cancer.
PPP24-024
CLINICAL STUDIES AND TREATMENT
OPTION OF PANCREATIC CANCER IN
ELDERLY PATIENTS OVER 80-YEARS-
OLD
K. Okubo, H. Shinchi, K. Maemura, Y. Mataki,
H. Kurahara, I. Satoshi, M. Sakoda, S. Ueno,
S. Takao and S. Natsugoe
Kagoshima University, Japan
Introduction: This study was undertaken to examine
the treatment option of pancreatic cancer in patients
over 80-years-old retrospectively.
Method: From 2006 to 2012, a total of 208 patients
with pancreatic cancer who were treated in Kagoshima
University Hospital analyzed in this study. 92 patients
(44%) received chemotherapy, 66 patients (31%) che-
moradiotherapy and 43 patients (20%) surgery, 7
patients (2%) Best supportive care (BSC). They were
divided into 2 groups of over 80 (18 cases) and under
80-years-old (190 cases), the clinicopathologic factor,
the treatment policy, and the prognosis were analyzed.
Results: No statistically significant differences were
observed in sex, tumor location, tumor size, CEA, CA19-
9, SUV max with FDG-PET between groups with over
80 and those with under 80, Performance status(PS) 2
and 3 patients rate is higher than PS 0 and 1 patients rate
(p < 0.0001). According to medical treatment of each
groups, surgery and CRT were more than the half, in
aged less than 80-years-old and was 23% in aged over 80-
years-old. 12 cases had died of disease related with cancer
among 18 elder groups except for one example of cerebral
hemorrhage. 11 patients were received chemotherapy
including the postoperative adjuvant chemotherapy, the
dosing period of the chemotherapy was 2–28 months (an
average of 8.4 months), and was 2 to 6 months during
the period from the last medication to death. PS0 and 1
patients had significantly better survival compared with
PS2 and 3 (p = 0.0003). Compared with survival accord-
ing to treatment, some treatment of an operation, a che-
motherapy or CRT had a better prognosis than BSC.
Conclusions: In the pancreatic cancer patient of
super-advanced age, it may be important to plan the
impossible curative program corresponding to each
consideration of ADL, physical, srtrength. However,
adding medical treatment can contribute to the
improvement in a prognosis.
PPP24-025
PRIMARY PANCREATIC
TUBERCULOSIS MASQUERADING AS A
PANCREATIC CANCER: A CASE
REPORT
K.-H. Yang, Y.-M. Park, J.-H. Ryu, K.-M. Moon and
C.-W. Chu
Yangsan Hospital, Pusan National University, Korea
Introduction: Primary pancreatic tuberculosis is a rare
disease even in endemic areas for tuberculosis.
© 2014 The Authors
HPB 2014, 16 (Suppl. 2), 603–697 HPB © 2014 Americas Hepato-Pancreato-Biliary Association
Poster Panel [Pancreas] 611
Method: We report a case of primary pancreatic tuber-
culosis masquerading as a pancreatic cancer.
Results: (CASE) A 48-year-old female initially pre-
sented with upper abdominal pain. Abdominal com-
puted tomography scan and magnetic resonance
imaging both showed a lobulated mass with cystic por-
tion in the pancreatic head suggestive of carcinoma.
She underwent a pylorus preserving pancreaticoduo-
denectomy. Histological examination of the specimen
showed chronic granulomatous inflammation with
extensive necrosis and there was no evidence of malig-
nancy. Antitubercular therapy was started and she
remains well after surgery.
Conclusions: Tuberculosis should be considered as a
differential diagnosis in a patient with a pancreatic
mass in endemic areas to avoid surgery.
PPP24-026
CLINICAL ADVANTAGES OF
MINIMALLY-INVASIVE APPROACH TO
PANCREATIC CANCERS: ISMETT
EXPERIENCE
C. Ricotta1, D. Pagano1, M. Paci2, A.M. Fratti2,
S. Gruttadauria1, D. Cintorino1, S.L. Petri1,
P. Bopnsignore1, B. Gridelli1 and M. Spada1
1Mediterranean Institute for Transplantation and
Advanced Specialized Therapies ISMETT, University of
Pittsburgh Medical Center UPMC in Italy, Italy;
2University of Pavia, and Epato-Pancreatic Surgery
Unit, IRCCS Pol. San Matteo, Pavia, Italy
Introduction: We aimed to argue that laparoscopic pan-
creatic resection (LPR) should have comparable or bet-
ter clinical outcomes to open procedures for pancreatic
cancers (PCs).
Method: In this single center retrospective study, 63
patients underwent surgical procedures for PC from
January 2012 to August 2013. The main reviewed out-
comes were patient age, pathology, operation time, hos-
pital stay, postoperative complication, and 30-day or
in-hospital mortality rates.
Results: In 7/63 (11.1%) cases only an explorative lap-
aroscopy was performed and a not resectable PC was
detected. In 12/63 (19%) cases a laparotomy was neces-
sary palliative options. 45/63 (71.4%) patients (age
range, 36–78 years) received a radical pancreatic resec-
tion for a neoplasm on pancreatic head in 30/45
(66.6%) cases, a distal biliary tree cancer in 8/45
(17.7%) cases and a PC of the body or the tails in 7/45
(15.5%). A LPR assisted by mini-laparotomy was per-
formed in 18/45 (40%) patients with a pancreaticoduo-
denectomy in 11/18 (61.1%) cases, a
splenopancreasectomy in 4/18 (22.2%) cases and body
resection in 3/18 (16.6%). No mortality was recorded
in LPR group of patients. There were 4/18 (22.2%)
cases of delayed gastric emptying, no case of bile leak-
age, 3/18 (16.6%) cases of pulmonary complications.
Pancreatic leakages were defined according to the Inter-
national Study Group of Pancreatic Fistula classifica-
tion: grade A occurred in 4/45 (8%) patients, grade B
in 1/45 (2%), and grade C in 1/45 (2%) case. Of the
27/45 (60%) patients with open pancreaticoduodenecto-
my, 2/27 (7.4%) deaths were experienced for bowel
infarction and for septic shock after pancreaticojejunos-
tomy dehiscence. Histology showed PC (25/45), cholan-
giocarcinoma (11/45), pancreatic ductal neoplasm (4/
45), duodenal sarcoma (1/45), neuroendocrine tumor
(4/45). We did not recognized discrepancies for proce-
dure length (308  107.6 min. vs 358.7  75.8 min.),
nor any post-operative complications (10/18 vs 19/27
cases), positive margin of resections for PC in 2/45
cases (1 vs 1 cases) and mean number of harvested
nodes (15 vs 16). Conversely, we evidenced advantages
for LPR group of patients in terms of Clavien compli-
cations>IIIa (1/18 vs 6/27 cases) and hospital stay
(13.1  13.3 vs 18.1  9.6 days).
Conclusions: In light of our experience, laparoscopic
approaches for pancreatic resection has demonstrated
equivalent morbidity and mortality rates to those of
open techniques, resulting in decreased severe post-
operative complications and shorter postoperative hos-
pital statement.
PPP24-027
NATURAL HISTORY OF
GASTROINTESTINAL FISTULAE IN
ACUTE PANCREATITIS
V. Gupta, J. Basha, S. Sinha, T. Yadav and
R. Kochhar
Postgraduate Institute of Medical Education and
Research, India
Introduction: Gastrointestinal tract fistulzation occurs
rarely in the clinical course of acute pancreatitis (AP).
Hence, data is lacking regarding the natural history of
these fistulae.
Method: All patients of AP with GI fistulae detected
both in retrospective (2006–2009) and prospective
(2010–2013) analysis were studied for demographic
characteristics, clinical presentation, etiology of pancre-
atitis, interval between onset of pancreatitis and fistuli-
zation, diagnostic studies, treatment and outcome.
Results: GI fistulization was detected in 38 patients
(mean age 39.03  12.2 years; 35 males). The time
duration between onset and detection of fistulae was
5.84  5.2 weeks. The presentation was persistent fever
(68.4%), GI bleed (50%) and pain abdomen (34.2%).
Fistulae were developed spontaneously 73.7% patients,
and after intervention in remaining. Fistulae were
detected were detected intra operatively in 21.1% and
postoperatively in 2.6%. Fistulous communication was
found in duodenum (44.7%), colon (39.5%), stomach
(7.9%), small bowel (2.6%) and both colon & duode-
num (5.3%). CECT abdomen raised suspicion of fistu-
lous communication by the presence of air foci within
the necrotic collection in 50% and by inflammatory
involvement of the bowel 16%, while only necrosis was
seen in 26.3% of patients. Out 21 patients, who under-
went endoscopy, 17 (81%) had direct visualization of
the fistulous communication, while 4 (19%) had edema-
tous inflamed mucosa. Surgical intervention was done
in 55.3%, conservative management in 21.1%, endo-
scopic in 15.8% and percutaneous intervention in
7.9%. Mortality was 31.6%. Patients who had GI bleed
had significantly higher chance of developing colonic
fistulae (p = 0.05) and worse outcome (p = 0.036). Sur-
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gical intervention and mortality were significantly
higher in colonic than upper gastrointestinal fistulae
(p = 0.008 & 0.003)). No correlation between the mech-
anism of fistula formation (spontaneous vs postinter-
vention) and outcome was found.
Conclusions: Development of GI fistula in patients with
acute pancreatitis is ominous and uncommon complica-
tion. Luminal bleed is presenting feature. Surgical inter-
vention and mortality was higher with colonic fistulae.
PPP24-028
PANCREATICOJEJUNOSTOMY
PERFORMED AT RIGHT SIDE OF
SUPERIOR MESENTERIC VEIN WITH
TRAUMATIC PANCREATIC NECK
FRACTURE
Y.M. Park, K.-H. Yang, J.-H. Ryu, K.-M. Moon and
C.-W. Chu
Pusan National University Yangsan Hospital, Korea
Introduction: Management of pancreatic injuries
involving the main pancreatic duct is both variable and
controversial.
Method: We report a case of preserving distal pancreas
using pancreatico-enterostomy after pancreatic main
duct laceration.
Results: (CASE) A 28-year-old woman was admitted
due to LUQ pain by traffic accident via ER. Abdomi-
nal CT showed a laceration of liver (grade II), hemo-
peritoneum, contusion of pancreatic head and body.
8 hours later, the patient complained of a whole
abdominal pain and the pancreatic enzyme level was
markedly elevated. And MRI showed a pancreatic
body laceration, traumatic pancreatitis. We performed
a diagnostic laparotomy. In the operative findings,
bleeding from liver laceration was already controlled
spontaneously and pancreatic body laceration was sus-
picious above grade III. After removal of peripancreat-
ic necrotic tissue by CUSA, we confirmed the patency
of main pancreatic duct by intraoperative pacreatogra-
phy. Proximal main pancreatic duct was ligated with
omental patch and distal pancreas was reconstructed
with pancreaticojejunostomy. The patient discharged at
2 weeks later without complication.
Conclusions: Treatment should be individualized
depending on the site of injury, timing of referral, pres-
ence of associated injuries, and institutional expertise.
PPP24-029
COMBINED ARTERIAL AND
TRANSHEPATIC PORTAL ACCESS IN
SUCCESSFUL TREATMENT OF
COMPLICATED SPLENIC ARTERY
STUMP ANEURYSM IN LIVER
TRANSPLANT RECIPIENT
K. Zieniewicz, O. Rowinski, U. Oldakowska-Jedynak,
L. Grabowska, R. Maciag and M. Krawczyk
Medical University of Warsaw, Poland
Introduction: The incidence of the splenic artery aneu-
rysm reaches 17% in adults. The main risk factors are:
female gender, multiparity, systemic hypertension, arte-
riosclerosis, vasculitis (periarteritis nodosa, lupus ery-
thematodes), fibrodysplasia, pancreatitis, portal
hypertension. Increased splenic blood flow is considered
to cause the splenic artery aneurysms in portal hperten-
sion and after liver transplantation. Arterioportal fis-
tula is a rare complication, but leads to significant
portal hypertension. The aim of the study is to present
a rare case of combined endovascular treatment in liver
transplant recipient with late occurrence of symptom-
atic splenic artery stump aneurysm.
Method: 54-year-old women with the medical history
of splenectomy for thrombocytopenia, underwent
cadaveric liver transplantation for AIH/HBV cirrhosis
in 2002. Posttransplant period was uneventful. 7 years
later (2009) she was admitted in emergency to the
regional hospital for acute upper abdominal pain, radi-
ating to the left shoulder, with ascites and oedema. The
ruptured splenic artery stump was diagnosed and endo-
vascular stenting of the coeliac trunk was performed. A
few months later unfortunately the arterio-portal fistula
has been developed, causing the portal hypertension. In
March 2010 the radiological intervention-combined
arterial and transhepatic portal approach and emboli-
zation allowed to close the fistula and heal the patient.
Results: In the follow up–repeated ultrasound examina-
tions confirmed the diminishing in size thrombosed
pseudoaneurysm, without flow in Doppler ultrasound
examinations. Patient currently, without symptoms, is
doing well.
Conclusions: Multidisciplinary approach allowed to
successful treatment of rare, but life threatening com-
plication after liver transplantation.
PPP24-030
VERIFICATION OF THE EFFECT OF
THE MESH AFTER
PANCREATICOJEJUNOSTOMY: DOES
MESH PREVENT PANCREATIC
FISTULA?
Y.R. Chang, J.-Y. Jang, M.J. Kang, W. Kwon,
W.H. Jung and S.-W. Kim
Seoul National University College of Medicine, Korea
Introduction: The pancreaticojejunostomy remains the
most challenging aspect of the pancreatoduodenectomy.
The method to prevent postoperative pancreatic fistula
(POPF) is a major concern that lacks consensus.
Recently, some studies reported synthetic mesh
decreases the rate of POPF. Therefore, prospective
cohort study was performed to investigate the effective-
ness of the mesh around pancreaticojejeunostomy to
prevent POPF.
Method: From January 2009 to June 2013, total 180
patients underwent pancreatoduodenectomy by one
experienced surgeon in Seoul National University Hos-
pital. Neoveil (polyglycolic acid, Gunze, Japan) was
applied around pancreaticojejunostomy in synthetic
mesh group (n = 90). Control group (n = 90) with no
mesh was compared with synthetic mesh group. End-
to-side, duct-to-mucosal pancreaticojejunostomy was
reinforced with out-layer continuous monofilament
suture and external stent (5- or 8-Fr Silastic tube) was
placed in all subjects.
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Results: Preoperative demographics of age, sex, body
mass index (BMI), and nutritional risk index as well as
texture of the pancreas and pancreatic duct size on CT
scan were equivalent between cohorts. The rate of the
POPF according to ISGPF criteria (B and C) (28.9 vs
32.2%) and definition by Johns Hopkins group (21.1 vs
23.3%) showed no statistical difference. By the Cla-
vien-Dindo classification, grade 2 and 3 POPF occurred
in 11 and 17 patients among mesh group, whereas 15
and 11 patients had grade 2 and 3 POPF among con-
trol group, respectively. The differences in overall and
abdominal complications were not observed (60.0 vs
50.0%, 52. vs 44.4%, respectively). Postoperative hospi-
tal stay was also similar (16.3 vs 16.7 days). There was
one mortality case in each group. Factors influencing
POPF were soft pancreas (p = 0.022), high BMI (23.6
vs 22.6, p = 0.044), and small pancreatic duct (2.4 vs
3.4 mm, p = 0.003).
Conclusions: The use of mesh did not decrease the inci-
dence or severity of POPF after pancreatoduodenecto-
my. Soft pancreas, high BMI, and small pancreatic
duct influenced the occurrence of POPF.
PPP24-031
PANCREATOGASTROSTOMY WITH
DUCT-TO-MUCOSA ANASTOMSIS,
FOLLOWING
PANCREATODUODENECTOMY
PERFORMED IN A LOW VOLUME
CENTER
K. Tazawa1, T. Manabe1, Y. Tuchiya1, F. Yamagishi1
and K. Tsukada2
1Itoigawa general hospital, Japan; 2Toyama university
hospital, Japan
Introduction: Pancreatic leakage was the major concern
complication after pancreatoduodenectomy (PD), espe-
cially in low volume centers. The purpose of this study
was to determine whether pancreatogastrostomy (PG)
with duct-to-mucosa can be a safe alternative to pan-
creatojejunostomy (PJ) in low volume center.
Method: A total of 35 patients who underwent PG or
PJ were retrospectively analyzed for the past 12 years
(2.9 cases a year), in our hospital. 16 case was under-
went PG in an end-to-side and duct-to-mucosa fashion
(a intraluminal lost stent), and compared with 19 case
underwent PJ with duct-to-mucosa anastomosis (a ex-
trabdominal drainage stent). In the 2 processes, no inci-
sions of the serosa were present in the stomach or
jejunum.
Results: The 2 groups were comparable for age, sex,
diagnosis, stage, operation time, presence of the pancre-
atic fistula (PF) and other post-operative factors. In
PG groups, we have never experienced PFs with grade
B or C. There are no differences of clinicopathological
parameters between 2 groups.
Conclusions: PG with duct-to-mucosa anastomosis
appears to be a useful method of pancreatic reconstruc-
tion in low volume center.
PPP24-032
VIDEO-ASSISTED RETROPERITONEAL
NECROSECTOMY AND CLOSED
LAVAGE FOR SEVERE NECROTIZING
PANCREATITIS-ANALYSIS OF
OUTCOMES
U.M. Muthuswamy, J. Sathyanesan, S. Perumal,
A. Pitchaimuthu, K. Rajendran, R. Ramasamy,
K. Balaraman, R. Palaniappan and M. Govindan
Government Stanley Medical College Hospital, Chennai,
India
Introduction: Surgery for severe necrotizing pancreatitis
is associated with a high rate of morbidity and mortal-
ity. We present a series of 26 patients who underwent
video-assisted translumbar retroperitoneal necrosecto-
my and analyse their outcomes.
Method: Records of 26 patients who underwent video-
assisted translumbar retroperitoneal necrosectomy and
closed drainage for infected pancreatitic necrosis
between January 2008 and March 2012 were reviewed,
retrospectively.
Results: Twenty-three out of 26 patients were males,
with a mean age of 38.6 (9.9) years. Alcohol was the
aetiology in 18 patients, gall stones in 7, and in 1 it
was idiopathic. The mean duration of symptoms before
patients were taken up for surgery was 47.2
(34.8) days. The mean computed tomography severity
index was 7.7 (1.2). All patients had undergone
video-assisted retroperitoneal necrosectomy through a
limited left lumbar incision. Post-operative lavage was
given through drains placed in the retroperitoneum.
Three patients required re-exploration. Eleven patients
developed complications and there were 2 mortalities.
The median intensive care unit (ICU) stay was 4 days
(range 2–14 days). The mean post-operative hospital
stay was 22.5 (6.6) days.
Conclusions: Video-assisted retroperitoneal necrosecto-
my followed by closed lavage of infected pancreatic
necrosis in select cases of severe acute pancreatitis was
associated with a low rate of ICU stay, hospital stay
and need for re-entry.
PPP24-033
TREATING PANCREATIC
INCIDENTALOMAS: IS IT WORTH THE
PRICE?
S.H. Lee1, S.G. Iyer2, S.K.Y. Chang2, K. Madhavan2
and A.W.C. Kow2
1National University of Singapore, Singapore; 2National
University Health System, Singapore
Introduction: Pancreatic lesions are commonly discov-
ered incidentally at imaging in asymptomatic patients.
Pancreatic incidentalomas have, for patients, resulted in
extensive investigation, and offered treatment including
surgical resection. We compared the outcomes of pan-
creatic lesions discovered incidentally with patients who
were symptomatic.
Method: This is a retrospective review of all patients
who were discovered to have pancreatic lesions at the
National University Hospital Singapore from 2010 to
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2012. Patients with known history of pancreatic malig-
nancy or a single visit were excluded. We defined “Inci-
dental” lesions as cases without symptoms of
pancreatic lesions e.g. epigastric pain/mass or hepatob-
iliary symptoms such as jaundice, biliary colic, epigas-
tric/right hypochondrial pain/mass. Demographics,
investigations, histopathology and treatment outcomes
were compared.
Results: The median age of the study population of 193
patients was 62.0 (23.0–92.0) years. 96 (49.7%) of
patients presented with non-incidentally, 34 (17.6%)
were asymptomatic and 63 (32.6%) had incidental symp-
toms initially unattributed to the pancreatic lesion.
Majority of the lesions were diagnosed on Computed
Tomography scan (symptomatic: 77 (80.2%), inciden-
tal: 75 (78.1%)). While masses were the most common,
there were significantly more dilated ducts in symptom-
atic group (72 (75.0%), incidental: 34 (35.1%),
p < 0.001). The odds of malignancy if asymptomatic
was 0.309 (p = 0.006) while the odds of malignancy if
incidental was 0.202 (p < 0.001).
24 (28.2%) of incidental patients underwent surgery
against 45 (45.0%), with no statistically different post-
operative morbidity (p = 0.533). The overall survival of
patients with incidental pancreatic lesions were signifi-
cantly better compared to symptomatic patients (med-
ian OS: 36.5 vs 27.9 months, p = 0.014). The survival
of malignancy through incidental diagnosis was signifi-
cantly better (median 39.0, 95% CI 37.3–42.5 months)
compared to those who were symptomatic (p = 0.037).
Conclusions: Pancreatic incidentalomas should be
offered surgical resection with equivalent post-op
recovery but significantly better long term survival.
There was significant proportion of incidental pancre-
atic malignancy and is worthy of aggressive surgical
treatment.
PPP24-034
CHANGING EPIDEMIOLOGY AND
SURVIVAL RESULTS OF
PERIAMPULLARY CANCER AT A
SINGLE INSTITUTION OVER THREE
DECADES
W. Kwon, J.-Y. Jang, Y.R. Chang, W. Jung,
M.J. Kang and S.-W. Kim
Seoul National University Hospital, Korea
Introduction: Despite similar histologic appearance and
adjacent anatomic location, the long-term survival of
periampullary cancers following resection varies greatly
among different origin sites. The aim was to investigate
the epidemiologic incidence and trend of resectable pe-
riampullary cancer as well as the survival outcome after
curative-intent resection.
Method: Retrospective analysis of patients that under-
went surgery for periampullary cancer between 1984
and 2011 was done. Non-curative operations were
excluded. Patients were divided into 4 groups of 7 years
for trend investigation. Comparative and survival
analyses were done.
Results: Among 1,867 operations, 1,412 were curative-
intent operations. The mean age was 61 years. Male-to-
female ratio was 1.5 : 1. The most common location
was pancreas (459), closely followed by ampulla (454),
then CBD (433) and duodenum (66). Cases steadily
increased from 147 cases in 1984–1990 to 635 in 2005–
2011. The proportions of location were similar
throughout the periods. Resection rates of cancers at
pancreas, CBD, ampulla, duodenum were 61.6%,
81.7%, 97.0%, 53.2%, respectively. That of ampullary
cancer was stationary at over 95% over time, but those
of other types tended to have increased. The overall
median survival (MS) and the 5 year-survival rate
(YSR) were 37 months and 41.1%. The best prognosis
was demonstrated by ampullary cancer, followed by
CBD cancer then duodenal cancer. Pancreas cancer
had the worst prognosis (MS, 18 months; 5 YSR,
12.0%). Overall survival improved significantly in the
last 7 years compared to previous years. However,
stage migration was not observed for all types of pe-
riampullary cancer over the decades.
Conclusions: Increasing resected periampullary cancer
may be due to increasing periampullary cancer patients
and better resection candidate selection. Prognosis
seemed to have improved in the last 7 years. Early
detection and surgical techniques contribute little to
this finding. More active application of adjuvant treat-
ment may be an explanation but the actual survival
results remain to be seen.
PPP24-035
VIDEO ASSISTED RETROPERITONEAL
DRAINAGE FACILITATES
SUBSEQUENT ABDOMINAL SURGERY
S. Shah, D. Desai, A. Joshi, P. Abraham, N. Mehta,
S. Maheshwari and A. Kulkarni
PD Hinduja Hospital, India
Introduction: Video assisted retroperitoneal drainage
(VARD) is a minimally invasive approach for removal
of infected pancreatic necrosis. Owing to the retorperi-
toneal approach, the intraperitoneal cavity is not brea-
ched. We hypothesize that subsequent abdominal
surgery becomes easier as there is no peritoneal breach.
Method: Restrospective evaluation of patients requiring
abdominal surgery after VARD between 2011 and
2013. All patients were treated with a step up approach
with initial insertion of a retroperitoneal 14 Fr percuta-
neous drain (Wilson Cook) under CT guidance fol-
lowed by a VARD. Records were evaluated for ease of
peritoneal access, presence of adhesions and additional
technical difficulty peri-procedure.
Results: Three patients were subjected to subsequent
abdominal surgery. Two laparoscopic cholecystectomy
for gallstone pancreatitis and 1 pancreaticoduodenecto-
my for a lower bile duct cholangiocarcinoma following
resolution of post ERCP severe pancreatitis. All had
uneventful access to the peritoneal cavity. Flimsy intra-
peritoneal adhesions were encountered in 1 cholecystec-
tomy. No intraoperative difficulty was encountered.
The laparoscopic cholecystectomy patients were dis-
charged after 24 hours and the pancreaticoduodenecto-
my on day 10 after suture removal.
Conclusions: VARD facilitates subsequent abdominal
surgery in patients with necrotizing pancreatitis by min-
imizing adhesions.
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PPP24-036
AN ANALYSIS OF COMPLICATIONS,
QUALITY OF LIFE, AND NUTRITIONAL
INDICES AFTER LAPAROSCOPIC
DISTAL PANCREATIC RESECTION
WITH REGARDS TO SPLEEN
PRESERVATION
W. Kwon, J.-Y. Jang, M.J. Kang, Y.R. Chang,
W. Jung and S.-W. Kim
Seoul National University Hospital, Korea
Introduction: Whether splenectomy is adverse or
spleen-preservation offers significant advantages in dis-
tal pancreatic resection is unclear. The aim is to com-
pare the early/late clinical results and the functional
outcomes in terms of quality of life (QoL) and nutri-
tion between conventional laparoscopic distal pancrea-
tectomy (LDP) and laparoscopic spleen-preserving
distal pancreatectomy (LSPDP).
Method: Clinical data and CT findings of 111 laparo-
scopic distal resections (79 LDP, 32 LSPDP) between
1999 and 2012 were retrospectively reviewed. QoL was
assessed by EROTC QLQ-C30. BMI, and biochemical
tests (protein, albumin, transferrin, prealbumin) were
examined as nutritional indices. Comparative analysis
was done between LDP and LSPDP.
Results: The mean follow-up was 25 months. There
were no differences in demographics and operative
data. The lesion size was larger in LDP (36.8 mm vs
27.2 mm, p < 0.01). MCN was the most common diag-
nosis in LDP and IPMN in LSPDP. Early results
showed similar hospital days and infection episodes.
Non-vascular complications were marginally more com-
mon in LDP owing to more fluid collections (43.0% vs
21.9%, p = 0.04). Vascular complications (varix, collat-
erals, spleen infarction) were more common in LSPDP
(64.5% vs 26.0%, p < 0.01). Excluding some fluid col-
lections, none required specific treatment. Late results
demonstrated no differences in non-vascular results.
Vascular complications were more common in LSPDP
(65.6% vs 4.2%, p < 0.01). None of the vascular
complications required specific treatment nor had any
serious sequelae. There was no overwhelming post-sple-
nectomy infection.
The QoL and nutritional indices showed no difference.
QoL decreased at discharge and recovered from
3 months thereafter. Nutritional indices showed similar
pattern.
Conclusions: LDP is associated with more fluid collec-
tions and LSPDP with more vascular complications; all
with minimal clinical impact. Both methods had simi-
lar functional outcomes. Until the significance of spleen
is fully understood, either LDP or LSPDP could be
performed depending on the indication and the sur-
geon’s preference considering the similar clinical and
functional results.
PPP24-037
THE IMPACT OF CIRRHOSIS ON
SURGICAL OUTCOME AFTER
PANCREATODUODENECTOMY
A.E. Nakeeb, W. Askr and T. Abdalla
Mansoura University, Egypt
Introduction: Cirrhosis has been considered a contrain-
dication to major gastrointestinal surgery. Indication
for cancer treatment in cirrhotic patients has expanded.
The aim of this study was to elucidate surgical out-
comes of pancreatoduodenectomy (PD) in patients with
liver cirrhosis.
Method: We retrospectively studied all patients who
underwent PD in our center between January 2002 and
December 2011. Group A (patients with cirrhotic liver)
and Group B (patients with non-cirrhotic liver). Preop-
erative demographic data, intra-operative data, and
postoperative details were collected.
Results: Only 67/442 patients (15.2%) had cirrhotic
liver. Intraoperative blood loss and blood transfusion
were significantly more in cirrhotic (p = 0.0001). The
mean surgical time in group A was significantly longer
than that in group B (p = 0.0001). Wound complica-
tions (p = 0.02), internal haemorrhage (p = 0.05), pan-
creatic fistula (p = 0.02) and hospital mortality
(p = 0.0001) were significantly higher in cirrhotic
patients. Postoperative stay was significantly longer in
group A (p = 0.03). The median survival was
19 months in group A and 24 months in group B. Cir-
rhotic patients with portal hypertension (PHT) was
present in 16/67 cases (23.9%). The intraoperative
blood loss and blood transfusion were significantly
more in PHT (p = 0.001). Postopertive morbidity (0.07)
and hospital mortality (p = 0.007) were higher in cir-
rhotic with PHT.
Conclusions: Patients with periampullary tumour and
well-compensated chronic liver disease should routinely
be considered for PD at high volume centers with
expertise available to manage liver cirrhosis. PD is
associated with an increased risk of postoperative mor-
bidity in patients with liver cirrhosis, and therefore it is
only recommended in patients with Child A cirrhosis
without portal hypertension.
PPP24-038
UNUSUAL MIGRATION OF RINGED
POLYTETRAFLUOROETHYLENE
MIDDLE HEPATIC VEIN GRAFT INTO
THE STOMACH IN A PATIENT
UNDERGONE LIVING DONOR LIVER
TRANSPLANTATION
S.H. Kang, S. Hwang, K.-H. Kim, C.-S. Ahn,
D.-B. Moon, T.-Y. Ha and S.-G. Lee
Asan Medical Center, Ulsan University, Korea
Introduction: Large vein allografts are suitable for mid-
dle hepatic vein (MHV) reconstruction, but their supply
is often limited. We have presented that ringed polytet-
rafluoroethylene (PTFE) grafts combined with small
allograft patches showed high patency rates comparable
to those of iliac vein grafts; thus, they can be used for
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MHV reconstruction when other sizable vessel allo-
grafts are not available. No serious complication
related to the use of PTFE graft was reported yet.
Method: We recently experienced a case of unusual
migration of ringed PTFE graft into the stomach
among more than 300 patients who underwent living
donor liver transplantation (LDLT) using a modified
right lobe graft with PTFE graft.
Results: The patient was a 48-year-old male with hepa-
titis B virus-associated liver cirrhosis and model for
end-stage liver disease score of 16. The patient recov-
ered uneventfully and discharged after 2 weeks. On
computed tomography follow-up at 6 months, the
PTFE graft was partially buried into the stomach wall,
implicating unusual migration and penetration into the
stomach. The PTFE graft was occluded with partial
filling of luminal air. At this time, the patient com-
plained of any specific symptoms. Gastrofibroscopy
revealed the PTFE graft was freely exposed into the
gastric lumen. Laparotomy was performed and the
PTFE graft was removed. The perforated gastric wall
was primarily repaired. The patient recovered unevent-
fully.
Conclusions: Through this case, we suggest that it is
necessary to closely monitor the PTFE graft because
any unexpected complication can happen after LDLT.
PPP24-039
EVAUATION OF BISAP SCORING
SYSTEM IN STRATIFYING ACUTE
PANCREATITIS
S. Kurunkar, S. Pujari, R. Prabhu, A. Supe, R. Bapat
and C. Kantharia
Seth GS Medical College & Kem Hospiatl Parel,
Mumbai, India
Introduction: Multiple risk stratification tools for acute
pancreatitis have been developed, but their clinical use-
fulness is limited. BISAP score-a bed side index score
of severity has been recently reported to be effective.
The present study is an evaluation of the ability of BI-
SAP score in identifying the patients at risk for
increased morbidity and mortality, in patients of Acute
Pancreatitis.
Method: This is a Prospective analysis undertaken over
the period of last 6 years from May 2008 to May 2013.
All patients presenting with Acute Pancreatitis were
included in the study. All patients underwent a com-
plete hemogram, coagulation profile studies, serum cal-
cium, RFT, LFT, Blood gas analysis within 48 hours
of admission. A CECT of abdomen was performed
after 4 days of onset of disease and repeated as indi-
cated, depending upon the course of disease. All
patients were managed conservatively Their BISAP
score was evaluated in all patients within 24 hours of
presentation.
Results: 90 cases of acute pancreatitis were admitted
during the study period. BISAP scores were calculated
within 24 hours of presentation. 34.4% patients had
BISAP score more than or equal to 3 and 65.6% had
BISAP score less than 3. Mortality was 3.3% and
organ failure seen in 20% and pancreatic necrosis in
15.5% of patients. Alcoholism was common etiological
factor. BISAP scores of ≥3 were found to have risk of
mortality.
Conclusions: BISAP score represents a simple way to
identify patients at risk of increased mortality and the
development of intermediate markers of severity within
24 hours of presentation.
PPP24-040
A CASE OF PSEUDOMYXOMA
PRITONEI ASSOCIATED WITH
INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASM OF PANCREAS
WITH ACUTE ABDOMEN
H. Kano1, K. Kida1, N. Fukino1, A. Kawasaki1, K.
Mimatsu1, Y. Kuboi1, T. Takayama2 and T. Oida1
1Social Insurance Yokohama Central Hospital, Japan;
2Nihon University School of Medicine, Japan
Introduction: Pseudomyxoma peritonei (PMP) is rare
disease, affecting 1 to 2 persons per million annually.
PMP is characterized by this extensive gelatinous mucin
and mucinous ascites. PMP has always been thought
that cases of ovarian origin, those of appendiceal ori-
gin. Recently reported a few are associated with pan-
creatic intraductal papillary mucinous neoplasms
(IPMN). We reported a case of pseudomyxoma perit-
onei associated with IPMN of pancreas with acute
abdomen.
Method: A 89-year-old man presented upper abdomi-
nal pain as acute onset with nausea, vomiting and high
grade 38.6°C body temperature. Laboratory examina-
tion revealed WBC count of 9520/lL, CRP 3.92 mg/
dL. Abdominal CT scan revealed oligocystic pancreatic
tail tumor following low density mass from bursa
omentalis to surface of liver. MRI revealed oligocystic
IPMN of pancreatic tail. Next day, laboratory exami-
nation was aggravated WBC count of 15200/lL, CRP
21.86 mg/dL. Operation was performed, full filled yel-
low mucosa intraperitoneum, especially in bursa omen-
talis, underwent removed mucus washing out and
drainage only. Pancreatic IPMN resection was not per-
formed, for risk of complications.
Results: The patient presented clinical and laboratory
improvement. The histology of mucus was benign. The
mucus culture revealed Klebsiella pneumoniae. Serum
CEA was 3.3 ng/mL, CA19–9 was 3 U/mL and CA125
62.1 U/mL.
Conclusions: We reported a case of pseudomyxoma
peritonei associated with IPMN of pancreas with acute
abdomen. Main duct IMPN was recommended surgical
resection, but the indication of blanch duct IPMN are
more conservative. Two turns operation was thought
one method of surgical treatment of the psuedomyx-
oma peritonei from IPMN of pancreas.
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PPP24-041
LAPAROSCOPIC DISTAL
PANCREATECTOMY AND
SPLENECTOMY IN PATIENT WITH
PANCREATICO- PLEURAL FISTULA
AFTER RUPTURED PANCREATIC
PSEUDOCYST
J.I. Moon, I.S. Choi, S.U. Cheon, S.E. Lee, Y.M. Ra,
W.J. Choi and D.S. Yoon
Kunyang University Hospital, Korea
Introduction: The pancreatico-pleural fistula is an
uncommon type of pancreatitis complications. Pancrea-
tico-pleural fistula is reported to occur in approxi-
mately 0.4%. These patients may need to undergo a
complex multidisciplinary treatment.
Method: We present the case of a patient with pancrea-
tico-pleural fistula. We successfully treated with laparo-
scopic distal pancreatectomy and splenectomy.
Results: A 50-year-old female alcoholic with known
chronic pancreatitis and pseudocyst required repeated
PCD over 5 years period for management of a recurrent
acute pancreatitis and pseudocyst. She was admitted to
the hospital with 6 weeks history of right chest pain
which was progressively getting worse. She complained
of some abdominal discomfort, cough and dark brown-
ish hemoptysis. In the past medical history, she had DM,
HTN, and angina. On admission, vital signs were unre-
markable; physical examination revealed increased
breath sounds with coarse crackle over the right lower
lung fields. Abdominal examination was remarkable for
mild epigastric tenderness without rebound, guarding,
distention, or palpable abdominal mass. Basic labora-
tory studies showed leukocytosis (WBC: 14400/UL), and
elevated serum amylase (>15000 U/L). Thoracic, abdom-
inal CT and MRCP demonstrated a right pleural effu-
sion with evidence of chronic pancreatitis and a
periesophageal pseudocyst behind the tail of the pan-
creas where it was seen to communicate with the right
pericardial area and right mediastinum. A thoracotomy
tube was placed. Right pleural effusion revealed an amy-
lase activity of 83495 U/L, fluid protein concentration of
4.1 g/dL, and fluid cytology negative for malignant cells.
We performed laparoscopic distal pancreatectomy and
splenectomy. At the time of laparoscopic distal pancrea-
tectomy and splenectomy, fistula tract was noted to be
fibrotic. Histologly revealed chronic pancreatitis. She
discharged postoperative 7 days without complications.
Conclusions: Laparoscopic distal pancreatectomy is
considered one of the useful methods to use in the
cases of Pancreatico- pleural fistula.
PPP24-042
A CASE OF LAPAROSCOPIC DISTAL
PANCREATECTOMY FOR SOLID
PSEUDOPAPILLARY TUMOR OF
PANCREAS
J. Ishii, A. Tamura, Y. Otsuka, S. Kagami,
Y. Kubota, T. Maeda, T. Katagiri, M. Tsuchiya and
H. Kaneko
Toho University School of Medicine, Japan
Introduction: Solid pseudopapillary tumor is uncom-
mon neoplasm of the pancreas and occur mainly young
woman. This tumor is low malignancy and surgical
resection offers an excellent chance for long-term sur-
vival.
Method: A 52-year-old woman referred to our hospital
due to a pancreatic tail tumor diagnosed at a nearby
hospital. Computed tomography and urtrasonography
showed a cystic tumor 3 cm in diameter with calcifica-
tion in the pancreatic tail. Dynamic magnetic resonance
imaging study revealed the partial staining in the
tumor. Solid pseudopapillary tumor of the pancreas
was suspected, and laparoscopic distal pancreatectomy
and splenectomy was performed. The pancreas was
transected by using an endolinear stapler. The resected
specimen is maneuvered into a plastic bag and
extracted through an additional transverse suprapubic
incision 5 cm in diameter.
Results: Pathologically, the tumor was diagnosed solid
pseudopapillary tumor and complete resection was con-
firmed. The post operative course was complicated by a
pancreatic fistula grade B and the patient was dis-
charged from the hospital on the 40th postoperative
day. She has been followed up for 2 years without
recurrence.
Conclusions: Laparoscopic distal pancreatectomy has
been considered technically feasible, safe, and reproduc-
ible outcomes. It seems to exhibit several benefits of
minimally invasive surgery and should be performed in
carefully selected patients.
PPP24-043
COMPARISON OF OPEN WITH
LAPAROSCOPIC DISTAL
PANCREATECTOMY IN LOW VOLUME
CENTER
J. Jeon1, J. Jung2, D. Kim2, J. Kim2, S. Chon4 and
J. Hwang3
1College of Medicine, Hallym University, Korea;
2Gangdong Medical Center, Hallym University, Korea; 3
Chuncheon Medical Center, Hallym University, Korea;
4Hanriver Medical Center, Hallym University, Korea
Introduction: Most data in the literature regarding lap-
aroscopic distal pancreatectomy (LDP) originate from
high-volume centers and has led some to suggest that
LDP should be performed at these centers only. The
aim of this retrospective review is to report our experi-
ence and assess the safety and outcomes of LDP per-
formed in a low-volume hospital.
Method: We conducted a retrospective review of all
patients who underwent open distal pancreatectomies
(ODPs) and LDPs between August 2007 and June
2012. Data included type of surgery, open versus lapa-
roscopy, demographics, operative time, blood loss,
length of hospital stay, histopathologic diagnosis, post-
operative complications, American Society of Anesthe-
siologists score, and mortality.
Results: Fifty patients with benign or low grade malig-
nant pancreatic masses underwent distal pancreatic
resection during the study period. Twenty-eight patients
(56%) underwent LDP, and twenty-two patients (44%)
underwent ODP. Mean patient age was 66 (range, 20–
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83) for the LDP group and 62 (range, 27–75) for the
ODP group. Mean operative time was 211 minutes
(range, 190–342) for LDP and 240 (range, 138–228) for
the ODP technique. Mean length of stay for LDP and
ODP was 8 (range, 3–7) and 12 (range, 8–13), respec-
tively. Morbidity was 25% (n = 4) in the LDP group
and 36% (n = 4) in the ODP group. None of the differ-
ences between the LDP and ODP groups were statisti-
cally significant. No mortalities occurred in either
group.
Conclusions: This study supports the idea that LDP
can be safely and effectively performed in a low-volume
hospital. Further data are required to make more defin-
itive conclusions.
PPP24-044
EARLY POSTOPERATIVE CT SCAN
CAN HELP PREDICT DEVELOPMENT
OF CLINICALLY SIGNIFICANT
PANCREATIC FISTULA IN THE
PATIENTS WITH GRADE A ON THIRD
POSTOPERATIVE DAY AFTER
PANCREATICODUODENECTOMY
H. Uchinami, M. Yoshioka, G. Watanabe, Y. ABe and
Y. Yamamoto
Akita University, Japan
Introduction: Although high concentration of drain
amylase on POD3 after pancreaticoduodenectomy (PD)
is defined as pancreatic fistula (PF), it is difficult to pre-
dict whether the PF will be settled as only a transient
event or is the sign of clinically significant PF. We eval-
uated whether early postoperative CT examination at
the site of pancreatic anastomosis is helpful for diag-
nosing latent significant PF in the patients with high
drain amylase on POD3.
Method: We retrospectively analyzed 28 patients with
amylase-rich drainage fluid on POD3 and underwent
CT scan 3 to 7 days after PD. PF was defined accord-
ing to ISGPF.
Results: In 14 patients (50%), clinically significant PF
(12 grade B, 2 grade C) became evident after POD7.
However, there was no significant difference in the drain
amylase on POD3 between the patients in whom PF was
stayed in grade A (926  994 U/L) and those who devel-
oped grade B/C PF (1,728  1,863 U/L) although the
former was lower than the later. CT findings at the site of
pancreaticojejunostomy was classified into 4 types: type I
(n = 2), no intervening space between the stump of rem-
nant pancreas and jejunal wall; type II (n = 6), partly
intervening low density at the anastomotic site; type III
(n = 13), fully intervening low density at the anastomotic
site; and type IV (n = 7), fluid collection close to the
anastomosis. None of the patients of type I progressed to
grade B/C PF and only one patient of type II developed
grade B PF (1/6; 16.7%). Whereas, clinically significant
PF developed in 10 of 13 (76.9%) patients with type III
and 3 of 7 (42.9%) patients with type IV.
Conclusions: Conclusion: Assessment of CT imaging
during early postoperative period is valuable for detect-
ing latent grade B/C PF in the patients with high drain
amylase content on POD3 after PD.
PPP24-045
HYPERTHERMIC INTRAOPERATIVE
INTRAPERITONEAL CHEMOTHERAPY
FOR ADVANCED PANCREATIC
CANCER
H. Shiomi, S. Naka, H. Akabori, K. Murakami,
S. Murata, H. Yamamoto, A. Mizuno, Y. Kurumi and
T. Tani
Shiga Univerity of Medical Sciense, Japan
Introduction: Five-year survival in patients with pancre-
atic cancer is poor. Even though after curative resec-
tion, the rate of recurrent at distant organ and in
abdominal cavity is still high. Hyperthermic intraopera-
tive intraperitoneal chemotherapy (HIPEC) is tried for
various carcinomas to control local recurrence after R0
resection. This study is designed whether HIPEC is fea-
sible for the patients with pancreatic cancer.
Method: Seven patients underwent tumor resection,
and HIPEC with MMC, CDDP, and 5FU, with or
without GEM.
Results: Five patients had distal pancreatomy and two
distal pancreatomy with celiac axis resection. The hos-
pital mortality and morbidity rate was 0% and 57.1%,
respectively. Five-year and median survival was 23%
and 11 months, respectively. Two patients, whose oper-
ations were ended R2 resection, died by the tumor
progeression. However other patients showed no evi-
dence of recurrence. No patient showed adverse effect
by anticancer agents.
Conclusions: Increased morbidity and mortality from
intraoperative gemcitabine was not apparent. HIPEC
with potentially curative resection in combination for
patients with pancreatic cancer at body and tail were
feasible. Further studies with greater number of
patients including with pancreaticoduodenectomy are
required to confirm these findings.
PPP24-046
EARLY PREDICTION OF CLINICALLY
SIGNIFICANT POST-OPERATIVE
PANCREATIC FISTULA FOLLOWING
PANCREATICODUODENECTOMY IN
PANCREATIC HEAD CANCER
M.J. Jung, C.M. Kang, K.S. Kim, H.K. Hwang,
S.H. Choi and W.J. Lee
Severance Hospital, Yonsei University, Korea
Introduction: Pancreaticoduodenectomy is generally
accepted as a safe and effective treatment modality in
the treatment of pancreatic head cancer. However,
postoperative pancreatic fistula (POPF) still remained
important complication after pancreaticoduodenecto-
my. We experienced relatively early presentation of
POPF symptoms and elevation of peritoneal amylase
level in severe POPF patients, hence we evaluated the
peritoneal amylase level and systemic inflammatory
response syndrome at early postoperative periods as a
predictor of clinically significant POPF (POPF ≥ B).
Method: All patients who underwent pancreaticoduo-
denectomy with pancreatic head cancer in Yonsei Uni-
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versity Severance hospital between January 2005 to
December 2010 were studied. All patient‘s medical
records were retrospectively reviewed. We checked
peritoneal amylase level and existence of SIRS at post-
operative day 1, 3, 5, 7 and 10. We evaluated the corre-
lation between peritoneal amylase level and SIRS with
clinically significant POPF (POPF ≥ B) at POD 1, 3, 5,
7 and 10 days.
Results: 120 patients were finally enrolled in our study.
Male were 52.6% and female were 47.4%. The mean
age of the all patients was 61.9  9.6-years-old. POPF
occurred in 35 patients (29.2%), Grade A was 27
patients (22.5%), Grade B was 8 patients (6.7%) and
Grade C was not occurred. Sensitivity, Specificity, PPV
and NPV of Peritoneal amylase level and SIRS at POD
3 as prediction for POPF ≥ B were (100%, 100%),
(90.8%, 83.3%), (44.4%, 29.6%) and (100%, 100%).
Combination of peritoneal amylase level with SIRS at
POD 3 showed highly sensitive and accurate prediction
of POPF > B, sensitivity, specificity, PPV and NPV
were 100%, 91.3%, 80.0% and 100%.
Conclusions: In our study, combination of peritoneal
amylase level with SIRS at POD 3 predicted POPF ≥ B
showing high sensitivity and specificity. We believe
early prediction of severe POPF can helpful in that
early drain removal can be possible for less likely
expected patients and hospital days can be shortened
with faster recovery protocols.
PPP24-047
A RESECTED CASE OF INTRADUCTAL
TUBULOPAPILLARY NEOPLASM OF
THE PANCREAS, AND THE REVIEW OF
INTRADUCTAL NEOPLASMS OF THE
PANCREAS EXPERIENCED IN OUR
INSTITUTION
K. Kitaguchi, Y. Kato, N. Gotohda, H. Shibasaki,
T. Kinoshita, S. Takahashi and M. Konishi
National Cancer Center Hospital East, Japan
Introduction: Intraductal tubulopapillary neoplasm
(ITPN) was first reported in 2009 by Yamaguchi et al.,
and adopted by WHO classification 4th edition as in-
traductal neoplasms of the pancreas. ITPN is defined
as an intraductal, grossly visible, tubule-forming epithe-
lial neoplasm with high-grade dysplasia and ductal dif-
ferentiation without overt production of mucin.
According to epidemiological data, the frequency is
only 3% of intraductal neoplasms of the pancreas.
Method: We report a resected case of ITPN, and
review the resected cases of intraductal neoplasms of
the pancreas experienced between 2000 and 2012 in our
institution.
Results: First, we report a resected case of ITPN. The
case pertains to a male in his sixties. Ultrasonography
and CT scan revealed dilatation of the main pancreatic
duct, and detected a protruded lesion within it on the
pancreas head side. MRCP revealed interruption of the
main pancreatic duct at the tumor site, and beaded
dilatation on the pancreas body and tail side. We per-
formed pancreaticoduodenectomy in the diagnosis of
invasive ductal carcinoma. The resected specimen
showed that the tumor invaginated into the main pan-
creatic duct, and mucin was not found grossly. Histo-
logical finding was the outgrowth of high-grade
dysplastic cells, and the tumor cells partly infiltrated
the stroma. Taking in the perspective of the morpho-
logical feature of tubule-forming pattern and immuno-
histological findings, we diagnosed the tumor with
ITPN. Secondly, we describe the review of intraductal
neoplasms of the pancreas. Between 2000 and 2012, we
experienced 116 resected cases of intraductal neoplasms
of the pancreas, and extracted only 3 cases of ITPN
including one case of intraductal tublar carcinoma. The
frequency of ITPN is 2.6% of intraductal neoplasms of
the pancreas in our institution.
Conclusions: The frequency of ITPN in our institution
is similar to previous reports. ITPN is a new concept of
disease; therefore, additional accumulation of cases is
critically important.
PPP24-048
HLA-A*0201 RESTRICTED KIF20A AND
VEGFR1/2 EPITOPE PEPTIDE
COCKTAIL VACCINATION IN
PATIENTS WITH ADVANCED
PANCREATIC CANCER
A. Kenjo, T. Kimura, N. Sato, T. Sato, J. Haga,
T. Anazawa, T. Tsuchiya, K. Yoshida and
M. Gotoh
Fukushima Medical University, Japan
Introduction: Immunotherapy for pancreatic cancer is
expected to become one of the alternative treatments
for this intractable disease. We previously conducted
phase I/II clinical trial of HLA-A*0201 restricted anti-
angiogenic peptides (VEGFR1/2) vaccine therapy with
gemcitabine for unresectable advanced pancreatic can-
cer patients who previously treated with chemotherapy.
There was no patient with severe adverse event related
to this treatment. Three of 8 patients were in stable dis-
ease after two course of vaccination. One of these 3
patients survived more than 2 years (28.8 months) after
initiation of this treatment.
Method: We are conducting clinical trial using vaccine
cocktail containing VEGFR1/2 and KIF20A. KIF20A
is a novel tumor-associated antigen which induces
tumor-specific Cytotoxic T cells in HLA-A*0201-
positive population. This study is prospective non-
randomized, single arm phase I clinical mono-therapy
trial with a fixed dose, 1 mg of each peptides for
patients with advanced unresectable pancreatic cancer.
Peptide cocktail with incomplete Freund’s adjuvant is
administered subcutaneously every week. The primary
endpoint of this study is safety.
Results: At present, three patients have been enrolled
in this trial. All three patients were Stage IV and previ-
ously treated with chemotherapy. There was only one
grade 3 anemia which was probably caused by progres-
sion of primary disease without a definite relation with
peptide vaccine. MST of 3 patients was 3.8 months.
Conclusions: Phase I clinical mono-therapy trial using
HLA-A*0201 restricted peptide KIF20A and VEG-
FR1/2 is currently underway to validate the safety of
this treatment.
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PPP24-049
PANCREATICOGASTROSTOMY
THROUGH AN ANTERIOR
GASTROTOMY IN
PANCREATICODUODENECTOMY
J.W. Park and S.K. Lee
Catholic University of Korea, Daejeon St. Mary’s
Hospital, Korea
Introduction: Postoperative pancreatic fistula is the
leading cause of death and morbidity after pancreatico-
duodenectomy. However, the best reconstruction
method to reduce occurrence of fistula is debated. Pan-
creaticogastrostomy (PG) has recently been reappraised
as a more secure procedure over pancreaticojejunosto-
my (PJ). In this study we describe our technique of PG
after PD: one layer continuous suture method through
an anterior gastrotomy.
Method: We retrospectively analyzed early surgical
outcomes in 9 consecutive patients who underwent this
PG after pancreaticoduodenectomy by a single surgeon
between August 2012 and August 2013. PG was com-
pleted with one layer continuous suture through the
retracted anterior gastrotomy.
Results: The patients consisted of 4 men and 5 women,
with an average age of 66.4 years (range, 53–74 years).
Of the 9 patients, 6 patients had a soft and the remain-
ing 3 had a firm pancreatic texture. The mean pancre-
atic duct size was 5.1 mm (2–10 mm) and the mean
operating time was 591 minutes (480–720 minutes).
The mean blood loss was 862.5 mL (300–2500 mL) and
the mean duration of postoperative hospitalization was
21.7 days (13–28 days). There were 1 patient with
abdominal fluid collection needed drainage and 3
patients with wound problem with conservative care.
And delayed gastric empting was developed in 3
patients then they recovered with conservative care.
There were no operative or hospital mortality and no
grade B or C pancreatic fistula occurred.
Conclusions: In our experience, this technique is simple
to perform and it has several advantages over the con-
ventional PG or PJ: it could be less traumatic to the
pancreatic stump and more secure suture is possible
due to good vision through anterior gastrotomy. How-
ever, to insist advantage of this technique, we need ran-
domized controlled trial in large scale.
PPP24-050
USEFUL PARAMETERS FOR
CONTINUOUS EVALUATION OF
NUTRITIONAL AND INFLAMMATORY
STATUS UNDER CHEMOTHERAPY
FOR ADVANCED PANCREATIC
CANCER
S. Wakiyama, T. Uwagawa, T. Iida, H. Shiba,
Y. Futagawa, Y. Toyama, Y. Ishida and K. Yanaga
The Jikei University School of Medicine, Japan
Introduction: Nutritional and inflammatory status are
suggested to be important for cancer cachexia and
prognosis, and may be influenced by treatment for can-
cer. The aim of the present study is to identify useful
parameters for continuous evaluation of nutritional
and inflammatory status under chemotherapy for
advanced pancreatic cancer.
Method: From January 2007 through September 2010,
we performed chemotherapy for 41 unresectable pan-
creatic cancer. Their median age was 64 years, and
male:female ratio was 29:12. The applied chemotherapy
was the combined therapy with gemcitabine and nafa-
mostat mesilate. (1) We investigated the prognostic fac-
tors at the following 3 points (before chemotherapy,
1 month and 3 months after starting chemotherapy) by
a uni- and multi-variate analyses of their clinical data
including age, albumin, tumor markers, CRP, white
blood cell count (WBC), neutrophil count, lymphocyte
count, and NLR (neutrophil-to-lymphocyte ratio). (2)
The changes of NLR and CRP were serially compared
during a period between pre-chemotherapy and
3 months after starting chemotherapy.
Results: (1) Uni- and multi-variate analyses showed
that NLR ≦ 4 and CRP ≦ 0.4 to be independent prog-
nostic factors (p < 0.05 each) at pre-chemotherapy,
NLR ≦ 4, and CRP ≦ 0.4 at 1 month after chemother-
apy (p < 0.05 each), and NLR ≦ 5 and CRP ≦ 0.4 at
3 months after chemotherapy (p < 0.01 each). (2) NLR
and CRP varied during the 3 months after starting che-
motherapy.
Conclusions: NLR and CRP might be useful parame-
ters for continuous evaluation of nutritional and
inflammatory status under chemotherapy for advanced
pancreatic cancer.
PPP24-051
OUTCOME OF CONVERSION SURGERY
FOLLOWING CHEMOTHERAPY FOR
LOCALLY-ADVANCED UNRESECTABLE
PANCREATIC CANCER
K. Wada, K. Sano, H. Amano, F. Miura,
N. Toyota, H. Ito, Y. Aoyagi, Y. Ikeda and
M. Kainuma
Teikyo University School of Medicine, Japan
Introduction: Recent advances in chemotherapy for
pancreatic ductal adenocarcinoma (PDCA) may give
opportunity with conversion surgery to patients with
unresectable pancreatic cancer, which has rarely been
done in the past. In this study we investigated conver-
sion rate for surgery and outcome in patients with
locally-advanced unresectable PDAC whom initial
treatment with chemotherapy was administered.
Method: Between 2010 and 2012 we prospectively col-
lected 19 consecutive patients with locally-advanced un-
resectable PDAC whom chemotherapy with
gemcitabine with S1 (GS) was given as an initial anti-
cancer treatment. Follow up CT was taken every
3 month. Conversion surgery is considered if primary
tumor status remains RECIST-SD or better, and if R0
resection is deemed after 6 months.
Results: Response to the initial chemotherapy with GS
during the initial 6 month was 5 PRs, 8 SDs, and 6
PDs, resulting in a response rate of 26% and a disease
control rate of 68%. Conversion surgery was scheduled
for 6 (32%) patients whose response was PR in 5 and
SD in 1. At laparotomy, 2 cases ended up with probe
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laparotomy due to peritoneal dissemination in 1, and
locally far advanced disease in 1, thus 4 cases (21%)
successfully achieved R0 resection. Pathologically, anti-
tumor effect such as tumor necrosis with dense fibrosis
and desmoplastic change was seen in all of the 4
resected specimens, but no complete response was
found. Survival is favorable for patients with conver-
sion surgery; one died of severe cholangitis without
recurrence at 20 months after the initial treatment, and
remaining 3 patients are alive without recurrence for
34, 27, 8 months, respectively.
Conclusions: Surgical resection remains only hope for
cure for PDAC. A conversion surgery may be vital
option even for initially unresectable PDAC if good
response to chemotherapy is obtained.
PPP24-052
DISTAL PANCREATECTOMY WITH EN
BLOC CELIAC AXIS RESECTION (DP-
CAR) FOR LOCALLY UNRESECTABLE
PANCREATIC BODY CANCER
T. Nakamura, S. Hirano, T. Asano, N. Sato, Y. Shoji,
E. Tamoto, Y. Nakanishi, J. Matsumoto,
T. Tsuchikawa and E. Tanaka
Hokkaido University Graduate School of Medicine,
Japan
Introduction: To evaluate the prognostic impact of sur-
gical intervention for initially-unresectable pancreatic
body ductal adenocarcinomas with long-term favorable
responses to the chemo (radio) therapy.
Method: Eight patients with initially-unresectable pan-
creatic body cancer who underwent radical surgery
after a favorable response to chemo (radio) therapy for
six months or longer in principle were enrolled in this
study. We retrospectively reviewed the charts of these 8
patients and performed a survival analysis.
Results: Initially, the included 8 patients were unable to
undergo resection for locally-advanced disease, and con-
verted to the radical operation after the chemo (radio)
therapy. The initial unresectable factors were as follows;
four patients had tumor invasion to the gastroduodenal
artery, 3 patients had tumor invasion to the superiorme-
thentric artery (SMA), and 1 patient had tumor invasion
to the ceriac artery. The length of preoperative therapy
was 6 to 44 months (median 14). The operative proce-
dure included resection of celiac axis initially involved by
the tumor. The postoperative mortality rates were 0%.
The R0 resection was achieved in seven patients (87%).
The pathological treatment effect was judged by Evans
grading to be grade I in four patients, and grade IIa, IIb
III and IV in 1 patient respectively. All the 7 patients
who had the R0 resection are survived with disease free,
however, 1 patient who was the R1 resection with SMA
invasion was dead with local recurrence. Estimated over-
all five-year survival from the initial therapy was 87%
(median follow up time 54 month, range 15–92).
Conclusions: Surgical intervention should be considered
for patients with initially-unresectable pancreatic body
cancers who demonstrate long-term favorable responses
to chemotherapy. Large cohort prospective studies will
be necessary to demonstrate the efficacy of this strat-
egy.
PPP24-053
SURGERY TO THE EXTREME: THE
CONCEPT OF “TRANSPLANT
ONCOLOGY”
T. Hibi, Y. Abe, O. Itano, H. Obara, H. Kohno,
M. Shinoda, M. Kitago, H. Yagi and Y. Kitagawa
Keio University School of Medicine, Japan
Introduction: Extreme cases of abdominal pathology
are a significant challenge both from the technical and
tumor biological perspective. We describe 3 patients
who underwent extended resections involving the pan-
creas under the principle of “no-touch isolation” and
by using techniques derived from liver/multivisceral
transplant and organ procurement.
Method: Case 1: A 69-years woman presented with
massive retroperitoneal recurrence of a liposarcoma
invading adjacent organs and vital vessels. After creat-
ing an axillo-femoral bypass, en-bloc resection with a
Whipple procedure, concurrent right hemicolectomy
and nephrectomy, and excision of the infrarenal aorta
distally at the bifurcation and inferior vena cava just
below the left renal vein down to the confluence was
performed. Case 2: A 36-years man developed tumor
thrombi in the main portal trunk and superior mesen-
teric vein after a Whipple procedure for a neuroendo-
crine tumor. We put the patient on portal bypass
between the tributary of the superior mesenteric vein
and right gonadal vein. The portomesenteric vein with
tumor thrombi was excised and reconstructed with an
autologous right femoral venous graft. Case 3: A 38-
years woman suffered ruptured renal cell carcinoma of
the left kidney with a tumor thrombus obstructing the
left renal vein. The ruptured tumor spread beyond
the kidney cranially/ventrally but was encapsulated by
the pancreas and spleen. After full mobilization of the
right colon and jejunum to approach the inferior vena
cava, the spleen, pancreas, and left kidney were mobi-
lized en-bloc to avoid tumor manipulation. Extended
left nephrectomy with distal pancreatectomy and sple-
nectomy was performed without exposing the tumor
capsule.
Results: Major complications included postoperative
bleeding and chylous ascites but no in-hospital mortali-
ties occurred. All patients resumed normal daily life
with no signs of recurrence during a follow-up period
of 3–6 months.
Conclusions: The integration of surgical oncology and
organ transplant, “Transplant Oncology,” has opened
up new horizons in the field of surgery.
PPP24-055
THE INDIGENOUS YOUNG MAN WITH
PROGRESSIVE ABDOMINAL
DISTENSION
Z. Zuhdi, N. Afdzillah, A. Azman, A. Ariffin,
H. Othman and R. Jarmin
Z Zamri, Malaysia
Introduction: Pancreatic ascites was first reported in
1953. It is commonly affected in male between age 20–
50-years-old. We reported a case of progressing abdom-
inal ascites in a young healthy man.
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Method and Results: This is a case of 22-year-old gen-
tleman with a complaint of progressive abdominal dis-
tention for the past 1 month. It was associated with
intermittent epigastric discomfort, loss of weight and
steatorrhoea. He had a history of recurrent pancreatitis
attack for the past 2 months. On examination he was
cachexic with a BMI of 21, dehydrated with a gross dis-
tended abdomen suggestive of ascites. Abdominal ultra-
sound revealed gross ascites fluid intraperitoneal with a
normal liver and pancreas. Peritoneal tapping was done
and the fluid was sent for cytology and the result come
back as negative. Only the body fluid amylase was
64000 U/L. Therefore CT scan of the abdomen was
done for further investigation. CT scan abdomen
showed a well defined cystic lesion at the body of the
pancreas measuring 4.7 9 4.9 9 5 with a continuity of
this lesion with the main pancreatic duct. There is also a
soft tissue density lesion within the pancreatic duct at
the region of the head of pancreas. Endoscopic retro-
grade pancreatogram was performed, however it was
unable to cannulate the pancreatic duct. Patient was
underwent laparotomy with Frey Procedure. Intraoper-
atively there was a stone at the pancreatic head that
obstructing the pancreatic duct with distal pancreatic
duct dilatation. Postoperatively he was uneventful.
There was no ascites fluid and he was discharge well.
Conclusions: Pancreatic ascites is an uncommon sequa-
lae of chronic pancreatitis. Its required CT scan imag-
ing to determine the causes for the chronic pancreatitis.
ERCP is recommend as a first line treatment however
Frey Procedure is an option if failure in managing
endoscopically.
PPP24-056
MODERATELY DIFFERENTIATED
ADENOCARCINOMA OF THE THIRD
DUODENAL PORTION ORIGINATED IN
A TUBULAR ADENOMA
M.J. Fuertes, M.D. Poveda, D.A. Jimenez,
E.R. Cuellar, C. Nevado, G.D. Garcıa, A. Moreno,
J.G. Gonzalez, A.M. Pozuelo and P.A. Pe
Rey Juan Carlos Hospital, Spain
Introduction: Duodenal carcinoma is very rare. It rep-
resents only the 33–45% of the all tumors of the small
bowel. The symptoms are nonspecific, and the diagno-
sis is often accidental. We present a case of the adeno-
carcinoma of the third duodenal portion.
Method: Case: A 35-year-old man was admitted to our
hospital with postprandial abdominal pain. Upper gas-
trointestinal examination revealed tumor of the third
duodenal portion, which was diagnosed as a tubular
adenoma with high grade dysplasia by endoscopic
biopsy. The serum levels of tumoral markers were nor-
mal. The CAT scan, the MRI and the echoendoscopy
showed the neoplasia of the second and third duodenal
portion without lymph node or peritoneal metastases.
Results: Partial resection of the duodenum (second,
third and fourth portions) was performed (negative
lymph node metastasis with no macroscopic invasion
of the pancreas. The postoperative course was unevent-
ful. The patient started oral feeding in the third postop-
erative day and he was discharged on the 7th day. The
definitive histopathological diagnosis was primary ade-
nocarcinoma of the third duodenal portion pT2 N0M0,
and he is without any sign of recurrence.
Conclusions: Primitive neoplasia of the duodenum is
very rare (0.3–0.5% of all gastroenteral malignancies).
The third and fourth duodenal portions are the most
common areas (45%), with 40% in the second and
15% in the first. The symptoms are not specific. Endos-
copy with biopsy is the diagnostic gold standard (but it
are usual false negative in the third and fourth duode-
nal portions). For the treatment, duodeno-cephalo-pan-
createctomy is recommended in proximally localized
tumors, while segmental resection of the duodenum is
appropriated for distal localizations, because segmental
resection has less complications, an easier postoperative
management and the same survival.
PPP24-057
A CASE OF DUODENAL
GANGLIOCYTIC PARAGANGLIOMA
WITH REGIONAL LYMPH NODE
METASTASIS
S.B. Choi1, P.J. Park1, H.J. Han2, W.B. Kim1,
T.J. Song2 and S.Y. Choi1
1Korea University Guro Hospital, Korea; 2Korea
University Ansan Hospital, Korea
Introduction: Gangliocytic paraganglioma derived from
neural crest is an unusual neuroendocrine tumor having
a characteristic triphasic microscopic appearance with
epitheloid cells, spindle cells, and ganglion cells. It is
generally considered to be a benign perampullary
lesion. Therefore local excision has been recommended.
However, several authors have reported a rare case of
gangliocytic paraganglioma demonstrating metastatic
lesion. Here, we report a case of gangliocytic paragan-
glioma with regional lymph node metastasis that was
performed pancreaticoduodenectomy.
Method: A 41-year-old man was admitted due to he-
matemesis. Upon arrival, he was evaluated and under-
went an esophagogastroduodenoscopy that revealed a
large submucosal tumor at second portion of duode-
num near ampulla of Vater. At first, the endoscopist
tried endoscopic mucosal resection regarding the tumor
as a gastrointestinal stromal tumor (GIST), however,
he was obliged to stop the procedure due to active
bleeding. Therefore the patient was referred to our
department to perform operation.
On exploration, there was an 1.5 cm-sized lymph node
in the paraduodenal area, which was located in the bor-
der between pancreas and second portion of duode-
num. The lymph node was proven to be a metastatic
malignant lesion in the frozen biopsy. Therefore we
decided to perform pancreaticoduodenectomy. Grossly,
the mass was soft, 2.5 9 1.7 9 0.9 cm in size, well
demarcated, located near the ampulla of Vater. Patho-
logically, the duodenal mass was a gangliocytic para-
gangliomoa with mitotic count <1/50 HPF. The tumor
invaded the duodenal wall from mucosa to muscle
proper layer. The tumor was positive cellular reaction
for chromogranin, synaptophysin, neurofilament by
immunohistochemistry. There was one metastatic
lymph node among 11 retrieved lymph nodes.
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Results:
Conclusions: Radical surgery was necessary in a patient
with lymph node metastasis. Close follow-up was advo-
cated because gangliocytic paraganglioma with lymph
node metastasis was considered as tumors with uncer-
tain malignant potential.
PPP24-058
SURGERY FOR WALLED OFF
PANCREATIC NECROSIS
P. Sinha1, N. Agrawal1, A. Arora1, V. Mangla1,
K. Bharthy1, S. Kumar1, V. Pamecha1 and S. Negi1
1Institute of Liver and Biliary Sciences, India
Introduction: Walled off pancreatic necrosis (WOPN) is
a recently recognized entity and there are very few reports
about its surgical management. Optimum management
strategy for this condition is yet to be established.
Method: WOPN was defined as per the revised Atlanta
classification, 2012. Data on patient profile, surgical
management and outcome was analyzed for cases of
WOPN managed in the Department of HPB Surgery,
Institute of Liver and Biliary Sciences from September
2009 to June 2013.
Results: A total of 11 patients were operated upon for
WOPN. The indications were persistent pain in 7
patients, weight loss in 3 patients, sepsis in 4 patients
and rupture in 1 patient. Median duration of pancreati-
tis at the time of surgery was 56 days (range 40–
180 days). Surgeries performed were open transgastric
necrosectomy in 4 patients, laparoscopic transgastric
necrosectomy in 3 patients, open necrosectomy with
closed lesser sac lavage in 1 patient, laparoscopic necro-
sectomy with closed lesser sac lavage in 1 patient,
transjejunal necrosectomy with cystojejunostomy in 1
patient, necrosectomy with cystojejunostomy in 1
patient. Mean blood loss was 90  100 mL and mean
operating time was 271  75 minutes. Median duration
of postoperative stay was 10 days (range 4–60 days).
There was 1 mortality due to sepsis and multiorgan
dysfunction. Five patients had complications in the
postoperative period among which 4 events were Cla-
vien–Dindo grade III-V. The 2 patients who underwent
necrosectomy with lesser sac drainage developed post
operative pancreatic fistula. Two patients had infected
pancreatic necrosis, one of whom died and the other
had prolonged hospital stay.
Conclusions: WOPN is a clinic-radiological entity
which can have varied presentations. Appropriate sur-
gical management tailored to individual patient results
in good outcome.
PPP24-059
EVALUATION OF DUODENAL
METALLIC STENT PLACEMENT FOR
PANCREATO-BILIARY CANCER
M. Noda, K. Maemura, Y. Mataki, Y. Kawasaki,
H. Kurahara, S. Ueno, S. Takao, H. Shinchi and
S. Natsugoe
Kagoshima University, Japan
Introduction: Malignant gastric outlet obstruction
(GOO) is often seen in advanced pancreato-biliary
cancer patients. We estimated the utility of Self-
expanding metallic stents (SEMS) for GOO.
Method: The eight consecutive patients who had GOO
due to ampullary or periampullary malignant tumor
were performed SEMS between January 2005 and June
2014 in our department. Average age was 65 (50–83)
year-old. ECOG performance status was less than 1 for
all patients. The cause of GOO was pancreas head can-
cer in six patients, recurrence of bile duct cancer in 1
patients and papilla of Vater cancer in 1 patient. Clini-
cal stage (TNM classification) of seven patients were
StageIII, and 1 patient was StageIIa. The esophageal
type SEMS were placed in 2 patients until 2009. After
2010, Wall Flex Stent or Niti-S stents were introduced
as improved type SEMS for 6 patients.
Results: The esophageal type SEMS caused duodenal
stenosis by kinking of anal side of duodenum in one
patient and obstructive jaundice by compression of
papilla of Vater in another. After 2010, all patients who
used improved type were able to drink the next day of
SEMS placement, and were treated with chemotherapy
or chemoradiotherapy within two weeks. There were no
complication due to the SEMS treatment in this group.
Conclusions: Recent type of SEMS placement for GOO
is safe and effective because of not only maintain of
quality of life but also early start of multimodality
treatment for cancer.
PPP24-060
EXTRA-GASTROINTESTINAL
STROMAL TUMOR OF THE
PANCREAS: REPORT OF A CASE
S.G. Kim, H.J. Kwon, J.M. Chun and Y.J. Hwang
Kyeongpook National University School of Medicine,
Korea
Introduction: Gastrointestinal tumors are mesenchymal
tumors that arise from the gastrointestinal tract. These
tumors are mainly stomach, jejuneum and ileum. In
rare cases, these tumors are found in the pancreas.
EGISTs of the pancreas are exceedingly rare and only
eleven cases have been reported in the literature, so
clinicopathologic features are not fully elucidated.
Herein, We report a case of a pancreatic extragastroin-
testinal stromal tumor in a 64-year-old female patient
together with a review of the literature.
Method: We report a case of GIST in the pancreatic
head. A 64-year-old woman was referred to us for
treatment of an abdominal mass detected by ultrasono-
graphic examination. Under a preoperative diagnosis of
a duodenal GIST, we performed a pylorus preserving
pancreatoduodenectomy for this lesion.
Results: The laboratory examination was within nor-
mal range. On pathologic gross examination, the tumor
measured 7 cm at its greatest dimension and involved
the pancreatic head. The cut surface was rubbery and
white. It was surrounded by a thin pseudocapsule and
well demarcated, but shown to infiltrate the duodenal
wall. Histopathological examination of specimen
showed a cellular lesion with compressed pancreatic tis-
sue at peripheral. Mitotic figures were 5/50 high power
fielded. Immunohistochemically, neoplastic cells were
positive for antibodies against C-KIT (CD117);
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whereas, smooth-muscle actin, reactions with antibodies
against S-100, CD34 and desmin were negative. Based
on the above findings, the tumor was finally diagnosed
as malignant GISTs originating from the pancreas.
Conclusions: Although rare, EGISTs should be consid-
ered in the differential diagnosis of the more common
solid neoplasms of the pancreas.
PPP24-061
THE CASE REPORT WHICH
ENFORCED AN OPERATION AND
CHEMOTHERAPY FOR HUGE P-NEC
(PANCREATIC NEUROENDOCRINE
CARCINOMA)
T. Shimizu1, S. Miyakawa1, S. Fujita1, H. Yamaguchi1,
K. Tsuda1 and A. Horiguchi2
1Toyota Community Health Center, Japan; 2Fujita
Health University, Japan
Introduction: P-NEC (pancreatic neuroendocrine carci-
noma) can be rarely operated, because it show high
grade malignancy and grow rapidly. We experienced
operable huge P-NEC, we report it.
Method: A patient is a 40-years-old man. The chief
complaint is abdominal pain and abdominal distension.
We found a huge pancreas tumor in CT, and P-NEC
was diagnosed by CT guide biopsy(poorly differenti-
ated neuroendcrine carcinoma: Immunostaining: chro-
mogranineA(+) synaptophysin() CD56() c-kit()
CD34() MelanA() Melanoma() CK AE1/3(+) posi-
tive rate of MIB-1 47.3% G3). We performed distal
pancreatectomy, total gastrectomy and left lobectomy
(poorly differentiated neuroendcrine carcinoma (P-
NEC). Ptb TS3 nodular type pCH() pDU() pS(+)
pRP() pPV() pA() pPL() pOO(+stomach liver)
med INFb ly2 v1 ne1 mpd() NEC(WHO) pT3N0M0
(AJCC/UICC)).
But POM(post operative month) 2 we found liver
metastasis and peritoneum dissemination. Therefore we
started chemotherapy (CDDP + CPT11 Day1 CDDP
60/m2 + CPT11 60/m2 Day15 CPT11 60/m2/4w) and
somatostatin analogue treatment (20 mg/4w).
Results: POM7, the liver metastasis and the perito-
neum dissemination reduced. (PR partial response).
Conclusions: We experienced a rare operable case of P-
NEC (pancreatic neuroendocrine carcinoma). P-NEC
has a dismal prognosis. Our case recurred after operation
in two months, too. However, by chemotherapy and
somatostatin analogue treatment, we was able to reduce
the recurrence. We think that a combination of operation
and chemotherapy improves the prognosis of P-NEC.
PPP24-062
TECHNICAL ASPECTS OF
TRANSVAGINAL NOTES LIVER
RESECTION IN PORCINE MODEL
T. Katagiri, J. Ishii, T. Maeda, Y. Kubota,
S. Kagami, M. Tsuchiya, A. Tamura, Y. Otsuka and
H. Kaneko
Toho University, Japan
Introduction: NOTES (Natural orifice translumenal
endoscopic surgery) liver resection is significantly lim-
ited by the technical difficulty encountered during tran-
section of substantial liver parenchyma, with
intraoperative bleeding and bile leaks. This study shows
the technical aspects of transvaginal NOTES liver
resection in porcine model.
Method: A total of 3 female porcines were underwent
transvaginal NOTES liver resections. The procedures
were partial and left lateral liver resections. A single
10 mm laparoscope was placed at the umbilicus, A
15 mm transvaginal trocar was placed under direct
vision. The flexible endoscope and a long flexible surgi-
cal grasper were placed via the vaginal trocar. The ten-
tative tumor and resection line were marked on the
surface of liver presumptively. The edge of liver was
transected partially using LCS, laparoscopic sealing
device from the umbilical port. The long laparoscopic
linear stapler was inserted through the side of vaginal
trocar and transected left lateral lobe. The specimen
was placed into the endobag and removed easily via
the vaginal trocar in partial resection cases. However,
the left lateral liver specimen could not remove via the
vaginal trocar. Necropsy studies were performed after
procedures and evaluated the hemorrhage and bile
leakage.
Results: The transvaginal NOTES liver resection was
successfully performed without hemorrhage and bile
leak in all cases.Mean operative time was 110 minutes.
Estimated blood loss was less than 50 mL. Mean length
of speciments were 5.8 cm in diameter.
Conclusions: In this initial report on feasibility of
transvaginal NOTES liver resction, we were able to
perform the procedures with minimal blood loss. Limit-
ted trocars were made more difficlut trianglation com-
pare with the laparoscopic liver resection. Further data
will be needed to determine the true safety and efficacy
of clinical NOTES.
PPP24-063
THE CLINICAL CHARACTERISTICS OF
AUTOIMMUNE PANCREATITIS AND
MIKULICZ’S DISEASE AS IGG4-
RELATED DISEASES
H. Shiomi, H. Kutsumi, Y. Shiomi, M. Takenaka,
A. Masuda, M. Sugimoto, Y. Arisaka and
T. Azuma
School of Medicine, Kobe University Graduate, Japan
Introduction: IgG4-related disease is a group of recently
recognized multi-organ disorders characterized by a high
level of serum IgG4 and dense infiltration of IgG4-posi-
tive cells into multiple organs. Autoimmune pancreatitis
(AIP) has recently been recognized as IgG4-related dis-
ease, and Mikulicz’s disease (MD) is characterized by
salivary and lacrimal infiltration. Despite the fact that
both AIP and MD are included in the IgG4-related dis-
ease, the clinical manifestation of AIP differs somewhat
from that of MD. We analyzed the clinical features of
AIP patients associated with MD.
Method: We analyzed data on AIP and MD patients.
A total of 32 AIP patients were divided into 2 groups:
those with and without MD. The clinical findings in
each group were compared to determine any recogniz-
able patterns.
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Results: MD was observed in 11 AIP patients (34%).
The average age of AIP patients with MD was signifi-
cantly lower than in patients without MD (55.5  14.5
vs 65.2  8.2-years-old, p = 0.021). A significantly
higher proportion of females was also noted in the
group of AIP patients with MD in comparison to those
without (p = 0.027). In addition, there were significant
differences in not only the levels of serum IgG and
IgG4 but also the site of pancreatic enlargement.
Conclusions: AIP patients with MD have distinctive
clinical features, including predominance of females
and onset at a young age, which clearly differ from
those of AIP patients without MD.
PPP24-064
RISK FACTORS OF PANCREATIC
FISTULA AFTER
PANCREATICODUODENECTOMY:
ANALYSIS OF 532 CONSECUTIVE
CASES
S. Fu, S. Shen, S. Li, Y. Hua, L. Liang and
B. Peng
The First Affiliated Hospital, Sun Yat-sen University,
China
Introduction: Pancreatic fistula (PF) remains the most
challenging complication after pancreaticoduodenecto-
my (PD). The purpose of this study was to find the risk
factors of PF following PD.
Method: From April 2000 to November 2011, a total
of 532 patients underwent PD for various indications
in our center. Demographic data, intraoperative proce-
dures, and postoperative data were collected. Patients
were divided into group 1 (PF) and group 2 (no PF).
Preoperative, intraoperative, and postoperative out-
comes were compared between 2 groups.
Results: PF was found in 65 (12.2%) cases, of whom
11 were classified into ISGPF grade A, 42 grade B, and
12 grade C. Clinically serious postoperative complica-
tions in the PF versus no PF group were mortality
(p = 0.006), abdominal bleeding (p = 0.002), bile leak
(p = 0.028), intraabdominal abscess (p < 0.001), pneu-
monia (p = 0.026) and reoperation (p < 0.001). Univar-
iate and multivariate analysis showed that blood loss
≥500 mL (hazard ratio [HR] = 2.281; 95% confidence
interval [CI] 1.334–3.901; p = 0.003), pancreatic duct
diameter ≤3 mm (HR = 0.351; 95% CI, 0.192–0.641;
p = 0.001) and pancreaticojejunostomy type
(HR = 1.355; 95% CI, 1.007–1.823; p = 0.045) were
independent risk factors of PF after PD.
Conclusions: PF was a severe complication following
PD and was related with more mortality, longer hospi-
tal stay, and other complications. Blood loss ≥500mL,
pancreatic duct diameter ≤3 mm and pancreaticojejun-
ostomy type were independent risk factors of PF after
PD.
PPP24-065
MALIGNANT PERIAMPULLARY
TUMORS
Mario A. Secchi, L. Rossi, L. Quadrelli,
M. Cantaberta, I. Carossi and E. Mateljan
Argentina
Introduction: Periampullary tumors include a wide
spectrum of diseases that affect the periampullary
region. Share clinical features, but differ in behavior,
frequency and prognosis. But older increases the possi-
bility of malignancy. At first may be malignant: adeno-
carcinoma ampullary or head of pancreas cancer
(80%), cholangiocarcinoma distal, Lymphomas, neuro-
endocrine, duodenal cancer and neoplastic cystic.
The purpose of grouping is due to their similar clinical
presentation, diagnosis and common treatment.
Method: Periampullary tumors include a wide spectrum
of diseases that affect the periampullary region. Share
clinical features, but differ in behavior, frequency and
prognosis. But older increases the possibility of malig-
nancy. At first may be malignant: adenocarcinoma
ampullary or head of pancreas cancer (80%), cholan-
giocarcinoma distal, Lymphomas, neuroendocrine, duo-
denal cancer and neoplastic cystic. The purpose of
grouping is due to their clinical.
Results: 89 patients were men and 52 women. Resec-
tion were: R1: n = 115; R1: n = 19 and R2: n = 7:
Morbidity was 38%. Mortality was 3.3%. In posopera-
tive non radical pancreaticoduodenectomy R1 and R2
a large chimio adyuvance was used. The 2012 follow-
up was: Survival rate (free desease) R0: n = 115:1 year:
87% and 5 years: 28%; R1: n = 19: 1 years 71% and
5 years: 14%, and R2: n = 7: 1 year: 55% and 5 year:
0%. (p < 0.05 R0 vs R1 in 1 and 5 years survival.
Prognostic factors were determining the type and origin
of the tumor, as well as tumor size (<2 cm longer sur-
vival).
Conclusions: In malignant periampullary tumors, the
early diagnosis and the surgery improves the prognosis.
Curative R0 resection is the most important, and adju-
vant chemotherapy improves outcome in some R0 cases
and in all R1 and R2 cases.
PPP24-066
ORGAN SPACE INFECTION AS A
SURROGATE FOR PANCREATIC
FISTULA IN THE NATIONAL
SURGICAL QUALITY IMPROVEMENT
PROGRAM
C. Scaife1, C. Johnston2, R. Glasgow1 and
S. Mulvihill1
1University of utah Huntsman Cancer Institute, USA;
2Providence Cancer Center, Portland Oregon, USA
Introduction: Postoperative Pancreatic fistula (POPF)
remains the dominant cause of morbidity following
major pancreatic resection. The National Surgical
Quality Improvement Program (NSQIP) database has
been criticized because it does not include specific data
pertaining to POPF. An HPB specific dataset has been
introduced in selected centers to prospectively correct
this deficiency. Many authors have suggested that
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organ space infection (OSI) is a surrogate for POPF.
The aim of this study is to determine the sensitivity
and specificity of OSI as an indicator of POPF.
Method: All pancreaticoduodenectomies (PD) at our
institution from 2001 to 2010 were identified from the
NSQIP dataset. In the 9 year study period, 204 patients
underwent a PD. The NSQIP database and patient
charts were abstracted for pertinent data related to
organ space infection and pancreatic fistula. POPF was
defined according to International Study Group on
Pancreatic Fistula (ISPF) criteria, and severity of
POPF was graded as A, B or C.
Results: 40 patients (20%) in this study group had a
POPF (grade A–C). Clinically significant fistulas (grade
B, C) occurred in 28 patients (14%). 19 of the 28
patients with grade B/C fistulas were characterized as
having an OSI (68% sensitivity). 7 of the 176 study
patients without a grade B/C fistula had an OSI (96%
specificity).
Conclusions: There is currently an effort to institute an
HPB-specific dataset within NSQIP that will include
adverse events such as pancreatic fistula. In the mean-
time, POPF remains a clinically important problem
that is not routinely captured in the database. We have
shown that OSI is a specific but not a sensitive surro-
gate for POPF in this patient population.
PPP24-067
OUR EXPERIENCE OF THE
TREATMENT OF PANCREATIC
NEUROENDCRINE TUMORS(P-NETS)
K. Yusuke
Kurume University, Japan
Introduction: P-NETs are relatively rare in 1.3% of
whole pancreatic tumors. Besides, P-NETs are slow
growing tumors. Diagnostic imaging make progress,
and P-NETs cases accidentally. 50–90% of non-func-
tional P-NETs are said to be a malignancy. As for the
treatment, surgical resection are only radical treat-
ments. P-NETs cause liver metastasis, lymph node
metastases. The survival rates of P-NETs are good with
approximately 70–80% for five years after the resec-
tion. However, the recurrence rates within 5 years are
high with approximately 60–84%.
Method: In our Hospital, the operation cases of P-
NETs increase. At first, for our policy, we perform sur-
gical resections of P-NETs (G1, G2, Non G3). For the
distant metastasis of P-NETs, we perform chemother-
apy (Everolimus, Sunitinib, LAR etc). So, we perform
surgical resections of the distant metastasis if surgical
resections are completely cure. But, plenty of consider-
ing prognostic factors (WHO Grade, V+, Ly+, N+).
Results: We report several P-NET cases of the com-
bined therapy (operation and chemotherapy) at our
Hospital. In all cases, combined therapy resulted good
prognosis. Chemotherapy (Everolimus, Sunitinib, LAR)
resulted reduction of P-NETs and distant metastasis
very well. However, many cases caused recurrence and
distant metastasis, too. So, severe and regularly obser-
vations are necessary.
Conclusions: Aggressive surgical resections of P-NETs
(G1, G2, Non G3) and chemotherapy cause good prog-
nosis. So aggressive surgical resections of the distant
metastasis if surgical resections are completely cure
cause good prognosis too. We report it based on the
literatures of P-NETs.
PPP24-068
PERIOPERATIVE CONDITION OF
PANCREATICODUODENECTOMY IN
ELDERLY PATIENTS
S. Sawada, S. Sekine, I. Yoshioka, K. Matsui,
T. Okumura, T. Nagata and K. Tsukada
University of Toyama, Graduate School of Medicine and
Pharmaceutical Science for Research, Japan
Introduction: The aging population has result in more
elderly patients undergoing pancreatoduodenectomy
(PD) and recently some author reported that PD may
be justified for selected elderly patients. In this study
we clarify the perioperative condition of PD and reveal
the risk for PD in elderly patients.
Method: Between October 1997 to December 2012 con-
secutive 123 patients underwent PD at Toyama Univer-
sity Hospital. We analyzed the perioperative
clinicopathological data in patients with PD aged over
80 years (elderly group) compared with those in
patients under 79 years (younger group).
Results: The elderly group consist of 16 patients
(13%). Preoperative albumin level and Onodera’s prog-
nostic nutritional index (PNI) were significantly lower
in elderly patients (p < 0.001) and mean PNI in elderly
group was 35.1. The percentage of preoperative biliary
drainage in elderly and younger patients were 56% and
48% individually and there were no significant differ-
ence. The operative time, intraoperative blood loss and
the incidence of intraoperative transfusion were not sig-
nificantly different between the 2 groups. The incidence
of post operative complications including SSI, pneumo-
nia, enteritis, cholangitis, pancreatic fistula, biliary fis-
tula, delayed gastric emptying, and intestinal ulcer did
not also differ significantly between the groups, how-
ever the number of patients without complication was
significantly lower in elderly group (p < 0.001). There
was no operative mortality in this series. The overall
survival rate did not differ significantly between the
groups, however there were no patients who survived
over 5 years after PD in elderly group.
Conclusions: We should realize the low level of the
nutritional condition in elderly patient and the appro-
priate indication and perioperative management are
necessary to safely perform PD in elderly patient.
PPP24-069
DIAGNOSTIC VALUE OF 18F-FDG PET/
CT IN PANCREATIC CANCER
S.B. Pan, H. Zhao and X. Geng
The First Affiliated Hospital of Anhui Medical
University, China
Introduction: To investigate the value of 18F-FDG
PET/CT in assessing the diagnose of pancreatic cancer.
Method: We retrospectively analyzed the imaging datas
of enhanced CT and 18F-FDG PET/CT of patients
with pancreatic lesions and the level of serum CA19-9
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was measured. The results of 18F-FDG PET/CT,
enhanced CT and CA19-9 in assessing the diagnosis
were compared. Diagnosis were confirmed by intraop-
erative findings and pathology.
Results: 41 patients were diagnosed as pancreatic can-
cer, and other 6 patients as benign diseases. The values
of mean SUV were insignificant different between pan-
creatic cancer and benign diseases (p = 0.434, however
the differences of the values of mean CA19-9 between
pancreatic cancer and benign diseases were significantly
(p < 0.001). Sensitivity, specificity and accuracy for
evaluation of diagnosis were 82.9%, 83.3% and 82.9%
in CA19-9, 85.3%, 33.3% and 78.7% in enhanced CT,
87.8%, 50.0% and 82.9% in combination of these 2
examinations and 90.2%, 66.6% and 87.2% in 18F-
FDG PET/CT.
Conclusions: 18F-FDG PET/CT has the highest speci-
ficity and high specificity in diagnosis of pancreatic can-
cer.
PPP24-070
SOLID PSEUDOPAPILLARY TUMORS
OF THE PANCREAS: RADIOLOGIC
CHARACTERISTICS AND SURGICAL
OUTCOMES
R. Kim1, J. Skweres1, Q. Chu1, M. Heldmann1,
H. Shokouh-Amiri2, H. D’Agostino1, G. Zibari2 and
G. Sangster1
1Louisiana State University Health Sciences Center -
Shreveport, USA; 2John C. McDonald Regional
Transplant Center, USA
Introduction: Pancreatic solid pseudopapillary tumor
(SPT) is an uncommon neoplasm that presents more
frequently in young patients and has a female predilec-
tion. SPT is associated with favorable clinical outcomes
following surgical resection. The aim of this study is to
characterize the clinical presentation, radiologic find-
ings, and surgical outcomes of SPT at an academic
medical center.
Method: A retrospective review was conducted on all
patients at a single institution with pathologically-con-
firmed pancreatic SPT from 2004 through 2012. Clini-
copathologic and radiologic characteristics and
operative outcomes were analyzed.
Results: Eleven patients were identified who had pan-
creatic SPT; seven (64%) were female, four were male.
The mean age at presentation was 28 (range 18–50). In
four cases (36%), the diagnosis was made incidentally
in an otherwise asymptomatic patient. The most com-
mon presenting symptoms were abdominal pain (45%)
and nausea/vomiting (36%). No patient presented with
jaundice. Computed tomography (CT) imaging was
performed in all cases; biliary or pancreatic ductal dila-
tion was absent in all cases. Body or tail lesions were
more common (73%) than SPTs located in the pancre-
atic head. The mean tumor size was 10.5 cm (range
4–20). One patient presented with metastatic disease.
Surgical resection was performed in the other 10 cases
(91%); distal pancreatectomy in 7 patients, pancreatico-
duodenectomy in 2, and total pancreatectomy in 1.
All patients had an R0 resection. Mean length of stay
following surgery was 16 days. There were no recur-
rences or deaths; mean follow-up time was 26 months.
Conclusions: SPT is a rare pancreatic neoplasm that
occurs predominantly in young females. Abdominal
pain is the most common presenting symptom. SPT
rarely causes obstructive jaundice and presents with
metastatic disease infrequently. Surgical resection is
associated with excellent prognosis.
PPP24-071
SPONTANEOUS RUPTURE OF
PRIMARY SPLENIC ANGIOSARCOMA:
REPORT OF A CASE
H.J. Kim, C.Y. Kim, Y.H. Hur, Y.S. Koh, C.K. Cho
and H.J. Kim
Chonnam National University Medical School, Korea
Introduction: Primary splenic angiosarcoma is an extre-
mely rare mesenchymal malignant tumor of vascular
origin with high metastatic potential and a very poor
prognosis. These aggressive mesenchymal tumor can
easily be neglected and splenic rupture is the most fre-
quently manifestation at the time of diagnosis. Herein,
we report a case of spontaneous rupture of primary
splenic angiosarcoma in 56-years-old woman.
Method: A 56-years-old woman visited our hospital
with diffuse abdominal pain and dizziness. Physical
examination revealed a palpable mass in the left upper
abdominal quadrant with tenderness. CT scan demon-
strated a heterogeneous, low-density signal within the
splenic parenchyma, with variable degrees of contrast
enhancement as well as intra-abdominal hemorrhage
originating most possibly from the spleen. After initial
fast fluid resuscitation, an emergency operation was
performed.
Results: Laparotomy revealed a huge spleen actively
bleeding, containing multiple variable sized hemorragic
cysts. The pathologic diagnosis of the excised spleen
was angiosarcoma originating from the spleen. Immu-
nohistochemical staining was positive for CD31, CD34,
and factore VIII. The Ki-67 proliferation index was
more than 10%.
Conclusions: Splenic angiosarcoma should be consid-
ered one of the differential diagnoses in patients with
spleen parenchymal lesions. Definitive diagnosis
requires laparotomy followed by splenectomy. Herein,
we report a rare case of splenic angiosarcoma.
PPP24-072
EFFICACY OF INFUSION THERAPY
PREVENTING PANCREATIC FISTULA
FOR PATIENTS WITH HIGH AMYLASE
LEVEL IN DRAINAGE: A PROSPECTIVE
STUDY IN A SINGLE CENTER
T. Adachi, T. Kuroki, A. Kitasato, M. Hirabaru,
H. Matsushima, A. Soyama, M. Hidaka, M. Takatsuki
and S. Eguchi
Nagasaki University, Japan
Introduction: Some reports have suggested that early
removal of the drain have prevented the pancreas fis-
tula (PF) after pancreatoduodenectomy (PD), however
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high drain amylase level on postoperative day 1(POD1)
remained as the risk factor of PF. The purpose of this
study was to determine the efficacy of the infusion ther-
apy for the case of high drain amylase level on POD1
as the prospective study.
Method: Total 117 patients undergoing PD were
enrolled. We prospectively divided into 2 groups of
these patients. Group 1 (control group: n = 50): post-
operative usual management was performed regardless
of the drain amylase level on POD1, Group 2 (medica-
tion group: n = 67): infusion therapy using three kinds
of medicine (protease inhibitor, octreotide, antibiotics)
administration was introduced if drain amylase level on
POD1 was over 10,000 (IU/L). The primary endpoint
of this study was the incidence of PF (according to IS-
GPF criteria) in respective groups, while the secondary
endpoint was duration of the drain insertion especially
in the high drain amylase cases.
Results: The incidence of PF was not statistically dif-
ferent between 2 groups (group 1: 20% vs group 2:
16.7%). Among the high drain amylase cases, 83% (5/6
cases) group 1 patients and 54% (6/11 cases) group 2
patients were developed PF. The duration of drain
insertion were statistically shortened (36.5 days in
group 1 and 18.0 days in group 2; p < 0.05).
Conclusions: Infusion therapy for high drain amylase
level was useful to shorten the duration of drain inser-
tion and has the possibility to prevent the PF after PD.
PPP24-073
PANCREATIC IPMC WITH
SARCOMATOUS AND
NEUROENDOCRINE COMPONENT
H.J. Kim, C.Y. Kim, Y.H. Hur, Y.S. Koh, C.K. Cho
and H.J. Kim
Chonnam National University Medical School, Korea
Introduction: Undifferentiated carcinoma (carcinosar-
coma) is a rare variant of a pancreatic neoplasm.
Immunohistochemical diagnosis is established by reac-
tivity of the carcinomatous and sarcomatous elements
to cytokeratin and vimentin, respectively. It is different
from sarcomatoid carcinoma, which shows only cyto-
keratin reactivity. Clinically, undifferentiated carcinoma
have poor prognosis. But, because of rarity, clinico-
pathologic characteristics are not clear. Herein, we
report a rare case of pancreatic IPMC with sarcoma-
outs and neuroendocrine component.
Method: A 57-year-old woman was admitted to our
hospital suffering from left flank pain. An abdominal
computed tomography (CT) and magnetic resonance
imaging (MRI) showed a 5 9 4 cm sized multiseptated
cystic mass in pancreatic body. On esophagogastroduo-
denoscopy, another mass was found in duodenum.
Pathologic result of it was papillary adenocarcinoma.
She underwent a total pancreaticoduodenectomy.
Results: Histopathologic examination revealed a pan-
creatic intraductal papillary mucinous carcinoma
(IPMC) with sarcomatous and neuroendocrine compo-
nent. Immunohistochemically, it has reactivity to cyto-
keratin, vimentin, CK7, CD56, synaptophysin, and
chromogranin. Duodenal mass was a moderately differ-
entiated adenocarcinoma. Ten monthes postoperatively,
no sign of recurrence was found.
Conclusions: We report a case of IPMC with sarcoma-
tous and neuroendocrine component, combined with
ampulla of Vater cancer.
PPP24-074
LONG TERM OUTCOME AFTER
SURGICAL RESECTION FOR
PANCREATIC DUCTAL
ADENOCARCINOMA (PDAC)
R. Kim1, S.B. Kim1, Y.-B. Kim1, E.-H. Cho1,
C.-S. Lim1, D.W. Choi2 and E.B. Ryu1
1Korea Cancer Center Hospital, Korea; 2Samsung
Medical Center,Sungkyunkwan University, Korea
Introduction: Even though poor outcome of pancreatic
ductal adenocarcinoma, only twenty percent patients
were survived more than 5 years after surgery. The aim
of this study was to identify clinicopathologic variables
influenced the long-term survival after surgical resec-
tion.
Method: We reviewed the medical records 55 patients
who underwent surgical exploration after diagnosed
with pancreatic ductal adenocarcinoma (PDAC)
between March 1989 and March 2008. 45 patients were
underwent surgical resection with curative intent. We
analyzed the clinicopathological variables associated
with long term survival.
Results: The median overall survival of whole patients
was 16.4 months. And the median overall survival of
surgical resection group was 21.5 months, whereas sur-
gically unresectable group was 4.7 months. (p = 0.0001)
Surgical resectability and lymph node status were inde-
pendent prognostic variables for overall survival. Long-
term survivors showed earlier cancer stage; lower path-
ologic T stage, negative lymph node metastasis.
Conclusions: Even though pancreatic ductal adenocar-
cinoma (PDAC) had a poor prognosis, aggressive sur-
gical resection is the most important treatment that
could be expected for a long term survival. Further
study for early detection of PDAC to long-term sur-
vival will be needed.
PPP24-075
TARGETED KNOCKDOWN OF
CLUSTERIN SENSITIZES PANCREATIC
CANCER MIA-PACA-2 CELL TO
GMCITABINE TREATMENT BY
INACTIVATION OF NF-jB/ BCL-2
D. Kong
Tianjin Cancer Hospital, China
Introduction: Clusterin (CLU) is known as a multifunc-
tional protein involved in a variety of physiological
processes including lipid transport, epithelial cell differ-
entiation, tumorigenesis, and apoptosis.Our rescent
study has demonstrated that knockdown of clusterin
sensitizes pancreatic cancer cell lines to gmcitabine
treatment.However the details of this survival mecha-
nism remain undefined.
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Method: Of the various downstream targets of CLU,
we examined activation of the NF-jB transcription fac-
tor and subsequent transcriptional regulation of Bcl-2
gene in pancreatic cancer cell MIA-PaCa-2. The MIA-
PaCa-2 cells were transfected with an antisense oligo-
nucleotide (ASO) against clusterin, which led to a
decreased protein level of the antiapoptotic gene Bcl-2.
Furthermore, inhibition of CLU decreased the function
of NF-jB, which is capable of transcriptional regula-
tion of the Bcl-2 gene.Inhibiting this pathway increased
the apoptotic effect of gmcitabine chemotherapy. Re-
activated NF-jB resulted in attenuation of ASO-
induced effects, followed by the bcl-2 upregulation,
and bcl-2 re-inhibition resulted in attenuation of
Re-activated NF-jB -induced effects. Animals injected
with ASO CLU in MIA-PaCa-2 cells combined with
gmcitabine treatment had fewer tumors than gmcita-
bine or ASO CLU alone.
Results: These findings suggest that knockdown of
CLU sensitized MIA-PaCa-2 cells to gmcitabine che-
motherapy through modulating NF-jB/Bcl-2 pathway.
Conclusions: These findings suggest that knockdown of
CLU sensitized MIA-PaCa-2 cells to gmcitabine che-
motherapy through modulating NF-jB/Bcl-2 pathway.
PPP24-076
FACTORS AFFECTING OUTCOME OF
PANCREATIC NECROSECTOMY IN SAP
S. Khuroo, S. Pujari, A. Supe, R. Bapat and
C. Kantharia
Seth GS Medical College & Kem Hospital, Parel,
Mumbai, India
Introduction: Despite the availability of several clinical,
biochemical and radiological grading systems, accurate
prediction of the best treatment option and outcome
after intervention remains enigmatic. The present study
identifies the factors affecting the outcome in a consec-
utive cohort of patients undergoing open necrosectomy
for severe acute pancreatitis.
Method: From January 2008 to June 2013, 24 patients
(3 females and 21 males) presented with acute necrotis-
ing pancreatitis. They underwent a complete hemo-
gram, coagulation profile studies, serum calcium, RFT,
LFT, Blood gas analysis within 48 hours of admission.
CECT of abdomen was done after 4 days of onset of
disease and repeated when indicated. All patients were
managed conservatively initially with image guided per-
cutaneous drainage when required. Necrosectomy was
deferred at-least till 4 weeks. Factors studied to predict
the outcome of patients with severe acute pancreatitis
included APACHE II score, Organ failure, Extent of
necrosis, CTSI, Extrapancreatic necrosis, PCD and tim-
ing of surgery.
Results: Of the 24 patients, 12 underwent open necro-
sectomy and 12 managed conservatively. 4 underwent
pigtail drainage under radiological guidance prior to
surgery. 3 had to undergo repeat exploration for resid-
ual collection and complications. 2 underwent USG
guided PCD of residual collection. There was 1 mortal-
ity. Patients with metabolic acidosis (pH < 7.2), multi-
organ failure, APACHE II score >8, higher CTSI,
extrapancreatic necrosis, non-reversibility of sepsis on
PCD, and early intervention had higher morbidity and
mortality.
Conclusions: Multidisciplinary care with emphasis on
aggressive radiological intervention before and after
surgery results in acceptable outcomes in this cohort of
critically ill patients. Reversal of sepsis after PCD,
APACHE II score, Organ failure within first week of
onset of disease, late surgical intervention after optimi-
sation can be used for prediction of outcome after pan-
creatic necrosectomy in patients with SAP.
PPP24-077
A CASE OF TRAUMATIC PANCREATIC
INJURY WITH A PSEUDOCYST IN A
CHILD TREATED WIH
PERCUTANEOUS DRAINAGE
S. Kadowaki
Tomioka Public General Hospital, Japan
Introduction: Surgical treatment is usually recom-
mended in cases of traumatic main pancreatic duct
injury in adults. Cases occurring in children are rare,
and the treatment strategy is unclear.
Method: A 3-year-old boy was admitted to our hospi-
tal after being crushed by a drawer in his house.
Results: His general condition was good; however, he
complained of mild nausea and epigastric pain. Com-
puted tomography (CT) showed fluid collection in front
of the pancreatic body, and the patient was suspected
to have traumatic pancreatic injury. The next day,
there were no changes on CT. On the sixth day of
admission, the patient complained of abdominal disten-
tion, and CT showed a large pseudocyst. A diagnosis
of main pancreatic duct injury was suspected. Emergent
percutaneous drainage was performed, and the amount
of discharge gradually decreased. The patient was dis-
charged on the 15th hospital day, and the drainage
tube was removed on the 30th day.
Conclusions: Depending on the patient’s general condi-
tion and grade of injury, conservative treatment may
therefore be effective.
PPP24-078
TOTAL PANCREATECTOMY FOR
PANCREATIC DISEASE: OUR
EXPERIENCE DURING 20 YEARS
Y.-D. Yu1, D.-S. Kim1, S.-W. Jung1, P.-j. Park2,
H.-J. Han1, S.-B. Choi2, S.-Y. Choi2, T.-J. Song1 and
S.-O. Suh1
1Korea University Anam Hospital, Korea; 2Korea
University Guro Hospital, Korea
Introduction: Total pancreatectomy can be associated
with significant metabolic abnormalities leading to con-
siderable morbidity. With the availability of modern
pancreatic enzyme formulations and improvements in
control of diabetes mellitus, the metabolic drawbacks
of total pancreatectomy have diminished. In addition,
as operative techniques and peri- and postoperative
management strategies have evolved, the indications for
total pancreatectomy in pancreatic disease changed. As
indications for total pancreatectomy have expanded, we
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examine our results in patients undergoing total pan-
createctomy during a 20 year period.
Method: Retrospective study of 21 patients undergoing
total pancreatectomy from January 1992 to July 2012
was performed. Patient data and clinical outcomes were
collected and entered into a database. Disease-free sur-
vival and overall survival were estimated using the
Kaplan–Meier method.
Results: Twenty patients received total pancreatectomy
for malignant disease. Among these, 2 patients under-
went completion pancreatectomy for tumor recurrence
after distal pancreatectomy and 4 patients for pancreat-
icojejunostomy leakage after pancreaticoduodenectomy.
The median duration of the operative procedure was
7.1 hours. Postoperative morbidity was 28.5% (6/21).
Median period of postoperative hospital stay was
21 days. Blood glucose level was well controlled by
subcutaneous injection of sliding scale insulin during
the postoperative period and the mean HbA1c level at
3 months after the operation was 6.2%. For patients
with malignant disease, the median follow up was
19.8 months and the median disease free interval was
9.4 months. The 2-year disease free survival was 34%
and the 5-year overall survival was 24.8%.
Conclusions: Total pancreatectomy could be performed
safely and postoperative control of blood glucose was
acceptable with effective medication. We suggest that
total pancreatectomy should be considered for the
treatment of pancreatic carcinoma when the patient
condition permits and offers a chance of cure, although
careful long-term medical care and follow up are essen-
tial.
PPP24-081
SEVERE ACUTE PANCREATITIS:
PROGNOSTIC CRITERIA
V. Syplyviy, V. Robak, V. Dotsenko, D. Ievtushenko
and A. Ievtushenko
Kharkiv National Medical University, Ukraine
Introduction: The timely prognosis of course of acute
pancreatitis allows correctly choosing tactics of treat-
ment, warning development of complications.
Method: There is an analysis of treatment of 125
patients with severe acute pancreatitis. All patients were
operated. In postoperative period 34 (27, 2%) patients
died. Reaction of periphery blood by hematological
indexes (one of these hematological indexes–the intoxi-
cation indicator–offered by us); estimation of severity
of the patient’s state by the Acute Sepsis Severity Eval-
uation Scale; impact of parapancreatic fat injury; pre-
sents of accompanying diseases in dynamics of
treatment of the patients were studied.
Results: It was revealed, that values of the index of
organism’s resistance less than 31, 59; the leukocyte
intoxication index more than 8, 18; the reactive neutro-
philic response index more than 40, 77; the intoxication
indicator more than 1, 14 are the factors of adverse
outcome of severe acute pancreatitis (p < 0.05). At
severity of the patient’s state by the Acute Sepsis Sever-
ity Evaluation Scale in a preoperative period more than
13 points lethality in a postoperative period was 51,
85%, less than 13 points - 19, 44%. In an early postop-
erative period at severity of the patient’s state more
than 16 points lethality was 70, 59%, less than 16
points–11, 11%. Parapancreatic fat injury is revealed at
80 (64, 0%) patients. At 26 (76, 5%) patients from 34
died parapancreatic fat injury revealed. Thus parapan-
creatic fat injury increase lethality risk in 32, 5%. Ana-
lyze of presents of accompanying diseases shown, that
patients with cachexia, obesity, inefficiency of cardio-
vascular system had statistically higher (p < 0.05)
lethality risk.
Conclusions: The values of the indexes of peripheral
blood, individual estimation of patient’s state by the
Acute Sepsis Severity Evaluation Scale, presents of
parapancreatic fat injuring and presents of accompany-
ing diseases are prognostic criteria of course of severe
acute pancreatitis.
PPP24-082
THE VAULE OF ENHANCED CT AND
18F-FDG PET/CT IN EVALUTAION OF
RESECTABILITY OF PANCREATIC
CANCER
S. Pan, X. Geng, H. Zhao and K. Xie
The First Affiliated Hospital of Anhui Medical
University, China
Introduction: To investigate the value of 18F-FDG
PET/CT and enhanced CT in assessing the resectability
of pancreatic cancer.
Method: We retrospectively analyzed the imaging datas
of 18F-FDG PET/CT and enhanced CT of patients
with pancreatic cancer. The results of 18F-FDG PET/
CT, enhanced CT and comprehensive analysis of these
two examinations in assessing the resectability were
compared. Diagnosis of pancreatic cancer and resect-
ability were confirmed by intraoperative findings and
pathology.
Results: 31 patients with pancreatic cancer underwent
surgery, of which only 18 cases were successful com-
plete resection of the tumor, and palliative operation
were performed in the other 13 cases because of unre-
sectable factors found during the operation. Resectbili-
ty was designated as positive index. Sensitivity,
specificity and accuracy for evaluation of unresectabili-
ty were 94.4%, 15.3%, 61.2% in enhanced CT, 94.4%,
38.4%, 70.9% in 18F-FDG PET/CT, and 88.8%,
53.8%, 71.3% in combination of these 2 examinations.
There was no significant diference between enhanced
CT and 18F-FDG PET/CT. Combination of these 2
examinations was better than each of them signifi-
cantly. With diagnostic criteria of the resectability is
affirmed if both of them are positive.
Conclusions: The enhanced CT and 18F-FDG PET/CT
are useful and complementary in assessing resectability
of pancreatic tumor and the values of them are equal.
Combination of these 2 examinations has more clinical
value.
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PPP24-083
IMPACT OF NEOADJUVANT
CHEMORADIOTHERAPY FOR
BORDERLINE RESECTABLE AND NON-
RESECTABLE PANCREATIC CANCER
T. Iida, H. Terajima, Y. Uchida, H. Kawamoto,
R. Toda, Y. Inoue, M. Yoshitomi, S. Ueda and
A. Kanazawa
Kitano Hospital, The Tazuke Kofukai Medical Research
Institute, Japan
Introduction: Neoadjuvant chemoradiotherapy (NAC-
RT) is increasingly becoming a valid treatment option
for patients with locally advanced pancreatic cancer.
Method: From January 2010 to August 2013, we had
performed chemoradiography (CRT) for 12 patients
with borderline resectable and non-resectable pancreatic
cancer as an initial treatment in our institute. Eventu-
ally, 3 patients underwent radical pancreatic surgery
after NACRT, we demonstrated the details of these 3
cases.
We defined that borderline resectable disease [≤180°
involvement of the superior mesenteric artery (SMA);
short-segment encasement/abutment of the common
hepatic artery (CHA); or tumor-associated deformity,
abutment or short-segment occlusion of the superior
mesenteric vein (SMV)/portal vein (PV) that was
amenable to vascular resection and reconstruction] and
un-resectable pancreatic cancer have wide vascular
involvement more than borderline resectable cases).
In this study, CRT was the radiotherapy (total 45 Gly)
with S-1 oral administration (80mg/m2/day 915 days).
Results: The mean age of study patients was 68 years
(56–74, all 3 women). Tumor was located in pancreatic
head in 1 case, pancreatic body in 2 cases. The reasons
of the induction of NACRT were the wide encasement
of celiac trunk to CHA, wide encasement of CHA and
PV trunk, and over 180° involvement of SMA plexus
in each 1 case.
The operations were consisted of distal pancreatectomy
with combined liac axis resection, total pancreatectomy
with portal venous resection, distal pancreatectomy,
respectively.
Pathological R0 resection was achieved in 2 cases, R1
resection in 1 case. Regarding to a postoperative com-
plication, 1 patient had a refractory massive ascites
against any conservative treatments. By introduction of
cell free concentrated ascites reinfusion therapy, they
were improved gradually. All patients are alive without
recurrence up to the present (for 2–8 months after sur-
gery).
Conclusions: NACRT is a very effective treatment and
may have a potential as a conversion therapy for bor-
derline and non-resectable pancreatic cancer.
PPP24-084
SURGICAL INDICATION AND
OUTCOME IN PATIENTS WITH
BRANCH DUCT-INTRADUCTAL
PAPILLARY MUCINOUS NEOPLASM
E. Nakadai, M. Ohtsuka, H. Shimizu, A. Kato,
H. Yoshitomi, K. Furukawa, T. Takayashiki,
S. Kuboki, D. Okamura and M. Miyazaki
Graduate School of Medicine, Chiba University, Chiba,
Japan
Introduction: According to international consensus
guideline 2012 for the management of IPMN, branch
duct (BD)-IPMN with “high-risk stigma” and “worri-
some features with indicated features observed by
endoscopic ultrasound” should be considered for surgi-
cal resection. The aims of this study were to assess the
outcome of surgical treatment for BD-IPMN and to
examine potential predictors of disease progression in
BD-IPMN.
Method: Until May 2013, surgical resection was per-
formed in 74 patients with BD-IPMN. Among them,
21 cases fulfilled the criteria of “high-risk stigma” and
29 cases conformed to the criteria of “worrisome fea-
tures with indicated features observed by endoscopic
ultrasound”. These 50 cases were clinicopathologically
reviewed.
Results: Pathological diagnosis was low- or intermedi-
ate-grade dysplasia in 20 cases, high-grade dysplasia in
16 cases, and an associated invasive carcinoma in 14
cases. The 1-, 3-, and 5-year survival rates were 100%,
100% and 100% in cases with low- or intermediate-
grade dysplasia, 100%, 100%, and 100% in cases with
high-grade dysplasia, and 93%, 61%, and 31% in cases
with an associated invasive carcinoma. The large size
of mural nodules (≥6 mm) and high serum level of
CA19-9 (≥37 U/L) were potential predictors that
showed disease progression from low- or intermediate-
grade dysplasia to high-grade dysplasia/ an associated
invasive carcinoma. In addition, high serum level of
CA19-9 (≥75 U/L) was a potential predictor that
showed disease progression from high-grade dysplasia
to an associated invasive carcinoma.
Conclusions: Although indication for resection of BD-
IPMN according to international consensus guideline
2012 for the management of IPMN is appropriate in
general, conservative clinical follow-up may be a possi-
ble option in some cases with no and small mural nod-
ules and low serum level of CA19-9.
PPP24-085
GEMCITABINE-BASED
INTRAPERITONEAL CHEMOTHERAPY
IN PANCREATIC DUCTAL
ADENOCARCINOMA WITH
PERITONEAL CARCINOMATOSIS
S. Jo, S. Song and N. Myung
Dankook University Medical College, Korea
Introduction: Pancreatic ductal adenocarcinoma
(PDAC) shows a very poor prognosis partly due to
advanced stages at diagnosis. Recently, adjuvant intra-
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peritoneal chemotherapy (IPCTx) after curative resec-
tion of PDAC has been reported. We applied this IP-
CTx to a case of PDAC with peritoneal carcinomatosis
as palliative setting and report early results.
Method: A 54-year male was referred for pancreatic
tumor. He had taken medicine for DM but had no sur-
gical history. Laboratory results including tumor mark-
ers were normal. CT scans showed a 4cm-sized mass
with cystic portion in the pancreas tail, encasing splenic
artery and vein. EUS revealed an irregular echogenic
3 cm-sized mass, extending to surrounding tissue and
obliterating splenic vessels. EUS-guided FNA demon-
strated malignant cells, consistent with well-differenti-
ated adenocarcinoma. As no distant metastases were
detected in PET-CT, the patient was transferred for
surgery. On intraabdominal exploration, the pancreatic
tumor directly invaded the stomach and transverse
colon but was expected to be resected. However, multi-
ple small metastatic nodules were encountered on mes-
entery and parietal peritoneum. In consideration of
patient’s age, pancreatic resection (RAMPS), wedge
resection of the stomach and segmental resection of the
transverse colon were performed and CAPD catheter
was installed for palliative IPCTx.
Results: Histopathological examination of the surgical
specimen demonstrated an about 3.5 9 2.2 9 3 cm-
sized moderately differentiated ductal adenocarcinoma,
extending to outermost muscle layers of the transverse
colon and stomach (pT3) with clear resection margins.
There were two metastatic lymph nodes among 20
regional nodes. The patient recovered without signifi-
cant complications and underwent palliative IPCTx
with gemcitabine (1,000 mg/m2) on days 1, 8 and 15 of
the 4-week cycle for a half year. No demonstrable evi-
dence of disease progression has been detected until
8 months after surgery.
Conclusions: IPCTx could have a place in contributions
to survival gain in selected patients with PDAC, how-
ever, more clinical results based on substantial cases
were warranted.
PPP24-086
IS BACTIBILIA A PREDICTOR OF
POOR OUTCOME OF
PANCREATICODUODENECTOMY?
U.M. Muthuswamy, J. Sathyanesan, S.K. Perumal,
A. Pitchaimuthu, K. Rajendran, K. B, R. Ramasamy,
R. Palaniappan and M. Govindan
Government Stanley Medical College Hospital, Chennai,
India
Introduction: Although bile infection has been pro-
posed to increase infective complications following pan-
creaticoduodenectomy, its association with infective
complications and non-infective complications like pan-
creatic fistula is still controversial.
Method: Seventy-six patients who had undergone pan-
creaticoduodenectomy between July 2011 and Decem-
ber 2012 were included in a prospective database and
their data analyzed. In all patients intraoperative bile
from the bile duct was cultured. Preoperative, intra-
operative, and post-operative variables were recorded
and analyzed.
Results: Bile culture showed positive growth in 35
patients and negative growth in 41. Twenty patients in
the positive group underwent ERCP and stenting. The
patients with a positive bile culture had a higher inci-
dence of infective complications including intra-abdom-
inal abscess (n = 8), wound infection (n = 27),
bacteremia (n = 10), and renal insufficiency (n = 9).
There was no increase in the rate of non-infective com-
plications of pancreaticoduodenectomy including pan-
creatic fistula (n = 7), delayed gastric emptying (n = 9),
and post-operative hemorrhage (n = 3). The hospital
stay was significantly prolonged in the patients with a
positive bile culture (p = 0.0002).
Conclusions: Pre-operative biliary drainage is signifi-
cantly associated with bile infection, and bile infection
increases the overall rates of infective complications
and renal insufficiency. A high incidence of complica-
tions is associated with infected bile and hence a rou-
tine intra-operative bile culture is recommended in
patients undergoing pancreaticoduodenectomy. Because
of its significant association with infected bile, biliary
stenting should be used in strictly selected cases.
PPP24-087
PANCREATIC INTRAEPITHELIAL
NEOPLASIA (PANIN) 3 LESION
TREATED BY
PANCREATICODUODENECTOMY: A
CASE REPORT
S. Jo, S. Song and N. Myung
Dankook University Medical College, Korea
Introduction: Pancreatic intraepithelial neoplasia (Pa-
nIN) is a putative precursor lesion of invasive pancre-
atic ductal adenocarcinoma (PDAC). Lethal PDAC
can be preventive and show a favorable prognosis
through early detection and appropriate surgery at a
preinvasive stage or PanIN.
Method: A 50-year-old male patient was referred for a
suspicious precancerous lesion of the main pancreatic
duct. He had been followed up for recurrent pancreati-
tis for about 2 years. On the last CT and MRI, the
main pancreatic duct showed diffuse mild dilatation
and abrupt narrowing with a small filling defect at
head portion. Sequentially performed ERP demon-
strated rectangular filling defects at the pancreatic head
portion. The histopathologic examination revealed
atypical glands in the extruded papillary material and
ampullary mucosa. CA 19-9 was elevated at 627.0 U/
mL. Neither hepatic nor peritoneal metastatic nodules
were detected during intraperitoneal exploration. The
pancreatic head contained an about 3 cm-sized poorly
demarcated hard mass and the whole parenchyma
showed chronic pancreatitis change. No enlarged regio-
nal lymph nodes were encountered. Pylorus-preserving
pancreaticoduodenectomy was performed without any
intraoperative event.
Results: On examination of the specimen, the main
pancreatic duct showed mild dilatation and mucosal
surface nodularity. Periductal desmoplastic change was
also found. Ampullary area was slightly hypertrophic
and indurated but had no tumorous lesions. No tumor
cells were identified on the distal resection margins of
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the pancreatic duct in frozen biopsy. The postoperative
histopathologic examination revealed atypical ductal
epithelial hyperplasia consistent with PanIN 3 and no
metastatic lymph nodes. The patient suffered from
delayed gastric emptying for about 2 weeks and then
was discharged on POD 28. He has been enjoying a
disease-free life for almost 5 years.
Conclusions: Surgical resection for PanIN 3 lesion has
an acceptable rationale in selected cases and is expected
to contribute toward reducing mortality of PDAC.
PPP24-089
CYSTIC TYPE DUCTAL
ADENOCARCINOMA OF THE
PANCREAS MIMICKING
INTRADUCTAL PAPILLARY
MUCINOUS CARCINOMA
S. Jo, S. Song and W. Lee
Dankook University Medical College, Korea
Introduction: Pancreatic ductal adenocarcinoma of cys-
tic pattern is a rare and emerging subtype, mimicking
intraductal papillary mucinous carcinoma (IPMC) and
is different from cystic degeneration of ductal adeno-
carcinoma. We report a case of pancreaticoduodenecto-
my for cystic type ductal adenocarcinoma.
Method: A 67-year male was admitted for incidentally
detected pancreatic head mass. He had no noticeable
past medical history. CT scans and pancreas MRI
showed a 3.8 cm-sized conglomerated tubular cystic
lesion with multifocal papillary portion in pancreas
head and uncinate process, suggestive of pancreatic in-
traductal papillary neoplasm of mixed type. ERP
revealed small amount of mucin from the ampulla and
irregular dilatation of the main pancreatic duct from
head to body. EUS-guided FNA demonstrated no
malignant cell. There being no definite distant metasta-
sis on PET-CT, the patient was prepared for surgery. A
few days before operation, acute pancreatitis with pus-
like discharge from the ampulla occurred. On perito-
neal exploration, no disseminated nodules were found.
There were peripancreatic inflammatory change and
tight adhesion between the cystic tumor and superior
mesenteric vessels. On the assumption of inflammatory
adhesion between them, fine dissection proceeded with
difficulty and finally pancreaticoduodenectomy was suc-
cessfully performed. Several enlarged regional lymph
nodes were encountered.
Results: Histopathological examination confirmed
4 9 3 cm-sized ductal adenocarcinoma of cystic papil-
lary pattern, different from IPMC or cystic degenera-
tion of ductal adenocarcinoma. Profound intraluminal
mucin and one metastatic regional lymph node were
also reported. Resection margin of the duct showed Pa-
nIN-1 lesion and resection margin to major vessels was
free of malignant cells. The patient had minor wound
complication and was discharged on POD 24th. Adju-
vant concomitant chemoradiation therapy was per-
formed without any event.
Conclusions: Cystic type ductal adenocarcinoma of the
pancreas is unique morphological pattern and should
be differentiated from IPMC. Further information on
this emerging pattern is warranted.
PPP24-090
LAPAROSCOPIC MIDDLE
PANCREATECTOMY: THREE CASES IN
OUR HOSPITAL
M. Kurata, G. Honda, S. Kobayashi and
K. Sakamoto
Tokyo Metropolitan Komagome Hospital, Japan
Introduction: Laparoscopic middle pancreatectomy
(Lap-MP), which is performed for benign or low-grade
malignancy in the pancreatic body, is a complex sur-
gery. Here we report our procedure and clinical out-
comes in 3 patients who had a serous cyst neoplasm, a
solid pseudo-papillary neoplasm and a pancreatic neu-
roendocrine tumor.
Method: Five ports are placed in a semilunar row
around the epigastral region. The pancreatic neck is
divided using a stapler, and the stump of which is
required anastomosis, is divided by HARMONIC. The
midline just above the pancreas is opened to 4 cm and
the specimen is removed through this incision. A
wound retractor is then placed with a 5-mm trocar con-
nected. The jejunal limb is brought in a retrocolic fash-
ion to the left of the middle colic vessels. For
pancreaticojejunostomy, a modified Kakita method is
employed, which is an end-to-side technique with
approximation of seromuscular layer of the jejunum
and full-thickness pancreas by several interrupted
sutures. And a short stent tube is placed and fixed at
the stump of the main pancreatic duct with a purse-
string suture of the pancreatic parenchyma, and then is
inserted into the jejunum through a small orifice with-
out duct-to-mucosal anastomosis.
Results: The operating time was 341, 406 and 417 min-
utes respectively. The blood loss was small amount in
each case. Although the first case had a complication
with a pancreatic fistula (grade B), the patient recov-
ered conservatively. Two others were free of complica-
tion and discharged on 9 and 11 days.
Conclusions: MP has higher risk of pancreatic fistula
than other types of resection, because 2 cut ends are
created. Recently, we have obtained comparable results
of laparoscopic pancreaticoduodenectomy and distal
pancreatectomy using a similar manner. Therefore, we
believe that Lap-MP is feasible.
PPP25-001
STANDARDIZATION OF
PANCREATICO-ENTERIC
ANASTOMOSIS TO REDUCE
PANCREATIC FISTULA IN SOFT
PANCREATIC TEXTURE AFTER
PANCREATICODUODENECTOMY
H.K. Hwang, S.H. Choi, C.M. Kang, D.S. Yoon and
W.J. Lee
Yonsei University College of Medicine, Korea
Introduction: Postoperative pancreatic fistula (POPF)
after pancreaticoduodenectomy is still remained as
unsolved complication even though operation-related
mortality reduced less than 5%. Our previous policy
was pancreaticogastrostomy if the pancreatic texture
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was soft. This study show changing in standardization
of pancreatico-enteric anastomosis method based on
significantly reduced POPF rate after changing from
pancreaticogastrostomy (PG) to pancreaticojejunosto-
my (PJ) in soft pancreas texture.
Method: Between December 2007 and January 2013,
among the patients who were underwent pancreatico-
duodenectomy due to periampullary tumor, patients
who had soft pancreatic texture were enrolled in this
study. Only PG was done from December 2007 to Feb-
ruary 2010 (period 1). PG or PJ was done by surgeon’s
preference from March 2010 to August 2011 (period 2).
Only PJ was done from September 2011 to January
2013 (period 3). The data was retrospectively analyzed.
POPF definition is followed by ISGPF definition and
clinical POPF is defined as grade B and grade C
POPF.
Results: 141 patients had soft pancreas texture. PG
was done in 73 patients and PJ in 68 patients. There
were no differentiations in clinic-pathologic findings
between 2 groups. Clinical POPF rate was 23.3% in all
PG group and 5.0% in PJ group (p = 0.004). Accord-
ing to periods, clinical POPF rate was 16.7% in period
1, 25% in period 2, and 5.9% in period 3 (p = 0.043).
In period 2, clinical POPF rate was 42.1% in PG
group, 5.9% in PJ group.
Conclusions: Based on significantly reduced POPF rate
in PJ group, duct to mucosa pancreaticojejunostomy is
being standardization method even though pancreatic
texture is soft during pancreaticoduodenectpmy.
PPP25-002
TWO CASE TRIALS OF NEOADJUVANT
CHEMORADIOTHERAPY WITH TS-
1+GEMCITABINE+50GY
RADIOTHERAPY IN UNRESECTABLE
(BORDERLINE RESECTABLE)
PANCREAS BODY CANCER
H. Jung, S. Yoon, D. Lee and H. Kim
Yeungnam University Medical Center, Korea
Introduction: Pancreatic cancer has a dismal prognosis.
Especially in advanced stage, there is no standard ther-
apy. But, several studies showed us higher rates of neg-
ative margin and better survival with neoadjuvant
therapy for unresectable (borderline resectable) pancre-
atic cancer. We report 2 cases of complete resection
with negative resection margin in unresectable (border-
line resectable) pancreas body cancer after neoadjuvant
chemoradiotherapy.
Method: Enrolled two patients had pancreas body can-
cer with celiac trunk encasement. They were diagnosed
with unresectable (borderline resectable) pancreatic
body cancer. They received neoadjuvant chemoradia-
tion regimen with TS-1(80 mg/BSA, alternative day,
for 5 weeks) and Gemcitabine (1000 mg/BSA, at 1,
8 day, for 3 weeks) plus concurrent radiotherapy
(50 Gy).
Results: After neoadjuvant chemoradiation therapy,
follow up study shows regression of tumor. They
received surgery for remained cancer, and negative
resection margin were achieved. All of them had experi-
enced 1 episode of NCI grade 3 myelosuppression after
gemcitabine IV infusion. One patient had experienced
postoperative intestinal obstruction and enterocutane-
ous fistula, and another had experienced postoperative
acute renal failure. We don’t think both complications
were related to neoadjuvant chemoradiotherapy. They
all recovered from complication, and survived until
now (Survival months were 13, 10 months, respec-
tively).
Conclusions: Our trial for unresectable (borderline
resectable) pancreas body cancer can be a promising
option. But controlled randomized trials are needed.
PPP25-003
THE CORRELATION BETWEEN
POSTOPERATIVE PANCREATIC
FISTULA AND BACTERIAL INFECTION
AFTER THE
PANCREATODUODENECTOMY:
IMPORTANCE OF THE IVR OF THE
EARLY POSTOPERATIVE PERIOD
M. Imamura, Y. Kimura, M. Meguro, T. Nishidate,
T. Ito, D. Kyuno, M. Ishii, M. Kawamoto,
T. Mizuguchi and K. Hirata
Sapporo Medical University, Japan
Introduction: In the recent study, a utility to remove
drains early was shown after pancreatoduodenectomy
(following, PD). However, because of concern of the
becoming severe by the poor drainage, most surgeons
hesitate to do so. We examined optimal drain with-
drawal time from the viewpoint of the correlation
between pancreatic fistula and bacterial infection after
PD.
Method: We intended for 120 patients on whom we
performed PD in our department between April 2007
and March 2012. The closed system continuance sump
drains were put around the pancreaticojejunostomy
and in the foramen of Winslow. On the postoperative
day (POD) 2 and 5, we obtained the drainage fluid and
measured amylase levels. In this study, a diagnosis of
pancreatic fistula followed the definitions of the ISGPF
and more than clinically significant grade B were PF
(+) group. We judged the drainage fluid that became
turbid with infection and examined bacterial culture
appropriately. In more than grade B, we applied IVR
early and conducted drain exchange and persistent
washing with the saline. We removed drains when
drainage became clearing up and the fistula was com-
pleted.
Results: About pancreatic fistula, it was grade A/B/
C = 10/39/4 cases. In 40 of 43 cases of the PF (+)
group, enteric bacteria such as Enterobacter and
Enterococcus were detected primarily. As for 25 of 40
cases, bacteria were detected within the POD 7. On the
other hand, in 12 of 86 cases of the PF () group, bac-
teria were detected. In the all cases of the PF (+) group,
IVR was conducted on the mean POD 9 and there was
no surgery-related death.
Conclusions: In the cases of ISGFP grade B or more,
infection was established in many cases within 1 week
after PD. Importance of active IVR to prevent aggra-
vation of the pancreatic fistula was suggested.
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PPP25-004
OUTCOMES OF
PANCREATODUODENECTOMY FOR
BENIGN AND PRE-MALIGNANT
LESIONS
J. Tol, O. Busch, T.Van Gulik and D. Gouma
Academic Medical Center Amsterdam, Netherlands
Introduction: Pancreatoduodenectomy is associated with
low mortality but still substantial morbidity in the treat-
ment of patients with (suspected) malignant periampul-
lary tumors. Up to 10% of suspected malignant lesions
are finally diagnosed as benign disorders. However, cer-
tain patients have preoperatively proven benign or pre-
malignant lesions such as chronic pancreatitis or ade-
noma. In this study we examined the short and long-term
outcomes in patients with a benign or pre-malignant pe-
riampullary tumor after pancreatoduodenectomy.
Method: All patients who underwent pancreatoduoden-
ectomy during 1992–2012 were prospectively registered.
Patients with benign or pre-malignant diagnosis were
selected. Clinicopathological data were analyzed and
compared to patients with malignant lesions. Outcomes
were stated as odds ratio (OR) with 95% confidence
interval (CI).
Results: From the total group of patients (n = 1037)
144 were diagnosed with a benign tumor and 86 with a
pre-malignant tumor. Mean age of patients with a
benign tumor and patients with a pre-malignant tumor
was 58 years vs 64 years in patients with malignant
tumors (p < 0.001). ASA classification was lower in
patients with pre-malignant tumors (p = 0.01). Jaundice
was reported in 34% vs 78% in malignant lesions.
Patients with benign tumors had a higher rate of hepa-
ticojejunostomy (HJ) leakage (p = 0.048). Patients with
pre-malignant tumors had a higher risk of postopera-
tive complications (OR 1.7; 95% CI 1.1–2.6). Mortal-
ity, 2% in each group, and hospital stay, 13–15 days,
did not differ. 5-year survival in patients with benign
or pre-malignant lesions was 93% and 92% respectively
vs 9% in patients with malignant lesions.
Conclusions: Patients undergoing pancreatoduodenecto-
my due to a benign or pre-malignant lesion are younger,
less frequently jaundiced and suffer from more postoper-
ative complications compared to patients with malignant
tumor. Mortality rates did not differ. 93% of patients
have a 5-year survival after surgery. Although postopera-
tive complications are increased in patients with benign
or pre-malignant lesions, long-term survival is high.
PPP25-005
LEARNING CURVE FOR
LAPAROSCOPIC
PANCREATICODUODENECTOMY: A
SINGLE SURGEON’S EXPERIENCE
WITH CONSECUTIVE PATIENTS
T. Kuroki, A. Kitasato, T. Adachi, A. Soyama,
M. Hidaka, M. Takatsuki and S. Eguchi
Nagasaki University, Japan
Introduction: Laparoscopic pancreaticoduodenectomy
(LPD) is regarded as one of the most complex surgical
procedures. The aim of this study was to examine a single
surgeon’s learning curve for LPD in consecutive cases.
Method: Thirty consecutive patients who underwent an
LPD by the same single surgeon, one of the authors
(T.K.), were divided into three groups (A, B, and C; 10
cases each). This operator has 15 years of experience as a
surgeon, and has experience of approximately 50 open
PD as an operator. Postoperative complications, opera-
tive time, and blood loss for each group were compared.
Results: There were no significant differences in the
occurrence of postoperative complications among the
groups. There were significant differences in both oper-
ative time and blood loss between group A (mean oper-
ative time, 796.8 minutes; mean blood loss 546.2 mL)
and group B (mean operative time, 563.9 minutes;
mean blood loss 242.0 mL), and between groups A and
C (mean operative time, 515.8 minutes; mean blood
loss 283.0 mL). Regarding operative time and blood
loss, the surgeon reached a learning curve plateau after
10 cases/LPD procedures.
Conclusions: LPD is a feasible and safe surgical proce-
dure with a steep learning curve when performed by a
surgeon who is experience in open PD, and LPD pro-
vides the advantages that would be expected from a
minimally invasive surgery.
PPP25-006
MESENCHYMAL CHONDROSARCOMA
FROM PANCREAS
J. Go and C.-N. Kim
Inje University Ilsan Paik Hospital, Korea
Introduction: In worldwide, mesenchymal chondrosar-
coma is a very rare and has more aggressive prognosis
than other chondrosarcoma. Just 2 cases of metastatic
chondrosarcomas in the pancreas have been reported in
the literature.
Method: A 41-year-old man presented with a 1-month
history of abdominal pain. His previous medical and
familial histories were unremarkable. CT scan of the
abdomen revealed an ill defined, lobulated mass that
measured about 13 9 12 9 17 cm in size and it
appeared as a heterogeneously low attenuated mass
with numerous areas of coarse calcification. Hemipan-
createctomy (involved splenectomy) and T-colectomy
was done.
Results: The pathological diagnosis was extraskeletal
mesenchymal chondro-sarcoma arising from the pan-
creas with invasion to the splenic vein.
Conclusions: Mesenchymal chondrosarcoma almost dis-
plays a lethal clinical course, as radical excision of the
tumor is the optimal treatment methods.
PPP25-007
DAY CASE ENDOSCOPIC
ULTRASOUND GUIDED DRAINAGE OF
PANCREATIC PSEUDOCYSTS
S. Fisher, V. Banwell, K. Mason and S. Norton
Derriford Hospital, UK
Introduction: This study assessed the efficacy and safety
of day case endoscopic ultrasound guided pancreatic
pseudocyst drainage. Pseudocysts are a common com-
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plication of pancreatitis. Options for the management
of symptomatic pancreatic pseudocysts include radio-
logically guided percutaneous drainage and operative
drainage. Percutaneous drains risk infection and pan-
creatic fistulae formation. Operative drainage risks sig-
nificant mortality. Endoscopic ultrasound provides the
benefits of a minimally invasive technique and ultra-
sonic visualisation of the drainage path decreasing the
risk of collateral damage and improving the chance of
successful drainage.
Method: A retrospective cohort study was performed
of all cases of attempted endoscopic ultrasound guided
pancreatic pseudocyst drainage at a tertiary referral
unit from January 2007 to September 2011. All cases
had proven pancreatic pseudocysts on axial imaging at
referral. Data collection included case note review and
post-procedure patient interview.
Results: 73 consecutive EUS pseudocyst drainages were
performed. 5 patients declined to participate. 1 was
unable due to stroke. 5 died during follow up (none
procedure related). All pseudocysts were drained either
via aspiration to dryness (66%, n = 41) or stent inser-
tion (34%, n = 21). 15 patients (34%) reported immedi-
ate post procedure symptoms of pain, vomiting or
fever. 60 cases (97%) were outpatients, 92% of these
(56 of 60) were treated as daycases. The remaining 8%
were discharged home after overnight observation. At
1-year review, primary success rate was 85% (53 of 62),
and 98% (61 of 62) after EUS guided re-intervention.
Conclusions: Endoscopic ultrasound guided drainage of
pancreatic pseudocysts is a safe effective day case pro-
cedure.
PPP25-008
PANCREATICOGASTROSTOMY: AN
EXCELLENT SURGICAL OPTIONS FOR
PANCREATIC ASCITES
S. Janakiraman, A. P, K. R, S. PS, R. R,
J. Sathyanesan, R. Palaniyappan and M. Govindhan
The Tamilnadu Dr.MGR Medical University, India
Introduction: Pancreatic ascites is a rare but well docu-
mented complication and should be suspected in
patients with chronic alcoholism and pancreatitis pre-
senting with ascites. The etiology is likely from a pan-
creatic pseudocyst leakage or due to ductal disruption.
Treatment is controversial but includes conservative
medical therapy or endoscopic transpapillary pancreatic
duct stenting or surgery. The aim of our study is to
evaluate role of pancreaticogastrostomy in the manage-
ment of pancreatic ascites. The choice of pancreaticoga-
strostomy was guided because of shortened mesentry
and gross edematous jejunum due to the chronic ascitic
fluid collection from the disrupted pancreatic duct.
Method: Patients with symptomatic ascites for at least
3 weeks with ascitic fluid amylase of >1000 S units/dL
were included. Retrospective analysis of 22 operated
cases with pancreatic ascites following failed conserva-
tive treatment were analysed. Outcome of the study
was defined in terms of morbidity and leakage in early
post operative period.
Results: Longitudinal pancreaticogastrostomy was
done for 10 of the twenty two patients with leak from
the dilated main pancreatic duct. Steatorrhea was
absent in all operated cases. None had recurrence of
ascites and deterioration of endocrine function.
Conclusions: Longitudinal pancreaticogastrostomy
offers an excellent viable option in patients with pan-
creatic ascites with dilated main pancreatic duct espe-
cially those with a subacute peritonitis causing
shortened mesentry with oedematous jejunum.
PPP25-009
IDENTIFICATION OF RISK FACTORS
FOR PANCREATIC FISTULA
FORMATION AFTER DISTAL
PANCREATECTOMY
R. Gomes1 and N. Doctor2
1NUSI Wockhardt Hospital, Goa, India; 2Jaslok
Hospital and Reasearch Centre, Mumbai, Maharashtra,
India
Introduction: Distal pancreatectomy (DP) has a high
post-operative morbidity predominantly due to pancre-
atic fistula though the mortality is very low. Data on
distal pancreatectomy was reviewed to analyse the risk
factors that contribute to this morbidity.
Method: Thirty three patients underwent distal pancre-
atectomy with sutured closure of the remnant, over a
5-year period between May 2006 and April 2011. Pan-
creatic fistula (PF) was defined according to the Inter-
national Study Group on Pancreatic Fistula definition.
Patient and surgical risk factors were subdivided as
those reflecting a poorer pre-morbid status, those asso-
ciated with increased complexity of surgery and those
related to pancreas gland and were analyzed for inci-
dence of pancreatic fistula.
Results: Indications for DP included 16 (51.5%) pan-
creatic tumours, 13 (39.4%) chronic pancreatitis and 3
(9.1%) trauma. Spleen was preserved in 12 patients
(36.4%).There was no mortality while the morbidity
rate was 45.5% (n = 15). Incidence of pancreatic fistula
was 30.3% (n = 10); eight were grade A (80%) and
two were grade C (20%). Incidence of clinically signifi-
cant pancreatic fistulae was 6.1%. PF was significantly
more common if the pancreatic duct was not identified
(p = 0.024) was significantly less with extensive peri-
pancreatic adhesions (p = 0.036).
Conclusions: Identification and ligation of main pancre-
atic duct can help reduce the incidence of pancreatic
fistulae. The identification of patients at high risk of
developing a PF helps to implement prevention strate-
gies.
PPP25-010
DUODENAL DYSTROPHY:
DIAGNOSTIC DILEMMA
S. Bhalerao and A. Rege
KEM Hospital, Pune, India
Introduction: A duodenal dystrophy a distinct form of
chronic pancreatitis in and around the duodenal wall.
It is a rare form of chronic pancreatitis may lead to
diagnostic dilemma. The underlying pathology involves
chronic inflammatory changesof duodenal wall, cyst
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formation and mucosal thickening. In literature it has
been reported under various names including cystic
dystrophy of heterotrophic pancreas, pancreatic hamar-
toma of duodenum, groove pancreatitis, paraduodenal
wall adenomatosis& duodenal dystrophy.
Method: We present occasional alcoholic two male
patients with chronic abdominal pain, dyspeptic symp-
toms, vomiting, GI bleeding, weight loss .Both were
investigated with repeated endoscopy, MDCT and
trans abdominal USG. One patient had received gas-
trojejunostomy and truncal vagotomy for bleeding and
outlet obstruction due to chronic duodenal ulcer and
other had GI bleeding due to duodenal ulcer needing
hospitalisation and endotherapy. Review of old
MDCT, endoscopy reports pathology of duoenal
dystrophy causing duodenal obstruction, bile and pan-
creatic duct was diagnosed. Before pancreaticoduoden-
ectomy, triphasic CT SCAN and GI endoscopy were
done, Liver function tests, CA19-9, CEA were done. In
viewof tripple obstruction, both patients underwent
pancreaticoduodenectomy.
Results: CA19-9, CEA, Liver function tests were no-
mal,MDCT MRCP showed duodenal pancreatic and
bile duct obstruction, thickened duodenal wall, cystic
changes and enlarged blood vessels pancratic & bile
ductal dilatation. GI endoscopy showed duodenal nar-
rowing, mucosal bulges, During pancreaticoduodencto-
my there was extensive fibrsis around PV, SMV &
SMA. There was portal hypertension due to entraping
of SMV, SPV. Frozen pathology did not show malig-
nancy. Postoperatively both patients relived of their
symptoms, pain had disappeared, showed good weight
gain and impoved diabetes.
Conclusions: Identification of duodenal dystrophyas a
rare varient of chronic pancreatitis causing tripple ob-
structionof duodenum, and both ducts., the pancreati-
coduodenectomy is associaed with relief of distressing
symptoms of patients.These patients otherwise would
be denied better quality life and may become crippled
with nonsurgical treatment.
PPP25-011
MENTAL DISORDER IS AN
IMPORTANT RISK FACTOR FOR
ADVERSE EVENTS AFTER
PANCREATECTOMY
Y.-C. Chou
China Medical University Hospital, Taiwan
Introduction: Patients with mental disorder were known
to have a higher risk of complications during hospitaliza-
tion. Quality of care has become the key factor in reduc-
ing their potential mortality afterwards. Our aim is to
validate the features of adverse outcomes after pancrea-
tectomy for surgical patients with mental disorder.
Method: We present a population-based study of
patients with mental disorder receiving pancreatectomy
from the Taiwan National Health Insurance Research
Database within the years 2004 and 2008 compared
with surgical patients without mental disorders. Eight
major postoperative complications and mortality after
complications were evaluated among patients with
mental disorder.
Results: Among 1009 patients with mental disorders
and 2018 matched controls receiving pancreatectomy,
we found that patients with mental disorder had signifi-
cantly increased risk for postoperative septicemia
(OR = 1.39, 95% CI = 1.11–1.74) after adjusted for
age, sex, low income, teaching hospital, and coexisting
medical conditions. The 30-day postoperative in-hospi-
tal mortality was associated with preoperative mental
disorders (adjusted OR = 1.92, 95% CI = 1.08–3.42).
Compared with controls, patients with mental disorders
had higher risk of admission to intensive care unit
(OR = 2.18, 95% CI = 1.61–2.94) and prolonged length
of hospital stay (OR = 1.26, 95% CI = 1.04–1.52) after
pancreatectomy.
Conclusions: In patients receiving pancreatectomy, peo-
ple with mental disorders showed significantly higher
30-day postoperative adverse events when compared
with people without mental disorders. Our findings sug-
gest the urgency revising the protocol of postoperative
care for this specific population.
PPP25-012
PANCREATIC ARTERIOVENOUS
MALFORMATION (P-AVM) SHOULD BE
TREATED BY PANCREATIC
RESECTION
K. Chiba1, H. Shimamura1, K. Sato1, A. Endo1,
H. Kodama1, S. Ishiyama2, Y. Narushima3 and
K. Takeda1
1Sendai Medical Cemter, Japan; 2Sendai Kosei Hospital,
Japan; 3Towada Central Hospital, Japan
Introduction: Arteriovenous malformation (AVM) is
defined as an abnormal connection between arteries and
veins, bypassing the capillary system. AVM can appear
in pancreas (P-AVM), though the incidence is rare. Here
we show and analyze our experienced cases of P-AVM.
Method: Between June 2005 and May 2013, patients
diagnosed as P-AVM and operated in our institute
were retrospectively analyzed.
Results: Three patients were included. All of them were
male (average age: 50). Primary symptom of all
patients was epigastralgia. Two patients had a past his-
tory of pancreatitis, whereas one patient had suffered
from hemorrhagic duodenal ulcer. We performed pan-
creaticoduodenectomy for 2 patients whose P-AVMs
were located in pancreatic head, and middle pancrea-
tectomy for 1 patient whose P-AVM was located in
pancreatic body. Arterio-portal (A-P) shunt was con-
firmed by DSA in 2 patients. After operation, all
patients were released from the symptoms without res-
urrence.
Conclusions: Since P-AVM causes A-P shunt which
leads to tissue ischemia, pancreatic resection including
the AVM is suitable treatment to cure this rare disease.
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PPP25-013
SURGICAL TREATMENT FOR
PANCREATIC NEUROENDOCRINE
TUMOR (PNET)
K. Sato1, H. Shimamura1, K. Chiba1, A. Endo1,
H. Kodama1, S. Ishiyama1, Y. Narushima2 and
K. Takeda1
1Sendai Medical Center, Japan; 2Towada Central
Hospital, Japan
Introduction: Pancreatic neuroendocrine tumor (PNET)
is a rare disease, and the treatment guideline for PNET
is currently under construction. Here we show and ana-
lyze our PNET patients, and consider about surgical
treatment for PNET.
Method: Between January 2004 and December 2012,
patients who diagnosed as PNET and underwent oper-
ation in our institute were included. Operative proce-
dures, histopathological findings and clinical outcomes
of these patients were retrospectively reviewed. All
specimens were re-classified by the WHO 2010 classifi-
cation.
Results: Fourteen patients were included (6 males and
8 females, average age was 64.0). Twelve of them
belonged to non-functioning PNET. There was 1 case
each of insulinoma and gastrinoma. By the WHO 2010
classification, 9 cases were classified into NET G1,
whereas 3 into NET G2 and 2 into NEC. We per-
formed pancreaticoduodenectomy with lumph node dis-
section for 5 cases, distal pancreatectomy with lumph
node dissection for 4 cases, middle pancreatectomy for
2 cases and tumor enucleation for 3 small PNET (NET
G1) cases. Two NEC patients died of recurrence.
Lymph node metastasis was found in 3 patients. One
of them, the gastrinoma case, appeared to metastasize
in para-aortic lymph nodes despite NET G1, though
the met lesion was controlled by Everolimus.
Conclusions: NEC cases tend to recur even underwent
pancreatic resection, including lymph node dissection,
for which careful follow-up is necessary. We performed
tumor enucleation for 3 patients, and this procedure
should be justified by long term follow-up.
PPP25-014
SWITCHING RECONSTRUCTION OF
JEJUNAL LOOP IN
PANCREATODUODENECTOMY
FOLLOWED BY TOTAL
GASTRECTOMY WITH DOUBLE-
TRACT-RECONSTRUCTION
Y. Nakajima, S. Yamazaki, T. Higaki, Y. Teshima and
T. Takayama
Nihon University School of Medicine, Japan
Introduction: The double tract methods of total gas-
trectomy by gastric cancer was a meticulous methods.
In case of re-separation and reconstruction of double
tract anastomosis by other metachronous cancer
require meticulous procedure.
Method: We encountered patients with common bile
duct cancer. He had been underwent total gastrectomy
by gastric cancer 20 years ago and the double-tract
reconstruction was performed at this operation. The
bile duct cancer was located in lower part of the com-
mon bile duct whereas no lymph node and distant
metastases were observed. We planed pancreatoduo-
denectomy for this patient. At operation, the duodenal
anastomosis and jejuno-jejunostomy of double tract
was divided. Next, the proper pancreatoduodenectomy
was performed. We preserved blood flow and length of
the jejunal loop as much as possible.
Results: The reconstruction was performed as the
Child methods. The original jejunal loop with jejuno-
jejunostomy of double tract was used for a loop of
pancreaticojejunostomy and choledochojejunostomy.
Therefore, no need for newly re-create a jejunal loop.
The post operative course was uneventful and no
adverse event observed relating for this switching
reconstruction.
Conclusions: This unique method was minimum inva-
sive and simple one for pancreatoduodenectomy fol-
lowing by total gastrectomy.
PPP25-015
INTERNATIONAL CONSENSUS
GUIDELINES 2012 FOR THE
MANAGEMENT OF IPMN AND MCN OF
THE PANCREAS IS USEFUL FOR THE
MANAGEMENT OF THE BRANCH
DUCT IPMN - ANALYSIS OF THE 363
RESECTED CASES -
W. Izumo, T. Hatori, S. Suzuki, N. Oshima,
R. Suzuki, A. Kimijima, K. Shimizu, T. Furukawa,
K. Shiratori and M. Yamamoto
Tokyo Women’s Medical University, Japan
Introduction: The international consensus guidelines for
the management of IPMN and MCNof the pancreas
were revised in 2012. The aim of this study was to eval-
uate the usefulness of the IPMN guidelines 2012 from
the point of view of branch duct IPMN (BD-IPMN).
Method: According to the IPMN guidelines 2012, the
definition of BD-IPMN was pancreatic cysts of more
than 5 mm in diameter that communicate with the
main pancreatic duct. Of 452 patients who underwent
pancreatectomyfor the IPMN between 1981 and 2012,
363 patients were classified into BD-IPMN and they
were evaluated according to the algorithm forBD-
IPMN.
Results: The high-risk stigmata were seen in 37% of
the patients. Histopathologically, low-grade dysplasia
(LG) was found in 19% of the patients, intermediate-
grade dysplasia (MG) in 3%, high-grade dysplasia
(HG) in 28% and an associated invasive carcinoma
(Invasive) in 50%. The worrisome features were
detected in 38% of the patients. LG was found in 25%
of the patients, MG in 20%, HG in 40% and Invasive
in 15%. In the remaining 90 patients without high-risk
stigmata nor worrisome features, Invasive was not
found. 36 patients had cysts more than 3 cm in diame-
ter (LG 81%, MG 5%, HG 14%), 28 patients had
cysts 2–3 cm in diameter (LG 86%, HG 14%), 20
patients had cysts 1–2 cm in diameter (LG 85%, MG
15%), 6 patients had cysts less than 1 cm in diameter
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(LG 83%, MG 17%). No malignancy was found in the
patients with cysts less than 2 cm in diameter.
Conclusions: The revised IPMN guidelines 2012 were
useful for the management of BD-IPMN.
PPP25-016
PANCREAS DIVISUM TREATED BY
PYLORUS-PRESERVING
PANCREATODUODENECTOMY: A
CASE REPORT
J.S. Kim, D.J. Kim, J.P. Jung, I.-K. Kim, J.Y. Jeon,
S.E. Cheon and J.W. Whang
Gangdong Medical Center, Hallym University, Korea
Introduction: Pancreas divisum is a rare anatomical
variant, and the incidence is reported as 7% of autop-
sies. Most cases remain without clinical symptoms.
However, some patients with pancreas divisum develop
symptoms of recurrent pancreatitis. When pancreatitis
occurs, the goal of management is the improvement of
the dorsal pancreatic drainage. This may be achieved
by endoscopic or surgical approaches. The indication
and method of surgical options are not clearly deter-
mined in each clinical situation. A case of young male
patient with pancreas divisum is resented, who under-
went PPPD and achieved clinical improvement.
Method: (case report) A 29-year-old male patient
admitted due to severe epigastric pain lasting for
3 months. The patient suffered from indigestion, post-
prandial discomfort and vomiting since childhood. The
patient admitted to hospital due to epigastric pain,
nausea and vomiting 5 years ago, and was managed
under impression of acute pancreatitis. The imaging
studies were done. Under the impression of pancreas
divisum the patient underwent PPPD. The head of pan-
creas showed chronic inflammatory changes.
Results: The patient was discharged without complica-
tions. Thirty months after operation, the patient is
doing well without indigestion and postprandial pain.
He gained 3 kg after operation.
Conclusions: In this case, the ampulla was not intro-
duced and endoscopic approach failed. Variable meth-
ods of operation are suggested by many authors.
Currently PPPD is regarded as a safe and effective
operation. Considering the patient age, the PPPD is
selected. The long-term result is needed to be evaluated
in this patient
PPP25-017
POSTOPERATIVE MORBIDITY AND
MORTALITY OF PANCREATECTOMIES
B. Serji, L. Jaiteh, A. Souadka, A. Benkabbou,
H.O.E. Malki, R. Mohsine, L. Ifrine and
A. Belkouchi
University Mohammed Vth Souissi Rabat Morocco,
Morocco
Introduction: Pancreatic resections are procedures used
in a diverse number of benign and malignant diseases
of the pancreas or its surrounding structures. Our study
focuses on the analyses of the surgical complications
that result from these interventions with the aim of
proposing preventive strategies.
Method: We analyzed retrospectively data from
patients included in a prospective database dedicated
to “pancreatic resections” in the General Surgery
Department “A” Ibn Sina Hospital in Rabat, from
January 2010 to December 2012 (3 years). A statistical
analysis investigated the risk factors for morbidity and
mortality.
Results: Sixty-one patients were included. In 48 (80%)
patients, the pancreatectomy corresponded to duodeno-
pancreatectomy. The other types of resections (20%)
corresponded to 8 distal pancreatectomy and splenec-
tomy, 2 enucleations, 1 ampullectomy, 1 distal pancrea-
tectomy and 1 total pancreaticoduodenectomy. The
severity of complications was assessed by the classifica-
tion of Clavien Dindo. Severe morbidity and mortality
(Grade ≥ 3b) was 20% with a mortality rate of 13%
and 7% of which were of medical origin: cerebral vas-
cular accident, myocardial infarction and respiratory
complications. Statistical univariate analysis showed
that the general condition of the patient, intraoperative
blood loss, transfusion and duration of surgery were
associated with higher morbidity.
Conclusions: Preoperative assessment of co morbidities,
evaluation of the general condition of patients as well
as standardization of perioperative care and surgical
techniques should contribute to reduce postoperative
morbidity and mortality of pancreatectomy in our con-
text.
PPP25-018
TOTAL LAPAROSCOPIC
PANCREATICODUODENECTOMY:
FEASIBILITY AND OUTCOME IN AN
EARLY EXPERIENCE
N. Thuan, T.C.D. Long, N.H. Bac, L. Tien Dat and
D.Q. Viet
Vietnam
Introduction: Laparoscopic pancreaticoduodenectomy
represents one of the most advanced applications for
laparoscopic surgery currently in use. In the past, the
minimally invasive techniques were only used for diag-
nostic laparoscopy to evaluate periampullary malignan-
cies, staging of pancreatic cancer, and palliative
procedures for unresectable pancreatic cancer.
Despite its first description by Gagner and Pomp1 in
1994, there has not been wide acceptance of the proce-
dure to date. Our aim was to describe the feasibility
and outcome of total laparoscopic pancreaticoduoden-
ectomy (TLPD) at a single institution.
Method: This study included 13 patients who under-
went TLPD between 5/2010 and 5/2012. Clinical vari-
ables, such operation time, blood loss, surgical
technique and complication.
Results: There were 13 patients in this study. All of
patients underwent TLPD. The mean age was 62, mean
operation time: 380 minutes, mean blood loss: 150 mL.
The mean hospital stay was 7.8 days. Conversion rate
was 0%, pancreatic fistula was seen in once patient.
Overall mortality rate was 0%.
Conclusions: The results of current study suggest that
Laparoscopic pancreaticoduodenectomy is feasible,
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safe, and effective. Experience in pancreatic resection
and possession of advanced laparoscopic skills are rec-
ommended prerequisites if patients are selected prop-
erly has low mortality and acceptable rates of
complications.
PPP25-020
INDICATIONS AND RESULTS OF
TEMPORARY MESENTERIC- PORTAL
BYPASS IN SURGERY OF THE
LOCALLY ADVANCED PANCREATIC
CANCER
S. Voskanyan, A. Artemiev, E. Naydenov and
A. Voevodin
State Scientific Center Burnazyan FMBC of the FMBA
of Russia, Russia
Introduction: Research objective. To study the results
of blood flow stops in the mesenteric-portal system and
using of the temporary mesenteric-portal bypass in sur-
gery of the locally advanced pancreatic cancer with
invasion of the main vessels of the mesenteric-portal
system.
Method: Pancreaticoduodenectomy with resection and
recovery of the main vessels of the mesenteric-portal
system have been performed to 75 patients with locally
advanced pancreatic cancer. R0-resections were per-
formed «en block». To 18 patients (group 1) the total
cross-clamping of the main vessels of the mesenteric-
portal system was applied while the stopping of the
arterial blood-flow through the superior mesenteric
artery for 40 minutes were performed on the stages of
the mobilization, resection and reconstruction. The
technologies of the direct short temporary venous-
venous bypass by not thrombogenic silicone canulas
were used to 57 patients (group 2). Functioning of the
bypass was 88.6 (46.2–154.7) minutes (28–172 minutes).
Results: Mesenteric venous thrombosis, thrombosis of
the bypass system, severe liver insufficiency due to pro-
longed compression of the portal vein weren’t observed
in both groups of the patients. Postoperative transient
increase of transaminases didn’t exceed three times and
were restored within 7–10 days. Cases of the thrombo-
sis of the bypass haven’t been noted. Venous edema of
the small intestine not observed during the observation
period in both groups of the patients.
Conclusions: Stopping of the mesenteric-portal blood
flow at the stage of resection and reconstruction of the
main vessels of the mesenteric-portal system at total
stopping of the arterial blood flow for not more than
40 minutes does not require usage of the temporary
vascular bypass, because it does not lead to the mesen-
teric thrombosis, ischemic intestinal edema and necro-
sis, acute hepatic failure in the postoperative period.
Stopping of the mesenteric-portal blood flow for more
than 40 minutes requires the use of temporary vascular
bypass.
PPP25-021
RESULTS OF NEW METHODS OF THE
PROPHYLAXIS OF THE ACUTE
POSTOPERATIVE PANCREATITIS AND
THEIR CLINICAL EFFICACY IN
SURGICAL GASTROENTEROLOGY
S. Voskanyan and E. Naydenov
State Scientific Center Burnazyan FMBC of the FMBA
of Russia, Russia
Introduction: Research objective. Evaluate the clinical
results of the complex prophylaxis of the acute postop-
erative pancreatitis (APP) in surgical gastroenterology.
Method: The work is based on the results of the surgi-
cal treatment of the 2968 patients with various disor-
ders of the digestive system, including peptic ulcer and
duodenal ulcer, cancer of the stomach, proximal and
distal pancreatic cancer, colorectal cancer and post-
gastrectomy syndromes. Empirical prophylaxis of the
APP has been performed in the control group of the
patients (1934 patients). Different methods of the pro-
phylaxis of the APP, such as the use of the drugs of
the Leu-enkephalin (Dalargin), parapancreatic microir-
rigation by drug cocktail (Dalargin, Lidocaine, Dex-
tran), permanent intravenous infusion of the
Octreotide, duodenal enzyme inhibition by Trypsin, in-
traduodenal reversion of the pancreatic secret, intro-
duction of the Lidocaine in the pancreatic duct and
outside transnasal drainage of the pancreatic and bile
ducts in the surgery of the “low” complicated duodenal
ulcers were used on a specially designed scheme in the
main group of the patients (1034 patients).
Results: Frequency of the complication was 12.2% in
the main group versus 36.9% in the control group. The
morbidity was 13.6% in the main group and 25.1% in
the control group. The mortality was 1.6% in the main
group and 3.5% in the control group. The postopera-
tive hospital stay was 12.1  0.4 days in the main
group and 16.7  0.6 days in the control group. Also,
clinical efficacy of the proposed scheme of the prophy-
laxis of the APP in terms of index “Number Needed to
Treat” (NNT) was found in the main group of the
patients (NNT = 3.5).
Conclusions: Using of the proposed scheme of the pro-
phylaxis of the APP allows to significantly reducing the
frequency of the complication, the morbidity, duration
of postoperative hospital stay, and hospital mortality in
patients after abdominal surgery.
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PPP25-022
DOUBLE
PANCREATICOJEJUNOSTOMY
WITHOUT PANCREATIC RESECTION
FOR TREATMENT OF MAIN
PANCREATIC DUCT INJURY WITH
PANCREATIC FISTULA: A CASE
REPORT
K.Y. Paik, D.J. Kim and W. Kim
Catholic University of Korea, Yoeuido St. Mary’s
Hospital, Korea
Introduction: We experienced surgical management in
68-years-old female patient with main pancreatic duct
injury during urologic laparoscopic operation.
Method: Hepatobiliary surgeon repaired pancreatic
duct which is suggested minor duct using surgical clip
during initial operation to avoid laparotomy. After
that, we detected the main pancreatic duct injury at
pancreatic head portion. Unless conservative therapy
for a month, the amount of pancreatic juice via exter-
nal drain was not reduced, we decided the operation to
control pancreatic fistula.
Results: We performed blunt primary repair for injured
pancreas head portion and pancreas neck division. For
preservation of whole pancreas, double pancreaticojej-
unostomy at distal and proximal stump were performed
using jejunal Roux limb. The result of pancreaticojejun-
ostomy was successful.
Conclusions: Pancreaticojejunostomy without pancrea-
tectomy can be a treatment option in patients with
main pancreatic injury to preserve pancreas volume.
However, cautious and complete surveillance to detect
of pancreas injury should be performed initially while
treating iatrogenic pancreas injury.
PPP25-023
THE EFFECT OF MODIFIED
PANCREATICOJEJUNOSTOMY FOR
REDUCING THE PANCREATIC
FISTULA AFTER
PANCREATICODUODENECTOMY
K.Y. Paik, D.J. Kim, W. Kim and E.K. Kim
Catholic University of Korea, Yoeuido St. Mary’s
Hospital, Korea
Introduction: Pancreatic fistula (PF) has traditionally
been a source of significant morbidity and mortality
after pancreaticoduodenectomy (PD). External drainage
of pancreatic duct with stent and Blumgart anastomosis
had reduced PF after PD in some studies. We applied
compounding described 2 methods for External drain-
age with Blumgart method of pancreaticojejunostomy
(PJ) during PD, and investigated the effectiveness of
this modified PJ technique to prevent PF.
Method: Between March 2002, and March 2013, 90
patients who underwent PD were enrolled. The patients
were divided into 2 groups according to pancreatienter-
ostomy method. Group 1 contain patients who did not
undergo modified PJ (n = 70) compared with group 2
(n = 20) those who did undergo the modified PJ tech-
nique. We compared clinical data between two groups.
Results: No differences were noted in the demographics
and operation-related factors, between the 2 groups. A
PF occurred in 38 of 70 patients in group 1 (54.3%)
and in 2 of 20 in group 2 (10.0%). Group 2 had a sig-
nificantly lower incidence of PF (P = 0.0016), and these
fistulas were classified as being grade A using the Inter-
national Study Group on Pancreatic Fistula Definition.
Mortality in group 1 was 10.0% and no mortality in
group 2.
Conclusions: External drainage with Blumgart method
of PJ showed reducing high grade PF after PD.
PPP25-024
RESECTION AFTER PREOPERATIVE
THERAPY FOR LOCALLY ADVANCED
UNRESECTABLE PANCREATIC
CANCER -SINGLE CENTER
EXPERIENCE-
Y. Toyoki, K. Ishido, D. Kudo, N. Kimura,
T. Wakiya, S. Sakuraba and K. Hakamada
Hirosaki University Graduate School of Medicine, Japan
Introduction: For patients with pancreatic cancer, cura-
tive treatment is only complete resection with adjuvant
chemotherapy. However, many pancreatic cancer
patients are unresectable cases. In this report, we were
analyzed for locally advanced unresectable pancreatic
cancer patients who underwent preoperative therapy in
our department.
Method: From August 2010 to December 2012, 14
locally advanced unresectable pancreatic cancer patients
underwent chemotherapy or chemoradiation. Main cri-
teria of unresectable pancreatic cancer were according
to the NCCN guideline. Resection rates, complication
during the treatments, and survival were analyzed.
Results: Of 14 patients, 13 patients were underwent
chemotherapy only, and 1 patient was underwent
chemoradiation. Of 14 patients, 7 patients were under-
went surgery (7/14, 50.0%). Five patients were under-
went successful resection (5/14, 35.7%), whereas 2
patients were underwent exploration only. The 1- and
2-year survival rate after macroscopic resection were
80.0 and 40.0%.
Conclusions: We believe that preoperative chemother-
apy or chemoradiation has potential benefits for locally
advanced unresectable pancreatic cancer patients
because of the associated improved resection rate and
prognosis.
PPP25-025
ISOLATED PHYSIOLOGICAL
RECONSTRUCTION AFTER
PANCREATICODUODENECTOMY
A. Lukashenko, V. Priymak, O. Kolesnik and
I. Shchepotin
National Cancer Institute, Ukraine
Introduction: Pancreatic anastomotic failure remains
the most dangerous complication after pancreaticoduo-
denectomy despite recent improving in operation tech-
nique. Delayed gastric emptying (DGE) is the second
common problems encountered postoperatively, which
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not always associated with pancreatic anastomotic leak.
Use of a Roux-en-Y loop for reconstruction of pancre-
atic drainage is a technique that has been suggested to
reduce pancreatic anastomotic leak–related morbidity
and mortality in patients undergoing pancreaticoduo-
denectomy.
Method: Study took place from January 2009 to Janu-
ary 2013 as a single center randomized controlled par-
allel grouped superiority surgical trial. Reconstruction
of the pancreatic remnant was done using a single loop
standard reconstruction (SR) in 31 patients and by an
original technique - totally isolated Roux-en-Y loop‘s
(RR) in 26 patients. The focus group were high risks
patients for postoperative pancreatic fistula, with “soft”
pancreatic tissue and without dilatation of the main
pancreatic duct. Pancreatic fistula was defined as drain-
age of greater than 50 mL of amylase rich fluid on or
after postoperative day 5.
Results: No statistically significant difference was
observed in the rates of pancreatic fistula comparing to
the type of reconstruction (RR, 35,5% vs SR, 38,5%;
p = 0.35). The rate of interventional radiology drainage
procedures was lower in RR group (RR, 12.9% vs SR,
30.8%; p = 0.033) as well as no need of reoperation (3
reoperation was performed in the SR group). There
were evident decreasing of incidences of DGE in RR
group (RR, 9.7% vs SR, 34.6%; p = 0.026) also as in
length of postoperative hospital stay - RR (15.7 days
[range, 7–30 days]) compared with those undergoing
SR (30.4 days [range, 12–54 days] P = 0.044).
Conclusions: Use of the alternative Roux-en-Y tech-
nique for reconstruction following the Whipple proce-
dure may decrease the incidence of DGE and necessity
of postoperative interventional radiology drainage,
achieved shorter hospital stays.
PPP25-026
PYLORUS PRESERVING AND
ANTRECTOMISED PD AND FAST
TRACK SURGERY
A. Coker1, A. Uguz1, T. Kemer3, B. Goktepe1,
R. Ortac2, E. Goker1 and O. Tekesin1
1Ege Uiversity, Turkey; 2Izmir University, Turkey;
3Private Practice, Turkey
Introduction: The goals of fast track protocols include
attenuating the surgical stress response and reducing
end organ dysfunction through integrated preoperative,
intraoperative, and postoperative pathways.
Method: In 91 patients with periampullary tumors were
performed pancreaticoduodenectomies. In year 2012 all
operations were pylorus preserving (56 patients) and in
2011 those were antrectomised (35 patients). The meth-
ods used include epidural or regional anaesthesia, opti-
mal pain control, and aggressive postoperative
rehabilitation, including early enteral (oral) nutrition
and ambulation. Epidural catheterisation and analgesia
through this catheter have been employed all patients.
All patients have been started oral nutrition on postop-
erative first day. It has been aimed to achieve enteral
feeding without any paremteral support on postopera-
tive 3rd day. Drains were withdrawn if discharge was
lower than 30 cc and amylase levels were not indicate
any leakage. All patients were followed up by home
enteral nutrition nurse. Glutamin and arginin included
enteral nutritional support was applied to all patients.
Diabetic formulas have been used for diabetic patients.
Antibiotic regimens, mobilisation and nursing care were
standardised. All patients were followed up in every
3 months for 5 years for malignant lesions.
Results: Only one patient died in 91 patients due to sur-
gical complication. 2 patients were died because of myo-
cardial infarction on postoperative 56th day and 27th
day. In pylorus preserving (PP) and antrectomised (AP)
group, re admission rate were 3.7% and 3.4% consequ-
tively. Anastomotic leakage were seen in pp group in 3
patients and 2 patients in AP group. Average discharge
day were 6.6 and 7.1 days in same manner. There was
not any statistical difference between 2 groups.
Conclusions: Use of protocols based on fast-track con-
cepts has been shown to reduce hospital stay, re admis-
sion rate. Mortality and morbidity rates are also almost
same for antrectomised and pylorus preserving groups.
PPP25-027
FAST TRACK HPB SURGERY
A. Coker1, O. Tekesin1, T. Kemer2, O. Unalp1,
E. Ekmekcigil1 and E. Goker1
1Ege Uiversity, Turkey, 2Private Practice, Turkey
Introduction: Enhanced recovery, otherwise known as
“fast-track” programs, are evidenced-based protocols
designed to standardize medical care, improve out-
comes, and lower health care costs. Fast-track proto-
cols for surgery patients were developed to reduce
physiological stress and postoperative organ dysfunc-
tion through optimization of perioperative care and
recovery.
Method: Between 2009 and 2012 467 patients with
HPB diseases were operated in the same Institute and
surgeon. Procedures performed were 165 pancreatico-
duodenectomies, 69 distal pancreatectomies, 22 pancre-
atic operations for benign etiology, 113 hepatectomies,
26 hydatid cyst operations, 22 Klatskin tumors and 50
bilioenetric diversions. Epidural catheterisation and
analgesia through this catheter have been employed all
patients. All patients have been started oral nutrition
on postoperative first day. In pancreaticoduodenectomy
patients it has been aimed to achieve enteral feeding
without any paremteral support on postoperative 3rd
day. Drains were withdrawn if discharge was lower
than 30 cc and amylase levels were not indicate any
leakage. All patients were followed up by home enteral
nutrition nurse. Glutamin and arginin included enteral
nutritional support was applied to all patients. Diabetic
formulas have been used for diabetic patients. Antibi-
otic regimens, mobilisation and nursing care were stan-
dardised. All patients were followed up in every
3 months in first year for benign lesions and every
3 months for 5 years for malignant lesions.
Results: Average age was 56.3 + 2.3, female/male ratio
was 1/1.2. Mean hospitalisation period was 6.8 days.
Overall complication rate related to surgery was 7.8%
and mortality rate was 4.7% in first month after sur-
gery. Re admission rate was 5.2% and reoperation rate
was 2.4%. Weight loss was less than 10% in all
patients except 17 patients with pancreatic tumors.
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Conclusions: Multimodal evidence-based care within
the fast-track methodology significantly enhances post-
operative recovery and reduces morbidity, and should
therefore be more widely adopted.
PPP25-028
CLINICAL IMPACT OF PERITONEAL
LAVAGE CYTOLOGY STATUS IN
PANCREATIC CANCER PATIENTS
S. Yamaki, S. Satoi, H. Yanagimoto, H. Toyokawa,
T. Yamamoto, S. Hirooka, T. Michiura, K. Inoue,
Y. Matsui and A.-H. Kwon
Kansai Medical University, Japan
Introduction: The clinical implications of peritoneal
lavage cytology (CY) status in patients with pancreatic
cancer have not been fully established. We retrospec-
tively reviewed clinical data from 176 consecutive
patients who underwent macroscopically curative resec-
tion for pancreatic cancer from 2001 to 2012.
Method: Clinical background, surgical factor, and sur-
vival curve were compared between CY positive
(n = 25) and negative (n = 151).
Results: There were no significant differences in back-
ground data (neo-adjuvant therapy, rate of portal vein
resection, N0 and R0, and adjuvant chemotherapy)
between 2 groups. Frequency of pancreas body and tail
cancer (52% vs 18%), borderline and unrespectable
cancer (48% vs 30%), arterial resection (16% vs 3%)
in CY positive group were significantly higher than in
CY negative (p < 0.05). Surgical complete response rate
(sCR), designated as R0/1 and post-resection tumor
marker normalization, in CY positive was significantly
lower than in CY negative (50% vs 71%, p = 0.036).
The median overall survival time of CY positive had
low tendency, relative to CY negative (18 vs
24 months, respectively). In comparison of primary site
of metastasis after surgical resection, the rate of perito-
neal metastasis in CY positive was significantly higher
than in CY negative (45% vs 14%, p = 0.003).
Conclusions: Patients with CY positive had advanced
stage cancer, lower sCR and higher rate of peritoneal
metastasis, resulting in low tendency of survival time.
Development of the adjuvant therapy to control perito-
neal metastases will be necessary in future.
PPP25-029
PANCREATICOJEJUNOSTOMY USING
A TECHNIQUE OF INVAGINATION
ANASTOMOSIS (END-TO-SIDE
ANASTOMOSIS) WITHOUT STENTING
I. Watanobe, S. Oomori, S. Miyano, M. Machida,
T. Kitabatake, M. Fujisawa and K. Kojima
Juntendo University School of Medicine, Juntendo
University Nerima Hospital, Japan
Introduction: We present a pancreaticojejunostomy
technique of invagination anastomosis (end-to-side
anastomosis).
Method: This study included 51 patients, 30 men and
21 women, average age 69 years, who underwent pan-
creaticoduodenectomy at our hospital. Endo-to-side
pancreaticojejunostomy was performed for all patients
without stenting. In the first place, the outer layer
encompasses the posterior wall of the remnant pancreas
and the jejunal seromusucularis separately using 4–0
nonabsorbable sutures. The inner layer encompasses
the capsular parenchyma of the pancreas and the jeju-
num through all layers of the bowel continuously using
4–0 absorbable sutures.
Results: There was no mortality in any of the 51
patients. Postoperative pancreatic fistula was evaluated
using an international study group (ISGPF) definition.
25 patients (49.0%) did not develop postoperative pan-
creatic fistula, and 26 patients (51.0%) developed pan-
creatic fistula; Grade A:23 (45.1%), Grade B:3 (5.9%),
Grade C:0. 23 patients (Grade A) developed very low-
output pancreatic fistula, it healed of short duration
with conservative management. 3 patients (Grade B)
were required to stay longer, but all of them healed
with conservative therapy. None of the patients devel-
oped postoperative intra-abdominal bleeding. 4 patients
developed delayed gastric emptying.
Conclusions: The incidence of fistula has been consider-
ably decreased by the technique of invagination anasto-
mosis (end-to-side anastomosis) without stenting.
PPP25-030
WHAT IS THE RISK FACTOR OF
MALIGNANCY PRESENT IN THE
BRANCHED-TYPE IPMN CASES WHICH
RESECTED AFTER FOLLOW UP
PERIODS?
Y. Kato, S. Takahashi, N. Gotohda and
M. Konishi
National Cancer Center Hospital East, Japan
Introduction: International consensus guidelines for the
management of IPMN of the pancreas were revised in
2012. The high-risk stigmata of malignancy present was
considered to be following only three factors; (1)
Obstructive jaundice in a patient with cystic lesion of
the head of the pancreas, (2) Enhancing solid compo-
nent within cyst, (3) Main pancreatic duct >10 mm in
size. Therefore, it is expected that the IPMN cases fol-
lowed up increase in the future.
Method: The aim of this study is to identify the risk
factor of malignancy present in the branched-type
IPMN cases which resected after follow up period. The
study involved 40 patients with branched-type IPMN
(BD-IPMN) who had no mural nodules at initial diag-
nosis, underwent resection after the follow-up periods
more than three months. Data of those patients were
reviewed retrospectively, and the clinicopathological
factors and survival outcomes were investigated.
Results: Median follow-up period was 19 months. 17
patients of all (47.5%) were diagnosed carcinoma,
remaining 23 (52.5%) were adenoma. 7 patients under-
went resection without tumor enlargement after follow-
up periods, all of them were diagnosed adenoma. 33
patients underwent resection because of tumor enlarge-
ment, 19 patients (57.6%) of them were carcinoma. 9
of 18 patients (50.0%) observed only cyst enlargement
were diagnosed carcinoma, 2 of 4 (50.0%) observed
increase in diameter of main pancreatic duct were carci-
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noma, 8 of 11 (72.7%) observed mural nodule newly
were carcinoma. All 7 patients observed increase of cyst
in diameter 1.5 times or more were carcinoma.
Conclusions: During the follow-up periods, if we iden-
tify mural nodule or increase of cyst in diameter 1.5
times or more, the malignant potential of the patients
with those findings are high, surgical resection should
be considered.
PPP25-031
A CASE OF ACINAR CELL CARCINOMA
OF PANCREATIC HEAD
H.J. KIM, C.Y. Kim, Y.H. Hur, Y.S. Koh, J.C. Kim,
C.K. Cho and H.J. Kim
Chonnam National University Medical School, Korea
Introduction: Acinar cell carcinoma is a rare pancretic
neoplasm. Because of its rarity, characteristics of this
disease have not been fully investigated. Herein, we
present a case of acinar cell carcinoma of pancreas with
its image and histologic findings.
Method: A 60-year-old woman was referred to our
hospital for evaluation of pancreatic mass found on CT
scan. Abdominal CT and MRI showed a about 3cm
sized well marginated non-enhancing round mass with
internal bleeding in pancreatic head.
Results: A preoperative diagnosis of solid pseudopapil-
lary tumor was made, and pylorus preserving pancrea-
ticoduodenectomy was performed. At laparotomy, a
3 9 3 cm sized brown soft mass was found in pancre-
atic head. Microscopic findings revealed invasive acinar
cell carcinoma. The patient discharged 17 days follow-
ing surgery without any complications. 2 months fol-
lowing the surgery, multiple hepatic metastases were
found on follow up CT scan.
Conclusions: Acinar cell carcinoma of pancreas is a
rare neoplasm showing a poor prognosis. Herein, we
report a case of acinar cell carcinoma of pancreas.
PPP25-032
MICROCYSTIC SEROUS
CYSTADENOMA MIMICKING
PANCREATIC MALIGNANCY
C.Y. Kim, H.J. Kim, Y.H. Hur, Y.S. Koh, J.C. Kim,
C.K. Cho and H.J. Kim
Chonnam National University Medical School, Korea
Introduction: Typically, serous cystadenomas of pan-
creas are frequently microcystic or oligocystic. On CT
scan, serous cystadenoma generally are surrounded by
a fibrous capsule and contain numerous tiny cysts,
which are sometimes so small that the cystic nature is
difficult to appreciate, because it is below the limits of
CT resolution. Herein, we present a case of serous cys-
tadenoma mimicking pancreatic adenocarcinoma on
imaging study.
Method: A 74-year-old woman was referred to our
institution for evaluation of incidentally found pancre-
atic body and tail mass on CT scan. Physical examina-
tion and laboratory data including tumor markers were
within the normal range. The patient had not experi-
enced a recent weight loss of abdominal pain. Abdomi-
nal CT revealed an about 7 9 6 cm sized
heterogeneously enhancing mass in pancreatic tail.
And, in pancreatic body, a about 5 9 3 cm sized heter-
ogeneously enhancing mass was found.
Results: A preoperative diagnosis of panceratic adeno-
carcinoma of body and tail was made, and anterior
radical antegrade modular pancreatosplenectomy was
performed. Macroscopically, there were a 6 9 6 cm
sized well marginated muticystic mass in body, and a
12 9 10 cm well capsulated multicystic mass in tail.
Microscopic findings revealed microcystic serous cys-
tadenoma.
Conclusions: Microcystic serous cystadenomas are
sometimes difficult to differentiate from soild tumor.
Herein, we present a case of microcystic serous cystade-
noma mimicking pancreatic malignancy.
PPP25-033
MORBIDITY AND MORTALITY IN
PATIENTS WITH PANCREATIC
CANCER UNDERGOING
CHOLECYSTOJEJUNOSTOMY
M. Belotto, T.De Campos, A.De Moricz, A. Pacheco
and R. Althenfelder
IHPB, Brazil
Introduction: Less than 30% of patients with pancre-
atic cancer undergo to resection surgery. The other
70% will have palliative treatments. Thus, palliative
treatment is important in providing patient improve-
ment of quality of life, mainly due to reduction of jaun-
dice. The aim of this study is to evaluate morbidity and
mortality in patients with pancreatic cancer undergoing
cholecystojejunostomy.
Method: A retrospective review of all patients with
advanced pancreatic cancer at Santa Casa in Sao Paulo
from 2002 to 2013, who underwent cholecystojejunosto-
my. Systemic and local complications, jaundice
improvement and mortality were evaluated.
Results: We analyzed 60 patients who underwent chol-
ecystojejunostomy. The mean age was 60.4-years-old.
Albumin level was 3.01 g/dL and direct bilirubin was
14.8 mg/dL. All patients had reduction in bilirubin levels
in the postoperative period. Eight patients (13.3%) died
in the first 30 days. The cause of deaths were renal injury
in four patients, acute myocardial infarction in 1 patient,
and other clinical causes in the remaining 3 patients.
Conclusions: Cholecystojejunostomy is technically a
simple procedure and effective in the relief of jaundice,
despite significant mortality.
PPP25-034
A CASE OF DISTAL
PANCREATECTOMY WITH CELIAC
AXIS RESECTION FOR LOCALLY
ADVANCED PANCREATIC CANCER
H.J. Kim, C.Y. Kim, Y.H. Hur, Y.S. Koh, J.C. Kim,
C.K. Cho and H.J. Kim
Chonnam National University Medical School, Korea
Introduction: Pancreatic body cancers often involve the
celiac axis or the common hepatic artery and are there-
fore considered unresectable. The distal pancreatectomy
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with en bloc resection of the celiac axis may offer a
chance of curative resection.
Method: We present a case of a 48-year-old man with
pancreatic body cancer invading the celiac axis. He suf-
fered from severe abdominal pain. The MRI scan
revealed a 4 9 3 cm sized mass invading celiac axis
and splenic vein in pancreatic body. There was several
enlarged lymph node around aorta. The patient under-
went a distal pancreatosplenectomy with en bloc resec-
tion of celiac axis. We tried to remove enlarged
paraaortic lymph nodes completely, but, multiple con-
glomerated lymph nodes could not be removed com-
pletely. At 2 months after the operation, the patient
underwent chemoradiation therapy for metastatic para-
aortic lymph nodes.
Results: The postoperative course was uneventful.
There was no ischemia-related complication of the
stomach and the liver. Severe abdominal pain was sub-
sided after operation. But, 6 months after the opera-
tion, multiple lung metastases were found, and
8 months after the operation, he died.
Conclusions: Distal pancreatectomy with celiac axis
resection can be performed with safety and it can
improve quality of life in selective patients. To clarify
the long-term survival benefit, more large scaled study
and long term follow up are needed.
PPP25-035
ENHANCED RECOVERY PROGRAMME
FOR PANCREATICODUODENECTOMY
SURGERY. EFFECT ON SURVIVAL
K. Elhadd, Z. Ali, R. DeSouza, P. Casey,
D. Chang, A. Kausar, E. Atkinson, J. Thomas and
D. Subar
Royal Blackburn Hospital NHS Trust, UK
Introduction: Several studies have demonstrated that an
enhanced recovery programme for pancreatic surgery
(PD-ERP) shortens hospital stay without compromising
morbidity and mortality. However to date no study has
reported on the effect of PD-ERP on survival. The aim
of this study was to assess the effect of the PD-ERP on
post-operative complications, length of hospital stay
and patient survival.
Method: Our unit started a multi-modal PD-ERP in
May 2011. This is a retrospective study of 85 patients
who have had Pancreaticoduodenectomy in the PD-ERP
compared to those who have had pancreatic surgery and
received standard care prior to the implementation of the
PD-ERP. The outcome measures assessed were post-
operative complications, length of hospital stay and long
term survival. 39 patients in the PD-ERP group were
compared to 46 patients in the standard care group.
Results: The mean age of the patients was 64 years
(range 27–84 years). The male to female ratio was
47 : 38. There were no differences in terms of age, sex
or post-operative complications between the groups.
The mean length of hospital stay was the same in the
PD-ERP group as compared to the standard care
group (20.4 vs 20.8 days) statistically significant
(p = 0.86). Two year survival was 48% and 45.6% in
the PD-ERP and standard care groups respectively
(p = 0.73).
Conclusions: The multi-modal enhanced recovery pro-
gramme for pancreaticoduodenectomy may reduce hos-
pital stay but does not appear to affect survival
however the results of this study were inconclusive in
view of the small sample size. Long term results in
terms of its effect on 5 year disease free and overall
survival are needed.
PPP25-037
ANNULAR PANCREAS: EXCEPTIONEL
CAUSE OF NEOPLASIC JAUNDICE
H. Hachim, A. Souadka, A. Benkabbou,
B. Serji, H.O.E. Malki, R. Mohsine, L. Ifrine and
A. Belkouchi
Ibn Sina Hospital, Morocco
Introduction: The pancreas is formed by ventral and
dorsal pancreatic buds which arise from the endoder-
mal lining of the gut. When the duodenum rotates to
the right, the ventral pancreatic bud migrates dorsally
and finally come and lie below the dorsal pancreatic
bud. some developmental errors in the rotation of these
components may lead to annular pancreas that can
mimic a pancreatic cancer.
Method: We report the case of 42-years-old morocan
women, who was admitted for cholestatic jaundice. CT
scan showed a intra and extra-biliary duct dilatation
with no evidence of pancreatic mass. Endoscopic ultra-
sonography failed to show a pancreatic abnormality.
Endoscopic duodenoscopy described a modified
ampulla of vater mimicking a periampular Tumour but
no signe of malignancy on the biopsy. Multidisciplinary
decision of a surgical approach was hold.
Results: The patient underwent a Whipple procedure
with normal peroperative and postoperative outcomes.
Histological examination revealed no signe of malig-
nancy but an annular pancreas.
Conclusions: Surgeons should keep in mind this excep-
tional anomaly as differential diagnosis of biliopancre-
atic tumors in healty young patients with cholestatic
jaundice to avoid abusive Whipple procedures.
PPP25-039
RESULTS OF A PHASE I STUDY FOR
THE EVALUATION OF THE
FEASIBILITY AND SAFETY OF
IRREVERSIBLE ELECTROPORATION
(IRE) IN PATIENTS WITH LOCALLY
ADVANCED PANCREATIC CANCER
S. Paiella1, G. Butturini1, R. Salvia1, G. Armatura1,
M. Bacchion1, M. Fontana1, I. Frigerio2,
M. D’Onofrio1, E. Martone1 and C. Bassi1
1University of Verona, Italy; 2Casa di Cura Pederzoli,
Italy
Introduction: Evaluate the safety and feasibility of the
NanoKnife Low Energy Direct Current (LEDC) Sys-
tem (AngioDynamics Inc., Latham, New York) to treat
unresectable pancreatic adenocarcinoma.
Method: Ten patients with cytohistological diagnosis of
unresectable non-metastatic locally advanced pancreatic
cancer (LAPC) unresponsive to continuing standard
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treatments were treated with focal pancreatic tumoral
Irreversible Electroporation (IRE) in this prospective,
open-label, non-randomized, clinical trial. Patients were
followed with imaging, clinical assessments, laboratory,
and quality of life assessments weekly for 90 days post-
IRE and then quarterly for at least 12 months if possi-
ble. Adverse events, device complaints, laboratory data,
physical findings and vital signs were collected. The pri-
mary outcome was rate of procedure-related abdominal
complications. Secondary endpoints included evaluation
of the short-term efficacy of IRE through evaluation of
imaging, clinical assessments, laboratory tumoral
response, and patient quality of life.
Results: All procedures were technically successful. In-
traoperatively, IRE was well tolerated; only one tran-
sient hypertensive intraoperative episode was reported,
and this resolved spontaneously. Intra-abdominal post-
operative complications were described in one patient
(10%). The patient did not require any invasive treat-
ment and responded to antibiotic therapy. Based upon
the RECIST criteria (version 1.1) four patients exhib-
ited a Partial Response (40%) at the final visit, while
three patients each exhibited either Progressive Disease
(30%) or Stable Disease (30%).
Conclusions: Pancreatic IRE requires placement of
probes immediately adjacent to critical structures to
deliver energy to provide desired lesion coverage and
cause tumoral cell death. In this study no intraopera-
tive or post-operative complications directly related to
the energy delivered during IRE (including thrombosis,
pancreatitis, duodenal bleeding, stenosis, or ulceration)
were observed. Therefore, we conclude, IRE is a safe
and feasible procedure in patients with LAPC and may
represent an advancement in the treatment and multim-
odality management of this disease.
PPP25-040
PANCREATIC FISTULA AFTER
PANCREATICODUODENECTOMY FOR
PANCREATIC TUMOUR
M. Kucera, M. Oliverius, M. Varga, K. Navratil and
J. Fronek
Ihpba new member, Czech Republic
Introduction: Pancreatic fistula (PF) after pancreatico-
duodenectomy (PD) for pancreatic tumour is a serious
complication with an incidence ranging from 10% to
30%. PF was defined by an International study group
for pancreas fistula in 2005.
Method: Retrospective analysis of prospective collected
data, pancreatic tumour patients who underwent PD
between April 2004 and April 2013 at our department.
The incidence of PF and mortality has been studied.
Results: Some 191 patients in total received PD. There
were two groups of patients: group I with tumour (ade-
nocarcinoma) and group II with chronic pancreatitis or
chronic pancreatitis with tumour incidentaly identified
in the histological specimen of the resected pancreas.
We performed 143 PDs in group I and 48 PDs in
group II. The incidence of PF was 28% in group I (40
pts) and 8.3% in group II (4 pts). The overall incidence
of PF was 23%. All patients with PF grade A or B
were treated using conservative approach without fur-
ther surgery. In the group of the 28 patients with PF
grade C we performed 22 total pancreatectomies, 4
pancreas preserved operations and 2 patients were not
operated on. There was an overall mortality rate of
3.7%. All 7 patients who died had PF grade C.
Conclusions: PF after PD is a serious complication
with a mortality rate of up to 80%. PF grade A and B
can heal without re-operation. PF grade C requires
surgery - drainage of the abdominal cavity or total
pancreatectomy (TP). TP is technically demanding pro-
cedure, if the decision to operate is made early enough
and the patient is without septic shock and multiorgan
failure, surgery can reduce mortality of this complica-
tion.
PPP25-041
CIRCUMDUODENAL PSEUDOCYST OF
THE ANNULAR PANCREAS
PRESENTING AS GASTRIC OUTLET
OBSTRUCTION
N. Shivathirthan, M. Karichery, S. Chethan and
A. Sattar
Apollo BGS Hospital, India
Introduction: Annular pancreas in adults is a rare
embryologic abnormality usually detected after devel-
opment of complications. Embryology, diagnosis and
treatment strategies for symptomatic adult annular
pancreas remain controversial. In this paper we
describe a case of annular pancreas which presented
with gastric outlet obstruction due to complete circum-
ferential pseudocyst of the annular pancreas. It was
successfully treated by Pseudocyst drainage.
Method: A 45-year-old man presented with a history of
chronic pancreatitis. Magnetic resonance cholangiopan-
creatography revealed ductal changes in the body and
tail and a large cystic mass in the region of the pancre-
atic head. With a diagnosis of chronic pancreatitis with
pseuodcyst in the head, the patient was taken for duct
drainage procedure.
Results: Intraoperatively it was found that there was a
partial annular pancreas with ductal dilatation in the
pancreas region of the body and tail. The annular pan-
creas had formed a circumferential pseudocyst around
the Duodenum completely surrounding it starting from
the antrum to the D2/D3 junction. There was compres-
sion on the duodenum due to the pseudocyst. The
patient underwent lateral pancreaticojejunostomy with
pseudocyst drainage and a antecoloic ante gastric loop
Gastrojejunostomy was done in view of the duodenal
narrowing. The operative time was 180 minutes and
blood loss was 150 mL. The patient did well in the post
operative period and was discharged on post operative
day 8 with full tolerance to oral diet.
Conclusions: Annular pancreas is a rare entity which
comes into notice when complications develop. Circum-
fernetial Pseudocyst of the annular pancreas is a rare
cause of duodenal obstruction/gastric outlet obstruction
in annular pancreas. Surgical drainage with or without
a gastrojejunostomy adequately cures this rare prob-
lem.
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PPP25-042
HEMOSUCCUS PANCREATICUS
SECONDARY TO A FISTULA BETWEEN
THE PORTAL VEIN AND PANCREATIC
DUCT. A CASE REPORT
F. Sanchez-Bueno, R. Garcia, G. Torres, N. Iba~nez,
P. Gil and P. Parrilla
Hospital Clinico Universitario “Virgen de la Arrixaca”.
Murcia, Spain
Introduction: The aim is to report a case of Hemosuc-
cus pancreaticus (HP) secondary to a fistula between
the pancreatic duct and portal vein, something not
described previously in the literature.
Method: A 55-year-old male, with a high alcohol
intake (>80 g/day), was admitted to another hospital
for upper gastrointestinal (GI) hemorrhage and epigas-
tric pain. Emergency gastroscopy revealed bleeding of a
papillay origin. Due to the persistence of bleeding an
exploratory laparotomy was performed. Cholecystec-
tomy, choledochotomy and exploration of the papilla
were done, none of which revealed the cause of bleed-
ing. On the 10th day postoperatively the patient was
asymtomatic on discharge from hospital. A week later,
he was re-admitted for recurrence of the bleeding symp-
toms and epigastric pain with severe haemodynamic
repercussions. An arteriography of the coeliac trunk
was performed, but did not reveal the origin of the
bleeding. Due to the persistence of the symptoms, the
patient was transferred to our hospital. An ERCP was
performed, which found blood remains in the duct of
Wirsung but was unable to fill it with contrast material.
A MRI was performed which revealed dilatation along
the whole of the pancreatic duct.
Results: Suspected with a HP the patient underwent
surgery by means of a bilateral subcostal laparotomy.
Exploration of the transcavity of the omenta revealed a
16 9 4 9 2 cm cystic mass in the pancreas secondary
to dilatation of the whole of the duct of Wirsung,
which yielded blood and clots when punctured. Dissec-
tion of the posterior Wall of the pancreas disclosed a
communication between the portal vein and pancreatic
duct. The portal defect was sutured and a total duode-
nopancreatectomy performed. The patient was dis-
charged on the 8th day postoperative and is
asymptomatic 36 months later.
Conclusions: HP is rare and difficult to diagnose. Angio-
graphic embolization and surgery are therapeutic options.
PPP25-043
THE ROLE OF PERFORMANCE
STATUS IN THE TREATMENT OF
ADVANCED PANCREATIC CANCER
F. Kurti1, D. Osmanaj1, S. Xinxo2 and J. Basho1
1QSUT, Albania; 2ISHP, Albania
Introduction: Pancreatic cancer is one of the four lead-
ing causes of cancer- related deaths in Western coun-
tries. Chemotherapy is the only therapeutic option of
treatment in patients with advanced pancreatic cancer,
despite its modest effect on the general survival. In
these cases, the role of the treatment is palliative, to
improve the quality of life. The aim of the study was to
evaluate the role of PS in the treatment of patients with
advanced pancreatic cancer.
Method: 45 patients with advanced pancreatic cancer
were involved in the study during 5 years. These patients
were diagnosed with advanced metastatic cancer at the
moment of presentation, or with recidives after surgical
resection of the tumor. All the patients were treated with
monochemotherapy with 5-FU, in cycles every 21–
28 days. We have evaluated the response to treatment
after three cycles of%-Fu with CT scanning, tumor
markers and clinical signs. We have excluded from the
treatment the patients with very low Performance Status
(PS) and severe hepatic dysfunctions.
Results: We divided the patients in two groups based
on the PS values. The first group was composed of 23
patients with PS 0–1; the second group was composed
of 22 patients with PS 2–3. In the first group we per-
formed 80 cycles of treatment, in the second group 110
cycles. We have interrupted the treatment when the dis-
ease advanced under treatment, or when the side effects
of the treatment where important. In the first group we
had a relative response in 8 patients (31%), in the sec-
ond group only in 1 patient (4, 5%) p = 0.03.
Conclusions: PS is an important parameter and has an
impact on the clinical course of patients undergoing
chemotherapy for advanced pancreatic cancer.
PPP25-044
EXPRESSION PROFILE OF MIRNA IN
LIVER METASTASIS OF COLORECTAL
CANCER
Anjali A. Roeth, A. Giebeler, P.L. Jansen, N. Gassler,
E. Krott, A. Lambertz, K. Junge, R. Rosch and
U.P. Neumann
RWTH Aachen University Hospital, Germany
Introduction: The role of microRNAs (miRNAs), non-
coding RNA molecules, as regulators of gene expression
has only been described recently. Abnormal expression
profiles have been examined in different cancers already.
Still, most of the literature has only looked at the expres-
sion profile in the primary tumor or which primary
tumor expression profile is associated with metastasis
formation. Our aim was to investigate the expression
profile in the metastasis of colorectal cancer itself.
Method: We isolated miRNA from FFPE tissues from
patients with T3 colorectal tumors and synchronous
liver metastases. For this endeavor, we took samples
from the liver metastasis, liver tissue far away from the
metastasis, the primary tumor and colon tissue far
away from the tumor. After confirmation of the RNA
quality with PCR, we examined the expression profile
of the different samples with miRNA arrays containing
88 miRNAs associated with cancer as well as 8 house-
keeping genes.
Results: Comparison between the different expression
profiles could identify several miRNAs that were differ-
entially regulated in the tumor as well as in the liver
metastasis. In addition, we could also identify 8 miR-
NAs that were only regulated in the metastasis com-
pared to the control liver and not in the tumor.
Conclusions: miRNAs provide a helpful tool on the
way to understanding metastasis formation and mainte-
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nance. Future experiments should address the specific
targets of the miRNAs identified in search of potential
biomarkers for metastasis formation.
PPP25-045
UNUSUAL DUODENO-
PANCREATECTOMY
B. Serji, A. Souadka, A. Benkabbou, H. Hachim,
H.O.E. malki, R. Mohsine, L. Ifrine and
A. Belkouchi
University Mohammed Vth Souissi Rabat Morocco,
Morocco
Introduction: Duodeno pancreatectomy has become a
routine procedure in specialized center, as a standard
treatment for tumour of the head of the pancreas. Its
most difficulty comes from the involvement of vascular
structures (superior mesenteric vein and artery). We
describe through this case a difficulty relied to ana-
tomic variation.
Method: We report a case of a 45-years-old woman,
with cholestatic jaundice since 4 months and weight
loss. She suffers from chronic constipation several years
ago. Abdominal and lymph node exam were normal.
Abdominal CT showed a tumour of the head of the
pancreas with biliary dilatation and without vascular
involvement or hepatic metastasis. Pulmonary CT was
normal. Patient was programmed for surgery.
Results: We performed a right subcostal incision,
exploration found no carcinose or hepatic metastasis,
the tumour was resectable, but there was a complete
common mesentery with all small bowel to the right
and all the colon to the left. In this exceptional situa-
tion, facility was the absence of Treitz ligament but the
difficulty was to perform the portal and superior mes-
enteric vein lymphadenectomy as usual in the vascular
sheath. We needed to avoid any lesion of the mesen-
teric superior vein or proximal ileal vein because any
excessive manipulation or ligation here can lead to a
thrombosis wish can cause necrosis of both small bowel
and colon. Whipple procedure with pancreatico-gastric
anastomosis was done and associated to appendectomy.
We didn’t perform a jejunostomy wish is a standard in
our service to avoid the risk of a volvulus. Immediate
outcomes were uneventful.
Conclusions: Duodeno pancreatectomy in a context of
complete common mesentery is feasible but dissection
with more precaution is recommended.
PPP25-046
SURGICAL SKILL MAY BE MORE
IMPORTANT THAN OPERATIVE
VOLUME IN ENSURING COMPARABLE
PERIOPERATIVE OUTCOME AFTER
PANCREATICO-DUODENECTOMY
M.A. Khan, S. Muhammad, A. Khan, S.M. Raza,
M. Mubarak and A.H. Rizvi
Sindh Institute of Urology & Transplantation, Pakistan
Introduction: Evidence has shown importance of
operative volume of a surgical team in ensuring better
outcome after pancreatico-duodenectomy (PD). Inter-
estingly more recent evidence suggests that the premise
may not hold true if experienced surgeon(s) perform
the procedure. We reviewed our operative experience as
a dedicated hepatobiliary surgical unit with low-volume
for PD. Our objective was to analyze whether lower
volumes impairs perioperative outcomes in this patient
population.
Method: We performed a retrospective cross-sectional
study of pancreatico-duodenectomies performed in our
surgical unit from November 2007 to August 2013.
Results: A total of 20 pancreatico-duodenectomies
were performed during this time. Among these were 9
females (m : f = 1.2 : 1) and mean age of patients was
51.1(12.4) years. Most underwent drainage (ERCP
n = 11, PTC n = 2) and stenting (n = 12) before sur-
gery. Preoperative mean bilirubin was 3.17 (3.11) mg/
dL and Albumin was 3.5 (0.66) gm/dL. Mean ASA
was 1.5 (0.5). Mean duration of surgery was 417 (75)
minutes with a mean operative blood loss of 287.5
(189.09) mL and transfusion of 0.7 (0.6) unit of packed
cells. Pylorus preserving resection was performed in
80% (n = 16) with a single loop used for reconstruction
in 75% (n = 15). Post operative complications included
wound infection (n = 5, mean Southampton
grade = 1.6  1.70) hemorrhage (n = 1), conservatively
managed anastomotic leak (n = 1, pancreatico-jejunos-
tomy), delayed gastric emptying (n = 3) and respiratory
complications (major n = 3, minor n = 4)). Mean
length of hospital stay was 13.2 (7.03) days. Two-thirds
of tumors were ampullary (n = 15), 80% were adeno-
carcinomas (n = 16) and 85% were well or moderately
differentiated (n = 12 and 5, respectively). R0 resection
was achieved in all but one case. Mean tumor size was
29.1 (14.3) mm. Average nodes examined by patholo-
gist was 3 (2.7) and node positive disease was found in
5 cases.
Conclusions: Surgical complications for pancreatico-du-
odenectomy may not depend on number of cases per-
formed but instead relate to the operative expertise of a
surgical team.
PPP25-047
A PROSPECTIVE STUDY OF SURGICAL
OUTCOME AND DIFFERENCES ON
HISTOPATHOLOGY IN PATIENTS
WITH ALCOHOLIC AND NON
ALCOHOLIC CHRONIC PANCREATITIS
Srinath S.R, Dr.Rajesh Gupta, Dr.Sunil Shenvi,
Dr.Deepak K Bhasin, Dr.Mandep Kang, Dr.Ritambra
Nada and Dr.Naresh Sachdeva
PGIMER, India
Introduction: Objective. To study outcome of surgery
in alcoholic and non-alcoholic CP and differences in
Histopathology of alcoholic and non-alcoholic CP.
Method: Patients: From January 2012 until September
2013, 12 patients underwent surgical treatment for
chronic pancreatitis at our institution. Intervention: 9
patients were operated on according to the Frey proce-
dure, and in 3 patients, a PPPD was performed and in
12 patients, 5 were non alcoholic CP. Study design
Patient data were documented throughout the duration
of the hospital stay with histopathology report. Postop-
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erative follow-up data were recorded prospectively at 1,
3, and 6 months. Main outcome measures: Postopera-
tive follow-up with postoperative pain scores and pres-
ervation of pancreatic exocrine and endocrine function
and quality of life and differences in histopathology of
alcoholic and non-alcoholic CP were carried out.
Results: During a follow-up period of 12 patients at 1,
3 and 6 months, an improvement in pain score, endo-
crine and exocrine function and quality of life was
observed in 7 alcoholic CP patients and completely free
from pain and improvement in endocrine and exocrine
function were seen in 4 non alcoholic CP patients and
histopathology differences in patients with non-alco-
holic chronic pancreatitis, pancreatic inflammation par-
ticularly involved the ducts, commonly resulting in duct
obstruction and occasionally duct destruction. None of
these features was seen in alcoholic chronic pancreatitis
which, however, showed pseudocysts and calcifications.
Conclusions: In this prospective study, non-alcoholic
CP patients has better outcome after surgery then alco-
holic CP and histopathologically pancreatic changes in
patients with non-alcoholic chronic pancreatitis clearly
differ from those with alcoholic chronic pancreatitis.
PPP25-048
PANCREATIC TUMORS ASSOCIATED
WITH VON HIPPEL LINDAU
SYNDROME
A.E.P. Rosciano, J.C. Rivera, H.N.L. Basave,
M.G.S. Thome, R.A.S. Hernandez and S.L.L. Silva
National Cancer Institute, Mexico
Introduction: Von Hippel Lindau (VHL) is an inherited
autosomal dominant syndrome manifested by a variety
of bening and malignant tumors. Pancreatic abnomali-
ties are common in patients with VHL disease, we pres-
ent one case and literature review.
Method: 29-years-old male with family history of von
Hippel Lindau syndrome (father and uncle), he starts
12 years ago with brain, cerebellum and spinal cord he-
mangioblastomas and epydidimal papillary cystadeno-
mas. Two years ago the abdominal nuclear magnetic
resonance shows multiple renal cysts and 2 solid
tumors in right kidney, right adrenal mass and 2 cystic
lesions in pancreas, right radical nephrectomy and right
adrenalectomy was performed, the pathological report
was pheochromocytoma and multifocal clear cell carci-
noma, the pancreatic cysts were unchanged and asymp-
tomatic.
Results: 60–77% of the patients with von Hippel Lin-
dau had lesions in the pancreas. True cysts are the
most common pancreatic lesions (47–70%) and are fre-
quently multiple. Serous cystadenomas (9–11%) are
well-delineated and usually multiloculated cysts. Renal
cysts represent a premalignant lesions however the pan-
creatic cysts in VHL do not have increased risk of pan-
creatic adenocarcinoma, the true cysts and serous
cystadenomas are asymptomatic. The neuroendocrine
tumors (10–15%) are tipically nonfunctional, multiple
more than 85% are benign but maybe malignant, resec-
tion is reserved for lesions greater than 3 cm, the
mucinous lesions are not linked with this condition.
Conclusions: Pancreatic abnormalities occur in most
patients with VHL syndrome. The cysts are the most
common lesions, although symptoms are rare medical o
surgical treatment is required in selects patients with
pancreatic lesions. The ocurrence of neuroendocrine
tumors requires careful evaluation because their poten-
tial malignancy.
PPP25-049
PRELIMINARY RESULTS USING
PREOPERATIVE LONG-ACTING
SOMATOSTATIN ANALOGUE IN
PANCREATICODUODENECTOMY
WITH PANCREATICOGASTROSTOMY
D. Cesar, R. Albagli, G. Ravanini, J. Leite, G. Stoduto
and J.P. Jesus
National Cancer Istitute - Brazil, Brazil
Introduction: Pancreatic fistula is a common problem
after pancreaticoduodenectomy, causing major morbid-
ity. Somatostatin and its analogues are known to have
an inhibitory effect on exocrine secretion of pancreas.
These drugs had been presumed to reduce the rate of
pancreatic fistula. Our aim was to determine if LAR
Octreotide, a potent long-acting somatostatin analogue,
would decrease pancreas-related complications.
Method: A non randomized prospective study assessing
patients undergoing pancreaticoduodenectomy for pan-
creatic and periampullary malignancy was conducted
from March 2012 to December 2012 in a single institu-
tion. Thirty eight patients without biliary drainage,
were assigned to receive a single injection of LAR
Octreotide 14 days before pancreaticoduodenectomy
with pancreaticogastrostomy. Patients defined having
hard pancreas were excluded. Pancreatic juice and peri-
pancreatic drainage fluid was collected and measured,
and serum pancreatic enzymes were monitored daily.
Pancreatic fistula was defined as drainage fluid of more
than 10 mL in 24 hours with the amylase at least 3
times the normal serum activity 3 or 4 days postopera-
tively. Complications were defined by objective criteria
before beginning the study.
Results: Fifteen patients treated with LAR Octreotide
were defined as having soft pancreatic remnant and
were analyzed. There was no incidence of clinical pan-
creatic fistula and no perioperative death. Six patients
(40%) had postoperative morbidity, 2 (13%) gastric
bleeding managed endocospically, 2 (13%) wound
infections, 1 (7%) pneumonia and 1 (7%) rhabdomyol-
ysis without renal failure. Median duration of hospital
stay was 9 days.
Conclusions: Our results suggest that LAR octreotide is
useful when the pancreatic remnant is soft and when
pancreatoduodenectomy is completed by pancreatoga-
strostomy. However, this is an interim analysis and the
end of the study is needed for definitive conclusions.
Then, the results must be compared to a randomized
clinical trial to validate our findings.
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PPP25-050
A PROSPECTIVE STUDY OF RISK
FACTORS PREDICTING INFECTION IN
ACUTE NECROTIZING PANCREATITIS
R. Sah, G.R. Verma, R. Kochhar, A. Bhalla,
D. Banerjee and R. Singh
Pgimer, Chandigarh, India
Introduction: Severe Acute Pancreatitis (SAP) is associ-
ated with mortality rate of 10% to 25%. The mortality
further increased to 40% to 70% when necrotizing pan-
creatitis becomes secondarily infected. Early identifica-
tion of pancreatic infection may alter the management
strategy.
Method: This prospective study included 22 patients of
SAP in 1 1/2 years. The inclusion criteria were clinical
symptoms of severe acute pancreatitis, admission within
72 hours of onset of symptoms and CT Severity index
>7. Intra abdominal pressure and abdominal perfusion
pressure were measured from 1 to 7th day of admis-
sion. Estimation of D-dimer and serum endotoxin lev-
els were performed on 1, 4, & 7th day of admission
and APACHE II score was calculated daily.
Results: Five patients succumb from SIRS within 2–
5 days of admission. Nine of the remaining 17 patients
(52.94%) later developed pancreatic infection .Five of
nine infected patients presented with abdominal lump
compared to 1/8 non infected cases. APACHE II score
of 12.83 was significantly higher in infected than 4.69
in non infected group of patients (p 0.001). Endotoxin
level showed rising trend in infected group on all
3 days. The mean Endotoxin level in infected group
was significantly high than non infected patients on day
4 (0.287080 IU/lL vs 0.116483 IU/lL p 0.021) and day
7 (0.08950279 IU/lL vs 0.0954700 IU/lL p 0.004). On
multivariate analysis the factors showing statistically
significant difference for developing infections were:
APACHEII at admission, serum endotoxin on day 4
and 7 of admission and presence of abdominal lump at
admission. There was no difference in intra abdominal
& abdominal perfusion pressure and D dimer levels in
both groups.
Conclusions: Presence of abdominal lump and
APACHE II score (>12.3) at presentation and high
serum endotoxin levels within 4–7 days of severe acute
pancreatitis predicts pancreatic infection in patients of
acute necrotizing pancreatitis.
PPP25-051
EARLY EXPERIENCE OF THE
LATERAL APPROACH FOR
LAPAROSCOPIC SPLENIC
PRESERVING DISTAL
PANCREATECTOMY
R. Jarmin1, Z. Zuhdi1, A. Azman1, Y. Yusoff1, A.C.
Ariffin2, N.R.N. Kosai1, H. Othman1 and R. Rahim1
1Universiti Kebangsaan Malaysia, Malaysia; 2Universiti
Sains Islam Malaysia, Malaysia
Introduction: Laparoscopic distal pancreatectomy has
been accepted as one of the surgical approach for neo-
plasm involving the body and tail of the pancreas.
Complete splenic preserving technique is the preferred
choice because the significant role of the spleen in the
immune system of the body particularly young patient.
We are describing our experience in lateral approach
for laparoscopic distal pancreatectomy with complete
preservation of the spleen.
This is to assess our early experience in performing lat-
eral approach laparoscopic total splenic preserving dis-
tal pancreatectomy (LA-TSPDP). The evaluation will
include feasibility of performing the procedure and the
surgical outcome.
Method: This is a retrospective study of prospective
data performed at UKMMC. Fifteen (n = 15) patients
underwent LA-TSPDP during the study period. The
surgical technique of LA-TSPDP will be described.
Results: All the patients had a successful laparoscopic
operation. Two patients (n = 2) required a completion
of splenectomy. The mean operating time was 100 min-
utes. There were no major post operative complica-
tions. Most of the patients were discharged within the
specified hospital stay.
Conclusions: LA-TSPDP is a feasible approach. The
technique allows the preservation of the spleen hence
maintaining the patient immune response. The laparo-
scopic approach also reduced post operative pain, early
mobilization and reduced hospital stay as compared to
the open distal pancreatectomy.
PPP25-052
HEMORRHAGE COMPLICATING THE
COURSE OF SEVERE ACUTE
PANCREATITIS
V. Gupta, P. Krishna, R. Kochhar, T. Yadav,
A. Bhalla and J. Wig
Postgraduate Institute of Medical Education and
Research, India
Introduction: Course of severe acute pancreatitis (SAP)
can be complicated by hemorrhage, which is associated
with poor outcome.
Method: 183 patients (mean age 39.6  13, M : F
2.6 : 1) of SAP were evaluated prospectively (n = 86)
and retrospectively (n = 97) for haemorrhagic compli-
cations. Hemorrhagic complications were categorised
based upon the site (luminal or intra-abdominal), tim-
ing (occurring prior to or after an intervention) and
severity (minor or major).
Results: 24 (13.1%) patients had haemorrhagic compli-
cations; 12 intra-abdominal and 12 intraluminal. 13
had a major and 11 had minor bleed. 16 patients bleed
before & 8 after intervention (radiological 3, surgical
5). The mean duration of pancreatitis prior to bleed
was 27  27.2 days. Predictors of bleed on univariate
analysis were male sex (p = 0.014), organ failure
(p = 0.008), venous thrombosis (p = 0.033), infective
necrosis (0.001) and systemic sepsis (0.037). On multi-
variate analysis infected necrosis (p = 0.015, OR 5.55)
was significant factor. Radiological drainage was asso-
ciated with decreased risk of bleeding (45.8% vs
54.4%; p = 0.000). Need for surgery (50% vs 12.6%,
p = 0.003), intensive care stay (7.4  7.9 vs
5.4  5.2 days; p = 0.001) and mortality (41.7% vs
10.7%; p = 0.000) were significantly higher in bleeders.
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7/13 of major bleeders had pseudoaneurysms. 7/12
intra-abdominal bleeders required surgical intervention.
4/12 with luminal bleed had hollow viscus erosion, all
of which required surgery. CT severity index and surgi-
cal intervention, were significantly associated with
intra-abdominal bleed. Organ failure, presence of
pseudoaneurysm and surgical intervention were associ-
ated with major bleed. No significant factor could be
identified for post-intervention bleed.
Conclusions: Hemorrhage in SAP indicates severe dis-
ease. Infection predisposes to hemorrhage. Luminal
bleed may be indicative of erosion into the adjacent vis-
cera. Pseudoaneurysms were associated with major
bleeding. Bleeding occurring after intervention have
similar course as those without.
PPP25-054
THE PANCREAS HISTOLOGY
CHANGES IN LIVER CIRRHOSIS AND
PORTAL HYPERTENSION
H. Li, A. Jiang, J. Li, F. Ji, J. Zhang, J. Yang, X. Guo
and Z. LI
The Second Affiliated Hospital, School of Medicine,
Xi’an Jiaotong University, China
Introduction: Liver cirrhosis often affect the digestive
function and metabolism of glucose, induce impaired
glucose tolerance even hepatogenous diabetes. The pan-
creas histology changes of cirrhotic patient may have
contact with the digestive symptom and impaired glu-
cose metabolism.
Method: Some pancreatic tail tissue residual often can
be find at hilum of surgical removed spleen. We exami-
nated the pancreatic tail tissue that was taken from in
splenectomy in our hospital from March, 2005 to
March, 2006. The patients with cirrhosis were divided
to Child A, B, C Class and portal vein pressure (PVP)
high, middle, low class according to the standardization
of hepatic functional classification and PVP level. We
observed pancreatic tissue, islet cells, B cells in light
microscope and electron microscope.
Results: Pancreatic tissue with portal hypertension
appears fibrous degeneration and hydropsia in anacrine
gland. With the rising of PVP, the fibering makes more
serious. Fiber trabs can be seen in mesenchymal obvi-
ously. Mitochondria swell and cristae disappear in aci-
nar cells. The cell population grows downwards along
with the rising of PVP (control: 188  6.5, low PVP:
165  14, middle PVP: 138  1.1, high PVP:
121  11.1, p < 0.05). No marked changes in endocrine
of low PVP and middle PVP patients. Langerhans islets
appear depauperate in endocrine of high PVP patients.
The A cell population in low PVP patients (32.5  3.5)
and middle PVP patients (29.0  6.0) has no significant
deviation compared with health adult (29.8  5.0)
(p > 0.05). High PVP patient (21.8  3.5) is lower than
health adult obviously (p < 0.05). The B cell population
in low PVP patients (82.5  10.6) and middle PVP
patients (81.6  5.7) has no significant deviation com-
pared with health adult (84.8  5.3) (p > 0.05). High
PVP patients (74.5  5.2) are lower than health adult
obviously (p < 0.05).
Conclusions: The anacrine and endocrine gland of pan-
creas occurs pathology changes when liver cirrhosis. It
may be one of the reasons for descending digestive
function and glycometabolism abnormality. But the
certain mechanism is to be investigated deeply.
PPP25-055
THE OUTCOMES OF
PANCREATICODUODENECTOMY IN
THE PATIENTS WITH METASTATIC
CANCER
J. Kwak
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: The metastatic cancer of pancreas is rare
surgically resectable state or histologically confirma-
tions. Because the pancreaticoduodenectomy have high
risk of morbidity and mortality, the pancreaticoduodec-
tomy were more rare done in metastatic cancer. So, we
review and anlayze for the clinical features and out-
comes of metastatic cancer of pancreas after pancreati-
coduodenectomy.
Method: We retrospectively reviewed all underwent
pancreaticoduodectomy from January 2004 to June
2013. The only 12 patients underwent pancreaticoduo-
denectomy due to metastatic cancer. There are 4
patients of renal cell carninoma, 3 patients of colon
cancer, 1 patient of breast cancer, 1 patient of lung
cancer, 1 patient of leiosarcoma and 2 patients of stom-
ach cancer. The clinicopathologic features and periop-
erative data of 12 patients were retrospectively
reviewed.
Results: There were 6 female patients and 6 male
patients and metastatic lesions are pancreas head, duo-
denum 2nd–3rd portion and distal common bile duct.
The Mean age of patients was 61.8 and mean operating
time was 6 hours 12 minutes (range 283–482 minutes),
mean hospital stay was 15.7 days (range 9–29 days)
postoperatively.
The Mean survival time after pancreaticoduodectomy
was 2 years d 7 months (8 month–77 months). There
were no fatal complications after surgery.
Conclusions: Some of metastatic tumors of the pan-
creas in patients after pancreaticoduodenectomy, the
survival rates were improved. So, Pancreaticoduodenec-
tomy can be considered as the choosable surgical strat-
egy in a selected patient population with metastatic
cancer.
PPP25-056
PREDICTOR OF ESOPHAGEAL
VARICES IN PATIENTS WITH
CIRRHOSIS
Dr M. Laeek, Z. Abass, R. Kumar and N.H. Luck
College of Physion and Surgeon, Pakistan
Introduction: Gold standard for diagnosing esophageal
varices is upper gastrointestinal endoscopy, However,
various non invasive markers have been studied to pre-
dict esophageal varices in cirrhotic patients. The aim of
this study was to find out any significance of ratios of
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left and right lobe of liver with albumin as predictors
of esophageal varices and compare both.
Method: All patients diagnosed to have clinical cirrho-
sis were included while patients with portal vein throm-
bosis, history of shunt surgery, inferior vein thrombosis
were excluded. Routine investigations included com-
plete blood counts, bilirubin, alanine and aspartate
transaminases, gamma glutamyl transferase, alkaline
phosphatase, serum albumin, prothrombin time, and
ultrasound abdomen with right and left liver lobe diam-
eter measurements in the midclavicular line. Endoscopy
was done to document presence of varices. The correla-
tion between the calculated ratios and presence or
absence of esophageal varices were estimated.
Results: One hundred and eleven subjects (80 males),
mean age 40.3 years, were studied. Esophageal varices
were seen in 68 (61.3%) patients; Child-Pugh class A
accounted for 41.4%, class B 48.8%, and class C
12.6% cases of varices. The mean value of right lobe
diameter/albumin ratio was 5.1  1.9 in patients with
varices versus 4.2  1.6 in patients without varices
(p = 0.023). The mean value of left lobe diameter albu-
min ratio was 2.4  0.9 in patients with varices versus
1.9  0.6 in patients without varices (p < 0.001). Areas
under ROC curves were 0.377 and 0.69 respectively.
Conclusions: The left lobe diameter/albumin ratio is a
better predictor of esophageal varices than right lobe
diameter/albumin ratio in patients with liver cirrhosis.
PPP25-057
LONG-TERM SURVIVORS AFTER
PANCREATICODUODENECTOMY FOR
PANCREATIC ADENOCARCINOMA:
ARE THEY DIFFERENT?
A.M. Roch1, D. Brachet1, O. Turrini2, P. Pessaux3,
J.-R. Delpero2 and J.-P. Arnaud1
1University Hospital of Angers, France; 2Institute Paoli
Calmettes, Marseille, France; 3Nouvel Hopital Civil,
University Hospital of Strasbourg, France
Introduction: Although considerable progress has been
made in cancer survival rates over the past decades, 5-
year survival for pancreatic adenocarcinoma has hardly
changed, rising from 3% in 1975 to 6% in 2012. Sev-
eral studies have analyzed prognostic factors, with con-
troversial results and case reports of survivors beyond
5 years still remain anecdotal. The purpose of this
study was to identify factors associated with long-term
survival (≥5 years) in pancreatic adenocarcinoma.
Method: Data regarding all consecutive patients who
underwent surgical resection for pancreatic head ductal
adenocarcinoma from 1996 to 2007 in 2 academic cen-
ters were collected prospectively. Sociodemographic,
clinical and pathological parameters were retrospec-
tively reviewed. Long-term survivors were matched for
age, gender and tumor stage to patients operated on
during the same period with survival <5 years. Uni-
and multivariate analyses were performed to identify
independent factors predicitve of long-term survival. P-
values ≤0.15 in univariate analysis were considered sig-
nificant and entered in a regression model. Statistical
significance was accepted at p-value ≤0.05 in multivari-
ate analysis.
Results: 273 patients underwent surgical resection. 42
patients with survival ≥5 years were identified (median
85 months, range 60–177). Among these patients, 45%
had a tumor size >30 mm, 50% had positive lymph
nodes and 19% had positive margins. The median sur-
vival in the control group was 25 months. In univariate
analysis, portal vein resection, lymph node ratio, surgi-
cal complications, pancreatic fistula and biliary leakage
were considered significant (p = 0.023, 0.02, 0.024, 0.10
and 0.12, respectively). However, multivariate analysis
failed to identify independent factors associated with
long-term survival.
Conclusions: Only surgical resection offers a chance for
long-term survival in patients with pancreatic ductal
adenocarcinoma and should be attempted even in case
of poor prognostic factors. However, the tumor molec-
ular and genetic signature seems to be the most impor-
tant factor responsible for a more indolent behavior
and thus a longer survival.
PPP25-058
LONG TERM OUTCOME OF
PORTOMESENTERIC VEIN INVASION
AND PROGNOSTIC FACTORS IN
PANCREAS HEAD ADENOCARCINOMA
J. Jeong, D.W. Choi, S.H. Choi, J.S. Heo, D.H. Kim
and H.S. Lee
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: The purpose of this study was to clarify
the postoperative prognosis of pancreatic head cancer
with portal vein (PV) or superior mesenteric vein
(SMV) pathologic invasion.
Method: From May 1995 through December 2009, pre-
operative, intraoperative, and postoperative data from
276 patients who underwent pancreaticoduodenectomy
for pancreas ductal adenocarcinoma were reviewed ret-
rospectively. The long-term prognosis was compared
between patients with a pathologic PV-SMV invasion
and those without invasion.
Results: Fourty-six patients (16.7%) underwent PV-
SMV resection during pancreaticoduodenectomy. Path-
ologic PV-SMV invasion was observed in 30 (65.2%).
Postoperative severe morbidity (Grade 3 or 4) was simi-
lar for patients with and without PV-SMV resection
(8.7% with vs 7.0% without p = 0.754). The mortality
rate was 2.2% with PV-SMV resection and 0.9% with-
out PV-SMV resection (p = 0.423). No significant dif-
ference in overall survival was seen between patients
with and without pathologic PV-SMV invasion (median
survival, 13 vs 16 months; p = 0.663). Tumor differenti-
ation, R status, tumor size and type of operation were
revealed as independent prognostic factors.
Conclusions: 34.8% of patients who underwent PV-
SMV resection had no pathologic invasion. And PV-
SMV resection did not increase the rate of severe com-
plications and mortality. Furthermore, the prognosis
for patients with pathologic PV-SMV invasion may be
nearly the same as patients with no invasion. So, PV-
SMV resection with reconstruction should be consid-
ered in pancreatic head cancer patients with suspected
PV-SMV invasion.
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PPP25-059
PORTAL-SUPERIOR MESENTERIC
VEIN RESECTION AND
RECONSTRUCTION FOR
CHOLANGIOCARCINOMA AND
PANCREATIC CANCER:
CLASSIFICATION, RISK ANALYSIS
AND OUTCOME
X. Bai1, Q. Zhang1, L. Ye1, Q. Hu1, X. Tang2, S. Gao1
and T. Liang1
1The Second Affiliated Hospital, Zhejiang University
School of Medicine, China; 2The First Affiliated
Hospital, Zhejiang University School of Medicine, China
Introduction: Advanced intrahepatic cholangiocarcino-
ma, hilar cholangiocarcinoma and pancreatic cancer
can invade the portal vein (PV), superior mesenteric
vein (SMV), and splenic vein (SV), which was previ-
ously considered as a contraindication to operation.
Currently a growing number of portal-superior mesen-
teric vein resection and reconstruction (PSRR) is used.
PSRR varies with resection locations and to date no
classification system for PSRR has been reported. Here,
we propose a classification system for PSRR and report
the morbidity and outcome of patients.
Method: Patients who had intrahepatic cholangiocarci-
noma, hilar cholangiocarcinoma, pancreatic cancer and
1 patient with chronic pancreatic inflammation under-
went PSRR from February 2010 to May 2013. We col-
lected all patients with similar diseases but without
PSRR as controls. We also classified the PSRR into 3
types and 5 subtypes (IM, IL, IR, II and III) based on
our clinical experience and anatomy of the PV-SMV.
The associations among PSRR type, post-operative
mortality, morbidity, hospital stay, pre- and intra-oper-
ation traits as well as survival were analyzed.
Results: Forty-seven patients with PSRR and 92
patients without PSRR were included. Patients under-
went PSRR had similar overall morbidity compared
with those without PSRR (51.1% vs 42.4%). Long-
term outcome showed no significance in each type of
malignancy. Long anastomotic time attributes to higher
morbidity (p = 0.034) and higher grade of complica-
tions (p = 0.013). PSRR types were not significant asso-
ciated with anastomotic time (p = 0.39), though
subtype IL seemed extremely tricky and time-consuming
in some cases. Different PSRR types do not have sig-
nificant difference in morbidity (p = 0.64) but subtype
IL has higher grade of complications (p = 0.0012).
Conclusions: PSRR is safe and benefit for patients with
vascular invasion of malignancies. The new classifica-
tion system for PSRR may be valuable for hepato-pan-
creato-biliary surgeon training, and along with
anastomotic time, offers a predictable factor for prog-
nosis after operation.
PPP25-060
COMPARE BISAP SCORE WITH
IMRIE’S IN PREDICTING
COMPLICATIONS, NEED FOR
OPERATION, PROLONGED HOSPITAL
STAY AND MORTALITY FOR ACUTE
PANCREATITIS IN CHINESE
C.-C. Chan, H.-F. Cheung, Y.-S. Ng and S.-K. Leung
Tuen Mun Hospital, Hong Kong, China
Introduction: It was to compare BISAP with Imrie’s
scores in predicting various clinical outcomes in Chi-
nese patients with acute pancreatitis.
Method: This retrospective study retrieved 483 records
of Chinese patients admitted for acute pancreatitis
from 01/01/2010 to 31/12/2012. The scores were calcu-
lated within 24 hours after admission. Area under
curve (AUC) of receiver operating characteristic (ROC)
curves was used to compare predictive accuracy of the
2 scoring systems.
Results: Patients aged from 18 to 101 (median 64), of
whom 261 (54.0%) were male. CT scan showed pancre-
atic necrosis in 29/145 patients (3.9%). 29 patients
(6.0%) needed ICU organ support. Length of stay was
from 1 to 194 days (median: 6, interquartile range: 5).
13 patients (2.7%) needed operations, 25 (5.2%) died.
AUC and (95% CI, P value) for BISAP and Imrie’s
scores in predicting mortality were 0.854(0.778–0.930,
p < 0.0001), prolonged hospital stay
(LOS ≥ 11 days) : 0.700(0.642–0.758, p).
Conclusions: BISAP score could be a simpler alterna-
tive to Imrie’s in predicting mortality, organ failure and
prolonged length of stay but not pancreatic necrosis.
Both could not predict need for operation.
PPP25-061
PREDICTORS OF THE PRESENCE OF
CONCOMITANT CARCINOMA IN
INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASM OF THE
PANCREAS
D.H. Han, H.S. Lee, J.H. Jeong, D.H. Kim, J.S. Heo,
S.H. Choi and D.W. Choi
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: Concomitant carcinoma is common in in-
traductal papillary mucinous neoplasm (IPMN). It is
not well known that the risk factors for high grade dys-
plasia, non-invasive and invasive intraductal papillary
mucinous carcinoma (IPMC). The aim of this study is
to determine the predictors of concomitant carcinoma
in IPMN.
Method: From September 1994 to April 2013, we ret-
rospectively reviewed the data of 277 patients who
underwent pancreatic resection for IPMN. We evalu-
ated personal characteristics, morphologic and patho-
logic features of IPMN and analyzed predictors of
concomitant carcinoma.
Results: Of the 277 patients, 67 patients (24%) were
diagnosed with IPMC, 21 patients (7.5%) were high
grade dysplasia or non-invasive carcinoma and 189
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patients (68.5%) were low or moderate grade dysplasia.
Among 88 patients with concomitant cancer, 35 cases
(40%) were main duct type, 28 (32%) cases were
branch duct type and 25 (28%) cases were combined
type. The tumor size more than 3.0 cm (p = 0.041,
95% CI 1.022–2.863) and main pancreatic duct size
more than 0.5 cm (p = 0.016, 95% CI 1.145–3.702)
were significant predictors of concomitant carcinoma in
pancreatic IPMN.
Conclusions: If the size of IPMN is more than 3.0 cm
or main pancreatic duct size is more than 0.5 cm, con-
comitant carcinoma is highly suggestive. Therefore
before surgical resection we should consider about
these findings.
PPP25-062
MULTIFOCAL EXTRA
GASTROINTESTINAL STROMAL
TUMOR OF PANCREAS: A CASE
REPORT
V.R. Vutukuru
Sri Venkateswara Institute of Medical Sciences, India
Introduction: Gastrointestinal stromal tumors (GIST)
are CD 117 (C-Kit) positive mesenchymal tumors aris-
ing from the interstitial cells of Cajal. GISTs are
described outside the gastrointestinal tract such as mes-
entery, omentum, retroperitoneum. However, pancre-
atic GISTs are extremely rare and there are few case
reports in the literature. But there is no description of
multifocal GIST arising from pancreas in the literature.
We report a case of multifocal GIST arising from the
pancreas.
Method: A 57-year-old gentleman who presented with
pain abdomen was evaluated. Computed tomogram
showed a focal lesion of 6 9 5 cms in the tail of pan-
creas with doubtful infiltration of left adrenal gland.
Also thickening at the gall bladder neck/polyp was
noted. Ca 19-9 was normal. On laparotomy, there was
a lesion of 6 9 5 cms in the tail of pancreas infiltrating
spleen and splenic flexure of colon and another lesion
of 2 9 1 cms in the body of pancreas. Gall bladder
showed wall thickening in the neck region. Distal pan-
createctomy with splenectomy and cholecystectomy
along with resection of splenic flexure of colon was
done. On histology, both lesions were GIST arising
from pancreas with tumor free resected margins and
tumor free spleen and colon. Lesion at gall bladder
neck was involved cystic lymphnode. Of the 12 lymph-
nodes assessed one was positive for tumor. All were
CD 117 positive. Patient was started on Imatinib.
Patient presented after 1 month with a large supracla-
vicular lymphnode. On cytology, it was found to be a
metastatic node. Inspite of being on imatinib therapy,
he developed multiple metastatic lesions and expired
after 5 months.
Results: Case report
Conclusions: We report a very rare case of multifocal
GIST arising from pancreas with lymphnodal metasta-
sis and very high malignant potential, with no such
case reported in literature.
PPP25-063
CYSTIC NEOPLASMS OF THE
PANCREAS: 10 YEAR EXPERIENCE
AND EVIDENCE BASED MODEL FOR
DIAGNOSIS AND MANAGEMENT
R. Dubey3, F. WANG1 and N. Merrett2
1Campbelltown Hospital, University of Western Sydney,
Australia; 2Bankstown Hospital, University of Western
Sydney, Australia; 3University of New South Wales,
Australia
Introduction: The approach to cystic neoplasms of the
pancreas is contentious due to its variable clinicopatho-
logical outcomes. Although individual management
options have been described, a decision making model
integrating all clinical and imaging modalities has not
been well accepted. This study aimed to determine the
clinicopathological features associated with malignancy
in cystic neoplasms of the pancreas and to develop a
predictive model of malignant potential.
Method: Retrospective analysis of prospectively collated
database of 120 consecutive patients diagnosed with a
cystic pancreatic neoplasm between 2001 and 2011.
Results: Benign cysts accounted for the majority of those
resected (n = 88, 73.3%), while the remaining 32 cysts
were malignant. Computed tomography (CT) had a sen-
sitivity and specificity of 64.3% and 72.2% for detecting
malignancy in comparison with 84.9% and 89.3%,
respectively, for magnetic resonance imaging (MRI). The
clinicopathological features associated with malignancy
included older age (p < 0.01), presence of symptoms
(p = 0.03), dilatation of the pancreatic duct (p < 0.01) or
the common bile duct (p = 0.05), presence of solid com-
ponent (p = 0.04), lymphadenopathy (p = 0.02) and high
CEA levels (p = 0.01). In a subset of 54 patients who
were given a clear preoperative diagnosis on the basis of
radiological imaging, the overall sensitivity and specific-
ity were 88.2% and 86.5%, respectively. Endoscopic
ultrasonography significantly improved the diagnostic
accuracy (p < 0.01) whilst CT did not (p > 0.05).
Conclusions: This study confirms the limitations in the
preoperative diagnoses of pancreatic cysts. Multiple
diagnostic modalities allied with clinical characteristics
are necessary in order to determine appropriate man-
agement. Malignancy should be suspected in older,
symptomatic patients presenting with ductal dilatation,
solid components or lymphadenopathy.
PPP25-064
PROGNOSTIC FACTORS IN 170 CASES
RESECTED OF PANCREATIC
EXOCRINE CANCER: 10 YEARS
EXPERIENCE
F. Sanchez-Bueno, R. Garcia, G. Torres,
M. Fuster, J.De la Pe~na, M.A. Claver, P. Ramirez and
P. Parrilla
Hospital Clinico Universitario “Virgen de la Arrixaca”,
Spain
Introduction: The aim is to present a serie of 170
patients with pancreatic resection in 10-years of experi-
ence, analyzing postoperative morbidity and mortality,
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histological features and prognostic factors influencing
survival at 3 and 5 years, respectively.
Method: In the last 10 years we have 398 patients diag-
nosed with pancreatic cancer, and 170 of them have
been resected. The ratio of patients with surgical resec-
tion from 2001 to 2006 was 56.1%, rising to 90.1% in
the last 5 years (p < 0.01). Mean age: 62  11.7 years
with a male predominance (58.7%). In 85% of cases,
the tumor was located in the pancreatic head. The sur-
gical procedure was: cephalic duodenopancreatectomy
(56.7%), distalpancreatectomy (15%) and total duode-
nopancreatectomy in 23.3%, respectively. In the histo-
logical study we found 131 cases of pancreatic ductal
adenocarcinoma, 22 cases mucinous adenocarcinoma, 9
cases IPMN and other histologic variants in 8 cases.
There was lymphovascular infiltration in 33.1% and
perineural infiltration in 52.2%. In histological differen-
tiation we found 21.3% of poorly differentiated tumors
and 9.6% more differentiated. In resection margins,
there was 64.7% R0 vs 35,3% R1, respectively.
Results: Postoperative morbidity was 20.6% (35
patients) and postoperative mortality was 5.9% (10
patients). In 22 cases (12.9%) a second surgery was
performed. The principal causes of this were hemoperi-
toneum and biliopancreatic dehiscence. The survival at
3 and 5 years was 65% and 50% in mucinous cancer,
while it was 55% and 15% in adenocarcinomas, respec-
tively. With univariate and multivariate analysis, pre-
dictors of survival are tumor size, vascular invasion,
lymphatic invasion, margins R1 and the cellular differ-
entiation.
Conclusions: In our experience, there is significant
increase resectability in patients with surgery in the last
5 years. There is not surgical mortality; there is 20.6%
of morbidity and 5.9% of mortality during the first
month.
PPP25-065
POSTOPERATIVE LABORATORY
PARAMETERS AFTER
PANCREATICODUODENECTOMY–CAN
THEY PREDICT COMPLICATIONS? A
PROSPECTIVE STUDY
R. Saxena, A. Kumar, G. Parthasarthy,
A. Prakash, R. Singh, A. Behari, A. Kumar and
V. Kapoor
Sanjay Gandhi Post Graduate Institute of Medical
Sciences, India
Introduction: Pancreaticoduodenectomy (PD) is a pro-
cedure fraught with high morbidity. Early diagnosis of
complications helps reduce morbidity. We investigated
whether serial postoperative estimations of serum and
drain fluid amylase along with other routine tests fol-
lowing PD could predict the development of complica-
tions.
Method: Prospective study on all consecutive patients
undergoing PD from September 2011 to December
2012. All patients underwent serum amylase (SA) and
drain fluid amylase (DFA) routinely on day 1, 3, 5 and
7 postoperatively in addition to hematological, liver
and renal function tests as warranted by the clinical
scenario. Appropriate imaging (sonography/CT scan-
ning/DSA) was obtained when warranted.
Results: 56 patients underwent PD during the study
period. The postoperative morbidity was 51% (n = 29)
and mortality was 14% (n = 8). Patients with morbid-
ity had a significantly higher serum amylase level than
those without morbidity on post operative day one
(POD1) (386.5  48.9 vs 205  64.9 IU/L). A drain
fluid amylase level ≥263 or more IU/L on POD1 pre-
dicted the occurrence of morbidity with 80% sensitivity
and 77% specificity. On univariate analysis the factors
which predicted the occurrence of morbidity were high
DFA on day 1, 3, 5 and 7 and a serially rising total
leucocyte count (TLC). A rising serum creatinine and
TLC, decreasing serum albumin and platelet levels and
high DFA on POD7 were associated with an increased
risk of mortality. However on multivariate analysis
there was no factor which could predict morbidity
while a rising creatinine and TLC levels were signifi-
cantly associated with increased risk of mortality.
Conclusions: DFA on day 1 and 7 remain a good pre-
dictor of post operative complications following PD.
Serially decreasing albumin and platelet levels are asso-
ciated with increased risk of death. These simple tests
may help better triage in vulnerable patients and effect
early aggressive management.
PPP25-066
THE COMPARISON OF BLUMGART
ANASTOMOSIS METHOD WITH
TRADITIONAL DUCTOMUCOSAL
METHOD RESULT IN POST
PANCREATICODUODENECTOMY
RECONSTRUCTION
A.M. Atak, M. Kerem, M. Sare, €O. Sakrak and
K. Dikmen
Gazi University’, Turkey
Introduction: The most important factor that responsi-
ble for morbidity and mortality in peri-ampullary site
tumor surgery is leakage in pancreatic anastomosis.
Recent studies show an approximately 10% leakage
rate in which several alternative surgical techniques
have been developed and still being developing to
reduce it. The aim of this study is to compare the post-
operative results of BA technique with traditional
ducto-mucosal (DM) anastomosis.
Method: 73 patients went under pancreaticoduedenec-
tomy surgery between April 2008 and August 2013.
Pancreaticojejunostomy was carried out via BA tech-
nique in 38 patients and traditional DM anastomosis
technique was performed in 35 patients. Age, gender,
anastomosis leak, type of leak, pathologic diagnosis,
morbidity, mortality and duration of stay in hospital
were inspected retrospectively. The pancreatic anasto-
mosis leakage and the resulting complications and mor-
tality were compared.
Results: The primary diagnosis, age and gender fea-
tures in both groups were similar. Pancreatic leakage in
BA and DM group were observed to be 10.5% and
31%, respectively (p < 0.05). Three patients had grade
A, 1 patient had grade B fistula and in BA group. Four
patients had grade A, seven patients had grade B fistu-
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las in DM group (p > 0.05). Neither of the groups had
patients with grade C fistula. General complications
rate were 27.8% in BA, and 48.5% in DM group
(p < 0.05). Perioperative mortality was observed in one
patient in BA group and three patients in DM group.
The causes of mortality were determined as thrombo-
embolism and myocardial infarction. The mean time of
discharge were 8 and 15 days in BA and the other
group, respectively (p < 0.05).
Conclusions: Blumgart anastomosis can be performed
to be a safe method to be used in post pancreaticoduo-
denectomy reconstruction in terms of reduction in pan-
creatic anastomosis leakage and complications
associated with fistulas.
PPP25-067
IS ENDOSCOPIC ULTRASOUND (EUS)
A POWERFUL TOOL IN DIAGNOSING
PATIENTS WITH SUSPECTED
PANCREATIC TUMOUR
C.-C. Chan, C.-K. Tang, LS.-W. Lai and
C.-C. Cheung
Tuen Mun Hospital, Hksar, Hong Kong, China
Introduction: Endoscopic ultrasound (EUS) has been
gaining more attention in diagnosing pancreatic
tumour. Is it really that powerful?
Method: Retrospective review of EUS performed from
1st July 2010 to 31st March 2013 for suspected pancre-
atic tumour in 27 patients.
Results: 28 EUS procedures were done to 27 patients
with suspected pancreatic tumour aged from 18–
76 years (mean: 54.8). Male to female ratio was 7 to 3.
All of them were referred to EUS because of a pancre-
atic lesion shown by imaging studies. Pathological
examination of specimen retrieved by either fine needle
aspiration cytology or core biopsy was done. The
results were shown as definite type of pathology, atypi-
cal, suspicious and benign. In this study, quantity insuf-
ficient (QI) was treated as no-yield, the first three
results were treated as positive, while benign was trea-
ted as negative. Apart from 1 patient who was “QI”
defaulted follow-up after 1 month, all were followed-up
regularly (ranged from 3 to 34, mean: 13.8 months). 10
patients died despite treatment with mean survival of
9.6 months after EUS. Yield of the test was 24/28
(86%). There were 17 test-positive patients, but one
was treated as false-positive because of contradicting
results of tumour markers and clinical course. There
were 7 patients with negative results but three were
treated as false-negative because of worsening clinical
course and imaging studies. Thus sensitivity, specificity,
positive predictive and negative predictive values were
84%, 80%, 94% and 57% respectively.
Conclusions: Although EUS seemed to be a fairly use-
ful test in diagnosing pancreatic tumour, it assumed
attending doctors treat atypical and suspicious results
as positive which was not without risks of over-diagno-
sis especially if the test was the sole mean the doctors
rely on. Also patients with no-yield still faced the
dilemma of exposing the challenge of another test or
stress of unsolved diagnostic problem.
PPP25-068
TNF-a, IL-6 AND IL-8 CYTOKINES IN
RELATION TO TNF-a-308 G/A
POLYMORPHISM IN POSTOPERATIVE
SEPSIS
K. Baghel, R.N. Srivastava, A. Chandra, H.R. Kazmi,
S. Raj and J. Agrawal
King George’s Medical University, India
Introduction: Early recognition of postoperative sepsis
remains problematic. We investigated association of
TNF-a-308 G/A polymorphism and serum level of
cytokine TNF-a, IL-6 and IL-8 with the development
of sepsis following major gastrointestinal surgery.
Method: 239 patients undergoing major elective gastro-
intestinal surgery were enrolled. Blood sample were
drawn and genomic DNA was isolated. TNF-a-308 G/
A polymorphism was studied using PCR-RFLP
method. All patients were followed for 1 month follow-
ing surgery for any evidence of sepsis. Serum cytokine
TNF-a, IL-6 and IL-8 levels were measured pre and
postoperatively by ELISA. Genotypes and cytokine lev-
els were related to the occurrence of sepsis if any.
Results: 19.66% (n = 47) patients developed postopera-
tive sepsis. Overall mortality was 3.34% (n = 8). The
allele frequencies of G and A were 0.67 and 0.33 in
patients with postoperative sepsis and 0.84 and 0.16 in
patients without postoperative sepsis. Development of
postoperative sepsis was significantly (p = 0.002) higher
in patients homozygous for the allele AA as compared
to other genotypes. When compared with patients car-
rying at least one G allele (GG homozygous and GA
heterozygous genotype), the AA homozygous genotype
was associated with an OR of 4.17 (p = 0.003; 95%
CI = 1.5 to 11.48) for the development of sepsis. Com-
pared with the homozygous GG genotype, the OR for
the homozygous AA genotype was 5.18 (p = 0.0008;
95% CI = 1.82 to 14.76). In patients with postoperative
sepsis, significantly increased level of TNF-a
(p = 0.03) and IL-6 (p = 0.008) cytokine was
observed in the AA homozygous genotype subgroup as
compared to other genotypes.
Conclusions: TNF-a-308 G/A polymorphism is signifi-
cantly associated with the development of postoperative
sepsis with increased expression of cytokine TNF-a and
IL-6.
PPP25-069
LONG TERM OUTCOMES OF
PATIENTS AFTER
PANCREATICODUODENECTOMY IN
BENIGN AND PREMALIGNANT
CONDITIONS
S. Wijerathne, N. Tan, A. Kow, S. Chang,
K. Madhavan and I. Shridhar
National University Hospital, Singapore
Introduction: The incidence of pancreaticoduodenecto-
my (PD) performed for benign and premalignant con-
ditions is rising. The long term outcomes of PD for
benign conditions is not well documented. Our aim was
to identify the long term outcomes and quality of life
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(QoL) for patients who undergo PD for benign or pre-
malignant conditions.
Method: Our study is a retrospective case series in a
single institution. Patients underwent open PD from
2000 to 2010 for benign and premalignant conditions
were included. Clinical records up to 3 years post-sur-
gery were assessed to identify patients who required
long term dietary, pancreatic enzyme, vitamin and iron
supplements. Weight-gain, development of anaemia,
Diabetes-mellitus and other complications during the
follow-up were also recorded. Phone interview with
patients was done using the EORTC QLQ-C30 version
3.0 questionnaire to assess their quality of life.
Results: 16 patients (12.1% out-of total 132 patients
who underwent PD) with 7 males and 9 females with
mean age of 56 years (range 38–80) were included.
Common histology findings were IPMN (5), ampullary
adenoma (3), solid-pseudopapillary neoplasm (2) and
serous-cystadenoma (2). One patient had PD for
trauma related injury. 5(31.2%) patients required pan-
creatic-enzyme supplements, 3(18.7%) patients devel-
oped anaemia, 2(12.5%) of them required iron and 1
(6.2%) required VitaminB12 supplements. 5(31.2%)
patients had weight-loss ≥7 kg during 6–24 months
post-operatively and 4 of them required dietary supple-
ments. All patients were alive at 3-years follow-up and
none of them developed Diabetes-mellitus. The results
for global health, emotional and social functioning
scales were superior to the reference values available in
literature for “all cancers”.
Conclusions: Patients who undergo PD for benign or
premalignant conditions can have nutritional (43.7%),
pancreatic enzyme (31.2%) or hormone deficiency. Fol-
low up protocols with multidisciplinary care is required
for these patients.
PPP25-071
THE INDICATIONS AND OUTCOME OF
PANCREATECTOMY FOR CYSTIC
NEOPLASMS IN CHINA: THE
ANALYSIS OF A 16-YEAR EXPERIENCE
FROM A SINGLE HIGH-VOLUME
ACADEMIC INSTITUTION
X. Bai, L. Ye, Q. Zhang, J. Wang and T. Liang
The Second Affiliated Hospital, Zhejiang University
School of Medicine, China
Introduction: The widespread use of abdominal imag-
ing in China in the past decade has resulted in the dra-
matic increase in the identification of pancreatic cystic
neoplasms (PCNs). However, very few Chinese studies
concerning surgical treatment of PCNs have been
reported. We aim to report the experience of clinico-
pathological features and surgical management patients
of PCNs resected at a single institution in China.
Method: The medical charts of patients pathologically
proven to have these PCNs, who had underwent opera-
tion at the Second Affiliated Hospital of Zhejiang Uni-
versity Medical College between January 1st 1997 and
June 31st 2013, were retrospectively reviewed and ana-
lyzed.
Results: We included 111 patients, 17 (15.3%) with IP-
MNs, 20 (18.0%) with MCNs, 39 (35.1%) patients with
SCNs and 35 (31.5%) with SPNs. The neoplasms were
incidentally found in 49 (44.1%) patients; the overall
accuracy of preoperative diagnosis was 74.8% (highest
at 85.0% in the MCN group). The postoperative mor-
bidity was 45.0% (50/111); pancreatic fistula (33/111,
29.7%) was the most common complication. However,
operative mortality was low (1/111). The proportion of
malignant neoplasms was 24.3% (9/37) in mucin pro-
ducing neoplasms. Elevated CA19-9 or CEA were inde-
pendently associated with malignancy. The overall
survival rate was 96.4%, with a median follow-up per-
iod of 35.67 months.
Conclusions: The proportion of PCNs varies with that
reported in Western countries, SPN is more prevalent
than their counterparts. Accurate preoperative differen-
tial diagnosis of these PCNs is still difficult. It is
strongly recommended that patients with elevated
CA19-9 or CEA levels undergo surgical resection.
PPP25-072
CENTRAL PANCREATECTOMY–SAFE
SURGERY FOR MIDDLE SEGMENT
PANCREATIC PATHOLOGY
R. Dama, P. Rabela, G.V. Rao and D.N. Reddy
Asian Institute of Gastroenterology, India
Introduction: Pancreatic pathologies in the neck and
body when treated by pancreatoduodenectomy or distal
pancreatectomy result in a significant loss of normal
pancreatic parenchyma and impairment of exocrine
and endocrine function. In Central pancreatectomy,
only the affected middle segment is removed, preserving
the normal pancreatic parenchyma on either side, the
spleen and it also maintains the enteric continuity. We
aim to assess the safety & effectiveness of central pan-
createctomy in pancreatic neck & body lesions.
Method: 21 patients underwent central pancreatectomy
between 2004 to 2013 august. 11 patients had serous
cystadenoma, 4 patients neuroendocrine tumor (NET),
solid cystic pseudopapillary tumour of the pancreas
(SCPT)-2. One patient each of IPMN, focal chronic
pancreatitis, post trauma and Inflammatory myofibrob-
lastic tumour of the pancreas. In 15 patients the proxi-
mal end was transected with a linear stapler and edges
oversewn, and the distal stump was anastomosed to
roux en y- jejunal loop. Six patients underwent Pancre-
aticogastrostomy. All patients were followed up for
exocrine and endocrine insufficiency.
Results: 17 patients had uneventful recovery. 4/21(20%)
patients had pancreatic fistula 3 patients had post opera-
tive grade A fistula and 1 patient had grade B fistula.
Preoperative Diabetes Mellitus in 4 patients did not wor-
sen during follow up. None of the patients had exocrine
or endocrine insufficiency on mean follow up of
40 months (10–100 months) as assessed by fecal elastase
and fasting blood sugar levels. Mean operative time,
blood loss, length of segment excised were 137 minutes,
100 mL, & 3.5 cms respectively.Mean stay was 7 days.
Conclusions: Central Pancreatectomy is a feasible and
safe option for patients with benign tumors /trauma/
lesions of low malignant potential in the neck/body of
the pancreas preventing the loss of exocrine and endo-
crine functions.
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PPP25-073
SIGNIFICANCE OF M2-POLARIZED
TUMOR-ASSOCIATED MACROPHAGE
INFILTRATION OF REGIONAL LYMPH
NODES IN PN0 PANCREATIC CANCER
H. Kurahara, S. Takao, K. Maemura, Y. Mataki,
M. Sakoda, S. Iino, S. Ueno, H. Shinchi and
S. Natsugoe
Kagoshima University, Japan
Introduction: Tumor-associated macrophages (TAMs)
are reportedly involved in lymphangiogenesis in pri-
mary tumors, playing a crucial role in lymphatic metas-
tasis. Further, nodal lymphangiogenesis precedes and
promotes regional lymph node (RLN) metastasis. We
investigate the relationship of M2-polarized TAM infil-
tration of the RLNs, nodal lymphangiogenesis, and
occult nodal involvement in pN0 pancreatic cancer.
Method: Hematoxylin and eosin (H&E)-stained pri-
mary tumor and regional LN specimens from 40
patients diagnosed with pN0 pancreatic cancer accord-
ing to the pathological TNM classification were
assessed. To evaluate lymphangiogenesis, lymphatic
vessel density (LVD) was measured by using D2-40
antibody. CD163 and cytokeratin AE1/AE3 antibodies
were used to detect M2-polarized TAMs and isolated
tumor cell (ITCs) in the RLNs, respectively.
Results: The nodal LVD had a strong association with
the M2-polarized TAM density in the RLNs
(p < 0.0001). Most of these TAMs expressed vascular
endothelial growth factor-C (VEGF-C). Furthermore,
in the RLNs, the M2-polarized TAM density was sig-
nificantly associated with the incidence of ITCs
(p = 0.0477).
Conclusions: M2-polarized TAM infiltration of RLNs
is significantly associated with nodal lymphangiogenesis
and occult nodal involvement in pN0 pancreatic cancer.
Node-infiltrating M2-polarized TAMs may facilitate
nodal lymphangiogenesis via the production of VEGF-
C and thus promote RLN metastasis.
PPP25-074
ANTIAPOPTOTIC AND CELL CYCLE
REGULATORY PROTEINS IN
ASSOCIATION WITH KI67 IN
PANCREATIC CANCER
M. Pavars1, Z. Simtniece2, I. Strumfa2, E. Vasko2,
A. Vanags2 and J. Gardovskis2
1P.Stradins Clinical University Hospital, Latvia; 2Riga
Stradins University, Latvia
Introduction: Pancreatic ductal carcinoma (PDAC) is
one of the most aggressive cancers. Mutations or epige-
netic alterations in the tumour suppressor or cell cycle
regulatory genes readjust cellular homeostasis and abil-
ity of apoptosis (Lang et al., 1998; Angela et al., 2013).
p53, p21, p27, cyclinD1 and bcl-2 are analysed as pre-
dictors of radiosensitivity and chemosensitivity (Fu et
al., 1998; Westphal et al., 2003; Wang et al., 2012). The
aim of this study was to determine the expression of
bcl-2 and cell cycle regulatory proteins and correlation
with Ki-67 in PDAC.
Method: Sixty-nine retrospective consecutive cases of
surgically treated PDAC were characterised by patient’s
age, tumour TNM, stage, histological grade (G1-3),
resection margins (R0-1). Expression of bcl-2, p53, p21,
p27, cyclinD1 and Ki-57 was detected by immunohisto-
chemistry (IHC). Descriptive statistics was performed
by SPSS, version 20. The study was approved by Com-
mittee of Ethics.
Results: The mean age was 63.7 years [95% confidence
interval CI: 61.1–66.3]. The most frequent tumour char-
acteristics were: size >2 cm: 92.3% [83.0–97.6]; T3:
94.1% [86.8–98.2]; N1: 68.7% [57.1–78.8]; stage IIA:
26.9% [17.3–38.1]; stage IIB: 64.2% [52.5–74.9]; G2:
58.8% [47.1–69.9]; R1: 56.9% [44.9–68.4]. The main
IHC data are presented as percentage of positive cases;
range and mean count of positive cells (%): bcl-2
showed no expression, p53–72.3 [60.8–82.1], 0–97, 33.2
[25.3–40.8]; p21–97.0 [90.9–99.5], 0–65, 25.7 [21.6–30.0];
p27–100[95.8–100], 6–82, 36.2[32.2–40.3]; cyclinD1–81.2
[70.9–89.1], 0–65, 20.9[17.0–24.7]; Ki-67–100[95.8–100];
1–65; 22.0[18.5–25.9]. Correlation was found between
p53 and p21 (p = 0.002), p53 and p27 (p = 0.002), cyc-
linD1 and p21 (p = 0.03).
Conclusions: Pancreatic cancer is characterized by
aggressive growth. Bcl-2 was not found in PDAC tis-
sues. The expression of the analysed cell cycle regula-
tory proteins p53, p21 and cyclinD1 is frequently
affected in pancreatic carcinogenesis suggesting possible
benefit from targeted treatment. Upregulated cell cycle
proteins do not correlate with proliferation activity,
but mutual association between p53, p27 and p21 is
present.
PPP25-075
TRANSDUODENAL AMPULLECTOMY
VERSUS
PANCREATODUODENECTOMY IN THE
PATIENTS WITH CARCINOMA IN SITU
OR T1 AMPULLA OF VATER CANCER
H. Lee, S.H. Choi, J. Jeong, D.H. Kim, J.S. Heo and
D.W. Choi
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: There are 2 ways of surgical treatment
for ampulla of Vater tumor defined in the ampulla of
Vater. There is concern that transduodenal ampullecto-
my is associated high local recurrence rate although
pancreatoduodenectomy is associated with high mor-
bidity and mortality. The aim of this study is to vali-
date the effectiveness of tansduodenal ampullectomy in
carcinoma in situ or T1 ampulla of Vater cancer.
Method: From September 1994 to July 2013, total 475
patients underwent surgery for ampulla of Vater tumor.
Among them, 137 patients who diagnosed with carci-
noma in situ or T1 invasive ampulla of Vater cancer
were identified and retrospectively reviewed. The
patients were divided into two groups according to the
method of surgery: transduodenal ampullectomy (group
1) and pancreatoduodenectomy (group 2).
Results: The 18 patients underwent transduodenal
ampullectomy and 119 patients underwent pancreato-
duodenectomy. After a median follow-up of 50 months,
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2 patients (11%) of group 1 and 16 patients of group 2
(13%) experienced recurrence (p = 0.993). In T1
ampulla of Vater cancer patients, lymph node metasta-
ses rate was significantly high when the cell differentia-
tion is moderately or poorly differentiated type
(p = 0.015).
Conclusions: Transduodenal ampullectomy might be a
substitution for the treatment of ampulla of Vater can-
cer in selected patients.
PPP25-076
A CASE OF AUTOIMMUNE
PANCREATITIS WITH PANIN-III
LESION
M. Pavars1, Z. Simtniece2, I. Strumfa2, E. Vasko2,
A. Vanags2 and J. Gardovskis2
1P.Stradins Clinical University Hospital, Latvia; 2Riga
Stradins University, Latvia
Introduction: Autoimmune pancreatitis (AIP), repre-
senting 2% of chronic pancreatitis, is characterised by
chronic inflammation, irregular narrowing of pancreatic
ducts and systemic fibroinflammatory disease. AIP is
classified into lymphoplasmacytic sclerosing pancreati-
tis, type 1 and idiopathic duct-centric chronic pancrea-
titis, type 2 (Paik et al., 2013). Elevated levels of IgG4
are found in 63% of type 1 cases versus 23% in type 2,
the abdominal pain–41% versus 68%, diffuse swelling
of the pancreas–40% versus 25% (Kamisawa et al.,
2011). PanIN lesions are present in 82% of AIP (both
types) and correlate with elevated risk of malignancy
(Gupta et al., 2013).
Method: The clinical, radiological, surgical and morpho-
logical data are reported to discuss the differential diag-
nosis between autoimmune pancreatitis and tumour.
Results: A 62-year-old man had 15 month history of
epigastric discomfort. The initial episodes resolved
spontaneously. One year later, recurrent episodes
became associated with epigastric pain, provoked by
diet mistakes. The pain worsened, attaining constant
character. The patient was urgently admitted to the
hospital. Computed tomography was suggestive of pan-
creatic head tumour. Surgical treatment was scheduled.
By objective examination, no pathology was found.
The blood tests demonstrated elevated number of leu-
cocytes–9.8 9 109/L [laboratory reference interval 4.5–
8.5 9 109/L], potassium–5.9 mmol/L [3.5–5.1 mmol/L],
total protein–114 g/L [64–83 g/L]. Patient underwent
pylorus-sparing pancreaticoduodenectomy. Grossly,
grey area in the pancreatic head was found, measuring
2.5 9 3 9 1.1 cm. Histologically, periductal and peri-
venous lymphoplasmacytic infiltration was associated
with presence of eosinophils, dense fibrosis, star-like
lumens of peripheral ducts, lymphoid follicles and few
ducts with PanIN-III lesion. Fibrosis and weak lym-
phoplasmacytic infiltration was detected in common
bile duct. Postoperative recovery was uneventful.
Patient was discharged on 9th postoperative day pro-
viding further recommendations.
Conclusions: The AIP is characterized by unspecific
clinical and radiological findings. AIP can be associated
with involvement of extrapancreatic tissues and devel-
opment of carcinoma in situ.
PPP25-078
THERAPEUTIC STRATEGY IN
PATIENTS WITH
POSTPANCREATECTOMY
HEMORRHAGE: A SINGLE CENTER
EXPERIENCE IN 25 PATIENTS
S. Asari, I. Matsumoto, M. Shinzeki, T. Goto,
T. Ajiki, T. Okazaki, M. Kido, A. Takebe,
T. Fukumoto and Y. Ku
Kobe University, Japan
Introduction: The management of postpancreatectomy
hemorrhage (PPH) is an important issue because it
remains a serious complication with a high rate of mor-
tality.
Method: We reviewed our prospective database to ana-
lyze the rate, management and outcome of PPH at
Kobe University Hospital between 2003 and 2012.
Results: Pancreatic surgeries were performed in 466
patients. The surgical procedures were as follows: pan-
creatoduodenectomy, 315; distal pancreatectomy, 133;
total pancreatectomy, 12; central pancreatemy, 12.
Thirty-one PPHs were totally developed in 25 of 466
patients (5.4%). The overall mortality rate was 1.1%
(5/466). Sentinel bleeding heralding a PPH was
observed in 12 of the 25 patients (48%). A diagnostic
angiography was performed in 18 of the 25 patients
(72%) following multidetector CT imaging. The bleed-
ing site of visceral artery determined following angiog-
raphy or relaparotomy was mainly as follows: hepatic
artery (HA), 5; gastroduodenal artery, 5; superior mes-
enteric artery (SMA), 5; splenic artery, 4; portal vein
(PV), 1. The first-line treatment of the 25 patients was
as follows: IVR, 12 (48%); surgery, 7 (28%); observa-
tion, 5 (28%); none, 1 (4%). Eleven of the 12 patients
(92%) who underwent IVR were rescued. Although
minor complications occurred in 3 of the 5 patients
who performed embolization of common HA, all the
patients were eventually recovered. Four of the 7
patients who underwent relaparotomy were resusci-
tated, and SMA bypass grafting was attempted in a
patient with the ruptured SMA-trunk. Twenty of the
25 patients (80%) were totally rescued. The ISGPS-
grading of PPH was as follows: Grade A, 1 (4%);
Grade B, 10 (40%); Grade C, 14 (56%).
Conclusions: We recommend IVR as first-line treat-
ment of PPH. It is required for the implementation of
TAE to maintain the blood flow of SMA- and PV-
trunk. In case of the failure of IVR or uncontrolled he-
modynamic, surgical treatment should be attempted.
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PPP25-079
SHORT TERM OUTCOMES FOR
MEDIUM-VOLUME
PANCREATICODUODENECTOMY
SURGEONS CAN BE EQUIVALENT TO
HIGH VOLUME CENTRES, WHEN
PERFORMED CONCURRENTLY WITH
AN OVERALL HIGH VOLUME OF
COMPLEX HPB CASES
Koroush Haghighi, David Links
University of New South Wales, Australia
Introduction: The study aim was to compare the short-
term outcomes for pancreaticoduodenectomy (PD) for
a surgeon performing medium-volume PD but an over-
all high-volume complex HBP caseload with outcomes
from high-volume PD centres.
Method: A retrospective case-note review was per-
formed for all patients undergoing PD between 2007
and July 2013 including baseline data, work-up, opera-
tive outcomes, pathology and follow up. A literature
review was performed to assess current high-volume
centre outcomes.
Results: 68 patients underwent PD, median age 63
years. Pathology: 33 pancreatic adenoca (PDAC), 11
ampullary/duodenal ca, 7 cholangioca, 9 NET, 3
IPMN and 5 other. 22 points underwent portal vein
resection (PVR) (18 lateral, 4 end-end/graft) including
18 of the 33 PD for PDAC. Mean lymph node yield
was 15. There were 8 positive margins in total, 6 were
PVRs, however the portal vein margin was not the
positive margin in these cases. R1 margin rate: PDAC
6/33 (PVR 4/18, non-PVR 2/15, p = 0.6), Cholangioca
2/7, ampullary and duodenal ca 0/11 and NET 0/9. No
30-day mortality. Median length of stay 11 days. Over-
all complication rate 35% (13% Clavien class III/IV).
There were 2 ISGPF-A pancreatic fistulas.
Conclusions: Short-term outcomes for PD by a med-
ium-volume surgeon were comparable to benchmarks
from high-volume centres. The surgeon has a complex
HPB caseload, including over 350 liver resections over
the same time period. This series demonstrates that sur-
geons with a medium PD caseload, but a high overall
complex HPB caseload, can perform PD and PVR
safely with an equivalent outcome to high-volume cen-
tres. We believe the skillset maintained with a concur-
rent high volume of liver resections is beneficial for
performing PVR with low morbidity and R1 margin
rate. Total complex HPB caseload should be considered
when rationalizing the performance of PD according to
unit and surgeon volume.
PPP25-080
A NOVEL TECHNIQUE OF
PANCREATODUODENECTOMY AFTER
SEVERE ACUTE PANCREATITIS USING
WATER DRIPPING BIPOLAR CAUTERY
T. Goto, I. Matsumoto, M. Shinzeki, S. Asari,
A. Takebe, T. Okazaki, M. Kido, T. Ajiki,
T. Fukumoto and Y. Ku
Kobe University, Japan
Introduction: Pancreatoduodenectomy (PD) represents
one of the most challenging operation of the gastroen-
terological surgery. Moreover, extremely high level
technique is required with PD after severe acute pan-
creatitis (SAP). Several technical variations have been
proposed in an effort to minimize intra and postopera-
tive complication rates. Severe adhesion and disorienta-
tion are risks of PD after SAP. We utilize bipolar
cautery in the situation of exfoliation and to divide tis-
sues expressly influenced by SAP.
Method: We use a bipolar cautery with an infusion line
to bring water (saline) droplets down the inner surface
of 1 arm of the tweezers through an opening about
1.5 cm proximal to its tip. The power of bipolar cau-
tery is adjusted to 150 Malis. This setting is higher than
usual for cutting stiff parenchima because of pancreati-
tis, and it can exfoliate sharply. Bipolar forceps with a
fine tip can be used for performing delicate work. Bipo-
lar cautery is also effective for stopping the oozing
from tissues. Complete hemostasis provides a dry surgi-
cal field and can find right direction to dissection.
Results: Case) A 43-year-old man who was diagnosed
IPMC after SAP (Japanese criteria for SAP diagnosis
classify this case as Grade 2 SAP). We performed
SSPPD 7 months after SAP using a modified method
with bipolar cautery. The operative time was 662 min-
utes, and the hemorrhagic volume was 790 mL. Trans-
fusion was not required. Postoperative course was
stable and no complication was observed.
Conclusions: This modified method using bipolar for-
ceps with dripped saline is a safe procedure and useful
for PD after SAP.
PPP25-081
PANCREATIC JUICE OUTPUT AND
AMYLASE LEVEL IN THE DRAINAGE
FLUID AFTER
PANCREATODUODENECTOMY IN
RELATION TO LEAKAGE
N. Hashimoto
Kinki University, Japan
Introduction: (Aim) The objective of this study was to
clarify the relationship between the consistency of the
pancreas and pancreatic anastomotic leakage.
Method: Sixty two patients who underwent proximal
pancreatectomy with pancreaticoenterostomy were
reviewed with regard to the consistency of the pancreas,
size of the main pancreatic duct,post-operative pancre-
atic juice output, and pancreatic leakage after partial
pancreatoduodenectomy. The pancreatic parenchyma
was classified as having soft, intermediate and hard
consistency (group 1, 2, and 3 respectively). Monitoring
the output of pancreatic juice and amylase level in the
drainage fluid after operation for the purpose of detect-
ing of dehiscence of pancreaticoenterostomy.
Results: The mean pancreatic juice output during a
period of 10 days (postoperative days 5 to 14) was
2446  27 cc in group 1 (n = 26), 846  13.5 cc in
group 2 (n = 19) and 460  8.1cc in group 3 (n = 17).
Anastomotic leakage occurred in 4 (15%) patients in
group 1, 3 (15%) in group 2 and none in group 3. In
patients with leakge abrupt decrease or fluctuating out-
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put of pancreatic juice occurred and amylase level in
the drainage fluid was more than 10000IU/L POD7.
Conclusions: Patients with a pancreatic parenchyma
with an intermediate or normal consistency produced
more pancreatic juice and had a higher leak rate.
Monitoring the output of pancreatic juice and amylase
level in the drainage fluid after operation may provide
a clue to the detection of dehiscence of pancreaticoent-
erostomy.
PPP25-082
MULTIORGANIC RESECTION FOR THE
SURGICAL TREATMENT OF A
LOCALLY ADVANCED ACINAR CELL
CARCINOMA OF THE PANCREAS,
CASE REPORT
A.E.P. Rossiano and A.G. Carrillo
Instituto Nacional de Cancerologıa de Mexico, Mexico
Introduction: Acinar Cell Carcinoma of the pancreas,
accounts only 1% of all pancreatic neoplasms, predom-
inates in male patients (3 : 1) and has a bimodal age
distribution (childhood and the second peak in older
adults, with a mean age of 56 years). Patients present
with nonspecific signs or symptoms (abdominal pain,
weight loss, abdominal mass, jaundice) and, in 10–15%
of the cases, the characteristic Schmid triad, subcutane-
ous fat necrosis, polyartralgia and eosinophilia, due
lipase hypersecretion.
Method: We presente the case of a 53-years-old male,
which initiated their illness 1 month earlier with
abdominal pain, weight loss of 13 kg, and fatigue. Dur-
ing physical exam, a mass of 12 cm was palpated in the
upper left cuadrant, fixed, causing pain on palpation,
no jaundice or hepatomegaly was noted.
With the endoscopic ultrasound was identified the pres-
ence of splenic vein thrombosis and gastric variceal
veins, the mass was not in contact with the mesenteric
vessels and neither with the celiac trunk.
Results: A distal pancreatectomy, splenectomy and
total gastrectomy was performed, the reported opera-
tive findings were: a 20 9 20 cm tumor originated in
the pancreatic tail, with firm adhesions to spleen and
gastric body, and after a 10 days of hospital stay, the
patient was discharged.
The pathology report was: acinar cells carcinoma with
invasion to pancreatic capsule and to peripancreatic tis-
sues, lymphatic and venous invasion, metastasis to 4/30
lymphatic nodes.
Adjuvant treatment was given 5FU + leucovorin and
radiotherapy, and after a follow up of 16 months the
patient is alive and disease free.
Conclusions: Acinar cell carcinoma of the pancreas,
have a better prognosis and behavior than the most
common ductal adenocarcinoma, the surgery remains
as the cornerstone of the treatment, as this case clearly
exemplifies, an adecuate resection of a locally advanced
neoplasm, and adjuvant therapy can assure a long term
survival.
PPP25-083
COMPARISON OF RESULTS BETWEEN
PYLORUS-PRESERVING
PANCREATICODUODENECTOMY AND
STANDART WHIPPLE PROCEDURE
A. Balik, E. Borazan, S. Coban and F. Yildiz
Gaziantep University Medical Faculty, Turkey
Introduction: The aim of this study was to investigate
the surgical procedures for periampullary tumors, clini-
cal features and postoperative morbidity - mortality in
operative interventions for patients with resectable
tumors.
Method: The patients operated in Gaziantep University
Hospital between January 2005 and April 2013 with
the diagnosis of periampullary tumor were retrospec-
tively analyzed.
Results: During the 8-year period 268 patients were
operated with the diagnosis of periampullary tumor.
Two hundred and four of the patients (76.1%) had
jaundice and 88 of patients (32.8%) had weight loss.
Upper gastrointestinal endoscopy and imaging radio-
logic imaging tests (CT, MRCP, US, etc.) were used
for diagnosis and staging. In 63 cases (25.3%) with
obstructive jaundice, stents were placed by ERCP pre-
operatively.
Pancreaticoduodenectomy were performed in 150
patients (55.97%) with resectable patients and palliative
surgical interventions and biopsy were performed for
patients with unresectable tumors. Pilor preserving pan-
creaticodudenectomy (PPPD) were performed on 47 of
the patients (31.3%) with resectable tumors and stan-
dart Whipple procedure were performed for the other
patients with resectable tumors. Pathologycal diagnoses
were adenocarcinoma for 140 patients, noroendocrine
tumor for two patients, GIST for 2 patients, dysplasia
for 2 patients, non-Hodgkin Lymphoma for one
patient.
In terms of postoperative complications, the incidence
of surgical site infection was 30 (20%), the incidence of
delayed gastric emptying was 21(14%), incidence of
pancreatic fistula was 5(3.3%), incidence of biliary fis-
tula was 3 (2%). There were four perioperative mortali-
ties.
Conclusions: Pancreaticodudenectomy may be a cura-
tive treatment for early stages of the periampullary
tumors but this procedure is risky and complex surgical
intervension. Currently, the number of the Pilor pre-
serving pancreaticodudenectomy is increasing as an
alternative to standart Whipple procedure SWPD.
This type of pancreaticodudenectomy procedures sug-
gests PPPD is a faster procedure with less blood loss,
higher survival and lower mortality rates compared
with SWPD in experienced centers.
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PPP25-084
CLINOPATHOLOGICAL CORRELATION
IN PANCREATODUODENECTOMY
WITH MIZUMOTO JAPANESE
RECONSTRUCTION IN MEXICO.
20 YEARS EXPERIENCE
V. Carrillo-Maciel1, R. Rangel-Rodarte1, S. Ramos-
Linaje1, J.E. Carrillo-Maciel1, A.L. Acosta-Saludado1,
P. Cano-Rios2, Omar M. Solorzano-Pineda1 and
J.H. Salazar-Gutierrez1
1Instituto de Ciencia, Mexico; 2UAAAN, Mexico
Introduction: Pancreatic cancer is the fifth most com-
mon in the West, with an incidence of 9 per 100,000
inhabitants. 20% of patients survive 1 year after diag-
nosis and survival at 5 years is only 3%. The procedure
is the cephalic pancreatoduodenectomy, described by
Whipple in 1935, with multiple modifications, nowa-
days. We perform the modifications made by Mizumot-
o in Mie University, Japan in 1979.
Objective: Clinicopathological correlation, results and
evolution accordding to the stage.
Method: A retrospective study of patients operated
from January 1991 to December 2011 with pancreatic
cancer, reconstruction with Mizumoto technique, evolu-
tion, complications and results as well as survival with
Kaplan–Meier.
Results: All patients underwent extended pancreatoduo-
denectomy with double Braun omega reconstruction.
Two patients developed biliary fistula, there were two
deaths, 1 for myocardial infarction and other acute respi-
ratory failure secondary to chronic obstructive pulmo-
nary disease, pancreatic fistula for none present. A patient
with ampulla of Vater carcinoma has now 13 years of sur-
vival without chemotherapy or radiotherapy.
Conclusions: The extended pancreatoduodenectomy
with double Braun omega is a safe surgery with regard
to pancreatic and biliary fistula successfully performed
by surgeons experienced in liver, pancreas and biliary
tract surgery.
PPP25-085
USE OF SUPERFICIAL FEMORAL VEIN
FOR VENOUS RECONSTRUCTION
DURING
PANCREATICODUODENECTOMY: A
CASE REPORT
D. Balci, C. Konca, A. Cetinkaya and
S. Hazinedaroglu
Ankara University, Turkey
Introduction: Patients with pancreatic tumors may have
portal vein (PV) and/or superior mesenteric vein
(SMV) invasion. Venous resections and reconstructions
of PV and/or SMV in course of pancreaticoduodenec-
tomy are becoming a common practice and many surgi-
cal options have been described. The ideal graft for
such reconstructions is to be defined and there is lim-
ited data regarding the usage of deep extremity veins
for portomesenteric reconstruction. In such cases, lower
extremity veins can provide an autogenous conduit for
PV/SMV reconstruction.
Method: 63-year-old man with pancreatic carcinoma
invading the PV and SMV was successfully treated by
en bloc PV and SMV resection combined with pancre-
atoduodenectomy. Splenic vein was tied and not recon-
structed. A 10 cm of superficial femoral vein was
harvested from the right lower extremity after preoper-
ative doppler mapping confirmed its patency and
healthy venous system in the ipsilateral extremity. Graft
was interposed between PV and SMV in the same ori-
entation with its native position.
Results: Operation time was 492 minutes with portal
clamp time was 42 minutes. Postoperative Doppler
Ultrasound follow up revealed patent hepatopetal por-
tal flow. Patient recovered uneventfully with no evi-
dence of venous insufficiancy in the donor lower
extremitiy and discharged on daily low molecular
weight heparin treatment.
Conclusions: The superficial femoral vein provides a
good alternative for PV/SMV replacement because it
has customizable length, a well-matched diameter, and
there is a low risk of clinical venous insufficiency after
unilateral resection.
PPP25-086
HISTOLOGICAL SURPRISES IN
PANCREATICODUODENECTOMY - A
CASE SERIES
S. Gopalan1, N. Ravuri2, S. Anand2, S. Narayanan2,
A. Ashok2 and S. Sankar2
1Madras Medical College, India; 2Sri Ramachandra
Medical College, Sriramachandra University, India
Introduction: Pancreaticoduodenectomy, an operation
with significant morbidity is done for malignant lesions
of the pancreatic head and periampullary region. How-
ever in clinical practice one encounters benign condi-
tions and borderline malignant lesions which pose
diagnostic and therapeutic dilemma. Herein we report
our experience of pancreaticoduodenectomy done for
atypical lesions (non adenocarcinomatous lesions).
Method: Case Report. Case 1: 50 years female with
history of recurrent jaundice, fever, rigors. USG, CECT
abdomen - dilated IHBR, 2 9 2 cm papillary growth
in ampulla. Endoscopic biopsy tubulovillous adenoma.
Case 2: 50 years female known chronic calcific pancre-
atiis,admitted with pain abdomen.CECT abdomen-
atrophic pancreas, dilated pancreatic duct and ductal
calculi.CA19.9 elevated. EUS chronic calcific pancreati-
tis, intraductal mucinous lesion.
Case 3: 45 years female chronic pain abdomen. CECT
well defined cystic lesion in head of pancreas.
Case 4: 62 years male jaundice.CECT homogenously
enhancing soft tissue lesion in ampullary region. ERCP
and biopsy inconclusive.
Case 5: 50 years female with pain abdomen and jaun-
dice.CECT, MRCP - ill defined mass lesion in distal
CBD with dilatation. EUC dilated CBD.1.1 9 0.9 cm
hypoechoic mass distal CBD infiltrating ampulla.
Biopsy inconclusive.
All the above patients underwent Whipple’s procedure.
Results: In our series the ampullary tubulovillous ade-
noma had carcinomatous element and reported as ade-
nocarcinoma in the specimen. A long standing chronic
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calcific pancreatitis was diagnosed with intra ductal
papillary mucinous neoplasm on frozen section (lesion
in head). Pancreatic head mass was an endocrine
tumor, ampullary tumor was a solid pseudopapillary
tumor. The suspected distal CBD tumor was a hetero-
trophic pancreatic tissue. All the above mentioned
patients underwent classical whipple operation after
maximum workup. Their post operative period and
1 year follow up uneventful.
Conclusions: The decision to perform pancreaticoduo-
denectomy for non- malignant or borderline malignant
lesions must be preceeded by appropriate imaging
modalities with justified indication only in experienced
centers.
PPP25-087
CLINICAL ANALYSIS AND SHORT
TERM POSTOPERATIVE OUTCOME OF
PANCREATICODUODENECTOMY - A
UNIVERSITY HOSPITAL EXPERIENCE
S. Gopalan1, N. Ravuri2, B. Elangovan2,
K. Sreenivasan2 and S. Sankar2
1Madras Medical College, India; 2Sri Ramachandra
Medical College, Sri Ramachandra University, India
Introduction: Among the various indications for pan-
creatic resection, cancer has been the most intensely
researched and the most meticulously documented. Sur-
gery for pancreatic cancer is considered as one of the
most complicated and technically challenging surgical
procedures through ages and pancreaticoduodenectomy
is the most well studied pancreatic surgical procedure.
We in our institute studied the clinical outcome of
patients who underwent pancreaticoduodenectomy dur-
ing the period August 2010 to January 2013.
Method: The aim of the study was to perform a pro-
spective clinical analysis and study the short term post-
operative outcome of patients who underwent
pancreaticoduodenectomy in the department of Surgi-
cal Gastroenterology, Sri Ramachandra Medical Col-
lege (August 2010–January 2013) with a designed
proforma. Inclusion criteria: All operable candidates.
Exclusion criteria: Patients with metastatic diseases and
in whom palliative procedure was done.
Results: A total of 54 patients were included in the
study. 38 males (70.4%) and 16 females (29.6%) respec-
tively. Mean age group 52.14, range 30–81 years. The
most common presenting complaint was jaundice
(83.3%). The most common diagnosis was periampul-
lary carcinoma (63%) followed by carcinoma pancreas
(29.6%). Carcinoma neck, carcinoma duodenum, intra
ductal papillary mucinous neoplasm (IPMN) and carci-
noma of hepatic flexure invading duodenum were 1.9%
respectively. Three cases were benign. 52 (96.3%)
patients underwent classical pancreaticoduodenectomy,
one patient (1.85%) underwent enbloc radical right
hemicolectomy with pancreaticoduodenectomy (PD)
and one patient (1.85%) underwent PD with neck
resection. All patients underwent end to side pancreati-
co jejunostomy.The overall mortality rate was 3(5.6%)
(cause reactionary hemorrhage in two, postop renal in
one) and morbidity 26(48.1%) in our series. The most
common complication was pancreaticojejunostomy leak
(13%) but all managed effectively.
Conclusions: A proper pre operative workup, through
knowledge of anatomy and dedicated postoperative
care is required in making pancreaticoduodenectomy a
successful surgery.
PPP25-088
FAST-TRACK SURGERY PROGRAM
AFTER TOTAL LAPAROSCOPIC
PANCREATICODUODENECTOMY.
INITIAL EXPERIENCE
I. Khatkov2, R. Izrailov2, A. Hisamov3 and
P. Tyutyunnik1
1Msumd, Russia; 2Moscow Scientific Research Institute
of Gastroenterology, Msumd, Russia; 3Moscow Scientific
Research Institute of Gastroenterology, Russia
Introduction: Fast-Track surgery associates with swift
recovery after surgical procedure. Fast-Track and enc-
hanced recovery after surgery (ERAS) programs are
the gold standard for colon and rectal cancer patients.
There is still not enough evidence based data to prove
or contradict fast-track protocol after pancreaticoduo-
denectomy. Fast-Track after laparoscopic pancreatico-
duodenectomy even less surveyed.
Method: Three patients with cancer of the pancreatic
head and periampularea zone who underwent total lap-
aroscopic pancreaticoduodenectomties were treated
using fast-track protocol. Main items of fast-track pro-
tocol were: remove nasogastric tube the next day after
surgery, first oral water take the next day after surgery,
first oral food take 3 days after surgery, early mobiliza-
tion the first day after surgery, only 2 drain tubes were
used. Left drain is pancreaticojejunostomy zone, right
drain is hepaticojejunostomy zone.
Results: Nasogastric tube was removed on the next day
after surgery (n = 3); first oral water take on the next
day after surgery (n = 3); First food take (soft meal) on
the third day after surgery (n = 3). First patient: left
drain was removed on the fifth day; right drain–on the
sixth day. Second patient: right drain–on the third day;
left drain–on the sixth day. Third patient: left drain–on
the third day; right drain–on the forth day. All 3
patients were discharged on the 7 day after surgery.
Conclusions: Fast-Track protocol safe and effective for
pancreatic cancer patient after laparoscopic pancreati-
coduodenectomy. Well managed and randomized stud-
ies are needed. Short-term and long-term results and
cost- efficiency should be evaluated to prove fast-track
program.
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PPP25-089
PANCREAS-PRESERVING DUODENAL
RESECTION TOGETHER WITH EARLY
DIAGNOSIS IS THE OPTIMAL
APPROACH FOR PARADUODENAL
PANCREATITIS TREATMENT.
EXPERIENCE OF 62 CASES OF CYSTIC
DUODENAL DYSTROPHY TREATMENT
V. Egorov1, R. Petrov2 and A. Vankovich3
1Sechenov First State Medical University, Ostroumov
14th City Hospita, Moscowl, Russia; 2Ostroumov 14th
City Hospital, Russia; 3Vishnevsky Institute of Surgery,
Moscow, Russia
Introduction: Background: The term “paraduodenal
pancreatitis (PP)” was proposed as an umbrella for cys-
tic dystrophy in heterotopic pancreas (duodenal dystro-
phy), paraduodenal cyst and groove pancreatitis, by
reasoning that these conditions mimic pancreatic head
tumors and share certain histological evidences. It is
still unclear what organ “paraduodenal pancreatitis”
originates of.
Objective: To assess the results of different types of
treatment for “paradudenal pancreatitis”.
Method: 1. Prospective analysis of 63 cases of PP
(2004-2012), comparing preoperative and histopatho-
logical findings in 40 surgical specimens; 2. Assessment
of clinical presentation and the results of DD treat-
ment.
Results: Preoperative diagnosis was correct in all the
cases except one, when cystic tumor of the pancreatic
head was suspected (1.9%). Patients were presented
with abdominal pain (100%), weight loss (76%), vomit-
ing (30%) and jaundice (18%). CT, MRI and endoUS
were the most useful diagnostic modalities. Ten patients
were treated conservatively, 26 underwent pancreatico-
duodenectomies (PD), pancreatico- and cystoenterosto-
mies (8), Nakao procedures (4), duodenum-preserving
pancreatic head (DPPH) resections (5), and 9 pancreas-
preserving duodenal resections (PPDR). No mortality.
Full pain control was achieved after PPRDs in 83%,
PDs in 85%, and after PPPH resections and draining
procedures in 18% of cases. Diabetes mellitus devel-
oped thrice after PD.
Conclusions: 1. The diagnosis of paraduodenal pancre-
atitis can be confidently determined by modern meth-
ods prior to surgery; 2. Early diagnosis makes
pancreas-preserving duodenal resection the treatment
of choice for PP; 3. PD is the main surgical option for
PP treatment at present; 4. The effectiveness of PPDR
provides compelling proof that “paraduodenal pancrea-
titis” is an entity of duodenal origin distinct from
tumors and orthotopic pancreatitis.
PPP25-090
LAPAROSCOPIC DISTAL
PANCREATECTOMY WITH SPLENIC
PRESERVATION FOR THE SURGICAL
TREATMENT OF PANCREATIC
NEUROENDOCRINE TUMOURS: AN
EFFICIENT AND SAFE PROCEDURE IN
DIFFICULT TIMES
M.J. Fuertes, M.D. Poveda, J.G. Gonzalez, C. Nevado,
G.D. Garcıa, P.A. Pe, A.M. Pozuelo, E.R. Cuellar,
D.A. Jimenez and A. Moreno
Rey Juan Carlos Hospital, Spain
Introduction: Pancreatic neuroendocrine tumours
(PNETs) represent a diverse group of neoplasms for
which surgery is the only curative modality. These
interventions have been traditionally carried out by
open approach. We present three consecutive cases of
non-functioning neuroendocrine tumours of the pancre-
atic body/tail treated by laparoscopic distal pancreatec-
tomy with lymphadenectomy and splenic preservation.
Method: Three laparoscopic left pancreatectomies with
splenic preservation for the removal of PNETs were
performed consecutively over a period of 1 year. Four
trocars were used. Parenchymal sectioning was per-
formed with a stapler. In all cases, a non-suction drain
was left in place. The ISGPF recommendations were
followed during the diagnosis and classification of post-
operative fistula. The 30-day postoperative morbidity
and mortality was assessed.
Results: Three patients were operated. All tumours
were non-functioning. Mean operative time was
183 minutes. Mean operative blood loss was 150 cc.
The average post-operative stay was 6.7 days. The 30-
day morbidity and mortality were both 0%.
Conclusions: The technical difficulty of performing a
laparoscopic left pancreatectomy (LLP) does not make
it the technique of choice in most medical centres even
though it is safe and oncologically adequate. Adequate
quality criteria set the morbidity rate at 39.8% and the
mortality rate at 3%. In our series of interventions,
both rates were 0% at 30 days post-operative. The
duration of the average post-operative stay is lower
than that cited in the literature and lower than with
conventional surgery, which implies savings achieved in
terms of average stay, taking into account that this
approach also promotes early resumption of a patient’s
normal activities.
Our results support LLP with splenic preservation as a
safe and efficient approach for the treatment of PNETs
if carried out by groups with expertise in laparoscopic
pancreatic surgery - although these conclusions are
derived from a limited number of cases, given the rarity
of these tumours.
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PPP26-001
PANCREATIC NECROSIS
CONFIGURATION DETERMINES
LOCAL COMPLICATIONS
DEVELOPMENT AND THE CHOICE OF
TREATMENT APPROACH IN ACUTE
PANCREATITIS
T. Dyuzheva
I.M.Sechenov First Moscow State Medical University,
Russia
Introduction: To study retroperitoneal lesions according
to pancreatic necrosis characteristics and to develop
treatment approaches.
Method: 127 acute pancreatitis patients underwent con-
trast-enhanced CT. Pancreatic necrosis configuration
evaluated according to location, volume, depth and via-
ble pancreatic parenchyma distally to necrosis (VP).
Retroperitoneal lesions assessed according to Baltha-
zar’s criteria and concept of interfascial planes (Ishika-
wa K et al.) Patients were divided into 3 groups: first
group (61 patients) with preserved VP, second group
(22 patients) with pancreatic tail necrosis, third group
(44 patients) with interstitial pancreatitis.
Results: Widespread parapancreatitis (WP) developed
in 31 (51%) patients of first group. Correlations
between WP and VP volume (r = 0.7, p < 0.001), WP
and necrosis depth (r = 0.45, p < 0.05) were found.
Infection appeared in 17 (28%) patients. Percutaneous
puncture (PP) of fluid collections (FC) performed in 12
(19.6%), surgery in–32 (52%) patients. 14 (22.9%) -
died. In survivors PP (first step) performed in sterile
stage on 6.7  1 days, who consequently died - on
11  2 days of disease onset. WP with infection devel-
oped in 4 (18%) patients of the second group. PP per-
formed in 6 (27%), surgery -in 5 (23%), died–1 (4.5%).
In the third group WP (dominated infiltrates) noticed
in 13 (29%) patients, infection - in 3 (7%). Conserva-
tive management was effective in 34 (78%) patients,
PP–in 5 (11%), surgery-in 5 (11%). 1 patient died.
Conclusions: Configuration of the pancreatic necrosis is
an important criterion which determines the choice of
treatment in acute pancreatitis. Deep (exceeding 50%)
pancreatic necrosis with VP leads to the internal pan-
creatic fistula, WP, and is an indication for early PP of
the sterile FC and surgery in the second step of man-
agement.
PPP26-002
A SAFE SURGICAL TECHNIQUE FOR
UNCINATE PROCESS RESECTION
DURING
PANCREATICODUODENECTOMY
USING A SELECTIVE ARTERY OR VEIN
FIRST APPROACH AND COMBINED
BLOOD FLOW BLOCKAGE OF THE
MESOUNCINATE: A SINGLE-C
R. Qin, M. Wang and F. Zhu
Affiliated Tongji Hospital, Tongji Medical College,
Huazhong University of Science and Technology, China
Introduction: Integrated resection of the pancreatic
uncinate process is the most difficult step in radical
pancreaticoduodenectomy (RPD) to achieve curative
resection (R0). Here we developed a selective artery or
vein first approach with combined blood flow blockage
of the pancreatic mesouncinate.
Method: From March 2005 to May 2012, a total of
582 patients underwent selective artery or vein first
RPD according to whether the portal vein (PV) and
superior mesenteric vein (SMV) were invaded by the
tumor. Clinical data of patients were reviewed.
Results: Among the 582 patients, 454 and 128 under-
went pancreaticoduodenectomy with the SMV first
approach and superior mesenteric artery (SMA) first
approach, respectively. 102 (17.5%) cases were classi-
fied R1 resections and 480 (82.5%) as R0 resections.
The median operative time was 4.2 hour (3.7–7 hour).
The median intraoperative blood loss was 450 mL. The
complication included postoperative bleeding, postoper-
ative pancreatic fistula, biliary fistula, delayed gastric
emptying, and abdominal abscess with total rate of
15.7%.Seven (1.2%) patients died.
Conclusions: The selective artery or vein first approach
with combined blood flow blockage is safe and useful
for integrated radical resection of the uncinate process
for patients with periampullary malignant tumors.
PPP26-003
A MODIFIED ROUX-EN-Y
RECONSTRUCTION AFTER
PANCREATICODUODENECTOMY
R. Qin, M. Wang and F. Zhu
Affiliated Tongji Hospital, Tongji Medical College,
Huazhong University of Science and Technology, China
Introduction: Postoperative pancreatic fistula remains
the most common and potiential lethal complications
of pancreaticoduodenectomy (PD). It contributes sig-
nificantly to prolonged hospitalization and mortality.
This study presents a new technical modification by
Roux-en-Y reconstruction aiming to decrease the inci-
dence of morbidity, which isolate the biliary anastomo-
sis from the pancreatic and gastric or jejunal
anastomoses, and evaluates its safety and feasibility.
Method: A retrospective review of patients who under-
went PD for periampullary malignancies by using this
modified technique from January 2011 to June 2012
was conducted. The indications, surgical procedures,
intra-operative data and outcomes of these patients
were collected and statistically analyzed.
Results: This technique was applied in 171 patients,
including 92 cases underwent pancreaticogastrostomy
and 79 cases underwent pancreaticojejunostomy. The
median duration of surgery was 4.0h (range 3.1–6.9).
The median blood loss was 530 mL (range 200–2000),
69 patients needed transfusion and the median blood
transfusion was 430 mL (range 200–1400). The median
hospital stay was 14 days (range 11–38). Operative
mortality was zero and overall mortality occurred in 31
patients (18.1%), included upper gastrointestinal bleed-
ing (n = 4), biliary fistula (n = 3), pulmonary infection
(n = 2), delayed gastric emptying (n = 6), abdominal
abscess (n = 4). Only 4 patients (2.3%) had pancreatic
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fistula (2 in grade A and 2 in grade B) and no patient
had grade C. None of the patients developed bile reflux
gastritis.
Conclusions: The modified Roux-en-Y reconstruction
with isolating the biliary anastomosis from the pancre-
atic and gastric or jejunal anastomoses is a safe, reli-
able and favorable technique. It merits further
investigation in future randomized controlled trials.
PPP26-004
EXTENDED WHIPPLE’S WITH
VASCULAR RESECTIONS: A FIRST
SINGLE CENTER REPORT FROM
PAKISTAN
F. Dar, A.W. Dogar, H.H. Zia, A. Liaqat,
M. Pervaiz, T. Ahmed, N.A. Khan, T. Begum,
M. Salih and N.H. Shah
Shifa International Hospital, Islamabad, Pakistan
Introduction: Whipple’s procedure is the standard treat-
ment for resectable pancreatic head tumor. However
the role of extended lymphadenectomy and vascular
resections remains controversial.
Method: All patients undergoing Whipple’s operation
with extended lymphadenectomy for localized pancre-
atic cancer from January 2011 to June 2013 were
included. A prospectively maintained data was retro-
spectively analyzed. Patient’s demographic, operative
details, postoperative complications and survival were
analyzed on SPSS version 18.
Results: A total of 48 patients’ underwent Whipple’s
operation with extended lymphadenectomy. Mean
patient age was 56.03  13.26 years. Vascular involve-
ment was noted in 11 (23%) patients. Among these
portal vein (PV) was involved in 9 (18.7%), common
hepatic artery (CHA) in 1 (2.08%) and replaced right
hepatic artery (RHA) in 2 patients (4.16%). Vascular
reconstructions were performed in all of these patients.
Portal vein resection and primary anastomosis was per-
formed in 4 (8.3%), PV reconstruction with PTFE graft
in 3 (6.25%) and lateral venoplasty in 1 (2.08%). Two
(4.16%) patients with involvement of replaced RHA
required resection and reconstruction with gastroduo-
denal artery. One patient (2.08%) with involvement of
CHA was resected and reconstructed with aortic con-
duit. Mean number of harvested lymph nodes were
26.78  13.33. Mean duration of surgery was
7.94  1.27 (range: 4–11) hours. Mean hospital stay
was 9.73  2.75 (range: 6–21) days .Postoperative com-
plications were observed in 9 (18%) patients. Of these
4 (8.3%) required intervention and 5 (10.04%) were
managed conservatively. In hospital mortality was 1
(2.08%). Five (10.04%) patients died with systemic
recurrence at mean of 9.2 (range: 5–15) months. Med-
ian survival among those who underwent vascular
resection was 15 months (range: 2–18). Thirty seven
patients (77%) are alive at median follow up of
14 months (range: 1–28) months.
Conclusions: Whipple’s with extended lymphadenecto-
my and vascular resections can be performed safely
without additional morbidity. In selected patients vas-
cular resections can provide reasonable survival.
PPP26-005
PANCREATIC METASTASIS FROM
COLON CARCINOMA: CASE REPORT
S. Vaccari, M. Mirarchi, E.De Raffele, S. Palumbo and
B. Cola
U.O. Chirurgia Generale e d’Urgenza - Prof.Cola, Italy
Introduction: The pancreas is an uncommon location
for metastases from other primary cancers; lesions from
colorectal cancer account for 1.7% of all metastases.
The role of surgery in these patients is not yet clear,
even though pancreatic resection is considered for iso-
lated pancreatic metastases. The interval between colo-
rectal surgery and pancreatic metastasis is usually
short, and an interval of more than 5 years is excep-
tional.
Method: We present a patient previously operated for
a colonic adenocarcinoma and metachronous liver
metastases who developed a tumour of the pancreas
during the follow-up, 7 years after colon resection. To
our knowledge, this is the first reported case of pancre-
atic resection after colon and liver resections.
Results: Case Report. On March 2005, an adenocarci-
noma of the left colon was diagnosed in a 67-year-old
male: he received left hemicolectomy (pT3N1,G2) fol-
lowed by adjuvant chemotherapy. In June 2006 meta-
chronous colorectal liver metastases were diagnosed
and the patient underwent right hepatectomy. In Octo-
ber 2008 liver metastases recurred and he received sub-
segmentectomy S3 followed by FOLFOX based
chemotherapy. He was regularly monitored with CT
scans of the chest and abdomen, tumour markers and
colonoscopy. In January 2012 a CT scan showed a
lesion of 26 9 18 mm in diameter of the tail of the
pancreas, confirmed by subsequent 18-fluorodeoxy-
glucose positron emission tomography. Colonoscopy
was negative for recurrence of the primary disease. A
ultrasonography-guided distal spleno-pancreatectomy
was performed. The patient was discharged on 16th
postoperative day after a low-flow pancreatic fistula
treated conservatively. Histological examination of the
surgical specimen demonstrated a metastatic adenocar-
cinoma of colorectal origin.
Conclusions: Colorectal metastases to the pancreas are
rare, but should be suspected in patients followed for
colorectal malignancies. Pancreatic resection can be
suggested in selected patients, but it should be deserved
to experienced centers, especially in case of iterative
abdominal surgery before pancreatic resection.
PPP26-006
THE ROLE OF INTERVENTIONAL
TECHNIQUES IN SURGICAL
PANCREATOLOGY
E. Abidov, N. Britskaya, Y. Avdosyev and
V. Boyko
V.T. Zaitcev SI “Institute of General and Urgent
Surgery AMS of Ukraine”, Kharkov, Ukraine
Introduction: Objective: Our research is directed on
determination of interventions role in a complex with
pancreatic surgery, also role of interventions in the
cases of unresectable pancreatic cancer.
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Summary Background Data: The amount of pancreatic
diseases grows inexorably, quite often accompanied
such threatenings complications as obstructive jaundice
or hemorrhage - as from pancreatobiliary vessels aneu-
rysm or from the vessels of disintegrating tumor.
Majority from such patients are unresectable because
of their critical condition. Huge amount of patients
with unresectable pancreatic cancer needs palliative
operations to treat complications of main disease.
Method: 130 patients cases with the diseases of pan-
creas in a period from 2009 to 2013. They were selected
due to next options: pancreatic surgery was impossible
because of such complications as a obstructive jaun-
dice, hemorrhage. Also were selected patients with pan-
creatic surgery complications such as obstructive
jaundice because of anastomosis stricture and patients
with unresectable pancreatic cancer.
Results: All interventions were directed in the first
place to stabilize the condition of the patients, and
afterwards to perform a pancreatic surgery or palliative
treatment. The next interventions were performed: bili-
ary duct draining (20), draining of biliodigestive anas-
tomoses stricture with stent implanting (4),
embolizations of pancreatobiliary vessels (29), and
chemoembolization of pancreatic tumor (17). Palliative
interventions consisted in draining of biliary duct with
stent implanting (12), several courses of embolization
(46).
Conclusions: Due to interventions became possible to
perform pancreas surgery at 66 patients, avoid second
surgery involvement on 4 patients, successfully perform
palliative treatment and stabilize condition of 60
patients pancre.
PPP26-007
OUTCOME OF SURGERY FOR
CHRONIC PANCREATITIS
Rajesh Gupta, Sunil Shenvi, H.S. Shruti, Deepak
Bhasin, Surinder Rana
Postgraduate Institute of Medical Education and
Research, India
Introduction: Debilitating abdominal pain remains the
most common presentation of chronic pancreatitis and
the treatment remains challenging. This study analyzed
the outcome of surgery in patients with chronic pancre-
atitis.
Method: Retrospective reviewed details of patients un-
dergoingsurgery for chronic pancreatitis between Janu-
ary 2002 and June 2012 at Division of Surgical
Gastroeneterology, PGIMER, Chandigarh. Total of 60
patients were admitted for surgery, however, surgery
was not performed in 5 due to medical reasons.Indica-
tions for surgery was pain in 51patients, gastric outlet
obstruction in 2 and bleeding in 2 patients.
Results: 38/60 were males and mean age was 37
(SD  12.94).47 patients were on oral and 10 patients
were on intravenous analgesics while 3 did not require
regular analgesics.10 patients had diabetes mellitus and
11 had steatorrhea preoperatively.39 patients under-
went Frey’s procedure while Whipple’s procedure was
done in 6 and Izbicki’s procedure was done in two.
LPJ was done in two while bipolar ligation and distal
pancreatectomy with splenectomy (for splenic artery
pseudo aneurysm) was done in another two. Roux-en-y
cystojejunostomyperformed in 2. Three patients under-
went reoperationsfor poor pain control; 2 patient with
LPJ done previously underwent Frey’s procedure after
2 years while one patientwho had undergone Frey’s
procedure underwent Whipple’s procedure after
4 years.
After a mean follow up of 23.9 months  SE
23.6 months (median: 13 months; range 1–84 months);
54% of patients reported excellent pain relief, 20%
patients reported good pain relief and 11.4% patients
had fair pain relief (on regular oral pain killers). Two
patients developed new onset diabetes controlled by
diet and medications, while in 4 patients diabetes wors-
ened. 5 patients had new onset stetorrhea which was
transient in all.
Conclusions: Tailored surgery for chronic pancreatitis
has excellent benefit in pain relief without significant
increase in functional abnormalities.
PPP26-008
ROBOT-ASSISTED LAPAROSCOPIC
PANCREATODUODENECTOMY
A. Horiguchi, I. Uyama, M. Ito, S. Ishihara, Y. Asano,
R. Ito, M. Shimura, T. Ochi, K. Shimizu and
C. Hayashi
Fujita-Health University School of Medicine, Japan
Introduction: We performed pancreatoduodenectomy
(PD) using the da Vinci surgical system (da Vinci PD)
and compared it with conventional laparoscopic PD
(LAP-PD) and laparotomic PD in order to determine
whether da Vinci PD was a minimally invasive proce-
dure.
Method: We recorded the durations of operations,
durations of pancreatojejunostomies, bleeding volumes,
durations of hospitalizations, and postoperative compli-
cations in 10 patients who underwent da Vinci PD, 5
patients who underwent conventional LAP-PD, and 10
patients who underwent usual laparotomic PD at
around the same time. Pancreatojejunostomy was per-
formed by pancreatic duct-to-jejunal mucosa anastomo-
sis; choledochojejunostomy, by a continuous suture or
knotted suture; and gastrojejunostomy, by an auto-
matic anastomosis device.
Results: Duration of operation: da Vinci PD,
773  129 minutes; LAP-PD, 606  53 minutes; and
laparotomic PD, 470  91 minutes (p < 0.05). Dura-
tion of pancreatojejunostomy: da Vinci PD,
85  46 minutes; LAP-PD, 82  35 minutes; and la-
parotomic PD, 26  6 minutes (p < 0.05). Bleeding
volume: da Vinci PD, 144  77 mL; LAP-PD,
268  88 mL; and laparotomic PD, 570  82 mL
(p < 0.05). Duration of hospitalization: da Vinci PD,
26  13 days (p < 0.05); LAP-PD, 42  37 days; and
laparotomic PD, 41  14 days. Postoperative compli-
cations: grade-A pancreatic juice leakage occurred in 1
patient of the da Vinci PD group; grade-A, grade-B,
and grade-C pancreatic juice leakage occurred in 1
patient each of the LAP-PD group; and grade-A and
grade-B pancreatic juice leakage occurred in 2 and 1
patients of the laparotomic PD patients, respectively.
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Conclusions: Robot-assisted surgery using the da Vinci
surgical system is very useful for performing fine and
safe lymph node dissection, pancreatojejunostomy, and
choledochojejunostomy, and is a minimally invasive
procedure compared with laparotomic PD.
PPP26-009
PANCREATIC TRAUMA: KING’S
COLLEGE HOSPITAL EXPERIENCE
F. Giovinazzo, S. Buscemi, A. Piccinini, E. Prassas,
E. Kontis, P. Srinivasan, N. Heaton and
A. Prachalias
King’s College Hospital, UK
Introduction: Pancreatic trauma (PT) is uncommon and
data regarding outcomes are scarce. Poor outcomes
have been associated with grade of the injury, associ-
ated injuries, delayed transfer to specialist centre and
surgical management. We retrospectively reviewed the
King’s College Hospital experience with pancreatic
trauma over 7 years hypothesizing that pancreatic
resection in a tertiary referral centre does not adversely
affect morbidity and mortality after pancreatic injury.
Method: Ten patients with an average age of 26.5 years
(SD  6.2) were admitted to King’s College Hospital
from 2006 to 2013 and retrospectively analysed. Each
PT was graded from I (lowest) to V (highest) according
to the American Association for the Surgery of Trauma
grading system (J Trauma, 1994) Main outcomes mea-
sured were delayed transfer >24 hours, success of non-
operative management, PT-related complications,
length of hospital stay and mortality.
Results: Eight patients (80%) had a blunt and 2 (20%)
a penetrating pancreatic injury. The majority of PTs
were grades III-IV 7 (70%). Other organ injuries were
present in 5 (50%) cases. Average time to transfer was
2.7 days (SD  4.2). 5 exploratory laparotomies were
performed and in 3 (60%) patients with grade III-IV
trauma a pancreatic resection was performed
(p = 0.02). In this subgroup PT was associated to other
organ injuries (p = 0.03) and complete transection of
the pancreas (p = 0.08). No trauma related mortality
was observed. Adverse outcomes did not differ in the
laparotomy group as compared to the non-operative
group. Hospital stay was of 21.5 (SD  22.9) and 22.8
(SD  9.9) days (p = 0.29), respectively.
Conclusions: In the present study, surgical exploration
was performed in 5 patients with grade III-IV PT and
preoperatively imaging signs of complete pancreatic
transection. No differences were observed with those
treated conservatively. The present experience shows
that patients early treated in a tertiary referral centre
may benefit of laparotomy and pancreatic resection
after PT.
PPP26-010
BINDING PANCREATO JEJUNOSTOMY
(BPJ) REDUCE PANCREATIC FISTULA
RATES AFTER PANCREATO
DUODENECTOMY,A COMPARATIVE
STUDY WITH CONVENTIONAL
MUCOSA TO MUCOSA PJ
G.R. Verma, A. Behera, L. Kaman and D. Dahiya
Pgimer, Chandigarh, India
Introduction: Pancreatic fistula is an important factor
responsible for the considerable morbidity associated
with pancreatico duodenectomy Many techniques have
been proposed for the reconstruction of pancreatic
digestive continuity to prevent fistula formation. Peng’s
technique of pancreato jejunal anastomosis has been
claimed to achieve zero rate of pancreatic fistula.
Method: A prospective, non-randomized study was
conducted to evaluate this new anastomosis technique
and compared with the conventional duct to mucosa
pancreato jejunal anastomosis. A total of forty three
patients of peri ampullary/pancreatic carcinoma, neuro
endocrine tumors and cholangio carcinoma were
included in the study. Binding pancreato jejunostomy
(PJ) technique as described by Peng’s et al. was per-
formed on 22 patients (Group A) and conventional
mucosa to mucosa PJ was contemplated in another 21
patients (Group B).
Results: There was no significant difference in patient
demographics, pancreatic consistency and pancreatic
duct diameter between 2 groups. Pylorus preserving
Pancreato duodenectomy and standard pancreato duo-
denectomy was done in 8 and 14 patients respectively
of group A patients. Two patients developed pancreatic
fistula (9.0%). One due to avoidable technical reason
(high conc. of carbolic acid) and the other patient had
chronic liver disease he developed post operative hepa-
tic encephalopathy, massive ascites leading to PJ leak.
He succumbed after two weeks of surgery. The morbid-
ity was 44.4% and mortality was 4.54% (1/ 22).
In group B patients, Pylorus preserving Pancreato duo-
denectomy and standard pancreato duodenectomy was
done in 7 and 14 patients respectively of. Five patients
developed pancreatic fistula (23.8%) (Grade B = 2,
C = 3). The morbidity was 38.6%. Mortality was 0%.
Conclusions: Binding PJ is associated with lower fre-
quency of pancreatic fistula as compared to conven-
tional PJ. There was no significant difference in
morbidity and mortality in 2 groups.
PPP26-011
THE INCIDENCE OF TRUE DUODENAL
CARCINOMAS
T. Buchbjerg, C. Fristrup and M.B. Mortensen
HPB Section, Odense University Hospital, Denmark
Introduction: Primary duodenal carcinoma (PDC) is a
rare GI tumor, but recent epidemiological data suggest
a rising trend in duodenal adenocarcinomas. The diffi-
cult distinction between PDC and other types of carci-
noma (e.g. within the periampullary region) is reflected
in the scarce literature on the incidence of true PDC.
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This study tried to establish the incidence of true PDC
based on data from a well defined geographical area.
Method: Based on data from a national pathology
database all patients with true PDC from 1997 to 2012
within the Region of Southern Denmark were re-evalu-
ated. Only patients where the surgeon and the patholo-
gist agreed on the tumor being classified as originating
from the duodenum were included. The WHO and the
Danish (2010) incidence rates for true PDC were calcu-
lated and compared with the literature.
Results: Seventy-one patients (43 M, 28 F) with a
mean age of 67 years (range 35–87) met the criteria for
true PDC in the Region of Southern Denmark. Using
the Danish population in 2010 as standard an incidence
rate of 5.89 per 1,000,000 person-years was calculated.
The corresponding WHO incidence rate was 3.5 per
1,000,000 person-years. These figures were comparable
to other Scandinavian data, whereas larger variations
were seen in data from other European and US institu-
tions.
Conclusions: Based on data from a well defined geo-
graphical area with a complete monitoring of all regis-
tered true PDCs we found an incidence rate of
approximately 6 per 1,000,000 person-years. This was
consistent with other Scandinavian data, but variations
seen in the international literature in general may be
explained by different study populations.
PPP26-012
COMPLETE AND NEAR COMPLETE
PATHOLOGIC RESPONSE FOLLOWING
CHEMOTHERAPY AND RADIATION IN
6 PATIENTS WITH ADVANCED
PANCREATIC ADENOCARCINOMA
D. Sanford, D. Kleiner, D. Linehan, W. Hawkins,
R. Fields and S. Strasberg
Washington University, USA
Introduction: Despite the fact that many patients with
advanced pancreatic adenocarcinoma receive chemo-
therapy and radiation in attempt to downsize tumors
to resectability, pathologic complete responses in
resected specimens are rare. We report 6 patients with
some similar characteristics who had pathologic com-
plete or near complete responses after preoperative
chemoradiation.
Method: Medical records were reviewed from 6
resected patients with biopsy-proven, locally advanced
or metastatic pancreatic adenocarcinoma who exhibited
complete pathologic responses following chemoradia-
tion.
Results: Patients (4 females, 2 males) were relatively
young and non-obese with a mean age of 53.5 (41–65)
and BMI of 25.0 (18.2–28.7). All patients had “border-
line” or non-resectable disease based on imaging. All
underwent radiation and chemotherapy. While there
was not a consistent chemotherapy regimen, 5/6
received an oxaliplatin containing regimen. One patient
had complete radiographic resolution, two had resolu-
tion of metastatic deposits, and the remainder had
either partial or no measurable responses by RECIST
criteria. Of the 4 patients with initially elevated CA19-
9, levels fell from a mean of 3585 IU before chemoradi-
ation to 34 IU prior to surgery. Operations tended to
be difficult (4 patients required SMV reconstructions,
mean EBL was 1135cc, mean operative time was
7.5 hours). Pathologic evaluation revealed a complete
response in 3 patients, while the remaining 3 patients
had <1 mm sized deposits. 17–28 lymph nodes (median
21) were recovered in the specimens, all of which were
negative. Post-operative follow-up interval varies from
6 to 29 months (median 17.5 months). 4 patients are
alive without recurrence, and 2 had disease recurrence
5 and 7 months after surgery.
Conclusions: Complete and near complete pathologic
responses following chemoradiation therapy are rare in
pancreatic adenocarcinoma. This case series yields some
interesting similarities among these patients, who
tended to be younger and non-obese. Larger case series
are needed to confirm these observations.
PPP26-013
ANAPLASTIC CARCINOMA WITH
OSTEOCLAST-LIKE GINAT CELLS OF
THE PANCREAS
H. Jung, C. Kim and S. Bae
Soonchunhyang University Hospital Cheonan, Korea
Introduction: Anaplastic carcinoma (undiffentiated) of
pancreas is a rare neoplasm. Less than 50 cases have
been reported in the literature. The pathogenesis is still
controversial. We report a case of anaplastic carcinoma
with osteoclast-like giant cells was diagnosed according
to the results of immunohistopatholoy.
Method: Case: a 74-year-old woman presented with
epigastric pain for the past day. She had no other med-
ical history, the physical examination revealed tender-
ness in the right upper quadrant and epigastric area.
Laboratory findings demonstrated elevated amylase
and lipase levels (443/1293 U/L).
CT scan showed a 3 cm sized mass on pancreas body,
no lymphnode mestastsis, ascites, metastasis was dem-
onstrated on MRI. We performed a laparoscopic distal
pancreatectomy and the patient discharged on POD 7
without complication. An immunohistochemial stain
showed positive staining for vimentin, P53, CD68,
SMA and focal positive by Pan-CK, EMA, CK7. The
tumor was diagnosed as an anaplstic carinoma with
osteoclast-like ginat cells. The patient was received 1-
cycle chemotherapy, and doing well 2 month after sur-
gery.
Results:
Conclusions:
PPP26-014
SPLEEN PRESERVING LAPAROSCOPIC
DISTAL PANCREATECTOMY
H. Lyu1, M. Cooper1, B. Edil2, A. Dackiw1,
J. Cameron1 and M. Makary1
1Johns Hopkins University School of Medicine, USA;
2University of Colorado, USA
Introduction: Splenectomy has been associated with
postoperative infections, thrombocytosis, thrombosis,
and hypogammaglobulinemia. For benign pancreas
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lesions, spleen preservation during distal pancreatec-
tomy is rarely performed and the feasibility of routine
spleen preservation has not been well described.
Method: All patients presenting to a single surgeon
(MAM) with benign appearing pancreas tail lesions
from June 2007–April 2013 were considered for laparo-
scopic spleen preserving distal pancreatectomy. Lapa-
roscopy was performed with a high-definition camera.
We collected data on blood loss, operative time, hospi-
tal length of stay, and mortality.
Results: We identified 55 candidates for spleen preserv-
ing laparoscopic distal pancreatectomy. Spleen preser-
vation was achieved in 69.1% (38/55). Splenectomy was
performed in 30.9% (17/55) of patients (12 for techni-
cal reasons and 5 for malignancy on frozen section).
Spleen preservation was associated with decreased
blood loss and operative time compared to splenectomy
(mean = 183 vs 779 cc, p < 0.001; mean = 207 vs
269 minutes, p = 0.02, respectively). Hospital length of
stay was similar for spleen preservation and splenec-
tomy (mean = 5.3 vs 6.9 days, respectively). There was
no mortality in either group.
Conclusions: We describe the feasibility and safety of
performing spleen preservation with laparoscopic dis-
tal pancreatectomy. The magnification of high-defini-
tion laparoscopy may enable increased rates of spleen
preservation compared to the traditional open
approach.
PPP26-015
LAPAROSCOPIC WHIPPLE:
FEASIBILITY AND OUTCOMES
M. Makary1, H. Lyu1, M. Cooper1, K. Hirose1,
J. Cameron1 and B. Edil2
1Johns Hopkins University School of Medicine, USA;
2University of Colorado, USA
Introduction: Laparoscopy has been applied to many
intra-abdominal operations resulting in improved out-
comes. We describe a series of laparoscopic Whipple
procedures.
Method: We conducted a retrospective review of lapa-
roscopic Whipple candidates presenting to two sur-
geons (MAM, BHE) over a 3-year period (2010-2013).
Candidacy was based on a clearly resectable mass in
the head of the pancreas without vessel involvement.
Data were collected on patient demographics, operative
time, estimated blood loss (EBL), postoperative bile
and pancreatic leak, delayed gastric emptying (DGE),
surgical site infection (SSI), hospital length of stay
(LOS), and mortality.
Results: We performed 44 laparoscopic Whipple proce-
dures. Mean operative time was 393 minutes
(range = 210–665 minutes). The initial 22 cases had
longer operative time compared to the last 22 cases
(418 vs. 369 minutes). Conversion to open took place
in 3 patients. Median EBL was 200cc (range = 20–
4500cc). Asymptomatic pancreatic leak occurred in 5
patients and asymptomatic bile leak occurred in 2
patients; all were managed with external drainage.
DGE occurred in 3 patients. 1 patient developed an
SSI. Median hospital LOS was 9 days (range = 5–
68 days). 60 day mortality was zero.
Conclusions: In this series of laparoscopic Whipple pro-
cedures, we observed high feasibility with reasonable
operative time and good patient outcomes.
PPP26-016
IMAGING OF PANCREATIC TRAUMA.
MAGNETIC RESONANCE
CHOLANGIOPANCREATOGRAPHY
(MRCP) CAN BE CONSIDERED ALL
WHAT WE NEED?
G. Christodoulidis1, D. Dimas2, F. Constantinidis2,
M. Spyridakis1 and K. Tepetes1
1University Hospital of Larisa, Greece; 2Elpis General
Hospital Athens, Greece
Introduction: Pancreatic injury is a rare entity and is
associated with increased mortality and morbidity. The
aim of our study is to evaluate the utility of magnetic
resonance cholangiopancreatography (MRCP) in the
diagnosis of pancreatic injuries and the pancreatic -spe-
cific complications and its impact upon treatment
options.
Method: In this study 12 patients with suspected pan-
creatic injury were included. All the patients were he-
modynamically stable. The MRCP findings were
correlated with results of computed tomography, endo-
scopic retrograde cholangiopancreatograms, operative
findings and with clinical and laboratory data.
Results: All the patients suffered from blunt abdominal
trauma. Pancreatic duct injuries were detected in 5
patients. In 2 patients the computed tomography failed
to reveal pancreatic duct injury. The computed tomog-
raphy findings in 4 cases were pancreatic laceration and
in 4 only peripancreatic fluid without any other direct
sign. Data obtained by the MRCPs were used to guide
treatment options in all patients. Disruption of the pan-
creatic duct is treated surgically in 2 patients and by
therapeutic endoscopy with stent placement in the rest
3 patients.
Conclusions: MRCP as a noninvasive diagnostic
modality plays a crucial role in detection of pancreatic
duct trauma and pancreas-specific complications and
provides adequate information which influence the
treatment decision making.
PPP26-017
SAFETY AND EFFICACY OF A
TARGETED ENHANCED RECOVERY
PATHWAY AFTER
PANCREATICODUODENECTOMY
R. Sutcliffe, S. Bramhall, J. Isaac,
R. Marudanayagam, D. Mirza, P. Muiesan and
K. Roberts
University Hospital Birmingham NHS Foundation Trust,
UK
Introduction: Early oral intake and early drain removal
are key elements of enhanced recovery pathways in gas-
trointestinal surgery. However, such measures are not
common practice after pancreatico-duodenectomy
(PD), due to concerns about their potential impact on
integrity of the pancreatic anastomosis. The aim of this
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study was to compare the outcome of patients who
underwent PD before and after introduction of a tar-
geted enhanced recovery pathway (ERP), stratifying
patients on the basis of drain fluid amylase (DFA) on
the first postoperative day (POD).
Method: 99 consecutive patients who underwent PD
(Sept 2011 to May 2013) were included. Pre-ERP
(N = 65), patients were allowed sips of water only until
POD5, when free oral fluids and light diet were com-
menced if DFA5 < 300 U/L, and surgical drains were
removed on POD6. Post-ERP (N = 34), low risk
patients (DFA1 < 350 U/L) were managed according
to an enhanced recovery protocol, which included free
oral fluids on POD1, removal of nasogastric tube and
light diet on POD2, and drain removal on POD3. Mor-
bidity, mortality, length of hospital stay and 30-day re-
admission rates were compared between groups.
Results: 24/34 (71%) post-ERP patients were classified
as low risk on POD1, and 18/24 (75%) successfully
completed the enhanced recovery protocol. There was
no difference in pancreatic fistula rate (20% vs. 15%,
p = NS) or hospital mortality (6% vs. 6%, p = NS)
before and after ERP. Surgical site infections were less
common after ERP (54% vs. 29%, p = 0.05), and med-
ian length of hospital stay was shorter in the post-ERP
group (10 vs. 8 days, p = 0.035). 30-day readmission
rates were similar between groups (13% vs. 9%,
p = NS).
Conclusions: Early oral intake and early drain removal
can be safely implemented in low risk patients after
pancreatico-duodenectomy, and these measures are
associated with fewer surgical site infections and
shorter hospital stays without an increase in hospital
readmission.
PPP26-018
ANOMALOUS RIGHT HEPATIC
ARTERIAL ANATOMY DISCOVERED
DURING WHIPPLE’S PANCREATICO
DUODENECTOMY
M. Chinthakindi, R. Pratap Reddy, T. Ravimohan,
M. Prasuna, D.V.L. Narayan Rao and
J. Vinod Kumar
Osmania General Hospital, Hyderbad, AP, India
Introduction: A number of variations in hepatic arterial
anatomy have been described. Knowledge of these
anomalous arterial supplies is especially important in
hepato pancreatico biliary (HPB) surgery in order to
avoid unnecessary potentially disastrous complications.
Few case reports described this condition in the litera-
ture. We present here, about our experiences of Anom-
alous Right Hepatic arterial anatomy discovered during
pancreatico duodenectomy (PD) and methods to avoid
injury to anomalous right hepatic artery.
Method: This is a retrospective data collected from the
case files of whipple’s pancreatico duodenectomy done
in Osmania General Hospital, Hyderabad from 2010 to
2013.Triphasic CT abdomen with pancreatic protocol
was done in all patients. CT films were reviewed for
Anomalous Right Hepatic Artery (ARHA) in all cases.
All underwent classical PD operation. After opening
the abdomen, the right margin of hepato duodenal liga-
ment was palpated for ARHA before starting of hepato
duodenal ligament dissection during whipples proce-
dure
Results: 82 Whipple’s PD records were reviewed for
ARHA. The ARHA anatomy was noted in 8 patients
(6 males and 2 females). Right accessory hepatic artery
was present in 2 patients. Right replaced hepatic artery
from SMA was noted in 6 patients. Tumor etiology
was cholangiocarcinoma in 1, ampullary carcinoma in
2 and carcinoma head of pancreas in 5 patients.In 1
case tumor involved the artery. The ARHA was dis-
sected and preserved in 7 cases. PG was done in 1 case
and PJ (duct to mucosa) was done in 7 patients. No
operative mortality.1 case had pancreatic leak. 2
patients had delayed gastric emptying.
Conclusions: Preservation of the blood supply to the
liver and biliary tree is important after PD to prevent
biliary fistula and hepatic ischaemia. Always try to
avoid injury to anomalous right hepatic artery by criti-
cal assessment of preoperative CT abdomen and make
protocol to anticipate and look for ARHA during sur-
gery.
PPP26-019
THE MANAGEMENT AND PROGNOSIS
OF TRUE DUODENAL CARCINOMAS
T. Buchbjerg, C. Fristrup and M.B. Mortensen
HPB Section, Odense University Hospital, Denmark
Introduction: Primary duodenal carcinoma (PDC) is a
rare GI tumor. The difficult distinction between PDC
and other types of carcinoma (e.g. within the periam-
pullary region) is reflected in the scarce literature on
true duodenal carcinomas. However, this distinction
may be important in relation to the overall prognosis
as well as in the choice of adjuvant or palliative treat-
ment strategies. This study evaluated the management
and prognosis of patients with true PDC within a well
defined geographical area.
Method: Retrospective analysis of all patients diag-
nosed with true PDC from 1997 to 2012 within the
Region of Southern Denmark. Only patients where the
surgeon and the pathologist agreed on the tumor being
classified as originating from the duodenum were
included.
Results: Seventy-one patients (43 M, 28 F) with a
mean age of 67 years (range 35–87) met the criteria for
true PDC. An adenocarcinoma was found in 62 (87%)
of the patients, mucinous adenocarcinoma in 5 patients
(7%), carcinoma in 3 patients (4%) and signet ring cell
carcinoma in 1 patient (1%). Intended curative resec-
tion was performed in 28 patients (39%) (22 Whipples
procedures and 6 local resections), and all but one
patient had negative resection margins, but 13 patients
(46%) had lymph node metastasis. Twenty-nine (67%)
of the palliative treated patients had single (24) or dou-
ble by-pass procedure (5). The median and 5 year sur-
vival for the resected patients were 23 months (CI 7–
44) and 27% (CI 10–44). The median survival in the
palliative group was 5 months (CI 2–11), and none of
the patients were alive after 3 years.
Conclusions: Approximately 40% of the patients with
true PDC within a geographical completely monitored
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area could be resected, but the prognosis resembled
that of ductal pancreatic adenocarcinoma with a med-
ian survival of only 23 months.
PPP26-020
POPULATION-BASED PATTERNS OF
CARE AND OUTCOMES OF
PANCREATIC CANCER IN NOVA
SCOTIA
S. Hurton, G. Porter, M. Walsh and M. Molinari
Dalhousie University, Canada
Introduction: Pancreatic cancer (PC) is a common gas-
trointestinal malignancy, and there are limited popula-
tion-based studies examining the quality of treatment
and its impact on survival and resource utilization.
Method: This population-based cohort study included
all patients identified with PC in Nova Scotia between
April 2001 and March 2010. Identification of the
cohort was obtained through the Nova Scotia Cancer
Registry and subsequently linked with administrative
databases for demographic data and resource utiliza-
tion. The primary aim of this study was to analyze the
treatment patterns and overall outcomes of patients
diagnosed with PC over a period of 10 years. Second-
ary outcomes were utilization of oncology services and
their impact on survival.
Results: A total of 1161 patients were included. Among
279 patients (24.0%) who presented with locoregional
disease, 165 (14.2%) underwent surgical resection with
curative intent. Palliative surgery was performed on
246 (25.2%) patients. Of those who were resected with
curative intent, 98 patients (60.1%) were referred to
medical oncology, whereas among patients who did not
undergo resection, 361 patients (37.4%) were referred
for palliative chemotherapy. The all-cause 1- and 5-year
survivals were 58.9% and 17.6% for resected patients,
and 10.3% and 1.5% for unresected patients. The PC-
specific 1- and 5-year survivals were 62.9% and 23.3%
for resected patients, and 13.3% and 3.1% for unre-
sected patients.
Conclusions: Resection rates and overall survival of PC
patients in Nova Scotia are comparable to outcomes
reported in the current scientific literature despite their
limited access to adjuvant therapies. The rationale and
clinical implications of these findings are currently the
aim of further research.
PPP26-021
THE CHOISE OF PANCREATO-
DIGESTIVE ANASTOMOSIS AFTER
PANCREATECTOMY
A. Shabunin, M. Tavobilov and A. Karpov
Moscow Pirogov’s state hospital #1, Russiaalhousie
University, Russia
Introduction: Postoperative pancreatic fistula rate after
pancreatectomy remains high even in the large surgical
centers. The aim of this study was to compare different
types of pancreatic anastomosis with regard to postop-
erative pancreatic fistula and other complications.
Method: From August 2007 to July 2013 in Moscow
Pirohov‘s state hospital #1 HPB Department were
treated 609 patients with periampullary tumors. We
performed 145 pancreatectomies: 47 pancreatojejunos-
tomies (PJ) and 47 pancreaticojejunostomies with inter-
nal pancreatic drain, when the condition of the
pancreatic stump was unsatisfactorily. Since 2010, for
the purpose to decrease postoperative pancreatic fistula
rate we began forming pancreatogastrostomies (PG)
(n = 49). Pancreatic anstomosis failure preventing
methods were every time the same. The ISGPS defini-
tions were employed for analysis. Occurrence of post-
operative pancreatic fistula, postpancreatectomy
hemorrhage, delayed gastric emptying, reoperation, and
mortality were evaluated. Comparing operative time
and overall hospital stay was also carried out. Another
complications rate was evaluated using Clavien-Dindo
classification.
Results: Pancreatogastrostomy has showed less cases of
postoperative pancreatic fistulae (PG vs PJ, 18.4% vs
29.8%), but more intraluminal hemorrhage (PG vs PJ,
12.2% vs 8.5%) and more delayed gastric emptying
(PG vs PJ, 18.3% vs 10.6%). PG general complications
(Clavien-Dindo classification) rate was comparable with
PJ (I grade: 14.7% vs 16.3%, grade II: 18.45 vs 21.2%,
grade III: 12.2% vs 12.7%, grade IV: 2% vs 2.2%,
grade V: 0% vs 2.2%).
Conclusions: Performing pancreatogastrostomy is better
method for patients with unsatisfactory conditions of
the pancreas and makes possible to decrease postopera-
tive complications.
PPP26-022
THE INFLUENCE OF FACTORS ON
RECURRENCE AFTER CURATIVE
RESECTION FOR AMPULLA OF VATER
CANCER
J. Jeon, J. Kim, D. Kim, S. Chon and J. Jung
Hallym University Medical Center, Korea
Introduction: Although patients with ampullary carci-
noma (AC) have improved survival compared to
patients with pancreatic adenocarcinoma, up to 40% of
patients develop recurrent disease.The aims of this
study were to identify those factors that affect recur-
rence after curative resection.
Method: The medical records of patients that under-
went pancreatoduodenectomy for ampullary carcinoma
from February 1999 to December 2012 at our institute
were retrospectively reviewed. Fifty four patients
received radical resection for ampulla of Vater carci-
noma. Six patients were excluded because of incomplete
clinicopathologic data. Finally, 48 patients were
reviewed and analyzed to assess predictors of tumor
recurrence.
Results: There were one perioperative death (2.1%).
Mean age was 62 years (50% male). Median survival
time (MST) was 29.2 months for all patients. Among
the 48 patients, 24 patients (50%) experienced recurrent
disease. The mean length of time to recurrence was
310.5  279.3 days, and the most common sites of
recurrence were the intra-abdominal organs: liver and
loco-regional lymph nodes. The 3- and 5-year disease
free survival rates were 50.1% and 42%, respectively,
and overall survival rates were 69.9% and 58%, espec-
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tively. The nodal status, T stage, TNM stage, and dif-
ferentiation were associated with DFS in univariate
analyses (p = 0.035, 0.037, 0.011, 0.000). However, the
nodal status, T stage, TNM stage, and differentiation
were not associated with OS in univariate analyses. In
the multivariate analysis, only advanced TNM stage
(HR, 8.0; p = 0.03) but not nodal status or differentia-
tion, was associated with disease free survival.
Conclusions: Lymph node metastasis, advanced T
stage, TNM stage, and differentiation are important
risk factor for recurrence after a curative resec-
tion.Patients with advanced tumor stage should be con-
sidered for clinical trials of adjuvant therapy after
curative resection and optimized radiation therapy
strategies.
PPP26-023
HEALTH ECONOMICAL ASPECTS ON
PANCREATIC FISTULA FORMATION
FOLLOWING PANCREATIC SURGERY
D. Ansari, G. Lindell and R. Andersson
Lund University, Sweden
Introduction: Pancreatic resections still represent one of
the major procedures in abdominal surgery, mostly per-
formed due to suspicion of underlying malignancy
where it provides the opportunity of extended survival.
Despite improvements in perioperative mortality fol-
lowing pancreatic surgery, morbidity still remains high
and postoperative development of pancreatic fistula
remains one of the major problems. The present study
aimed at evaluating health economical aspects of pan-
creatic fistula formation.
Method: 430 patients undergoing pancreatic resection
at the Dept of Surgery in Lund, Sweden, were investi-
gated. 115 patients (26.7%) developed a pancreatic fis-
tula according to the ISGFPF criteria where a majority
(16%) had a grade A fistula, 7% grade B, and 3%
grade C fistula. Effects on length of stay, outcome and
in-hospital costs were evaluated.
Results: Formation of a pancreatic postoperative fis-
tula significantly increased length of hospital stay to
13 days (grade A) and 29 days (p < 0.01) for grades B
and C. Postoperative pancreatic fistula grades B and C
significantly increased postoperative costs (60%
increase; p < 0.01, from 20 800 to 32,900 EUR) and
were associated with delayed gastric emptying, abscess
formation, postoperative bleeding and wound infection.
Overall, on multivariate analysis of predictor of hospi-
tal costs, pancreatic fistula grades B and C, deep infec-
tions/abscess formation, wound infection, delayed
gastric emptying and postoperative bleeding all were
significant predictors.
Conclusions: The development of postoperative pancre-
atic fistulas following pancreatic resection (both Whip-
ple and tail resection) is associated with a significant
increase in postoperative hospital stay (grades B and C)
and associated costs (60% increase). As this represents
the major cause of postoperative morbidity following
pancreatic resection, further efforts to decrease the fis-
tula rate is warranted.
PPP26-024
ACUTE PANCREATITIS AS A RARE
PRESENTATION OF RENAL CELL
CARCINOMA
J.K. Koong, P.S. Koh, A.H. Razack and
B.K. Yoong
University of Malaya, Malaysia
Introduction: Association between acute pancreatitis
and renal cell carcinoma are uncommon. Pancreatitis
occurring as a presentation of metastatic renal cell car-
cinoma or as a paraneoplastic phenomenon had been
reported. Although various cases had been reported
associating the two conditions, such presentation
remained rare and few in literature.
Method: We report a case of a 45-year-old man who
presents to our institution with acute pancreatitis and
subsequently found to have renal cell carcinoma. A
comprehensive literature search and review was made
following this rare dual presentation.
Results: A patient with no known medical illness pre-
sented with a sudden onset of severe epigastric pain for
1 day which radiates to the back and aggravated by
food intake. Examination was unremarkable other than
an elevated blood pressure. Serum amylase was raised
at 1700 IU/L with an IMRIE score of 1 and no other
evidence of end organ damage. Ultrasonography of the
abdomen incidentally revealed a left renal mass and
computer tomography (CT) scan showed features of
left renal cell carcinoma. No other cause of pancreatitis
was found. Acute pancreatitis was treated and he was
discharged well. There were no recurrence of pancreati-
tis. He was later electively admitted for a partial left
nephrectomy where histopathological examination
(HPE) confirmed the diagnosis of a renal cell carci-
noma.
Conclusions: Acute pancreatitis can be a presentation
of renal cell carcinoma albeit uncommon. Few cases of
acute pancreatitis associated with renal cell carcinoma
have been reported where the cause of the pancreatitis
is attributed to metastases, paraneoplastic phenomenon
or purely a coincidental occurrence. In a presentation
of acute pancreatitis with associated finding of renal
mass, possibility of renal cell carcinoma should be con-
sidered.
PPP26-025
PANCREATICODUODENECTOMY IN
ELDERLY PATIENTS
S. Sugita, K. Hiramatu, S. Saeki, T. Amemiya,
H. Goto, T. Seki, M. Kato, H. Tanaka, S. Suzuki and
T. Arai
Anjo Kosei Hospital, Japan
Introduction: Surgery can offer the chance for a cure in
patients with pancreatic cancer or bile duct cancer, and
a growing number of elderly patients have been under-
going pancreaticoduodenectomy (PD). But, PD has rel-
atively high rate of mortality and morbidity compared
with the other digestive surgery. The purpose of this
study was to evaluate the impact of patient age on the
short-term outcomes of PD.
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Method: From 2002 to 2012, one-hundred and twelve
PDs were performed at Department of Surgery, Anjo
Kosei Hospital. Perioperative outcomes after surgery
were compared between patients 75 years and older
(group A, n = 19) and patients under the age of 75
(group B, n = 93).
Results: All of the 19 patients in group A were healthy
and deemed to be candidates for surgery; however, sev-
enteen (89.4%) had one or more comorbidities. Postop-
erative morbidity (such as pancreatic fistula,
anastomotic leakage, delayed gastric emptying, wound
infection etc.) and mortality occurred in 73.7 and 5.3%
of the group A, respectively. These rate were similar to
those in group B (p = 0.741 and p = 0.209, respec-
tively). There were no cardiovascular or pulmonary
complications in group A. Average number of hospital-
ization days in group A were 34.3, and were similar to
those in group B (p = 0.201) .
Conclusions: PD can be safely performed even in
patients 75 years and older, and careful patient selec-
tion can lead to acceptable morbidity and mortality.
Elderly patients should not be precluded from undergo-
ing PD only because of their ages.
PPP26-027
THE CHOISE OF PANCREATO-
DIGESTIVE ANASTOMOSIS AFTER
PANCREATECTOMY
A. Shabunin, M. Tavobilov and A. Karpov
Moscow Pirogov’s state hospital #1, Russia
Introduction: Postoperative pancreatic fistula rate after
pancreatectomy remains high even in the large surgical
centers. The aim of this study was to compare different
types of pancreatic anastomosis with regard to postop-
erative pancreatic fistula and other complications.
Method: From August 2007 to July 2013 in Moscow
Pirohov‘s state hospital #1 HPB Department were
treated 609 patients with periampullary tumors. We
performed 145 pancreatectomies: 47 pancreatojejunos-
tomies (PJ) and 47 pancreaticojejunostomies with inter-
nal pancreatic drain, when the condition of the
pancreatic stump was unsatisfactorily. Since 2010, for
the purpose to decrease postoperative pancreatic fistula
rate we began forming pancreatogastrostomies (PG)
(n = 49). Pancreatic anstomosis failure preventing
methods were every time the same. The ISGPS defini-
tions were employed for analysis. Occurrence of post-
operative pancreatic fistula, postpancreatectomy
hemorrhage, delayed gastric emptying, reoperation, and
mortality were evaluated. Comparing operative time
and overall hospital stay was also carried out. Another
complications rate was evaluated using Clavien-Dindo
classification.
Results: Pancreatogastrostomy has showed less cases of
postoperative pancreatic fistulae (PG vs PJ, 18,4% vs
29,8%), but more intraluminal hemorrhage (PG vs PJ,
12,2% vs 8,5%) and more delayed gastric emptying
(PG vs PJ, 18,3% vs 10,6%). PG general complications
(Clavien-Dindo classification) rate was comparable with
PJ (I grade: 14,7% vs 16,3%, grade II: 18,45 vs 21,2%,
grade III: 12,2% vs 12,7%, grade IV: 2% vs 2,2%,
grade V: 0% vs 2,2%).
Conclusions: Performing pancreatogastrostomy is better
method for patients with unsatisfactory conditions of
the pancreas and makes possible to decrease postopera-
tive complications.
PPP26-028
IDENTIFICATION OF HIGH RISK
CATEGORIES FOR
PANCREATICODUODENECTOMY
BASED ON DIAGNOSIS: NOT ALL
GLANDS ARE EQUAL
C. Shubert, E. Habermann, K. Thomsen,
M. Farnell and M. Kendrick
Mayo Clinic, USA
Introduction: Soft gland texture and small duct are
associated with postoperative complications after pan-
creaticoduodenectomy (PD). While diagnosis is associ-
ated with gland texture and duct size studies of
postoperative complications frequently overlook diag-
nosis or group patients into “benign vs malignant”.
Insurers determine value and compensate all PD’s inde-
pendent of diagnosis. There has been no large multicen-
ter study comparing postoperative outcomes for PD
while stratifying by diagnosis. We hypothesized that
postoperative morbidity and length of stay (LOS) fol-
lowing PD varies by diagnosis and patients may be
grouped into low- and high-risk categories.
Method: A large multicenter prospective database
(American College of Surgeons- National Surgical
Quality Improvement Program) was reviewed for all
PD’s between 2005 and 2011. Patients with severe pre-
operative conditions, without pancreaticojejunostomy,
or with concurrent operations not typical of PD were
excluded. Diagnoses were identified using ICD9 codes.
Chi-square and multivariable logistic regression were
utilized to assess the impact of diagnosis on PD out-
comes.
Results: Of 5,537 patients: pancreas cancer (3173) and
chronic pancreatitis (485) (combined major morbidity
of 23.4%) were grouped as “low risk”, while bile duct
and ampullary (1181), duodenal (558), and neuroendo-
crine (140) (combined major morbidity of 33.5%) were
grouped as “high risk” (p<0.001). Multivariable logistic
regression analysis identified “high risk” diagnoses as
an independent risk factor for prolonged LOS
(≥14 days: OR 1.62), organ space infection (OR 2.60),
sepsis/septic shock (OR 1.82) and major morbidity (OR
1.72). Serum albumin <3.5 g/dL is a risk factor inde-
pendent of diagnosis for prolonged LOS (OR 1.76),
organ space infection (OR 1.50), sepsis/septic shock
(OR 1.36), and major morbidity (OR 1.40). Diagnosis
did not predict readmission.
Conclusions: “High risk” diagnoses are independently
associated with prolonged length of stay and postoper-
ative complications. PD outcomes comparisons, value
and compensation should be stratified by diagnosis to
more accurately reflect postoperative risk of complica-
tion and complexity of care.
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PPP26-029
PANCREAS SPARING TOTAL
DUODENECTOMY FOR MULTIPLE
DUODENAL ADENOMAS IN FAMILIAL
ADENOMATOUS POLYPOSIS; REPORT
OF A CASE
Y. Watanabe1, H. Baba1, H. Ishida1 and M. Tanabe2
1Saitama Medical Center, Japan; 2Tokyo Medical and
Dental University, Japan
Introduction: Duodenal adenomas occur frequently in
patients with familial adenomatous polyposis (FAP).
Final prevalence is said to be 90% and similar to colo-
rectal polyps, it transforms to adenocarcinoma in the
time course, especially those in periampullary region.
Surveillance is necessary and the treatment strategy
should follow the criteria of the Spigelman classifica-
tion. Although prophylactic pancreaticoduodenectomy
is a treatment option, its surgical morbidity and mor-
tality is a concern. We advocate pancreas-sparing duo-
denectomy (PSD) as an alternative for radical
operation.
Method: A 51-year-old man with FAP, who had total
colectomy thirty three years ago, had been visiting our
out patient clinic from 2010 for surveillance. Recent
upper gastroduodenoscopy revealed growing size of
IIa-like polyp, biopsy specimen conclusive for tubular
adenoma with moderate atypia with villous change.
Spiegelman classification was stage IV (score; 10), sug-
gestive for surgery. We conducted PSD reconstructed
by the Billroth-I method.
Results: Minor pancreatic fistula (ISGPF classification
Grade A) and cholangitis occurred but was discharged
on the 24th postoperative day. Pathologically, numer-
ous adenomas were identified macroscopically, but all
polyps investigated microscopically were all conclusive
for adenoma.
Conclusions: PSD is a theoretically optimal procedure
for benign large polyps and diffuse duodenal adenomas
for prophylactic purpose. Long-term outcome after
PSD must be warranted in the future.
PPP26-030
STANDARD PROCEDURE OF
PANCREATICODUODENECTOMY IN
OUR INSTITUTE
H. Shimamura, H. Kodama and K. Takeda
Sendai Medical Center, Japan
Introduction: Procedures of pancreaticoduodenectomy
(PD) vary in each institute, and there is no general
standard. Since we have been trying to make our own
standard, we here show and analyze our PD proce-
dures.
Method: We usually choose Subtotal Stomach-preserv-
ing PD (SSPPD) except in cases after gastrectomy. For
reconstruction of remnant pancreas, we prefer pancre-
aticojejunostomy by the modified Kakita method. We
once adopted total diversion method using pancreatic
tube (external stenting). Then, since 2011, we have
adopted the internal stenting method (lost stent). We
retrospectively compared these 2 groups.
Results: There was no significant difference in opera-
tive time and blood loss between the 2 groups. But,
postoperative hospital stay was significantly shorter in
the internal stenting group. Incidence of pancreatic fis-
tula in the internal stenting group seemed lower than
that in the total diversion group, but not significant.
Conclusions: We conclude so far that our standard pro-
cedure is SSPPD with reconstruction by the modified
Kakita method using the internal stenting.
PPP26-031
POST-OPERATIVE OUTCOME AFTER
PANCREATIC SURGERY FOR
PATIENTS WITH PANCREATIC
NEUROENDOCRINE TUMOR (PNET)
A. Jilesen, O. Busch, T.Van Gulik, D. Gouma and
E.N.van Dijkum
Academic Medical Center, Netherlands
Introduction: pNET is a rare disease. Surgery is the
only available curative treatment. Although enucleation
seems less invasive, complications such as pancreatic
fistulas frequently occur. This study compares the out-
come of enucleation versus other pancreatic resections
for pNET.
Method: All patients with pNET in the database on
pancreatic resections were selected. Patients were oper-
ated between January 2000 and July 2013. Surgical pro-
cedure and post-operative outcome were analysed.
Results: A total of 96 patients underwent resection for
pNET, 26% (25/96) underwent enucleation and 74%
(71/96) another pancreatic resection. Type of pancreatic
resections were pancreatoduodenectomy (PPPD)
N = 33, left pancreatectomy N = 19, left/central pan-
createctomy N = 17 and total pancreatectomy N = 2.
Enucleations were mainly performed for tumors less
than <2 cm 92% (23/25) and located in the head of the
pancreas 56% (14/25). Overall complication rate was
56% (14/25) after enucleation versus 69% (49/71) after
pancreatic resection (p = 0.2). Major complications
after enucleation were delayed gastric emptying 36%
(5/14) and clinically relevant pancreatic fistula 71%
(10/14). Major complication after pancreatic resections
were delayed gastric emptying and chylous leakage,
both 20% (10/49) and clinically relevant pancreatic fis-
tula 27% (13/49) (p < 0.05 compared with enucleation).
Post-operative hospital stay (10 vs 12 days), ICU
admission (2 vs 6 patients), number of relaparomies (2
vs 6 patients) and readmission after discharge (3 vs 12
patients) weren’t significantly different after enucleation
versus pancreatic resection. Mortality rate was 1% (1/
96) after pancreatic resection due to abdominal sepsis
and aspiration.
Conclusions: Although enucleation for pNET seems a
less invasive technique, complication rate was high,
mainly caused by pancreatic fistula. Careful patient
selection and operation should be performed in particu-
lar for small lesions.
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PPP26-032
COMMON BILE DUCT REINSERTION
IN TO RESECTION CAVITY FOR
TREATMENT OF BILIARY TRACT
OBSTRUCTION IN CHRONIC
PANCREATITIS
A. Sileikis, A. Beisa, S. Jurevicius, M. Kryzauskas and
K. Strupas
Vilnius University hospital Santariskiu klinikos,
Lithuania
Introduction: Appropriate operation technique for
treatment of biliary tract obstruction in chronic pancre-
atitis is being discussed. We present late results of sur-
gical treatment of biliary tract obstruction in chronic
pancreatitis by making bile duct reinsertion into the
resection cavity of pancreas modo Izbicki.
Method: A retrospective analysis of patients who had
chronic pancreatitis and underwent a surgical interven-
tion in 2004–2011 was made. Patients who during the
first operation underwent a bile duct reinsertion into
the resection cavity due to mechanical jaundice or cho-
lestasis were selected, n = 62. After 18 months patients
were asked to come back for follow up. They were
divided into 2 groups: recurrence (group A) and recov-
ery (group B). Demographic (age, gender), pathologic
(diameter of: intrahepatic ducts, common bile duct and
pancreatic duct), biochemical (concentrations of: alka-
line phosphatase and total bilirubin), clinical (amount
of removed tissues) features were analyzed and com-
pared.
Results: 41 (66.1%) of the patients came back for con-
trol: recurrences - 32 (78%), recoveries - 9 (22%).
93.8% of recurrentes underwent an additional opera-
tion - hepaticojejunostomy on the same loop. We have
not found any significant differences when comparing
A and B group in anatomical (intrahepatic ducts, com-
mon bile duct and pancreatic duct) or biochemical
(alkaline phospatase and total bilirubin) findings or the
amount of removed tissue.
Conclusions: Reinsertion of common bile duct into
resection cavity does not guaranty permanent and ade-
quate drainage for chronic pancreatitis complicated by
obstructive jaundice. It can be stated that hepaticojej-
unostomy is the procedure of choice for such patients.
PPP26-033
LAPAROSCOPIC DISTAL
PANCREATECTOMY FOR HIGH-RISK
PATIENTS
H.-Y. Ho, C.-H. Liao, Y.-Y. Liu and T.-S. Yeh
Chang Gung Memorial Hospital, Chang Gung
University, Taiwan
Introduction: Laparoscopic distal pancreatectomy
(LDP) has been increasingly accepted by laparoscopic
surgeons with respect to its safety and inherent benefits;
whereas the advantages of this technique for high-risk
patients remain unexplored.
Method: Ten consecutive patients had undergone LDP,
who had been associated with one or more high risks
such as old myocardial infarction, cerebral vascular
accident, morbid obesity, obstructive sleep apnea,
refractory diabetes, SLE, ESRD, frequent seizure and
elderly status, were recruited. Their ASA scores were 3
at leaast. Their demographics, surgical indications,
comorbidity, operation time, blood loss, mortality and
morbidity, and hospital stay were analyzed.
Results: There were 5 men and 5 women, with a mean
age of 53  12 years. The surgical indications included
intraductal papillary mucinous neoplasm (n = 2), ser-
ous cysadenoma (n = 2), neuroendocrine tumor of the
pancreas (n = 3), and pancreatitis associated with
pseudocysts ((n = 3). Of the 10 LDP, 7 were with
spleen preservation. The concomitant sleeve gastrec-
tomy and transverse colectomy were performed in one
each. The mean operation time was 241  116 minutes.
The blood loss was 701  751 mL. There was no surgi-
cal mortality. However, there were five pancreatic
leaks; of them, 3 needed a percutaneous drainage. The
mean hospital stay was 11.2  7.3 days.
Conclusions: LDP for high risk patient (ASA > 3) is
considered feasible and safe with respect to zero surgi-
cal mortality and controllable specific complications
such as pancreatic leak. Obvious benefits of LDP is
reflected by a gratifying postoperative stay.
PPP26-034
SURGICAL TREATMENT OF
PANCREATIC NEUROENDOCRINE
TUMORS: PRELIMINARES RESULTS
E.R.R. Figueira1, T. Bacchella1, R. Jureidini1,
G.N. Namur1, J. Okubo2, A.G.V. Fernandes2,
U.R. Junior1 and I. Cecconello1
1Hospital das Clinicas University of Sao Paulo School of
Medicine, Brazil; 2University of Sao Paulo School of
Medicine, Brazil
Introduction: Pancreatic neuroendocrine tumors
(PNET) are rare neoplasms with heterogeneous presen-
tation due to its various subtypes. The association
between tumor size and survival is still controversial.
We aimed to evaluate the results of patients that under-
went pancreatic resection of neuroendocrine tumors
with different subtypes.
Method: We retrospectively evaluated 86 patients with
diagnosis of pancreatic neuroendocrine tumor that
underwent pancreatic resection at our Institution.
Patients with distant metastasis were not included. We
analyze age, sex, clinical diagnosis, surgical procedure,
histology, tumor size, and follow-up time.
Results: We included 75 patients, 43 (57%) women and
32 (43%) men with mean age of 46.61  23.68 years.
Diagnosis was nonfunctional PNET in 19 (25%) cases,
insulinoma in 42 (56%), gastrinoma in 6 (8%), gluca-
gonoma in 4 (5%), somatastinoma in 3 (4%) and pan-
creatic polypeptide secretor 1 (2%). Main surgical
procedures were corpo-caudal pancreatectomy in 29%,
enucleation in 25%, duodenopancreatectomy in 20%
or gastroduodenopancreatectomy in 7%. Seventy three
percent of the tuomors were carcinomas. The median
tumor size was 3.75 cm (0.5–16 cm) in nonfunctional
PNET and 2.0 cm (0.6–3.4 cm) in insulinomas
(p = 0.0031). The mean follow-up time was
13.17  7.95 years. The table shows characteristics by
diagnosis.
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Conclusions: Fifty six percent of PNETs were insulino-
ma, accounting for 75% of functioning tumors in the
study. Nonfunctioning tumors have higher diameters at
time of resection, what is justified by the silent growing
and late development of symptoms related to compres-
sion of other structures by the tumor.
PPP26-035
TOTAL PANCREATECTOMY IN
EXTENSIVE CYSTIC NEOPLASM OF
PANCREAS: A CASE REPORT
C. Bunchaliew, R. Chanwat, V. Panchan,
H. Moungthard and T. Khuhaprema
National Cancer Institute, Thailand
Introduction: Pancreatic cystic lesions are increasingly
identified on routine imaging. These lesions have the
probability of malignant potential that require surgical
resection. However even with improvements in present
imaging, these lesions are still challenging to accurately
diagnose preoperatively and difficult to dicision for
observation or resection. Total pancreatectomy maybe
performed in a patient with extensive lesion and highly
suspicious pancreatic malignant neoplasm.
Method: A case of 54-years-old female had Modified
radical mastectomy for breast cancer. After Ultraso-
nography work up for liver metastasis, the imaging
show cystic lesion at pancreatic head size 1.5 9 1.5 cm.
She had no symptom and her laboratory tests including
tumor marker were normal. For 2 years CT scan fol-
lowed by MRI, there were mixed solid and cystic
lesions at pancreatic head and unciness process mea-
sured about 4.5 9 4.1 cm. Moreover the imaging
showed multiple small cysts in unciness process, body
and tail that communicating between the cysts and the
main pancreatic duct. According to imaging lesion, sur-
gical resection was planned for remove lesion because
of unable to distinguished malignant neoplasm.
Results: Due to the extensive and multiple cystic
lesions along pancreas that confirmed by intraoperative
ultrasonography. Total pancreatectomy was performed
with splenectomy.Operative time was 5 hours 15 min-
utes. Postoperative serum glucose was monitored and
controllable with minimal doses insulin. Pathological
diagnosis was serous cystadenoma of pancreatic head,
body and tail, negative for malignancy of 3 mesenteric
lymph node and 11 peripancreatic lymph node.
Conclusions: It is difficult to make a definite preopera-
tive diagnosis of pancreatic cystic neoplasm. Observa-
tion or surgical resection depended on clinical and
radiological finding. Total pancreatectomy may be
mandated if cystic lesions were entirely distribution
along a pancreas.
PPP26-036
“NATURAL HISTORY” OF
PANCREATICODUODENECTOMY
P. Pessaux
Nouvel Ho^pital Civil, France
Introduction: The aim of this study was to describe the
clinical and biological changes in a group of patients
who underwent pancreaticoduodenectomy (PD) with-
out any complications during the postoperative period.
These changes reflect the “natural history” of PD, and
a deviation should be considered as a warning sign of
possible complications.
Method: Between January 2000 and December 2009,
131 patients underwent PD. We prospectively collected
and retrospectively analyzed the following data: demo-
graphics, pathological variables, associated pathological
conditions, and preoperative, intraoperative, and post-
operative variables. The postoperative variables were
validated using an external prospective database of 158
patients.
Results: The mean postoperative hospital stay was
20.3  4 days. The mean number of days until naso-
gastric tube removal was 6.3  1.6 days. The maximal
decrease in hemoglobin levels occurred on day 3 and
began to increase after postoperative day (POD) 5 in
patients with or without transfusions. The white cell
count increased on day 1, and high white cell counts
persisted until day 7. There was a marked rise in ami-
notransferase levels at day 3. The peak is significantly
higher in patients who had hepatic pedicle occlusion
(866  236 Units/L vs 146  48 Units/L; p < 0.001).
Both c-glutamyl transpeptidase and alkaline phospha-
tase decreased on POD1 and persisted until day 5
before stabilizing. The bilirubin levels decreased pro-
gressively from POD1.
Conclusions: This study created a standardized biologi-
cal and clinical pathway of follow-up. Each patient
who does not follow this recovery indicator might have
complications, and additional exams are required to
prevent the consequences of these complications.
PPP26-037
DIAGNOSIS AND SEVERITY
ASSESSMENT IN PATIENTS WITH
ACUTE PANCREATITIS IN A LARGE
TEACHING HOSPITAL: A CLOSED
LOOP AUDIT
K. Patel, K. Dajani, S. Vickramarajah, P. Singh,
R. Praseedom, N. Jamieson, E. Huguet, S. Harper and
A. Jah
Addenbrooke’s Hospital, UK
Introduction: Diagnosis and severity assessment of
acute pancreatitis in the UK is principally based on
British Society of Gastroenterology guidelines. The aim
of this study was to audit diagnosis and severity assess-
ment in acute pancreatitis against standards of practice
in the UK guidelines.
Method: Retrospective data was collected from all
acute pancreatitis patients admitted to Addenbrooke’s
hospital during two periods, June 2012 to September
2012 (period 1), and February 2013 to April 2013 (per-
iod 2). Between these periods, a pancreatitis proforma
was introduced based on the UK guidelines. Data was
collected using hospital software, discharge summaries
and patient paper notes.
Results: Fifty-five acute pancreatitis patients were
admitted during period 1 while forty-two patients were
admitted during period 2 (re-audit). Patient demo-
graphics in period 1 (mean age 51.4 years, 50.9% male
& 49.1% female) differed from period 2 (mean age
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59.0 years, 54.8% male & 45.2% female). 66.7% of
patients (n = 31) in the re-audit had a proforma in
their hard copy notes, of which only 81.4% had com-
plete forms. The pancreatitis proformas improved com-
pletion of the full Glasgow pancreatitis score from
40% to 55%. The proforma also improved referral to
higher level care of severe pancreatitis patients (3 or
more on the Glasgow score) from 50% to 67%. Recog-
nition of pancreatitis aetiology also improved from
78% to 81% (43/55 and 34/42 respectively). Requests
for amylase levels improved from 96.3% to 100%,
while lipase level requests reduced (80% to 69%).
Conclusions: Prompt diagnosis and severity assessment
is essential in acute pancreatitis, which is highlighted in
this study. The introduction of Pancreatitis proformas
has led to significant improvements in severity scoring
for acute pancreatitis and subsequent care of severe
cases. We aim to raise further awareness throughout
the hospital by presenting the proforma at local meet-
ings and posters. Regular re-audits are important.
PPP26-038
THE STUDY OF PATIENT WITH
PANCREATIC CANCER ON SOCIAL
SUPPORT AND COPING STYLE
P. Hongying
Party member, China
Introduction: The patients with pancreatic cancer usu-
ally feel down in spirits and feel anxious. The article is
to explore the social support and coping style of pan-
creatic cancer patient, in order to provide the basis for
the individual nurse.
Method: Applied symptom checklist, social sup-port
questionnaire and medical coping modes questionnaire
to 40 patients to analysis.
Results: Retrieving 36 questionnaires in effect, among
them 10 cases are positive according to the score of
SCL-90. Comparing to the normal patient, the score of
subjective support and surrender are low significantly
in positive cases.
Conclusions: The pancreatic cancer patients usually
take passive coping style, nurses would encourage them
to take an active coping strategy and use of social sup-
port effectively.
PPP26-039
COMPARISON BETWEEN
LAPAROSCOPIC
GASTROJEJUNOSTOMY AND OPEN
GASTROJEJUNOSTOMY FOR
UNRESECTABLE PANCREATIC AND
BILIARY CANCERS
Y. Futagawa, N. Okui, J. Shimada, Y. Kumagai,
T. Iida, H. Shiba, T. Uwagawa, S. Wakiyama,
Y. Ishida and K. Yanaga
Jikei University School of Medicine, Japan
Introduction: Since 2011, we have used laparoscopic
gastrojejunostomy (Las-GJ) for patients with duodenal
obstruction due to unresectable pancreatic or biliary
cancers. We assessed the usefulness of Lap-GJ.
Method: Operation time, blood loss, complications,
and prognosis were compared between 6 patients who
underwent Lap-GJ between September 2011 and
December 2012 (including 4 pancreatic, 1 bile duct, and
1 gallbladder cancer patients; mean age, 62.5 years;
male:female = 1 : 5) and 20 patients who underwent
open gastrojejunostomy (Open-GJ) between April 2007
and December 2012 (including 11 pancreatic, 1 bile
duct, and 5 gallbladder cancer patients, and 3 patients
with other diseases; mean age, 66.9 years; male:
female = 13 : 7).
Results: The average operation time and blood loss in
Lap-GJ and Open-GJ groups were 262 minutes (range,
196–444 minutes) and 190 minutes (range, 61–420 min-
utes), and 0 mL and 131  50 mL, respectively. No
serious perioperative complications were observed in
either group. Three patients in Open-GJ group died of
cancer during hospitalization. In Lap-GJ and Open-GJ
groups, the median duration of postoperative hospital
stay was 19.7  3.1 days and 35.2  7.6 days respec-
tively, whereas the number of patients who could
resume a normal diet was 5 (83%) and 15 (75%),
respectively. Chemotherapy could be initiated in 4 and
11 patients in Lap-GJ and Open-GJ groups at
13.7 days (mean, 9–16 days) and 17.6 days (mean, 14–
21 days) after surgery, respectively. Moreover, the med-
ian postoperative survival duration was 179.3 days
(mean, 36–303 days) and 121 days (mean, 16–310 days)
in Lap-GJ and Open-GJ groups, respectively. None of
the abovementioned values indicated a significant dif-
ference.
Conclusions: Lap-GJ is a useful treatment associated
with minimal invasion and unproved quality of life due
to a low complication rate, shorter postoperative hospi-
tal stay, high resumption rate of oral intake, and earlier
initiation of chemotherapy, as compared to Open-GJ.
PPP26-040
TROPICAL PANCREATITIS AND
ALCOHOLIC CHRONIC
PANCREATITIS: COMPARISON &
EFFCT OF SURGERY
C. Khandelwal1, U. Anand2, R. Priyadarshi2 and
A. Kumar2
1Bihar Institute of Gastroenterology, India; 2I.G.I.M.S.
Patna, India
Introduction: Tropical pancreatitis (TP) is the common-
est form of chronic pancreatitis in our experience. We
have reviewed 78 such cases and also compared with 21
cases of alcoholic chronic pancreatitis (AP).110 patients
with chronic pancreatitis were treated at Patna, North
India. Tropical Pancreatitis was the commonest (78),
followed by alcoholic chronic pancreatitis (26), hyper
parathyroidism (4) and pancreatic divisum (2). 53 cases
of TP were operated.
Method: Patients presented with serve episodic or con-
tinuous pain. Age ranged from 11 to 60 years.23
patients had diabetes. Surgery was advised for intracta-
ble pain. Threshold of surgical intervention was lower
if the patient had diabetes and pancreatic duct more
than 7 mm.The median age for AP was 41 years. Aver-
age body mass index of TP patient was 17 kg/m2 where
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as it was 18.6 kg/m2 in AP. Diabetes was present in 23/
78 patients of TP whereas only 4/26 patients in AP
were diabetic. Symptomatic steatorrea was more pro-
nounced in TP. In AP, calcification was mainly paren-
chymal. Pancreatic duct were less than 7 mm and
without large intraductal stones. All TP had intraductal
calculi ranging from 0.5 cm to 3 cm, including stag-
horn calculus.
Results: All patients (53) operated for TP had dilated
main pancreatic duct (mean diameter 8 mm) with mul-
tiple large intraductal calculi in atrophic small firm
pancreas.Twenty six patients of TP underwent lateral
pancreaticojejunostomy and twenty five underwent
Frey’s procedure. Additional biliary bypass was done
in four cases. In 2 patients, pancreaticoduodenectomy
was done for head mass (turned out malignant). Only 7
patients of AP underwent surgery. Diabetes improved
in 70% patients, pain relief was 80–100% and weight
gain in 90% cases.
Conclusions: TP is not uncommon in North India and
is much different from AP. TP presents in early age
and surgery helps in relieving pain. Frey’s procedure
probably delays or stops futther damage of pancreatic
parenchyma.
PPP26-041
EN BLOC ARTERIAL RESECTION FOR
BORDERLINE RESECTABLE
PANCREATIC HEAD CARCINOMA
H. Kitagawa, H. Tajima, H. Nakagawara, I. Makino,
T. Miyashita, H. Terakawa, S. Nakanuma,
H. Hayashi, H. Takamura and T. Ohta
Kanazawa University, Japan
Introduction: Borderline resectable (BR) pancreatic
head carcinoma (PhC) is an advanced disease, with
infiltration of major vessels. Major vascular resection
(VR), especially arterial resection, to achieve micro-
scopic no residual tumor (R0) is controversial because
of potential complications. We aimed to clarify the
benefit of en bloc R0 resection with VR for PhC.
Method: We retrospectively evaluated 78 PhC patients
who underwent pancreatoduodenectomy at our insti-
tute. They were divided into 4 groups: resectable (R)
(20 patients), BR involving the superior mesenteric vein
or portal vein (BR-V) (28 patients), BR involving the
superior mesenteric artery (BR-SMA) (21 patients), and
BR involving the hepatic artery (BR-HA) (9 patients).
Results: Sixty-five patients underwent VR. Sixty-three,
21, and 9 patients underwent portal vein, SMA, and
HA resection, respectively. R0 rates were as follows: R
group, 85%; BR-V group, 82%; BR-SMA group, 71%;
and BR-HA group, 33%. Median survival time and 5-
year survival rate in R0 were as follows: R group, 31
months and 25%; BR-V group, 22 months and 28%;
BR-SMA group, 17 months and 27%; and BR-HA
group, 10 months and 0%, respectively. Prognosis was
comparable between the BR-V and BR-SMA groups
and the R group but significantly poorer in the BR-HA
group. Five (6.4%) patients died perioperatively (4,
postoperative hemorrhage and 1, suffocation by failure
of expectoration without pneumonia or asthma). Of the
4 patients with hemorrhage, 3 had undergone arterial
resection.
Conclusions: En bloc resection with major VR for R0
is suitable for BR-V and BR-SMA PhC, but not BR-
HA PhC.
PPP26-042
MODIFIED METHOD OF BUMGART’S
PANCREATICOJEJUNAL
ANASTOMOSIS WITH ONLY TWO-
TRANSPANCREATIC U SUTURE-
TECHNIQUE
M.J. Kim and K.Y. Hur
Soonchunhyang University Hospital Seoul, Korea
Introduction: Pylorus-preserving pancreaticoduodenec-
tomy (PPPD) is the standard method of treating benign
and malignant diseases of the pancreatic head and pe-
riampullary region. Although associated mortality rates
have significantly decreased in the past decades, mor-
bidity rates still remains high. Pancreatic fistula (PF)
has been a major source of the high morbidity rate
after PPPD. In addition, the existing methods of pan-
creaticojejunal anastomosis (PJA) are time-consuming
and wearisome. Transpancreatic U-suture PJA tech-
nique has been introduced by Blumgart and has made
incidence of PF decrease. We aimed to describe our
PJA technique which modified the Blumgart PJA and
to report the surgical outcomes about PF.
Method: We have performed 86 cases of PPPD since
2008 for treatment of various kinds of periampullary
diseases. Every PJA has been performed using only
two-transpancreatic U sutured technique which modi-
fied the PJA of Blumgart for outer layer of anastomo-
sis and duct-to-mucosa PJA with internal stent for
inner layer of anastomosis.
Results: According to the definition of PF by ISGPF,
there were 13 cases of Grade A PF (16%) after the sur-
gery. There was no grade B or C PF. And 3 delayed
gastric emptying which needed Levin tube drainage, 6
wound complications, and 10 abnormal fluid collections
not related to PF which needed to be drained have
occurred. There was no mortality related the surgery.
The mean hospital day after the surgery was 18 days.
Conclusions: The modified transpancreatic U-suture
technique with only two stitches and internal pancreatic
duct stent for PJA can be applied safely and feasibly in
terms of decreasing occurrence of PF after PPPD, but
further evaluation is mandatory.
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PPP26-043
MODIFIED BLUMGART ANASTOMOSIS
FOR PANCREATICOJEJUNOSTOMY
DECREASE RATE OF PANCREATIC
FISTULA: COMPARISON WITH
MODIFIED CATTELL-WALLEN
ANASTOMOSIS AND MODIFIED
KAKITA METHOD
T. Kojima, T. Niguma, T. Mimura, Y. Nishiyama,
Y. Akazai, T. Takahata, M. Kataoka, T. Kimura,
Y. Nitta and T. Ohara
Okayama Saiseikai General Hospital, Japan
Introduction: Pancreatic fistula (PF) from pancreat-
icojejunostomy is one of the most common complica-
tions after pancreatic head resection. Original Blumgart
anastomosis using transpancreatic U sutures has been
proposed to decrease the PF rates and its associated
morbidity. We have used this technique with minor
change. In this study, we compared a new anastomosis
technique with two conventional methods.
Method: Between January 2003 and August 2013, 300
patients at our institute underwent pancreatic head
resection by a total of 3 experienced surgeons. Modified
Blamgart anastomosis (BA) (n = 21) was compared
with modified Cattle–Wallen anastomosis (CWA)
(n = 103) and modified Kakita method (KM) (n = 176)
retrospectively.
Results: Three patient cohorts were similar with respect
to primary diagnosis, age, gender and pancreas texture.
There were no significant difference in operating time
and blood loss among 3 groups. There were no signifi-
cant difference in the drain fluid amylase level at post-
operative day 1 and 3 among three groups, however,
the PF rates (BA, 0% vs CWA, 21%; p = 0.026; BA vs
KM, 27%; p = 0.011) was significantly low in BA
group. No patient in BA group developed pancreatic
fistula grade B or C. Overall postoperative major com-
plications (BA, 5.3% vs CWA, 22.3%; p = 0.05; BA vs
KM, 31.2%; p = 0.02) and postoperative hospital stay
(BA, median 22.5 days vs CWA, 34 days; p = 0.004;
BA vs KM, 29.5 days; p = 0.04) were significantly
reduced in BA groups. There were 2 and 3 postopera-
tive death due to a PF-related complications in CWA
and KM groups respectively, while no patients in BA
group.
Conclusions: BA significantly decreased PF rates and
postoperative complication. BA appears to be a simple
and safe procedure for pancreaticojejunostomy.
PPP26-044
ROBOTIC-ASSISTED DISTAL
PANCREATECTOMY: A CASE SERIES
J. Wong, K.-F. Lee, C.C.-N. Chong, Y.-S. Cheung and
P.B.-S. Lai
The Chinese University of Hong Kong, Hong Kong,
China
Introduction: Robotic surgery is being used increas-
ingly. Its benefits over conventional laparoscopic tech-
nique include provision of a 3-dimentional magnified
view, increased freedom of instrument movement,
reduced operator fatigue and elimination of tremor.
This is particularly helpful in pancreatic surgery which
requires fine dissection. We retrospectively reviewed the
cases of robotic distal pancreatectomy in our centre
from March 2011 to August 2013.
Method: Nine patients (4 males; 5 females) underwent
robotic distal pancreatectomy, with concomitant sple-
nectomy performed in 8 of them. Operations were per-
formed by the same team of HPB surgeons with a
similar technique. Two to three robotic arms with 2
accessory ports were placed. Upon entering lesser sac,
the upper and lower borders of pancreas were dis-
sected. In cases where splenectomy was needed, liga-
ments around the spleen were divided. Splenic artery
and vein were transfixed individually. Pancreatic body
was transected by vascular stapler or diathermy scis-
sors; and transection surface further secured by sutures.
Tissue-glue was applied and a drain was placed in all
cases.
Results: The median blood loss was 300 mL (range 50–
1770), median operating time was 400 minutes (range
247–480). One case (11%) required conversion to open
because of bleeding. The median hospital stay was
6 days (range 4–8). There was no operative mortality.
Pancreatic fistulation occurred in two cases (22%),
both managed by endoscopic drainage. Pathology
included neuroendocine tumours (n = 3), adenocarci-
noma (n = 1), serous cystadenoma (n = 1), metastatic
hepatocellular carcinoma (n = 1), metastatic renal cell
carcinoma (n = 1), intraductal papillary mucinous neo-
plasm (n = 1) and lymphoepithelial cyst (n = 1). The
median tumour size was 2 cm (range 1–6). Clear pan-
creatic resection margins were achieved in all cases.
Conclusions: Robotic-assisted distal pancreatectomy for
removal of pancreatic tumour is safe and feasible. The
use of robot enhances the conventional laparoscopic
approach for distal pancreatectomy.
PPP26-045
THE CLINICAL FEATURE AND
NURSING STRATEGIES OF
FUNCTINOAL DELAYED
GASTRICEMPTYING AFTER
PANCREATIC OPERATION
C. Yanshuang and P. Hongying
The General Hospital of Chinese People’s Liberation
Army, China
Introduction: To summarize the clinical feature and
nursing strategies of functional delayed gastric empty-
ing (FDGE) after pancreatic operation.
Method: Analyzed the reason of ten cases of FDGE
after pancreatic operation, and summarized the charac-
teristics of FDGE.
Results: Ten patients occurred FDGE, the mean time
of FDGE was 6.2  3.1 days after gastrointestinal
decompression stopping. Eight cases of FDGE
occurred in 4.3  2.3 days after taking liquid diet.
During the period of FDGE, the lowest amount of the
gastrointestinal decompression drainage was 320 mL,
the highest was 1540 mL, and the mean was
578  446 mL. The mean amount was 176  168 mL
before the gastric tube was pulled out.
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Conclusions: The key points to promote the early
recovery of the patients with FDGE were properly diet
guidance especially 3 to 5 days after taking liquid diet,
scientific nutritional support, closely observation of
gastrointestinal decompression drainage, early detection
and early treatment.
PPP26-046
VASCULAR RESECTION DURING
PANCREATIC SURGERY.
PERIOPERATIVE RESULTS AND
LONG-TERM SURVIVAL
F. Leon, J.P. B€achler, J.F. Guerra, M. Gabrielli,
J. Martınez and N. Jarufe
Pontificia Universidad Catolica de Chile, Chile
Introduction: Pancreatic surgery (PS) traditionally has
been associated with significant perioperative morbid-
ity. Eventually it is needed to perform vascular resec-
tions (VR) due to tumoral invasion, with uncertain
perioperative results and long-term survival.
Aim: to analyze perioperative results and long-term
survival of patients submitted to VR during PS in our
institution.
Method: Retrospective analysis of our PS database,
between 2005 and 2013. Patients submitted to VR dur-
ing PS were described. Perioperative results and long-
term survival were analyzed using non-parametrics tests
and Kaplan Meier.
Results: During this period, 210 cases of PS were per-
formed, 14 (6%) including VR. Mean age was 59 yo
(40–89). The indication for surgery was malignancy in
86%, mainly pancreatic adenocarcinoma. Non-malig-
nant indications for VR were PSC in one case and a
pseudopapillary tumor in another. All operations were
performed by open approach, 72% Whipple’s proce-
dure and 28% distal pancreatectomies. Regarding to
VR, 71% included superior mesenteric vein and 29%
portal vein. In 86% the reconstruction was performed
with primary suture of the vein defect and 2 cases
required a PTFE vascular graft. There were no intraop-
erative complications. Median in-hospital stay was
14 days (6–77). 36% of patients developed postopera-
tive complications, including three cases of pancreatic
fistula (one type A, one type B and one type C). One
patient required a reoperation, due to a biliary fistula.
Pathologic specimen revealed vascular invasion of
tumor in only two patients (17% of oncologic patients).
Median survival of the series was 35 months.
Conclusions: VR is frequently performed in patients
with infiltrative disease, however real vascular invasion
is seldom found in surgical specimen. Despite being
more aggressive and challenging technique, VR is not
associated with impaired perioperative results or long-
term survival in this series. These results confirm the
feasibility and safety of VR during PS in case of suspi-
cion of infiltrative disease.
PPP26-047
THE ROLE OF CT IN THE
EVALUATION OF THE STRUCTURAL
CHANGES IN THE PANCREAS IN
CHRONIC PANCREATITIS AGAINST
SURGICAL, ENDOVASCULAR AND
CONSERVATIVE TREATMENT
T. Kharlamova
Radiologist, Russia
Introduction: The article deals with the analysis of
diagnosis and the dynamic assessment of CT changes
in patients with chronic pancreatitis treated by opera-
tive, conservative and endovascular methods. Investiga-
tion of changes in the pancreas, based on a set of
symptoms characteristic of the different severity of
chronic pancreatitis is relevant diagnosis and can lar-
gely help in selection of treatment. CT helps to assess
not only the quantitative and qualitative characteristics
of pancreatic parenchyma changes due to the calcula-
tion of the X-ray density in units Haundsfild.
Method: The study was conducted in 117 patients with
chronic pancreatitis. Pancreas underwent CT before
and after treatment (surgical, endovascular and conser-
vative) without and with contrast bolus enhancement
nonionic low-osmolar agent. Was used as the standard
algorithm description of the pancreas and developed by
us. Included determination of parameters such as spe-
cific gravity and index compression. On the basis of the
results was performed treatments: surgical and endo-
vascular conservative.
Results: The results were evaluated according to the
Cambridge classification and changes introduced by the
new parameters.In patients after surgical treatment
remain mild parenchymal changes of the stump pan-
creas, remains low specific density and poor growth
index seal. Following the suspension of the regional
infusion of hydrocortisone showed positive dynamics,
the index increased compaction and specific gravity.
Standard medical therapy does not provide complete
relief of inflammation, leading to progression of the
disease and the development of complicated.
Conclusions: In patients after the surgical treatment the
CT signs of chronic pancreatitis restore in the stump of
pancreas. The most significant regression of pathologi-
cal symptoms has been observed after the endovascular
treatment. The indicators of absolute and relative den-
sity have been normalized. The use of conservative
methods of treatment doesn’t influence on CT dynam-
ics of chronic pancreatitis.
PPP26-048
SARCOPENIA IN PATIENTS
UNDERGOING SURGERY FOR
PANCREATIC CARCINOMA – DOES IT
INFLUENCE POSTOPERATIVE
OUTCOMES?
M. Coolsen, M. Bakens, M.De Jong, D.Van Dijk,
R.Van Dam, K. Dejong and S.O. Damink
Maastricht University Medical Centre, Netherlands
Introduction: The influence of sarcopenia, defined as
depletion of muscle mass, on postoperative short-term
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outcomes following pancreatic surgery and its effects
on postoperative infectious complications remains
undefined and is therefore the aim of the present study.
Method: All patients scheduled to undergo a pancreati-
coduodenectomy (PD) for malignancy between July
2008 and August 2012 were included. Sarcopenia was
assessed according to established methods; a cutoff
value of 55.4 cm2/m2 in men and 38.9 cm2/m2 in
women was used to define sarcopenia. Patient charac-
teristics and postoperative complications were prospec-
tively collected and subsequently analysed.
Results: 154 patients were enrolled. 95 patients under-
went a PD, 59 received a double bypass (DB) because
of irresectability. 91/154 patients (59.1%) were classi-
fied as sarcopenic. 90-day-mortality was higher in sar-
copenic patients (n = 11 (7.1%) vs n = 1 (0.6%);
p = 0.02). Infectious complications occurred in 59/154
patients (38.1%) and overall complications in 79/154
patients (51.3%). Of the total group, significantly more
patients with sarcopenia developed infectious complica-
tions (n = 41 (26.6%) vs n = 18 (11.7%);p = 0.04);
while the occurrence of overall complications was com-
parable (n = 51 (33.1%) vs n = 28(18.2%); p = 0.15).
Significantly more sarcopenic patients developed infec-
tious as well as overall complications after PD (n = 31
(32.6%) vs n = 11 (31.6%); p = 0.009 and n = 37
(38.9%) vs n = 17 (17.9%); p = 0.03, respectively). No
differences in complications were observed in the DB
group (all p > 0.05). On univariate analysis but not on
multivariate analysis, sarcopenia was found to increase
the risk of infectious complications (OR = 2.1 [95%-CI
1.0–4.1]; p = 0.04), On multivariate analysis, obesity
(OR = 2.3 [95%-CI 1.2–4.7]; p = 0.01) and undergoing
a PD (vs DB: (OR = 2.2 [95%-CI 1.0–4.6]; p = 0.04))
were associated with an increased risk of infectious
complications.
Conclusions: 90-day mortality seems higher in sarcope-
nic patients. However, due to low incidence further
analysis was not possible. Whereas sarcopenia might
negatively impact short-term outcomes, its real effects
remain ill-defined. Conversely, obesity and undergoing
a pancreaticoduodenectomy were found to be indepen-
dent predictors of postoperative morbidity.
PPP26-049
LAPAROSCOPIC MEDIAN
PANCREATECTOMY FOR SELECT MID
BODY TUMORS OUR INDICATIONS,
TECHNIQUE AND RESULTS
S. Palanisamy, V.P.Nalankilli, S. Balamuralii,
R. Parthasarathy, P. Chinnusamy and S. Srivatsan
GEM Hospital and Research Centre, Coimbatore, India
Introduction: Conventional pancreatic resections may
be unnecessary for mid body tumors of the pancreas
that are benign or of low malignant potential. Median
pancreatectomy is an option that has been investigated
in the management of such tumors. Our objective of
this study is to evaluate the feasibility and safety of
laparoscopic median pancreatectomy.
Method: 14 patients including 8 females and 6 males,
age group ranging from 13 to 79 years underwent lapa-
roscopic median pancreatectomy during the period of
October 2003 to October 2012. All patients underwent
CT scan of the abdomen. Tumours located in the body
of pancreas were chosen, tumours more than 3 cm or
with suspicion of malignancy were excluded.
Results: Tumours included 10 mucinous cystadenomas,
4 serous cystadenomas. The proximal pancreatic rem-
nant was suture ligated. The distal pancreatic end was
anastomosed to a Roux-en-Y jejunal loop. The mean
operative time was 240 minutes. Mean blood loss was
around 160 mL (range 30–320 mL). Mean Post op
ICU stay was one day and overall hospital stay was
around 4.5 days. There were no mortalities, no major
post op complications, however 2 patients had a pan-
creatic fistula ISGPF Grade A and were managed con-
servatively. Margins were negative in all cases and with
a mean follow up of 2 years no recurrence has been
reported till date.
Conclusions: Laparoscopic central pancreatectomy is a
feasible and safe procedure which preserves the paren-
chymal function. The minimally invasive approach
ensures an adequate treatment despite requiring the
expertise of highly skilled laparoscopic surgeons.
PPP26-050
UNUSUAL CASE OF
INTRAPANCREATIC CYSTIC
NEOPLASM, CASE REPORT
G. Miranda, A. Padilla/Rosciano, H. Lopez/Basave,
N. Reyes, M. Robles and J.M. Ruiz/Molina
National Cancer Institute Mexico, Mexico
Introduction: Cystic pancreatic lesions are becoming
increasingly recognized with improvements in diagnos-
tic imaging. Among them, cystic neoplasms represent
only a minority of pancreatic cystic lesions. The distinc-
tion between nonneoplastic pseudocysts and cystic neo-
plasms is critical, because some cystic neoplasms,
including mucinous cystic neoplasms (MCNs), progress
to invasive carcinoma.
Method: Postpartum Female patient, 29 years of age
which began 15 months clinical picture prior to testing
at the National Cancer Institute, characterized by
enlargement of the left upper quadrant and epigastric
pain accompanied by partially disappears analgesics
intake specified.
Physical examination revealed no lymphadenopathy in
the neck, abdomen with approximately 25 9 20 cm
tumor involving all partially fixed upper quadrant and
left flank, soft, painless, no peritoneal irritation.
Within the study protocol was reporting Computed
Tomography, 21 9 16 9 13 cm tumor involving upper
quadrant and left flank cystic characteristics with multi-
ple thick septa that enhance with contrast, presents
solid component in the lower pole. Endoscopic USG;
tracking duodenal pancreatic head and uncinate pro-
cess and unaltered biliary ampulla without being
affected, body and tail of the pancreas with injury that
exceeds the field of heterogeneous liquid content dis-
play with multiple septa. Refuses to structures such as
the spleen, kidney and large vessels. No lymph
observed hepatic hilum level. Normal Laboratories.
Results: Were subjected to total splenectomy and distal
pancreatectomy with final pathology report mucinous
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cystic neoplasm of the pancreas, with immunopheno-
typing focal foveolar and intestinal Adenocarcinoma
pancreatoduodenal intracystic type, surgical margins
without neoplasia.
Conclusions: Tumor size and postpartum presentation
are unusual presentations in these tumors.
PPP26-051
SEROUS CYSTADENOCARCINOMA
WITH SOLID GROSS APPEARANCE
O. Kainuma, H. Yamamoto, A. Cho,
Y. Muto and H. Yanagibashi
Chiba Cancer Center, Japan
Introduction: Serous cystic neoplasms (SCN) of the
pancreas are regarded as a benign entity with rare
malignant potential. Characteristically the tumors are
comprised of multiple microcysts lined by cuboidal cells
with clear glycogen-rich cytoplasm. However, some
variants in gross appearance such as macrocystic or
solid type have been reported. Recently we experienced
a case of solid type of serous cystadenocarcinoma with
liver metastases. To clarify specific clinical features of
serous cystadenocarcinoma, we reviewed this rare dis-
ease reported in the literatures.
Method: A 69-year-old man complained of epigastric
discomfort. A CT scan revealed 5cm well-enhanced
mass at the pancreas body and multiple wedge-shaped
hypervascular lesions in the liver. Based on imaging,
this case was initially diagnosed as pancreatic neuroen-
docrine tumor. A systematic review of the literature
was performed utilizing PubMed. Twenty-four articles
including thirty patients were analyzed.
Results: The patient was histologically identified as
solid variant type of SCN after distal pancreatectomy.
During 14 months follow-up, size and number of liver
tumors did not changed. Then laparoscopic liver resec-
tion was performed for histological confirmation as
liver metastases.
Literature review showed that the mean age of the
patients was 68 years, with 65% being female. Tumor
location was head 21%, body and tail 67%, and entire
pancreas 12%. Average size of the tumor was 9.3 cm.
Gross appearance of the cut surface was microcystic in
most cases, however, was not solid in any case. Syn-
chronous and metachronous liver metastases were
observed in seven cases each. The prognosis was excel-
lent even in metastatic disease.
Conclusions: To our knowledge, this is the first case of
solid type of serous cystadenocarcinoma of the pan-
creas. Accurate diagnosis of variant type of SCN is still
difficult. SCN has a small but finite risk of malignancy.
We should manage the surgical treatment considering
malignant SCN is slow-growing tumor.
PPP26-052
IMMUNOHISTOCHEMICAL ANALYSES
OF THYROID TRANSCRIPTION
FACTOR-1 EXPRESSION DISTINGUISH
BETWEEN PRIMARY PULMONARY
ADENOCARCINOMA AND
METASTASIS OF PANCREATIC
DUCTAL ADENOCARCINOMA
K. Takano, M. Minagawa, K. Takizawa, J. Sakata,
T. Kobayashi and T. Wakai
Niigata University Graduate School of Medical and,
Japan
Introduction: Isolated pulmonary metastasis after cura-
tive resection for pancreatic ductal adenocarcinoma
(PDAC) tends to occur in the long term survivor. How-
ever, pulmonary metastasis is rarely confirmed histolog-
ically with surgical specimen. We report herein two
cases with the isolated pulmonary metastasis after cura-
tive pancreatectomy. Recently, thyroid transcription
factor-1 (TTF-1) has been regarded as a reliable marker
for primary pulmonary adenocarcinoma. This study
evaluates the expression of TTF-1, CK7 and CK20 im-
munohistochemically in the specimens to elucidate
whether pulmonary tumor was primary or metastasis.
Method: Two females underwent pulmonary resection
after curative pancreatectomy, followed by adjuvant
gemcitabine chemotherapy. Disease-free interval was 26
and 37 months, respectively. Immunohistochemistry of
the resected specimens was conducted using each of the
following primary antibodies against TTF-1, CK7 and
CK20.
Results: One patient underwent partial resection of the
lung, whereas the other underwent pulmonary
lobectomy. There were no in-hospital mortalities or
complications after pulmonary resection. Immunohisto-
chemical examination revealed that the pulmonary
tumor was metastasis from PDAC because tumor cells
were negative for TTF-1 and positive for CK7 and
CK20 in two cases. After pulmonary resection, they
received gemcitabine and S-1 combination therapy. One
patient died of peritoneal metastasis 58 months after
initial pancreatectomy. The other patient undergoing
pulmonary lobectomy was still alive 120 months after
initial pancreatectomy, whereas she underwent second
pulmonary resection for another pulmonary metastasis
51 months after initial pulmonary resection. They
obtained relatively long-term survival after initial pan-
createctomy since they received appropriate chemother-
apy based on diagnosis of recurrence from PDAC.
Conclusions: Immunohistochemical analyses of TTF-1
expression are useful for distinguishing between pri-
mary pulmonary adenocarcinoma and metastasis of
PDAC and histological confirmation is important for
appropriate chemotherapy.
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 2), 603–697
684 Poster Panel [Pancreas]
PPP26-053
PANCREATIC ADENOCARCINOMA:
ANALYSIS OF THE RESULTS OF
CEPHALIC
PANCREATICODUODENECTOMY
VERSUS TOTAL
PANCREATICODUODENECTOMY
S. Sanchez-Cabus, J. Sampson, D. Saavedra-Perez,
M. Cubel, D. Calatayud and L. Fernandez-Cruz
Hospital Clınic de Barcelona, Spain
Introduction: Pancreatic cancer in the head of the pan-
creas is currently managed by Cephalic pancreaticoduo-
denectomy (CPD) and in selected cases, by total
pancreaticoduodenectomy (TPD). The aim of this study
is to evaluate the results of patients with pancreatic
head adenocarcinoma treated by CPD vs TPD in the
Hospital Clınic de Barcelona.
Method: Patients operated on for adenocarcinoma of
the pancreatic head from 2007 to 2013 were retrospec-
tively studied, comparing between CPD and TPD.
Overall surgical complications (Clavien-Dindo score),
pancreatic fistulae (ISGPF) as well as non-pancreas
related complications (ISGPS score) were analyzed.
Results: 97 patients were included, 76 in the CPD
group, 21 in the TPD group. Most postoperative com-
plications were minor (grade I:7; II:42; IIIa:7; IIIb:4;
IVa:3; IVb:3; V:5). Overall mortality was 5.15%. Sur-
vival at 1, 3 and 5 years was 70.1%, 36.2% and 14.3%,
respectively. Comparisons between CPD and TPD
groups showed significant differences in preoperative
ASA score (CPD patients having lower surgical risk
(p = 0.021)) and lower rate of preoperative diabetes
(18.4% vs 42.8%, p = 0.02). Clinically relevant pancre-
atic fistulae occurred in 11 patients in CPD group
(grade B: 10.6%, grade C: 3.9%). Analysis of complica-
tions between groups only showed statistical differences
in pancreatic fistula, but no differences regarding hospi-
tal stay, delayed gastric emptying, hemorrhage, biliary
fistula, infection and respiratory complications. No sig-
nificant differences were found in Clavien-Dindo classi-
fication between CPD and TPD patients. Survival was
similar in both groups.
Conclusions: This study shows that no differences were
found between CPD and TPD groups in the postopera-
tive outcome, despite TPD patients had higher surgical
risk. No differences between patient survival were
found between groups.
PPP26-054
PANCREATICOPLEURAL FISTULA: AN
UNUSUAL CAUSE OF PERSISTENT
PLEURAL EFFUSION
M.J. Fuertes, M.D. Poveda, G.D. Garcıa,
A.M. Pozuelo, D.A. Jimenez, C. Nevado, P.A. Pe,
E.R. Cuellar, A.M. Posadas and J.G. Gonzalez
Rey Juan Carlos Hospital, Spain
Introduction: There are multiple causes of recurrent
pleural effusion. Pancreaticopleural fistula (PPF) is a
rare entity. It is usually manifested by respiratory
symptoms secondary to pleural effusion. Initial treat-
ment should be medical, consisting of the inhibition of
exocrine pancreatic secretion with octreotide, with or
without stent in the pancreatic duct, surgery being a
final option. We report the case of recurrent and mas-
sive pleural effusion resulting from a pancreaticopleural
fistula in a patient with chronic pancreatitis.
Method: 63-year-old male complaining of progressive
dyspnea, cough and fever with a history of chronic
pancreatitis. A chest X-ray was performed, revealing a
massive left pleural effusion and thoracentesis in which
12400 IU/L of amylase in the pleural fluid stood out.
Suspicion of a parapneumonic effusion led to medical
treatment, which produced no positive result. Given the
recurrent pleural effusion, a thoracic-abdominal CT
was performed revealing a pancreatic pseudocyst with a
collection extending from the pancreas to the subphren-
ic space, associated with massive left pleural effusion.
These findings indicated the presence of a pancreatico-
pleural fistula.
Results: An ERCP and medical treatment were initi-
ated aimed at stenting the pancreatic duct, but this was
not possible for technical reasons. The patient showed
no improvement, prompting a surgical intervention,
which revealed a 2 cm diaphragmatic orifice exposing
the pseudocyst to the pleural cavity and constituting
the pancreaticopleural fistula. A distal pancreatectomy
was performed, as well as closure of the left diaphrag-
matic orifice, followed by pleural drainage. The pleural
drain was removed on the third post-operative day,
and the patient was discharged on the sixth. The
patient remained asymptomatic 2 years following the
intervention.
Conclusions: PPF is a rare entity. Initial treatment
should be medical with chest drainage, although there
are studies supporting early surgical intervention since
this reduces recovery time and has a higher success
rate.
PPP26-055
NEW CLASSIFICATION OF CHRONIC
PANCREATITIS (CP) BASED ON
CRITERIA OF PANCREAS HARDNESS
AND CHARACTER OF CP
COMPLICATIONS
E.I. Galperin1, T.G. Dyuzheva1, I.A. Semenenko1, A.E.
Kotovskiy1, V.N. Sholokhov2, A.A. Ivanov1, A.N.
Kovalevskaya1, S.N. Berdnikov2 and M.S. Makhotina2
1I.M. Sechenov First Moscow State Medical University,
Russia; 2N.N. Blokhin Russian Cancer Research Center,
Moscow, Russia
Introduction: We aimed to develop a classification of
CP on the basis of the integral simple sign’s selection,
which allows determining the severity of CP and differ-
entiated approach to the treatment of patients.
Method: Duodenum preserving pancreatic head resec-
tion (DPPHR) was performed in 105 pts (in 95 pts with
longitudinal pancreaticojejunoanastomosis (PJA)). 74
pts with acute obturation of the main pancreatic duct
(MPD) and 115 pts with complicated pancreatic pseud-
ocysts were subjected to endoscopic interventions and
traditional surgery. “Hardness” was assessed by intra-
operative palpation of pancreas, elastometry and dual-
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phased CT, histological study of resected pancreas tis-
sue.
Results: There was a direct correlation of pancreas
“hardness” with pancreatic fibrosis (R = 0.45;
p < 0.001) and significant differences in the duration of
CP, the presence of jaundice, portal hypertension, duo-
denostasis, diabetes, steatorrhea, postoperative compli-
cations, depending on the degree of pancreas
“hardness” (p < 0.05). A direct correlation between pal-
pable pancreas “hardness” and elastometry parameters
(R = 0.75; p < 0.01), between parameters of elastome-
try and dual-phased CT (R = 0.73; p < 0.05) have been
revealed. The results of operations depended on the
kind of CP complication. Classification of Chronic
Pancreatitis. A-Soft CP - conservative treatment.
B-Hard CP (total, head, body, tail) - operative treat-
ment accordingly to localization: DPPHR and/or PJA.
C*-Hard complicated CP - operative treatment.
C1.Compression of adjacent organs by PH–
DPPHR + choledochopancreatoanastomosis or hepati-
cojejunoanastomosis; gastroenteroanastomosis.
C2.Acute MPD obturation - draining, lithoextraction,
stenting etc. DPPHR and/or PJA (1-st or 2-nd stage).
C3.Complicated pseudocyst - draining, vascular emboli-
zation, pancreas resection. DPPHR and/or PJA,
DPPHR and/or cystopancreaticojejunoanastomosis (1-
st or 2-nd stage). *Soft complicated CP - urgent resto-
ration of MPD patency or pseudocyst sanation.
Conclusions: The major integral sign that determines
the severity of CP, clinical symptoms, morphological
and functional pancreas disorders, the choice of treat-
ment, the operation possibility, its volume, and the sub-
sequent prognosis is pancreas “hardness”. The specific
operation selection depends on the localization of pan-
creas “hardness” and the type of the CP complications.
PPP26-056
A NOVEL POSTOPERATIVE
INFLAMMATORY SCORE PREDICTS
POSTOPERATIVE PANCREATIC
FISTULA AFTER PANCREATIC
RESECTION
Y. Fujiwara, T. Misawa, H. Shiba, Y. Shirai,
R. Iwase, K. Haruki, K. Furukawa, T. Iida,
Y. Futagawa and K. Yanaga
The Jikei University School of Medicine, Japan
Introduction: The aim of this study is to characterize a
high-risk group for postoperative pancreatic fistula
(POPF) after pancreatic resection using postoperative
clinical variables of the patients.
Method: The retrospective study included 297 patients
who underwent pancreatic resection between January
2001 and December 2011. We examined the relation-
ship between perioperative findings and the incidence
of POPF among patients who underwent pancreatic
resection between 2001 and 2009 (early period). Next,
patients were stratified into three groups using serum
albumin and CRP on postoperative day (POD) 1
(Score 0: albumin ≥2.7 g/dL and CRP ≤10 mg/dL,
Score 1: albumin <2.7 g/dL or CRP >10 mg/dL, Score
2: albumin <2.7 g/dL and CRP >10 mg/dL) as Postop-
erative Inflammatory Score (PIS). We examined periop-
erative findings including PIS and POPF among
patients who underwent pancreatic resection between
2010 and 2011 (late period).
Results: In univariate and multivariate analyse, male
gender (p = 0.032), postoperative serum albumin on
POD 1 (p = 0.024) and postoperative serum CRP on
POD 1 were identifical as independent risk factors for
POPF in early period patients. In univariate and multi-
variate analyse, postoperaive hospital stay (p = 0.009)
and PIS (score 1: p = 0.005, score 2: p = 0.017) were
identifical as independent risk factors for POPF in late
period patients.
Conclusions: We have identified a novel PIS as risk fac-
tors for POPF after elective pancreatic resection.
PPP26-057
THE SAFETY AND EFFICIENCY OF
BLUMGART ANASTOMOSIS IN THE
PANCREATICOJEJUNOSTOMY AFTER
T.-Q. Song, X.-J. Zhang, W. Zhang, T. Zhang,
Y.-L. Cui and Q. Li
Tianjin Medical University Cancer Institute and
Hospital, China
Introduction: Postoperative pancreatic fistula (POPF)
remains a leading cause of morbidity and mortality
after pancreaticoduodenectomy (PD). Thus, a number
of technical modifications regarding the pancreatoenter-
ic anastomosis after PD have been proposed to reduce
POPF rate. Until now, there is no consensus regarding
the best management. This study aims to evaluate the
safety and efficiency of Blumgart anastomosis in pan-
creaticojejunostomy after PD.
Method: A total of 205 patients who underwent PD
between January 2011 and February 2013 were retro-
spectively studied. The patients were divided into three
groups depending on the pancreaticoenteric reconstruc-
tion: Blumgart anastomosis group (n = 37), duct-to-
mucosa anastomosis group (n = 39) and invagination
group (n = 129). Patients’ basic characteristics were
similar, including age, pancreatic texture, and pancre-
atic main duct size. Postoperative mortality and mor-
bidity were analyzed.
Results: With regard to POPF, there were 3 cases (2
grade A and 1grade B) in the Blumgart anastomosis
group, 9 (6 grade A, 2 grade B and 1 grade C) in the
duct-to-mucosa anastomosis group, and 39 (22 grade
A, 12 grade B and 5 grade C) in the invagination anas-
tomosis group. Significant differences were found
among these three groups (p < 0.05). Multivariate
analysis revealed soft pancreatic texture, pancreatic
duct diameter <3 mm and Blumgart anastomosis as the
independent risk factors for POPF. In subgroup analy-
sis, Blumgart anastomosis was superior to duct-to-
mucosa anastomosis in patients with pancreatic duct
diameter <3 mm (p = 0.038), and showed an advantage
over invagination anastomosis in patients with soft
pancreatic texture (p = 0.001), as well as in patients
with pancreatic duct diameter <3 mm (p = 0.011).
Conclusions: As a safe technique, Blumgart anastomo-
sis could significantly reduce the rate of POPF and
should be routinely used for pancreatoenteric recon-
struction after PD.
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PPP26-058
SOLID PSEUDOPAPILLARY TUMOR
OF THE PANCREAS: A POPULATION-
BASED COMPARISON WITH
PANCREATIC ADENOCARCINOMA
G. Paul Wright1, B. Goslin1 and M. Chung2
1GRMEP/MSU General Surgery Residency Program,
USA; 2Spectrum Health Medical Group, USA
Introduction: Solid-pseudopapillary tumor of the pan-
creas (SPTP) is a rare neoplasm that has been investi-
gated only in individual case series from single
institutions. We sought to identify characteristics of
these tumors and compare outcomes with pancreatic
adenocarcinoma (PA) using a national database.
Method: A query of the Surveillance Epidemiology and
End Results database was made for patients with malig-
nant SPTP and PA from 2001 to 2010. Demographic,
staging, treatment, and survival data were obtained for
both groups. The primary outcome measure was 5-year
overall survival. A Cox regression analysis was per-
formed using age group, gender, and stage to identify
independent variables associated with survival.
Results: One hundred seven patients with SPTP and
53,353 PA were identified for study. For patients with
SPTP, 74.8% were under age 50 (6.3% for PA,
p < 0.001), 82.2% were female (48.6% for PA,
p < 0.001), and 69.2% were white (81.2% for
PA, p < 0.001). SPTPs were more frequently located in
the tail than PA (46.7% vs. 11.8%, p < 0.001), more
often stage I (57.3% vs. 5.6%, p < 0.001), and were
more likely to undergo surgical treatment (79.5% vs.
13.6%, p < 0.001). Nodal involvement was only seen
in 8.4% of patients with SPTP. Overall 5-year survival
was 84.7% for SPTP and 2.8% for PA. When selecting
out patients who underwent surgical treatment, 5-year
overall and cancer-specific survival were 92.7% and
95.9% for SPTP and 13.5% and 16.7% for PA, respec-
tively.
Conclusions: SPTP is a rare pancreatic neoplasm found
more commonly in young women and associated with
a significantly more favorable prognosis than PA.
PPP26-059
IDENTIFICATION OF THE RISK
FACTORS OF PANCREATIC EXOCRINE
INSUFFICIENCY AFTER
PANCREATODUODENECTOMY USING
13C-LABELED MIXED TRIGLYCERIDE
BREATH TEST
S. Hirono1, Y. Murakami2, M. Tani1, M. Kawai1,
K.-I. Okada1, K. Uemura2, T. Sudo2 and
Y. Hashimoto2
1Wakayama Medical University, Japan; 2Hiroshima
University, Japan
Introduction: There are only a few reports concerning
long-term pancreatic exocrine function after pancreato-
duodenectomy (PD), although the number of long-term
survivors has increased. We assessed pancreatic exo-
crine function after PD in 189 patients to identify risk
factors for exocrine insufficiency.
Method: The present study included 90 patients that
underwent pancreaticogastrostomy (PG) at Hiroshima
University Hospital and 99 patients that underwent
pancreaticojejunostomy (PJ) at Wakayama Medical
University Hospital, the standard reconstruction tech-
niques during PD at the respective hospitals. We evalu-
ated patients’ exocrine function by using the 13C-
labeled mixed triglyceride breath test, a noninvasive test
feasible in outpatient service units. We also analyzed
long-term morphological changes of remnant pancreas
by computed tomography (main pancreatic duct dila-
tion and parenchymal atrophy), nutritional status
(body weight change, serum total protein, albumin, tri-
glyceride, and total cholesterol, and prognostic nutri-
tion index by calculating as 10 9
albumin + 0.005 9 total lymphocyte count), and endo-
crine function after PD.
Results: The independent risk factors for the exocrine
insufficiency after PD include hard pancreas (p = 0.003,
odds ratio; 3.157) and PG reconstruction (p = 0.040,
odds ratio; 2.321). The results of the breath test were
significantly correlated with postoperative morphologi-
cal changes, nutritional status, and endocrine function.
The atrophic changes of the remnant pancreas in the
PG group were more severe than those in the PJ group
(p < 0.01). Furthermore, for patients with a soft pan-
creas, the postoperative body weight changes
(p = 0.02), prognostic nutritional index (p < 0.01),
serum total protein levels (p = 0.01) as well as exocrine
test were worse in the PG group, compared with the PJ
group.
Conclusions: Our results showed that PJ reconstruction
might be superior to PG during PD, from the view-
point of long-term pancreatic exocrine function,
although further prospective studies are needed.
PPP26-060
ADVANCED PANCREATIC CANCER IN
A PATIENT TREATED FOR COLO-
RECTAL CANCER – CASE REPORT
F. Kurti1, P. Kristani2, S. Taci1 and J. Basho1
1University Hospital Center “Mother Theresa”, Albania;
2Durres Hospital, Albania
Introduction: Pancreatic cancer is one of the leading
causes of cancer mortality. It’s incidence increases with
age, slightly more in men than women. Less than 20%
live longer than 1 year.
Method: We present a case of a female patient who
was diagnosed with a colo-rectal cancer. The cancer
was staged as pT-3, N-0, M-0, G-2, R-0. He underwent
a surgical intervention with colo-anal anastomosis.
Than he was treated with neoadjuvant chemotherapy:
5-FU and radiation. He was followed –up at the outpa-
tient clinic of surgery. Two years later the patient com-
plaint of back pain. A CT scan was performed, which
found a solid lesion of the body of the pancreas with
peripancreatic and truncus celiacus infiltration. Multi-
ple liver metastes were found. A thoracic CT scan
revealed metastatic lesions of both lungs, 7–8 mm in
diameter. In these conditions the clinical diagnosis was
made: Pancreatic cancer with pulmonary and liver
metastatis, diabetes mellitus.
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Results: The stratification of the cancer showed a Stage
4 B, non resecable. The celiac plexus was accessed per-
cutaneosly. It was decided that the patient will be trea-
ted with paliative chemotherapy with gemcitabine
1000 mg/m2 weekly for up to 7 weeks followed by
1 week rest: then weekly for 3 weeks out of every
4 weeks, plus ondasentron for the nausea and vomit-
ing.
Conclusions: Adenocarcinomas of the body of the pan-
creas usually do not obstruct the intrapancreatic por-
tion of the common bile duct, early diagnosis is rare;
the vast majority have locally advanced or metastatic
disease at the time of presentation. The diagnosis of
pancreatic cancer, however, is typically made radio-
graphically. Celiac plexus neurolysis may maintain the
quality of life better than alternative treatments. Gem-
citabine is an option for treatment of patients with
poor performance status and/or pain or for manage-
ment of metastatic disease. The prognosis is poor.
PPP26-061
PREDICTIVE FACTORS OF SEVERITY
AND MORTALITY IN ACUTE
PANCREATITIS, ROLE OF BISAP
SCORE
F. Kurti1, A. Duni2, V. Shpata2 and J. Basho1
1QSUT, Albania; 2Faculty of Medical Technical
Sciencies, Albania
Introduction: Acute pancreatitis (AP) is a sudden
inflammation of the pancreas. A variety of scoring sys-
tems are available to evaluate the severity of AP. To
evaluate the accuracy of bedside index for severity in
acute pancreatitis (BISAP) in predicting the severity
and prognosis of AP.
Method: We retrospectively studied 109 cases admitted
at the UHC. AP was classified as mild or severe
according to the 1992 Atlanta classification. BISAP
was calculated using data within 24 hours following
admission, and the Ranson score was calculated using
data from the first 48 hours following admission; CTSI
score within 3 days following symptom presentation.
Results: We had 78 males (71.56%) and 31 females
(28.44%), mean age 43.74 Std  12.05 years. 84
patients (77.06%) had mild AP (MAP), while 22
patients (20.18%) had severe AP(SAP), 3 patients died
(2.75%). We found significant correlations between the
scores of any 2 systems. BISAP performed similarly to
other scoring systems in predicting SAP, pancreatic
necrosis, mortality, and organ failure in SAP patients,
in terms of the area under the receiver-operating char-
acteristic curve.
Conclusions: We compared BISAP scores with Ranson,
and CTSI scores (when applicable) in predicting the
severity and prognoses of AP in our patients. We dem-
onstrated that BISAP has the advantages of simplicity
and speed over traditional scoring systems and per-
formed similarly to other scoring systems in predicting
SAP and the prognoses of SAP. We confirmed that the
BISAP score is an accurate and very useful method in
the clinical practice for risk stratification and prediction
of prognosis in patients with AP.
PPP26-062
CLINICAL OUTCOMES COMPERED
BETWEEN LAPAROSCOPIC AND OPEN
DISTAL PANCREATECTOMY
A. Slepavicius and V. Eismontas
Klaipeda University Hospital, Lithuania
Introduction: Laparoscopic distal pancreatectomy
(LDP) for benign and borderline pancreatic lesions
appears to offer advantages and is replacing open distal
panreatectomy (DP) in some centers. The purpose of
this study is to compere these surgical procedures.
Method: A retrospective chart rewiew of consecutive
patients with benign and borderline pancreatic tumors
who underwent DP or LDP in a Abdominal and Endo-
crine surgical department of Klaipeda University Hos-
pital between January 2005 to August 2013 was
performed. Data relative to demographic and clinical
characteristics, indications for surgery, surgical proce-
dure, postoperative course and final pathology results
were recorded.
Results: A total of 44 cases were analysed. 21 patients
underwent LDP and 23 open distal pancreatectomy.
There were no significant differences regarding demo-
graphic, clinical and pathological data. We excluded
from the study malignant cases. All of the resections
attempted laparoscopically were completed. EndoGIA
(Ethicon Endosurgery) was used to transect the pan-
creas in both: LDP and DP. The operation time, intra-
operative transfusion requirements, rate of splenic
preservation ant rate of pancreatic fistula were similar
in both groups. Blood loss for laparoscopic patients
was 220 mL, then in open group 450 mL (p < 0.004).
The median hospital length of stay was 8 days (range
5–21 days) for the LDP cohort and 13 days (range 8–
32 days) for the DP cohort (p < 0.001). The amout of
analgesic drugs administered after LDP was signifi-
cantly less then in DP group (morfin hydrochlorid 1%
i/m 8 mg vs 56 mg, p < 0.001).
Conclusions: The laparoscopic approach to DP offers
advantages over open surgery with less blood loss,
shorter hospital stay and less analgesic consumption.
PPP26-063
PERSURING THE BETTER OUTCOME
OF SURGERY FOR PANCREATIC
DUCTAL ADENOCARCINOMA:
POSSIBLE USEFULNESS OF
NEOADJUVANT CHEMOTHERAPY
AND PREOPERATIVE RADIOTHERAPY
T. Mimura
Okayama Saiseikai General Hospital, Japan
Introduction: Although surgery is the only curative key
for pancreatic ductal adenocarcinoma (PDA), its prog-
nosis is still unsatisfactory even in the combination
with the latest antineoplastic agents. We reevaluated
our strategy to determine the best predictive factors for
long time survival of PDA. Furthermore, we tried to
clarify the reason for high recurrence rate even after
“no residual tumor (R0) operation”, by analyzing the
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mode of recurrence from the standpoint of original site
and pathological findings.
Method: 317 consecutive patients (1990–2012) who
underwent pancreatic resection in our ward were ana-
lyzed. They consisted of head 72.2%, body and tail
27.8%; UICC TisT1T2 11.4% T3T4 88.6%, N0 54.3%;
extended lymphadenectomy (EL) 15%, R0 90.5%.
Adjuvant chemotherapy (AC) was applied to 18.9%.
For data analysis, Kaplan–Meyer and univariate/multi-
variate method were employed.
Results: Over all 1, 3 and 5 year survival rate after sur-
gery were 63.9, 32.2 and 23.2% respectively. Those for
R0 were 67.7, 34.4 and 25.3%, and those for AC were
94.8, 55.8 and 48.6% respectively. AC was the best
independent factor for survival (p < 0.000, OD 3.75)
followed by UICC N and R0, while AC was accom-
plished only by 20% of patients. Although the rate of
R0 was over 90%, recurrence/metastasis were observed
as high as 22% at local site, 33.6% at liver, or 18.1%
as peritoneal dissemination. In many cases of head can-
cer with pathological “margin-free”, cancer cells were
found very close to the edge.
Conclusions: AC was found to be effective but was tol-
erated only by a part of PDA.
R0 had some but little effect and EL had no influence
on recurrence, indicating the importance of radical
removal of cancer cells near surgical margin. Taken
together, we propose that neoadjuvant chemotherapy
and preoperative radiotherapy would be the hopeful
adjunct for PDA operation especially for head cancer.
PPP26-064
PROTECTIVE ROLE OF AHCC
ADMINISTRATION FOR ADVERSE
EVENTS OF CHEMOTHERAPY IN
PANCREATIC CANCER MODEL OF
RATS
S. Hirooka, S. Satoi, H. Toyokawa, H. Yanagimoto,
T. Yamamoto, S. Yamaki, R. Yui, D. Ryota and
A.-H. Kwon
Kansai Medical Uiniversity, Japan
Introduction: AHCC is an extract of a basidiomycete
mushroom that has been used as a supplement by some
cancer patients undergoing chemotherapy to increase
anticancer effects and decrease the rate of anticancer
adverse events in breast, prostate and head and neck
cancer. We evaluated the protective role of AHCC for
adverse event of chemotherapy using rat model.
Method: We made subcutaneous tumor model of pan-
creatic cancer by injecting DLS-6A/C1 cells into subcu-
taneous tissue of the right large thigh in Lewis rats.
Administration of gemcitabine (GEM) and/or AHCC
was started when tumor grew into 10mm in a diameter
about 6 weeks after transplantation. We divided into
the following four groups; Control (C) group, which
were not given any drugs; AHCC (A) group, which
were administered AHCC 1000 mg/kg/day every day;
GEM (G) group, which were intravenously adminis-
tered GEM 50 mg/kg on days 1, 8 and 15 of each 28-
day cycle, and were treated for 2 cycles.; Combination
therapy of GEM and AHCC (GA) group, which
received above mentioned treatments of both A and G
group.
Several parameters (i.e., RBC, WBC, AST, ALT, BUN
and Cr) were measured before starting treatments and
after finishing treatments. Furthermore we sacrificed
rats two months after starting treatments and removed
tumor.
Results: Although the estimated tumor volumes (=1/
2 9 major axis 9 (minor axis)2) significantly increased
in C and A groups 2 months after starting chemother-
apy, significant decreases in tumor volume of G and
GA groups were found (G group: p < 0.0001, GA
group: p < 0.0001).
Although the median value of WBC counts signifi-
cantly decreased from 15.5( 9 103/uL) to 3.0( 9 103/
uL) after chemotherapy in G group (p < 0.0001), there
was no change in GA group (p = 0.2228).
There were no significant differences in RBC, AST,
ALT, BUN and Cr among 4 groups.
Conclusions: AHCC administration may be associated
with less incidence of leukocytosis after chemotherapy
in rat pancreas cancer model.
PPP26-065
THE INFLUENCE OF STANDARDIZED
HISTOPATHOLOGICAL WORKUP ON
REPORTING OF THE RESECTION
MARGIN STATUS IN PANCREATIC
HEAD CANCER
A. Elgendi1 and S. Elgendi2
1Lecturer of Surgery, Egypt; 2Assistant Lecturer of
Pathology, Egypt
Introduction: Resection margin (RM) status in pancre-
atic head adenocarcinoma is assessed histologically, but
pathological examination is not standardized. Our aim
was to determine the influence of the technique of his-
topathological examination of pancreaticoduodenecto-
my specimens on the reporting of the RM status and
to test prospectively the hypothesis that current histo-
pathological reports underestimate the proportion of
R1 pancreatic head resections.
Method: Starting October 2009, 14 patients with pan-
creatic ductal adenocarcinoma were reported according
to standardized protocol (SP) involving five color mar-
gin staining, axial slicing and extensive tissue sampling
and were compared to our conventional bivalve slicing
in which a non-standardized protocol was used. We
reevaluated different sites of R1 resections according to
the color code and demonstrate the most frequent site
of incomplete tumor resection.
Results: Applying our conventional protocol, 12 can-
cers were curatively (R0) resected (85.7%), while 2
cases were R1 resections (14.2%) based on infiltration
of pancreatic neck margin. Applying the standardized
histopathological workup, an additional set of 7 speci-
mens was considered R1 resections (64.2%), reducing
the rate of R0 resection to 35.7%. An additional 12
sites of tumor infiltration were detected; uncinate mar-
gin (n = 6), posterior surface (n = 4), anterior surface
(n = 1), SMV groove (n = 1). 35% of R1 resections
exhibited multifocal margin involvement. Interestingly,
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the uncinate margin was the commonest site of infiltra-
tion in 6 (56.4%) of these R1 specimens either alone
(n = 3) or in combination (n = 3).
Conclusions: Standardization of the histopathological
examination of pancreaticoduodenectomy specimens
influences the reporting of RM status. The resection
margin involvement is significantly more frequent than
commonly reported.
PPP26-066
MAIN DUCT AND MIXED PANCREATIC
INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASM: ANALYSIS OF
CLINICOPATHOLOGICAL FEATURES
AND SURGICAL OUTCOMES
A. Elgendi1, S. Elgendi2, A. Zeid4 and M. Elgendi3
1Lecturer of Surgery, Egypt; 2Assistant Professor of
Pathology, Egypt; 3Professor of Surgery, Egypt;
4Assistant Professor of Hepatology, Egypt
Introduction: Intraductal papillary mucinous neoplasms
(IPMNs) are increasingly recognized entities, whose
management remains sometimes controversial, due to
the high rate of benign lesions and on the other side to
the good survival after resection of malignant ones.
Our study aim to underline the clinical problems they
set, related both to the diagnostic procedures and to
the therapeutic indication including extent of surgical
resection.
Method: From 2008–2012, 25 patients presented with
operable non metastatic pancreatic cystic tumors. 10/25
were resected and diagnosed as IPMN and were subject
to further analysis of clinicopathologic data, diagnostic
procedures, extent of surgical resection, histopathology,
disease free survival and recurrence.
Results: 80% of patients were symptomatic; the cho-
langio-MRI diagnostic accuracy was 90%. One patient
underwent pancreaticoduodenectomy, 9 total pancrea-
tectomies with morbidity of 40 and 0% hospital mor-
tality. Main duct and mixed type were found in 7 and
3 patients respectively; this corresponded to the preop-
erative imaging classification in 70%. 6/10 resected
lesions were malignant (3 insitu and 3 invasive carci-
noma) which corresponds to preoperative diagnostic
accuracy of 66.6%. 2/6 malignant patients had meta-
static nodes and had a relapse after 14 months and
deceased 17 months after the operation. The mean fol-
low-up was 18 months (range 9–32); 6/10 patients are
alive and disease-free.
Conclusions: Main duct IPMN or mixed type warrants
complete resection due to its significant malignant
potential and multifocal pattern. Surgical indication is
mainly based upon radiological evaluation of its risk of
malignancy. Total pancreatectomy was tolerated in all
patients with minimal morbidity and mortality and
produces excellent long-term survival.
PPP26-067
FEASIBILITY AND ONCOLOGICAL
OUTCOMES OF LIMITED DUODENAL
RESECTION IN PATIENTS WITH
PRIMARY NONMETASTATIC
DUODENAL GIST
A. Elgendi1, S. Elgendi2 and M. Elgendi3
1Lecturer of Surgery, Egypt; 2Assistant Professor of
Pathology, Egypt; 3Professor of Surgery, Egypt
Introduction: Duodenal gastrointestinal stromal tumors
(GISTs) are rare but still represent approximately 30%
of primary duodenal tumors. This study aimed to audit
the feasibility and oncological outcomes of limited duo-
denal resection in patients with primary nonmetastatic
duodenal GIST.
Method: Twelve patients who underwent surgery at
our institution since 2002 were prospectively followed
up. The duodenal GISTs were located in the first
(n = 3), second (n = 1), third (n = 3), and fourth of
duodenum (n = 1). Involving both D1/D2 (n = 2), D2/
D3 (n = 1), and D3/D4 (n = 1). The primary endpoint
for this analysis was disease-free survival.
Results: The commonest presentation was melena and
anemia (83%). All the patients underwent limited resec-
tion; six wedge resections with primary closures and six
segmental resections with end-to-end anastomosis. The
median tumor size was 8 cm (range, 5–16 cm). Accord-
ing to Fletcher scale, 2 GISTs were low risk, while 10
patients were intermediate and high risk. The latter
received adjuvant therapy. All the patients had a com-
plete resection with no postoperative mortality. One
patient had three liver metastases 4 months after lim-
ited resection and had partial hepatectomy. After med-
ian follow-up of 45 (15–78) months, all patients are
alive and disease free.
Conclusions: When technically feasible, limited resec-
tion should be considered a reliable and curative option
for duodenal GIST achieving satisfactory disease-free
survival. The technical feasibility is guided by the
tumor size, possible adjacent organ involvement, and
its exact anatomical location.
PPP26-068
PRIMARY HYPERPARATHYROIDISM
WITH PANCREATITIS: EXPERIENCE
OF MANAGEMENT IN 5 PATIENTS
WITH REVIEW OF LITERATURE
A. Gupta1, M. Madnani1, J. Mistry1, H. Soni1,
A. Shah1, K.S Patel1, S. Chandra2, P. Dileep2,
N. Mehta2 and S. Haribhakti1
1Kaizen Hospital, India; 2Sterling Hospital, India
Introduction: Parathyroid adenoma accounts for less
than 1% cases of acute pancreatitis. The cause and
effect relationship has been shown in most of the stud-
ies. Parathyroidectomy leads to resolution of acute
pancreatitis. Management of acute pancreatitis with
parathyroid adenoma is challenging and may involve
treatment of comorbidities like hypercalcemia, ARF
and acidosis before surgical management of parathy-
roid adenoma and pancreatic necrosis.
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Method: We retrospectively analysed 5 cases of pancre-
atitis with hyperparathyroidism admitted and treated
from may 2006 to july 2013. All patients underwent
parathyroidectomy and three patient underwent necro-
sectomy /cystogastrostomy. Concomitant etiological
factors were also investigated and surgical outcome
analysed.
Results: Four patients developed acute necrotizing pan-
creatitis and 1 patient developed acute edematous pan-
creatitis. All parathyroid adenoma were diagnosed
following work-up of acute pancreatitis. Concomitant
etiological factors present were gall stones in 1 case,
gall bladder sludge in 1 case and hyperlipidemia in 1
case. Mean pre-operative serum calcium was 12.04 mg
% (10.88 to 13.02), mean Serum PTH was 380 IU
(87.22–1039).
All patients were admitted in ICU and dehydration
and hypercalcemia was corrected. Creatinine level was
normalized before surgery. All 5 patients underwent
parathyroidectomy. 2 patients underwent simultaneous
necrosectomy/cystogastrostomy. 4 patients recovered
completely while mortality occurred in 1 patient on 3rd
post op day following refractory hypotention.No recur-
rence of pancreatitis was seen in any patient after mean
follow up of 24.8 months(6–84).
Conclusions: Parathyroidectomy is necessary to prevent
recurrence of pancreatitis. Acute attack of pancreatitis
should be treated in ICU with correction of dehydra-
tion, acidosis, hypercalcemia and creatinine level. Para-
thyroidectomy and necrosectomy should be done as
elective surgery.
PPP26-069
COLONIC FISTULAE IN SEVERE
ACUTE NECROTIZING PANCREATITIS
S. Chooklin and O. Usach
Medical University, Ukraine
Introduction: Colonic involvement in acute necrotizing
pancreatitis accounts for 6–40% of cases. Colonic
involvement is a rare but potentially lethal complica-
tion of severe acute pancreatitis which has a frequency
of 3.3–15%. The spectrum of colonic complications
includes a localized ileus with “pseudoobstruction”,
obstruction, necrosis, hemorrhage, fistula and ischemic
colitis.
Colonic fistula is a rare and potentially critical sequel
of severe acute pancreatitis, which requires surgical
treatment.
Method: We present a series of 9 patients who devel-
oped colonic fistulae spontaneously during the course
of acute necrotizing pancreatitis and following pancre-
atic necrosectomy for severe acute necrotizing pancrea-
titis.
Results: A colonic fistula was diagnosed at the time of
pancreatic necrosectomy in 4 patients; a post-necrosec-
tomy colonic fistula was diagnosed in 5 cases. We per-
formed a diverting loop ileostomy in all the patients
with colonic fistulae. Four patients required segmental
colectomy and fistula closure occurred in 5 patients
with ileostomy alone. Operative mortality was 22.2%.
Conclusions: A colonic fistula associated with severe
acute necrotizing pancreatitis carries a high mortality
and an ileostomy should be performed early to divert
the faecal stream and control the peritoneal infection.
Resection of the fistulated colon was not always
required and in some patients the fistulae healed with a
diverting ileostomy. In acute pancreatitis cases with
extensive pericolitis at surgery the subsequent develop-
ment of a colonic fistula is likely and an ileostomy (per-
haps during necrosectomy) might be an effective pre-
empting manoeuvre
PPP26-070
MACROPHAGE MIGRATION
INHIBITORY FACTOR EXPRESSION
PREDICTS SURVIVAL OF PATIENTS
WITH RESECTED PANCREATIC
DUCTAL ADENOCARCINOMA
K. Takano, M. Minagawa, K. Takizawa, J. Sakata,
T. Kobayashi and T. Wakai
Niigata University Graduate School of Medical and,
Japan
Introduction: Macrophage migration inhibitory factor
(MIF), an inflammatory cytokine, is overexpressed in
various types of solid tumors and is associated with
poor prognosis. However, MIF expression in pancreatic
ductal adenocarcinoma (PDAC) has been described in
a few reports. This study aimed to elucidate the prog-
nostic significance of MIF expression in patients with
resected PDAC.
Method: A retrospective analysis was conducted of 67
patients who underwent macroscopically curative resec-
tion for PDAC. Of the 67 patients, 62 (93%) received
adjuvant chemotherapy. Immunohistochemistry using
anti-MIF monoclonal antibody on paraffin-embedded
primary tumor tissue samples was performed. Survival
analysis was performed using the Kaplan–Meier method
with log-rank test for univariate analyses, and multivari-
ate analysis for survival was performed using the Cox
proportional hazards regression models. p-values less
than 0.05 were considered statistically significant.
Results: MIF-positive cells were observed in the cyto-
plasm of tumor cells and absent in non-neoplastic pan-
creatic epithelium. Of the 67 patients, 51 (76%) were
classified as having tumors with high MIF expression
and 16 (24%) had tumors with low MIF expression.
There were no significant differences in other clinico-
pathological factors between patients with tumors with
high MIF expression and those with low MIF expres-
sion. Disease-free survival was significantly worse in
patients with MIF-high tumors than in patients with
MIF-low tumors (cumulative 3-year disease-free sur-
vival rate of 24.4% and 61.9%, respectively;
p = 0.012). Post-resection survival was significantly
worse in patients with MIF-high tumors than in
patients with MIF-low tumors (cumulative 5-year sur-
vival rate of 0% and 51%, respectively; p = 0.005). The
Cox proportional hazards regression analysis revealed
that high MIF expression was an independent prognos-
tic factor for disease-free survival (p = 0.005) and post-
resection survival (p = 0.004).
Conclusions: Assessment of MIF expression may be
useful as a prognostic marker for patients with resected
PDAC.
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PPP26-072
SOLID PSEUDOPAPILLARY TUMOUR
OF THE PANCREASE: INCIDENCE,
PROGNOSIS AND OUTCOME OF
SURGERY
A.E. Nakeeb
Mansoura University, Egypt
Introduction: Solid pseudopapillary tumour (SPT) of
the pancrease is a rare neoplasm of low malignant
potential. The pathogenesis and guideline for treatment
remain unclear.
Objective: This study is designed to evaluate the diag-
nosis, surgical treatment and outcome of SPT.
Method: Study design: A retrospective study during the
period from January 1996 to April 2012, were eligible
for the study. Patients and method: Fourteen Patients
had SPTs treated at our institution were reviewed.
Demographic data, clinical manifestations, radiological,
surgical, and pathological records were reviewed for
patients with SPT.
Results: All of the 14 patients were female and the aver-
age age was 30.9  15.9 years (16–64 years). The
tumour was located in the head in 8 patients (57.1%).
and in the body and tail in 5 patients (42.9%). The mean
size was 4.25  1.24 cm (2.5–6). The clinical presenta-
tion was abdominal pain in 9 patients (64.3%), jaundice
in 6 patients (42.85%). Elevated CEA and CA19-9 was
recorded only in two cases. The content was necrosis and
hemorrhage in 11 patient (78.6%) and thick fluid in 4
patients (28.6%). None of the patients had definite pre-
operative diagnosis. All 14 patients had curative resection
including 8 pancreaticoduodenectomy (57.1%), 3 central
pancreatectomy (21.4%) and one distal pancreatectomy
(7.14%). No hospital mortality, all patients were alive
and disease free at follow up period. The recurrence was
recorded in one case (7.14%) after 5 year postoperative.
Conclusions: SPT are rare neoplasms with malignant
potential. Aggressive surgical resection is needed even
in presence of local invasion, as patients had a good
long term survival.
PPP26-073
THE IMPACT OF VASCULAR
RESECTION ON EARLY
POSTOPERATIVE OUTCOME AFTER
PANCREATICODUODENECTOMY: A
SINGLE CENTER EXPERIENCE
K. Chaiyabutr1, A. Deeprasertvit2, J.
Singhirunnusorn1, K. Leelawat1, S. Subwongcharoen1
and S.-A. Treepongkaruna1
1Rajavithi Hospital, Thailand; 2Police General Hospital,
Thailand
Introduction: Pancreaticoduodenectomy (PD) combined
with vascular resection (VR) is increasingly accepted as
a viable treatment option for periampullary carcinoma
with suspected involvement of the portal vein (PV),
superior mesenteric vein (SMV), or superior mesenteric
portal vein (SMPV) confluence. However, its clinical
benefit remains controversial. Our objective is to review
the outcomes associated with VR during PD.
Method: One-hundred and eighteen consecutive
patients underwent macroscopically curative PD, Pylo-
rus-preserving pancreaticoduodenectomy (PPPD) or
total pancreatectomy for periampullary carcinoma and
other benign lesions of the pancreas between October
1, 2006 and November 30, 2012. VR was performed in
13 patients (11%). Data on surgical mortality, morbid-
ity, perioperative outcome, initial recurrence site, and
survival were retrospectively compared between the
patients with and without VR.
Results: The duration of surgery and blood losses were
significantly more important in PD combined with VR
groups, however, postoperative morbidity and mortal-
ity rates were similar. Almost of the primary tumor in
VR group were pancreatic carcinoma (69.2%), differ-
ence from non-VR group which the primary tumor
were ampullary carcinoma (58.1%). Subgroup analysis
of pancreatic carcinoma, overall survival and disease-
free survivals were not significantly difference between
2 groups (18.56 months vs 15.29 months).
Conclusions: PD combined with VR for periampullary
carcinoma increases local resectability without increas-
ing mortality and morbidity rates compare with stan-
dard PD.
PPP26-074
PANCREATIC METASTASIS OF
FOLLICULAR THYROID CARCINOMA:
A CASE REPORT
S.P. Yun, H.I. Seo and E.Y. Park
Busan National University Hospital, Korea
Introduction: Follicular thyroid cancer (FTC) is the
second category of well-differentiated thyroid cancer
and constitutes about 10% of all thyroid malignancies.
FTC is more likely to metastasize to distant organs
than regional lymph nodes, most commonly to lung
and bone. Here we describe a patient with pancreas
metastasis from widely invasive follicular thyroid carci-
noma and discuss the unique features of these lesions.
Method: A 68-year-old woman underwent total thy-
roidectomy and prophylactic central compartment node
dissection for widely invasive FTC in 2010.
Results: After 2 years, 18F-FDG PET/CT scan showed
multiple lung metastasis and a hypermetabolic mass on
pancreas head which is neuroendocrine tumor more
likely. Serum Tg was elevated at >250 ng/mL while on
L-thyroxine with TSH of 0.03 mIU/mL. I131 whole
body scan showed a remnant thyroid activity without
local recurrence. Despite 200mCi I131 ablation treat-
ment, Serum Tg was not decreased and pancreas mass
grew in size. Pylorus preserving pancreaticoduodenecto-
my was performed with a histopathological diagnosis
of metastatic follicular thyroid carcinoma in 2013.
Conclusions: Pancreas metastases from follicular thy-
roid carcinoma are very uncommon. To the best of our
knowledge, FTC with pancreatic metastases has been
not described in the literature. If a pancreas mass is
identified in a patient with history of a primary cancer
in other regions, metastasis should be considered poten-
tially. Also the management must be individualized and
selective surgical approach is needed.
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PPP26-075
PROTON THERAPY MAY ALLOW FOR
COMPREHENSIVE ELECTIVE NODAL
COVERAGE FOR PATIENTS
RECEIVING NEOADJUVANT
RADIOTHERAPY FOR LOCALIZED
PANCREATIC HEAD CANCERS
Z. Awad
University of Florida, USA
Introduction: Neoadjuvant radiotherapy has the poten-
tial to improve local disease control for patients with
localized pancreatic cancers. Concern about an
increased risk of surgical complications due to small
bowel and gastric exposure, however, has limited
enthusiasm for this approach. Dosimetric studies have
demonstrated the potential for proton therapy to
reduce intestinal exposure compared with X-ray-based
therapy. We sought to determine if neoadjuvant proton
therapy allowed for field expansions to cover high- risk
nodal stations in addition to the primary tumor.
Method: Twelve consecutive patients with nonmetastat-
ic cancers of the pancreatic head underwent proton-
based planning for neoadjuvant radiotherapy. Gross
tumor volume was contoured using diagnostic com-
puted tomography (CT) scans with oral and intrave-
nous contrast. Four-dimensional planning scans were
utilized to define an internal clinical target volume
(ICTV). Five-mm planning target volume (PTV) expan-
sions on the ICTV were generated to establish an initial
PTV (PTV1). A second PTV was created using the ini-
tial PTV but was expanded to include the high-risk
nodal targets as defined by the RTOG contouring atlas
(PTV2). Optimized proton plans were generated for
both PTVs for each patient. All PTVs received a dose
of 50.4 cobalt gray equivalent (CGE). Normal-tissue
exposures to the small bowel space, stomach, right kid-
ney, left kidney and liver were recorded. Point spinal
cord dose was limited to 45 CGE.
Results: Median PTV1 volume was 308.75 cm3 (range,
133.33–495.61 cm3). Median PTV2 volume was
541.75 cm3 (range, 399.44–691.14 cm3). In spite of the
substantial enlargement of the PTVwhen high-risk lymph
nodes were included in the treatment volume, normal-tis-
sue exposures (stomach, bowel space, liver, and kidneys)
were only minimally increased relative to the exposures
seen when only the gross tumor target was treated.
Conclusions: Proton therapy appears to allow for field
expansions to cover high-risk lymph nodes without sig-
nificantly increasing critical normal-tissue exposure in
the neoadjuvant setting.
PPP26-076
VISFATIN AND RESISTIN AS MARKER
OF PERIPANCREATIC NECROSIS IN
ACUTE PANCREATITIS
S. Chooklin and M. Shavarova
Medical University, Ukraine
Introduction: Severe acute pancreatitis is characterized
by lipase-induced peripancreatic fat cell necrosis. Peri-
pancreatic necrosis determines clinical severity in acute
pancreatitis. Early markers predicting peripancreatic
necrosis and clinical severity are lacking. Adipocytes of
peripancreatic and intrapancreatic adipose tissue are
secret adipocytokines. Adipocytokines could serve as
potential markers predicting peripancreatic necrosis
and severity in acute pancreatitis. It was the aim of this
study to investigate whether the adipocytokines visfatin
and resistin is able to serve as an early marker predict-
ing peripancreatic necrosis and clinical severity.
Method: A total of 39 patients with acute pancreatitis
were included in monocentric cohort study on diagnos-
tic accuracy. Clinical severity was classified by the Ran-
son score. Pancreatic and peripancreatic necrosis were
quantified by using the Balthazar CT score. Resistin
and visfatin were measured by enzyme-linked immuno-
sorbent assay.
Results: Visfatin and resistin values were significantly
and positively correlated with clinical severity and with
death and need for interventions. Admission resistin
and visfatin levels were significantly elevated in patients
with higher pancreatic and extrapancreatic necrosis. An
admission resistin and visfatin concentration provides a
high positive predictive value in predicting the extent of
peripancreatic necrosis.
Conclusions: An admission resistin and visfatin concen-
tration serves as an early predictive marker of peripan-
creatic necrosis and clinical severity in acute
pancreatitis.
PPP26-077
POSTOPERATIVE CHANGES OF THE
PANCREATIC PARENCHYMAL
VOLUME ACCORDING TO EXTERNAL
VERSUS INTERNAL DRAINAGE OF
THE PANCREATIC DUCT AFTER
PYLORUS-PRESERVING
PANCREATICODUODENECTOMY
D. Yoo and S. Hwang
Asan Medical Center, Ulsan University, Korea
Introduction: Atrophy of the pancreatic parenchyma is
a common finding after pylorus-preserving pancreatico-
duodenectomy (PPPD), which is often associated with
clinical and subclinical pancreatic exocrine insuffi-
ciency. Many centers prefer to insert a drainage tube
into the remnant pancreatic duct primarily to prevent
pancreatic leakage at the pancreaticojejunostomy (PJ)
after PPPD. There are wide variations in their preferred
drainage method, but they can be roughly classified
into 2 types as internal or external drainage. It is diffi-
cult to objectively evaluate the real preventive effect on
pancreatic leak, thus this study was focused on their
influence on pancreatic parenchymal atrophy following
PPPD.
Method: We selected 57 patients who underwent PPPD
and divided into 2 groups according to external
(n = 28) and internal (n = 29) pancreatic drainage. The
external drainage tube was removed 4 weeks after
PPPD. Patients showing marked atrophy of the native
pancreas before surgery were excluded. We investigated
the serial postoperative changes of the pancreatic vol-
ume after PPPD. The volume of pancreatic paren-
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chyma was measured before surgery, postoperative
7 days, 3 months, 6 months and 12 months by using
abdomen computed tomography (CT) scans. The
degree of pancreatic parenchymal atrophy was deter-
mined with the proportion of postoperative pancreas
volume relative to that at day 7 CT scan.
Results: Univariate analysis showed that patient sex,
age, body mass index, concurrent pancreatitis, pathol-
ogy and types of PJ did not have a significant influence
on the changes in pancreatic volume following PPPD.
The degree of pancreatic volume atrophy was not sig-
nificantly different in the external and internal drainage
group. The incidence of external drainage-related surgi-
cal complication was absent. The incidence of PJ leak
was comparable in both groups.
Conclusions: The results of this study support that
external pancreatic drainage is not inferior method
compared to internal pancreatic drainage for protecting
the pancreatic parenchyma following PPPD.
PPP26-078
ADULT PANCREATIC HEMANGIOMA
U. Gurbadam1, E.-A. Tsiiregzen1, C. Jigjidsuren1,
T. Erdenebileg1, S.H. Choi2, G. Khatanbaatar3,
B. Tserenlhagva3 and N. Sukhbaatar3
1National Cancer Center of Mongolia, Mongolia;
2Yonsei University College of Medicine, Korea;
3National Pathology Center of Mongolia, Mongolia
Introduction: Pancreatic hemangioma is very rare and
hardly suspected clinically due to their nonspecific
symptoms and diagnostic characteristics. We report an
adult pancreatic hemangioma diagnosed on pathologi-
cal specimen review following laparoscopic distal pan-
createctomy with splenectomy for a 2 cystic mass in the
body of the pancreas.
Method: A 49-years-old woman was admitted to our
institution because of bowel distention, constipation,
and fatigue. Pancreatic cystic lesions were incidentally
found on ultrasound when she visited a gynecologist
for evaluation of suspected uterus myoma. A computed
tomography (CT) scan demonstrated two lesions, first
lesion was 2.7 9 2.3 cm sized unilocular cystic tumor
and second lesion was 2.4 9 2.3 cm sized multilocular
cystic tumor with septation and intramural nodules in
the pancreatic body. The suspicious intramural nodule
and wall enhancement could not exclude a malignancy,
and then we decided a surgical removal. She underwent
in laparoscopic distal pancreatosplenectomy.
Results: The surgery was successfully finished by lapa-
roscopy without a perioperative complication. Gross
examination of the tumor revealed a two mass; first
lesion composed of well-defined wall, containing a dark
green fluid, and second lesion is composed of cystic
spaces containing gelatinous material and hemorrhages.
On microscopic examination shows pancreatic acinar
tissue consisted of blood vessel with dilated cystic
lumen filled with red blood cell. Immunohistochemistry
(IHC) examination revealed that this lining was posi-
tive for CD34 and CD68 stain shows macrophage cells
in cystic lumen filled with red blood cell. The histologi-
cal results demonstrate that tumor was pancreatic cav-
ernous hemangioma.
Conclusions: This case of an adult pancreatic hemangi-
oma is the sixteenth reported in literature since 1939.
The histological examinations are very important role
for pancreatic hemangioma diagnosis. In pediatric
cases, they often regress, no surgical removal is advo-
cated other than follow-up. But in adult cases, the risk
of sudden hemorrhage, abdominal pain, and possible
differential diagnosis with malignant tumors, surgical
resection is recommended.
PPP26-079
DOES THE HIGH FREQUENCY OF
ACINAR CELLS AND THE DEGREE OF
FATTY INFILTRATION OF THE CUT
EDGE OF THE PANCREAS INFLUENCE
THE PANCREATIC FISTULA RATE
AFTER DP?
S. Silvestri, A. Franchello, V. Guglielmino, D. Campra,
D. Cassine, F. Gonella, L. Chiusa, P. Campisi and
G. Fronda
AOU Molinette, Turin, Italy
Introduction: Many factors are suggested to be
involved in development of pancreatic fistula (PF). The
role of acinar cells density, pancreatic fatty infiltration
and fibrosis in occurence of major complications and
PF after pancreaticoduodenectomy (PD) have been
investigated.
Method: 46 consecutive PD were performed in our cen-
ter. Variables considered were: age, gender, ASA score,
pancreatic texture, Wirsung diameter, postoperative
mortality and pancreatic fistula - PF, post pancreatec-
tomy haemorrage - PPH, delayed gastric emptying -
DGE, hospital stay, histology and preoperative biliary
drainage. Analisys regarding histological findings (pan-
creatic fibrosis, pancreatic fatty infiltration, acinar cell
frequency) and correlation with PF was conducted.
Univariate and multivariate models were used to deter-
mine factors correlated to PF.
Results: All patients underwent standard PD with
dunking, sutureless, end to end PJ anastomosis. Overall
morbility rate and operative mortality rate were respec-
tively 43.2 and 5%. PF rate was 21.7%. PPH rate was
17.8% and DGE 27.3%. Fibrotic pancreas has lower
rate of acinar cells (p < 0.05); no correlation with fatty
infiltration. 88.9% of patients with PF had high fre-
quency of acinar cells; no correlation between BMI and
high grade fatty infiltration and BMI >25 and PF. At
univariate analysis PF rate correlates with Wirsung
diameter <3 mm (p = 0.015), pancreatic cancer
(p = 0.016), soft pancreatic texture (p = 0.001), male
gender (p = 0.01) and acinar cells >40% (p < 0.05).
Conclusions: In our series BMI was not usefull to iden-
tify PF high risk patients and is not an accurate index
of pancreatic fatty infiltration. High Acinar cells fre-
quency on pancreatic cut edge could be an interesting
marker to identify high risk pancreas which could lead
to a reduction of PF severity, probably not of its occu-
rency.
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PPP26-080
PANCREATIC HEAD RESECTION:
OPERATIVE MORBIDITY AND
MORTALITY
N.A. Benamer, M.L. Achab, Z. Belkaid,
M. Haoues and A.A. Benamar
Djiillali Rahmouni Clinic, Algeria
Introduction: Death rates after pancreatoduodenectomy
have decreased dramatically during the 2 last decades.
However, despite a low death rate, there is still a rela-
tively high complication rate. Studies of risk factors
after pancreatoduodenectomy are few and sometimes
with conflicting results. The aim of our study was to
evaluate risk factors for complications rate after pan-
creatic head resection.
Method: Seventy eight patients undergoing pancreato-
duodenectomy were recorded retrospectively.We evalu-
ated age, gender, jaundice, Pitt & Cameron risk factors,
preoperative biliary drainage for complications
rate.Pancreatic fistula was analyzed for texture of rem-
nant stump and type of pancreatoenteric anastomosis.
Results: Pancreatoduodenectomy was performed for pe-
riampullary carcinoma in 37 (47.4%), pancreatic head
carcinoma in 29 (37.2%), distal bile duct carcinoma in 10
(12.8%) and duodenum cancer in 2 (2.6%). The main
symptom leading to diagnosis was jaundice in 69
(88.5%) and 15 of them (21.7%) had a preoperative bili-
ary drainage. Drainage was performed endoscopically in
11 cases and surgically in 4 cases. A pancreatogastrosto-
my was carried out in 57 patients (73%) and isolated
Roux-loop pancreatojejunostomy in 21 patients (27%).
Five patients died postoperatively (6.5%). Causes of
death were myocardial infarcts (2), pulmonary embolism
(1) and pancreatic leakage (2). Postoperative complica-
tions occurred in 25 patients (32%), they had to be trea-
ted by repeat laparotomy in 10 patients (40%). None
assessment parameters has revealed as risk factor for rate
complications. Pancreatic fistula was the most frequent
complication documented in 09 patients (36%). The type
of pancreatoenteric anastomosis after pancreatoduoden-
ectomy does not significantly influence the rate of pan-
creatic fistula but the severity of this complication was
observed only in pancreatogastrostomy.
Conclusions: Our study confirms the results from recent
reports that pancreatic head resection can be performed
with a low mortality rate and acceptable morbidity,
which may reflect changes in operative strategy and
prefer as well as possible an isolated roux-loop end to
end pancreatojejunostomy.
PPP26-081
ECTOPIC PANCREATIC NEOPLASIA
(PANIN) IN THE SMALL BOWEL WITH
SYNCHRONOUS PANCREATIC, RENAL,
AND BREAST CANCER
F. Macedo1, D. Taggarshe1, T. Makarawo1,
B. Herschman2 and M. Jacobs1
1Providence Hospital and Medical Centers, USA
Introduction: Ectopic pancreatic tissue is relatively rare
and results from embryological rotation defects. Malig-
nant transformation of this tissue is extremely unusual
with only few cases being previously reported. Further-
more, the combination of multiple primary malignan-
cies in the same patient is also uncommon. Herein, we
present a patient who developed synchronous primary
pancreatic adenocarcinoma, renal cell, and breast can-
cer. Intraoperatively, concurrent ectopic pancreatic in-
traepithelial neoplasia (PanIN) was identified in the
small bowel.
Method and Results: Case Report: A 69-year-old
woman with prior history of left breast ductal carci-
noma in situ presented with ductal invasive carcinoma
of the right breast and underwent bilateral total mas-
tectomy with right superficial lymph node dissection.
Postoperative computed tomography staging showed
incidental distal pancreatic mass and a solid heteroge-
neous mass of the left kidney. She underwent a subtotal
pancreatectomy with splenectomy, regional lymphaden-
ectomy, radical left nephrectomy and resection of a
proximal small bowel neoplasm with primary anasto-
mosis. Patient was discharged home on postoperative
day 7. Final pathology showed invasive poorly differen-
tiated adenocarcinoma of distal pancreas with features
of PanIN-3, left renal clear cell carcinoma, and the
small bowel mass was consistent with ectopic pancre-
atic tissue that contained PanIN-2.
Conclusions: Herein, we have described a previously
unknown association between multiple synchronous
primary malignancies and ectopic PanIN-2, which is a
suspected precursor of pancreatic ductal adenocarci-
noma. Furthermore, the patient was a non-smoker,
BRCA-negative, and had no prior significant family
history. No other predisposing factor could be identi-
fied that could have contributed to these malignancies
suggesting a yet unidentified genetic predisposition for
multiple neoplasias in this subset of patients.
PPP26-082
INNOVATIVE SURGICAL TECHNIQUES
IN 244 PANCREATICO-DOUDENAL
RESECTION
A. Hassoun, O. Robert, R. John and S. Janak
CPMC, USA
Introduction: Although pancreatico-doudenectomy
techniques has been changed over time, still significant
incidence of complications like, pancreatitis, pancreatic
fistula/leakage, infection, delayed gastric emptying, chy-
lus ascitis, etc., is significant. Between 2002 and 2010, a
244 pancreatico-doudenectomy were done in 5 different
but innovative techniques with the attempt to improve
outcome and avoid complications.
Method: A 244 pancreatico-doudenectomy that were
done between 2002 and 2010 CPMC. They were done
for Adenocarcinoma (N = 165), Benign diseases
(N = 65), IPMN (N = 8), Neuroendocrine tumors
(N = 4), metastatic ancer (N = 1). Innovative tech-
niques were practiced in sequence and they share the
following priniciples: R & Y reconstruction with the R
limb retro-mesenteric and directed to panrease/ hepatic
duct anastomosis (R1-reconstruction), or bile duct
alone (R2-reconstruction). The Y limb was retro-colic
toward doudenum (R1-reconstruction), or pancreas/
doudenum (R2-reconstruction) and here initially the
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pylorus were made incompetent with the use of trans-
gastric EEA pyloromyotomy and hence pyloric incom-
petent R1 (1 patient)/R2 (45 patients) vs pyloric
competent R1 (110 patients)/R2 (66 patients) when py-
loromyotomy was not done. The pancreatico-jejunosto-
my in all techniques were done in 2 layers with the use
of self deposed silastic tube stent. Studied in all tech-
niques are; 30 and 90 days mortality, pancreatits/leak-
age, infection, delayed gastric emptying (defined by
requirement for feeding tube on discharge with or with-
out vomiting), days of hospital stay.
Results: Overall infection rate is 2.8%, length of stay
was 8–15 days, pancreatic leakage was 2.5%, chylus as-
citis was 6%, with no statiscal difference in all groups.
Delayed gastric emptying when pylorus were made
incompetent was 20% which is similar to when distal
gastrectomy was done vs 23% in R1-competent group.
30/60 days mortality 2.4%/3.6%.
Conclusions: Multiple innovative techniques in pan-
creatico-doudenectomy that shows less over all compli-
cations.
PPP26-083
A RESTROSPECTIVE CASE-CONTROL
STUDY OF LAPAROSCOPIC SPLEEN-
PRESERVING DISTAL
PANCREATECTOMY WITH OR
WITHOUT SPLENIC VESSELS
CONSERVATION
C. Jiang, G.-Y. Wang, G.-Y. Lv, W. Qiu and
X.-D. Sun
First Hospital of Jilin University, Changchun, China
Introduction: Aim of this study was to evaluate the
outcomes of patients who underwent laparoscopic
spleen-preserving distal pancreatectomy (LSPDP) with
or without splenic vessels conservation (Kimura and
Warshaw method), and the safety and feasibility indica-
tions of both methods.
Method: Retrospective study was employed on 20
patients collected between August 2007 and July 2012.
Cases were divided into an LSPDP with splenic vessels
conversion (Kimura) group(n = 12) and an LSPDP
without splenic vessels conversion (Warshaw) group
(n = 8). Parametric and nonparametric statistical analy-
ses were used to compare perioperative and oncologic
outcomes.
Results: Demographic characteristics, length of stay,
transfusion requirement, pathologic diagnosis, and
complication rate were similar between groups. Patients
who underwent Warshaw method tended to have less
operating time and less blood loss. Two out of 8
patients underwent Warshaw method showed perioper-
ative and long-time complications, one for engorgement
of gastric varices and one for splenic infraction.
Conclusions: Although the Warshaw method is accept-
able with a low incidence of complications in this
analysis, Kimura method is a feasible approach for
LSPDP. For the proper cases, Warshaw method may
contribute to spleen perservation.
PPP26-084
TOTAL LAPAROSCOPIC
LONGITUDINAL
PANCREATICOJEJUNOSTOMY IN
CHRONIC PANCREATITIS
M. Sahoo1 and A. Kumar
1S.C.B Medical College, India
Introduction: Chronic pancreatitis (CP), typically asso-
ciated with variable etiology. Ductal decompression
and drainage are the basis for surgical treatment of a
dilated and strictured main pancreatic duct, with or
without calculi.
Method: Twenty two (22) patients with males (n = 9)
and females (n = 13) of age ranging from 18–65 years
of either sex underwent electivelaparoscopic longitudi-
nal pancreaticojejunostomy for chronic pancreatitis ful-
filling the inclusion and exclusion criteria. Alcohol
consumption was seen in 8 patients. Pain was present
in all patients for which they were on analgesics.
Weight loss was present in 12 patients (male = 4,
female = 8). 12 patients were taking pancreatic enzyme
supplements. 8 patients were taking insulin for diabetes
mellitus preoperatively. All patients have undergone
MRCP.
Results: Mean operating time was 247.8 minutes. There
were no conversions, intra operative and major postop-
erative complications. Mean dose of narcotic analgesia
required was 4. Only 2 patients required pancreatic
enzyme supplements postoperatively but in lower doses
than they used to take preoperatively. Insulin require-
ments in those 8 patients were maintained at same
dose. Mean postoperative stay in hospital was 5.2 days.
Mean duration of follow up was 25.5 months. All
patients had excellent pain relief measured by a yes or
no question. 6 out of 8 patients quit alcohol. Mean
weight gain of 6kgs in 6 months was seen in 18
patients. Another two patients developed diabetes
newly during this follow up. Two patients had pain
after 6 months and these two patients continued to
consume alcohol and another patient had pain recur-
rence after 2years and were managed conservatively
and responded well in this follow up.
Conclusions: Laparoscopic longitudinal pancreaticojej-
unostomy is safe, effective and feasible technique for
chronic pancreatitis in selected patients in the presence
of adequately dilated pancreatic duct containing stones
and has favourable outcome in short term followup.
PPP26-085
PANCREATICODUODENECTOMY FOR
PANCREATIC AND PERIAMPULLARY
LESIONS IN THE YOUNG
Y.-M. Shyr and S.-E. Wang
Taipei Veterans General Hospital, Taiwan
Introduction: The purpose of this study was to clarify
surgical outcomes and to assess the biological behavior
of periampullary malignancy after pancreaticoduoden-
ectomy (PD) in the young. PD remains a formidable
challenge to many pancreatic surgeons. There is no lit-
erature report regarding PD in the young.
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Method: Data on patients undergoing PD were
retrieved for study between January, 1997, and Decem-
ber, 2010. Demographics, disease patterns, clinical pre-
sentations, operative findings, surgical risks, tumor
pathologic characteristics, and survival outcomes were
evaluated in the young patients less than 60-years-old
and compared with those in the older population.
Results: There were 585 patients in our study. Of there,
172 were patients 60 years or younger. Higher propor-
tions of female patients were found in the young age
group compared to old in regards to sex distribution.
Young group had more benign tumor compared to the
old, ex. neuroendocrine tumor. The surgical mortality
rates are significant less in the Young group. However,
there was no significant difference in surgical morbidity
and pancreatic leakage. As for the initial presentations,
young group patients are often asymptomatic (4.7%)
when compared to the old (1.5%, p = 0.026) but less
jaundice and GI upset (p = 0.004, p = 0.012).
Conclusions: PD in the young did not carry more sur-
gical morbidity or pancreatic leakage, but had less sur-
gical mortality, as compared to the old. Young group
patients after PD had better 5 year survival in periam-
pullary malignancy and pancreatic head adenocarci-
noma.
PPP26-086
LONG-TERM SURVIVAL AFTER
PANCREATICODUODENECTOMY FOR
PANCREATIC AND PERIAMPULLARY
ADENOCARCINOMAS
Y.-M. Shyr and S.-E. Wang
Taipei Veterans General Hospital, Taiwan
Introduction: This study was to identify predictors for
long-term survival and to compare survivals for pe-
riampullary adenocarcinomas after a pancreaticoduo-
denectomy.
Method: Clinicopathological factors were compared
between short-term (<5 years) and long-term (≥5 years)
survival groups. Both actuarial and actual 5-year sur-
vival, as well as actuarial 10-year survival for those that
survived over 5 years, were determined.
Results: There were 109 (21.8%) long-term survivors.
Most (76%) of the long-term survivors were those with
ampullary adenocarcinoma. Long-term survival was
highest for ampullary adenocarcinoma (32.8%) and
lowest for pancreatic adenocarcinoma (6.5%). Jaun-
dice, tumor size, and lymph node involvement were
found to be independent predictors for long-term sur-
vival. Prognosis was significantly worse for pancreatic
adenocarcinoma, which had an actuarial 5-year survival
of only 6.7%. There was no difference in subsequent
actuarial 5-year survival (actuarial 10-year survival)
between pancreatic adenocarcinoma and other periam-
pullary adenocarcinomas for patients surviving over
5 years after resection. However, there was a difference
in actuarial and actual 5 year survivals.
Conclusions: Jaundice, tumor size, and lymph node
involvement are independent predictors for long-term
survival after pancreaticoduodnectomy. The biological
factors of pancreatic adenocarcinoma no longer play a
role in determining the prognosis for those who survive
to the 5 year landmark.
PPP26-087
EN BLOC SIMULTANEOUS PANCREAS
AND KIDNEY COMPOSITE GRAFT
TRANSPLANT WITH LIMITED
VASCULAR ACCESS
Y.-M. Shyr and S.-E. Wang
Taipei Veterans General Hospital, Taiwan
Introduction: Limited vascular access could be encoun-
tered in an obese or re-transplant patient. We described
modifications that facilitated an en bloc simultaneous
pancreas and kidney (SPK) composite graft transplant
in an obese type 2 diabetic patient with renal failure
under hemodialysis.
Method: At the back-table, the superior mesenteric
artery and splenic artery of the pancreas graft were
reconstructed with a long “Y” iliac artery graft. The
smaller left renal artery is anastomosed end-to-side to
the larger and longer common limb of the arterial Y
graft and the shorter portal vein is anastomosed end-
to-side to the longer graft left renal vein. Thus, this en
bloc composite graft allowed to facilitate “real” SPK
transplant using single common graft artery and vein
for anastomosis to one recipient arterial and venous
site. The en bloc pancreas and kidney composite graft
was implanted by suturing the graft left renal vein to
IVC and graft common iliac artery the recipient distal
aorta. Exocrine drainage was provided by anastomosis
of the graft duodenum to a roux-en-y jejunum limb in
a side-to-side fashion. Immunosuppressants included
basiliximab, tacrolimus, mycophenolate mofetil, and
methylprednisolone.
Results: The operative time was 7 hours with cold
ischemic time of 6 hours and 25 minute. and warm
ischemic time of 47 minutes The patient was discharged
on postoperative day 20, with a serum creatinine level
of 1.4 ng/mL and a blood glucose level of 121 mg/dL.
He has not had any rejection episodes or postoperative
complications in the following 12 months after the en
bloc SPK transplant.
Conclusions: En bloc pancreas and kidney composite
graft might be an option for patients with limited vas-
cular access. This technique (1) facilitates “real” simul-
taneous pancreas and kidney (SPK) transplant with
only single common artery and vein for implanting the
composite graft; (2) minimizes dissection of vessels and
conserves recipient vessels.
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